No., subject, TM-score, RMSD, Sequence Identity, Subject length, Aligned length, Description
1, d4qv0C_, 1.0000, 0.00, 1.000, 240, 240, YCP BETA5-A49T-A50V-DOUBLE MUTANT
2, d4qzzQ_, 0.9999, 0.05, 1.000, 240, 240, YCP IN COMPLEX WITH OMURALIDE
3, d4qzzC_, 0.9999, 0.05, 1.000, 240, 240, YCP IN COMPLEX WITH OMURALIDE
4, d4qv8Q_, 0.9999, 0.05, 1.000, 240, 240, YCP BETA5-C52F MUTANT
5, d4qv8C_, 0.9999, 0.05, 1.000, 240, 240, YCP BETA5-C52F MUTANT
6, d4qv7Q_, 0.9999, 0.05, 1.000, 240, 240, YCP BETA5-A50V MUTANT
7, d4qv7C_, 0.9999, 0.05, 1.000, 240, 240, YCP BETA5-A50V MUTANT
8, d4qv4Q_, 0.9999, 0.05, 1.000, 240, 240, YCP BETA5-M45T MUTANT
9, d4qv4C_, 0.9999, 0.05, 1.000, 240, 240, YCP BETA5-M45T MUTANT
10, d4qv1Q_, 0.9999, 0.05, 1.000, 240, 240, YCP BETA5-M45A MUTANT
11, d4qv1C_, 0.9999, 0.05, 1.000, 240, 240, YCP BETA5-M45A MUTANT
12, d4qv0Q_, 0.9999, 0.00, 1.000, 240, 240, YCP BETA5-A49T-A50V-DOUBLE MUTANT
13, d4quyQ_, 0.9999, 0.05, 1.000, 240, 240, YCP BETA5-A49S-MUTANT
14, d4quyC_, 0.9999, 0.05, 1.000, 240, 240, YCP BETA5-A49S-MUTANT
15, p6gopQ_, 0.9998, 0.07, 1.000, 240, 240, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
16, p6gopC_, 0.9998, 0.07, 1.000, 240, 240, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
17, d5fgaQ_, 0.9998, 0.07, 1.000, 240, 240, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
18, d5fgaC_, 0.9998, 0.07, 1.000, 240, 240, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
19, d5czaQ_, 0.9998, 0.07, 1.000, 240, 240, YEAST 20S PROTEASOME BETA5-D166N MUTANT
20, d5czaC_, 0.9998, 0.07, 1.000, 240, 240, YEAST 20S PROTEASOME BETA5-D166N MUTANT
21, d5bxnQ_, 0.9998, 0.07, 1.000, 240, 240, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
22, d5bxnC_, 0.9998, 0.07, 1.000, 240, 240, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
23, d5bxlC_, 0.9998, 0.08, 1.000, 240, 240, YEAST 20S PROTEASOME BETA2-G170A MUTANT
24, d4y9yQ_, 0.9998, 0.08, 1.000, 240, 240, YEAST 20S PROTEASOME BETA2-H116E MUTANT
25, d4y9yC_, 0.9998, 0.08, 1.000, 240, 240, YEAST 20S PROTEASOME BETA2-H116E MUTANT
26, d4qwuQ_, 0.9998, 0.06, 1.000, 240, 240, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
27, d4qwuC_, 0.9998, 0.06, 1.000, 240, 240, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
28, d4qw1Q_, 0.9998, 0.06, 1.000, 240, 240, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
29, d4qw1C_, 0.9998, 0.06, 1.000, 240, 240, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
30, d4qvnQ_, 0.9998, 0.07, 1.000, 240, 240, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
31, d4qvnC_, 0.9998, 0.07, 1.000, 240, 240, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
32, d4qvlQ_, 0.9998, 0.06, 1.000, 240, 240, YCP IN COMPLEX WITH BORTEZOMIB
33, d4qvlC_, 0.9998, 0.06, 1.000, 240, 240, YCP IN COMPLEX WITH BORTEZOMIB
34, d4qv5Q_, 0.9998, 0.06, 1.000, 240, 240, YCP BETA5-M45I MUTANT
35, d4qv5C_, 0.9998, 0.06, 1.000, 240, 240, YCP BETA5-M45I MUTANT
36, d4qv3Q_, 0.9998, 0.08, 1.000, 240, 240, YCP BETA5-M45V MUTANT
37, d4qv3C_, 0.9998, 0.08, 1.000, 240, 240, YCP BETA5-M45V MUTANT
38, d5fg9Q_, 0.9997, 0.10, 1.000, 240, 240, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
39, d5fg9C_, 0.9997, 0.10, 1.000, 240, 240, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
40, d5fg7Q_, 0.9997, 0.09, 1.000, 240, 240, YEAST 20S PROTEASOME BETA2-T1A MUTANT
41, d5fg7C_, 0.9997, 0.09, 1.000, 240, 240, YEAST 20S PROTEASOME BETA2-T1A MUTANT
42, d5d0wQ_, 0.9997, 0.09, 1.000, 240, 240, YEAST 20S PROTEASOME BETA5-T1S MUTANT
43, d5d0wC_, 0.9997, 0.09, 1.000, 240, 240, YEAST 20S PROTEASOME BETA5-T1S MUTANT
44, d5cgfQ_, 0.9997, 0.10, 1.000, 240, 240, YEAST 20S PROTEASOME BETA5-G48C MUTANT
45, d5cgfC_, 0.9997, 0.10, 1.000, 240, 240, YEAST 20S PROTEASOME BETA5-G48C MUTANT
46, d5bxlQ_, 0.9997, 0.08, 1.000, 240, 240, YEAST 20S PROTEASOME BETA2-G170A MUTANT
47, d4ya4Q_, 0.9997, 0.08, 1.000, 240, 240, YEAST 20S PROTEASOME BETA2-H114D MUTANT
48, d4ya4C_, 0.9997, 0.08, 1.000, 240, 240, YEAST 20S PROTEASOME BETA2-H114D MUTANT
49, d4ya1Q_, 0.9997, 0.09, 1.000, 240, 240, YEAST 20S PROTEASOME BETA2-H116N MUTANT
50, d4ya1C_, 0.9997, 0.09, 1.000, 240, 240, YEAST 20S PROTEASOME BETA2-H116N MUTANT
51, d4y8rQ_, 0.9997, 0.09, 1.000, 240, 240, YEAST 20S PROTEASOME BETA2-H116D MUTANT
52, d4y8rC_, 0.9997, 0.09, 1.000, 240, 240, YEAST 20S PROTEASOME BETA2-H116D MUTANT
53, d4r00Q_, 0.9997, 0.10, 1.000, 240, 240, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
54, d4r00C_, 0.9997, 0.09, 1.000, 240, 240, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
55, d4qvyQ_, 0.9997, 0.09, 1.000, 240, 240, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
56, d4qvyC_, 0.9997, 0.09, 1.000, 240, 240, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
57, d4qvwQ_, 0.9997, 0.09, 1.000, 240, 240, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
58, d4qvwC_, 0.9997, 0.09, 1.000, 240, 240, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
59, d4qvpQ_, 0.9997, 0.09, 1.000, 240, 240, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
60, d4qvpC_, 0.9997, 0.09, 1.000, 240, 240, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
61, d4qv9Q_, 0.9997, 0.10, 1.000, 240, 240, YCP BETA5-C63F MUTANT
62, d4qv9C_, 0.9997, 0.10, 1.000, 240, 240, YCP BETA5-C63F MUTANT
63, d4qv6Q_, 0.9997, 0.09, 1.000, 240, 240, YCP BETA5-A49V MUTANT
64, d4qv6C_, 0.9997, 0.09, 1.000, 240, 240, YCP BETA5-A49V MUTANT
65, d5cz7Q_, 0.9996, 0.10, 1.000, 240, 240, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
66, d5cz7C_, 0.9996, 0.10, 1.000, 240, 240, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
67, d5cz6Q_, 0.9996, 0.11, 1.000, 240, 240, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
68, d5cz6C_, 0.9996, 0.11, 1.000, 240, 240, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
69, d4z1lQ_, 0.9996, 0.10, 1.000, 240, 240, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
70, d4z1lC_, 0.9996, 0.10, 1.000, 240, 240, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
71, d4y8mQ_, 0.9996, 0.11, 1.000, 240, 240, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
72, d4y8mC_, 0.9996, 0.11, 1.000, 240, 240, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
73, d4quxQ_, 0.9996, 0.10, 1.000, 240, 240, YCP BETA5-A49T-MUTANT
74, d4quxC_, 0.9996, 0.10, 1.000, 240, 240, YCP BETA5-A49T-MUTANT
75, d5l6bQ_, 0.9995, 0.13, 1.000, 240, 240, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
76, d5l5uQ_, 0.9995, 0.12, 1.000, 240, 240, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
77, d5l5uC_, 0.9995, 0.12, 1.000, 240, 240, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
78, d5l5rQ_, 0.9995, 0.12, 1.000, 240, 240, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
79, d5l5rC_, 0.9995, 0.12, 1.000, 240, 240, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
80, d5l5bQ_, 0.9995, 0.12, 1.000, 240, 240, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
81, d5l5bC_, 0.9995, 0.12, 1.000, 240, 240, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
82, d5dkjQ_, 0.9995, 0.12, 1.000, 240, 240, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
83, d5dkjC_, 0.9995, 0.12, 1.000, 240, 240, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
84, d5d0tQ_, 0.9995, 0.12, 1.000, 240, 240, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
85, d5d0tC_, 0.9995, 0.12, 1.000, 240, 240, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
86, d4qvqQ_, 0.9995, 0.12, 1.000, 240, 240, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
87, d4qvqC_, 0.9995, 0.12, 1.000, 240, 240, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
88, d5lttQ_, 0.9994, 0.14, 1.000, 240, 240, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
89, d5lttC_, 0.9994, 0.14, 1.000, 240, 240, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
90, d5l6bC_, 0.9994, 0.13, 1.000, 240, 240, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
91, d5l6aQ_, 0.9994, 0.13, 1.000, 240, 240, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
92, d5l6aC_, 0.9994, 0.13, 1.000, 240, 240, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
93, d5l65Q_, 0.9994, 0.13, 1.000, 240, 240, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
94, d5l65C_, 0.9994, 0.13, 1.000, 240, 240, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
95, d5l5zQ_, 0.9994, 0.14, 1.000, 240, 240, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
96, d5l5zC_, 0.9994, 0.14, 1.000, 240, 240, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
97, d5l5xQ_, 0.9994, 0.14, 1.000, 240, 240, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
98, d5l5xC_, 0.9994, 0.14, 1.000, 240, 240, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
99, d5l5wQ_, 0.9994, 0.13, 1.000, 240, 240, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
100, d5l5wC_, 0.9994, 0.13, 1.000, 240, 240, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
101, d5l5hQ_, 0.9994, 0.14, 1.000, 240, 240, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
102, d5l5hC_, 0.9994, 0.14, 1.000, 240, 240, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
103, d5l5fQ_, 0.9994, 0.13, 1.000, 240, 240, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
104, d5l5fC_, 0.9994, 0.13, 1.000, 240, 240, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
105, d5l5aQ_, 0.9994, 0.13, 1.000, 240, 240, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
106, d5l5aC_, 0.9994, 0.13, 1.000, 240, 240, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
107, d5d0xQ_, 0.9994, 0.13, 1.000, 240, 240, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
108, d5d0xC_, 0.9994, 0.13, 1.000, 240, 240, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
109, d4qw0Q_, 0.9994, 0.14, 1.000, 240, 240, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
110, d4qw0C_, 0.9994, 0.14, 1.000, 240, 240, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
111, d5l6cQ_, 0.9993, 0.15, 1.000, 240, 240, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
112, d5l6cC_, 0.9993, 0.15, 1.000, 240, 240, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
113, d5l67Q_, 0.9993, 0.14, 1.000, 240, 240, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
114, d5l67C_, 0.9993, 0.14, 1.000, 240, 240, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
115, d5l66Q_, 0.9993, 0.15, 1.000, 240, 240, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
116, d5l66C_, 0.9993, 0.15, 1.000, 240, 240, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
117, d5l64Q_, 0.9993, 0.14, 1.000, 240, 240, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
118, d5l64C_, 0.9993, 0.14, 1.000, 240, 240, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
119, d5l63Q_, 0.9993, 0.14, 1.000, 240, 240, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
120, d5l63C_, 0.9993, 0.14, 1.000, 240, 240, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
121, d5l62Q_, 0.9993, 0.15, 1.000, 240, 240, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
122, d5l62C_, 0.9993, 0.15, 1.000, 240, 240, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
123, d5l61Q_, 0.9993, 0.15, 1.000, 240, 240, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
124, d5l61C_, 0.9993, 0.15, 1.000, 240, 240, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
125, d5l5sQ_, 0.9993, 0.15, 1.000, 240, 240, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
126, d5l5sC_, 0.9993, 0.15, 1.000, 240, 240, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
127, d5l5pQ_, 0.9993, 0.15, 1.000, 240, 240, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
128, d5l5pC_, 0.9993, 0.15, 1.000, 240, 240, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
129, d5l5eQ_, 0.9993, 0.14, 1.000, 240, 240, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
130, d5l5eC_, 0.9993, 0.14, 1.000, 240, 240, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
131, d5l5dQ_, 0.9993, 0.14, 1.000, 240, 240, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
132, d5l5dC_, 0.9993, 0.14, 1.000, 240, 240, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
133, d5d0vQ_, 0.9993, 0.15, 1.000, 240, 240, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
134, d5d0vC_, 0.9993, 0.15, 1.000, 240, 240, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
135, p5cghQ_, 0.9993, 0.15, 1.000, 240, 240, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
136, p5cghC_, 0.9993, 0.15, 1.000, 240, 240, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
137, p4y8uQ_, 0.9993, 0.14, 1.000, 240, 240, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
138, p4y8uC_, 0.9993, 0.14, 1.000, 240, 240, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
139, p4y6vQ_, 0.9993, 0.15, 1.000, 240, 240, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
140, p4y6vC_, 0.9993, 0.15, 1.000, 240, 240, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
141, p4y69Q_, 0.9993, 0.15, 1.000, 240, 240, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
142, p4y69C_, 0.9993, 0.15, 1.000, 240, 240, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
143, d4rurQ_, 0.9993, 0.15, 1.000, 240, 240, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
144, d4rurC_, 0.9993, 0.15, 1.000, 240, 240, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
145, d4qz4Q_, 0.9993, 0.14, 1.000, 240, 240, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
146, d4qz4C_, 0.9993, 0.14, 1.000, 240, 240, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
147, d4qwxQ_, 0.9993, 0.15, 1.000, 240, 240, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
148, d4qwxC_, 0.9993, 0.15, 1.000, 240, 240, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
149, d4qvmQ_, 0.9993, 0.15, 1.000, 240, 240, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
150, d4qvmC_, 0.9993, 0.15, 1.000, 240, 240, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
151, d5m2bQ_, 0.9992, 0.16, 1.000, 240, 240, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
152, d5l5yQ_, 0.9992, 0.16, 1.000, 240, 240, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
153, d5l5yC_, 0.9992, 0.16, 1.000, 240, 240, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
154, d5l5tQ_, 0.9992, 0.16, 1.000, 240, 240, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
155, d5l5tC_, 0.9992, 0.16, 1.000, 240, 240, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
156, d5l5qQ_, 0.9992, 0.16, 1.000, 240, 240, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
157, d5l5qC_, 0.9992, 0.16, 1.000, 240, 240, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
158, d5l5oQ_, 0.9992, 0.16, 1.000, 240, 240, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
159, d5l5oC_, 0.9992, 0.16, 1.000, 240, 240, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
160, d5l5iQ_, 0.9992, 0.16, 1.000, 240, 240, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
161, d5l5iC_, 0.9992, 0.16, 1.000, 240, 240, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
162, d5jhrQ_, 0.9992, 0.16, 1.000, 240, 240, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
163, d5jhrC_, 0.9992, 0.16, 1.000, 240, 240, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
164, p5fghQ_, 0.9992, 0.16, 1.000, 240, 240, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
165, p5fghC_, 0.9992, 0.16, 1.000, 240, 240, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
166, p5cggQ_, 0.9992, 0.16, 1.000, 240, 240, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
167, p5cggC_, 0.9992, 0.16, 1.000, 240, 240, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
168, d5bouQ_, 0.9992, 0.15, 1.000, 240, 240, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
169, d5bouC_, 0.9992, 0.15, 1.000, 240, 240, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
170, p4ya9Q_, 0.9992, 0.15, 1.000, 240, 240, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
171, p4ya9C_, 0.9992, 0.15, 1.000, 240, 240, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
172, p4ya7Q_, 0.9992, 0.16, 1.000, 240, 240, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
173, p4ya7C_, 0.9992, 0.16, 1.000, 240, 240, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
174, p4y9zQ_, 0.9992, 0.16, 1.000, 240, 240, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
175, p4y9zC_, 0.9992, 0.16, 1.000, 240, 240, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
176, p4y8pQ_, 0.9992, 0.16, 1.000, 240, 240, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
177, p4y8pC_, 0.9992, 0.16, 1.000, 240, 240, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
178, p4y8nQ_, 0.9992, 0.16, 1.000, 240, 240, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
179, p4y8nC_, 0.9992, 0.16, 1.000, 240, 240, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
180, p4y77Q_, 0.9992, 0.16, 1.000, 240, 240, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
181, p4y77C_, 0.9992, 0.16, 1.000, 240, 240, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
182, p4y75Q_, 0.9992, 0.16, 1.000, 240, 240, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
183, p4y75C_, 0.9992, 0.16, 1.000, 240, 240, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
184, d4qz6Q_, 0.9992, 0.16, 1.000, 240, 240, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
185, d4qz6C_, 0.9992, 0.16, 1.000, 240, 240, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
186, d4qz5Q_, 0.9992, 0.16, 1.000, 240, 240, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
187, d4qz5C_, 0.9992, 0.16, 1.000, 240, 240, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
188, d4qz3Q_, 0.9992, 0.16, 1.000, 240, 240, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
189, d4qz3C_, 0.9992, 0.16, 1.000, 240, 240, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
190, d4qz0Q_, 0.9992, 0.16, 1.000, 240, 240, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
191, d4qz0C_, 0.9992, 0.16, 1.000, 240, 240, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
192, d4qwfQ_, 0.9992, 0.16, 1.000, 240, 240, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
193, d4qwfC_, 0.9992, 0.16, 1.000, 240, 240, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
194, d4qw6Q_, 0.9992, 0.16, 1.000, 240, 240, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
195, d4qw6C_, 0.9992, 0.16, 1.000, 240, 240, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
196, d4qvvQ_, 0.9992, 0.16, 1.000, 240, 240, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
197, d4qvvC_, 0.9992, 0.16, 1.000, 240, 240, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
198, d5m2bC_, 0.9991, 0.16, 1.000, 240, 240, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
199, d5l68Q_, 0.9991, 0.17, 1.000, 240, 240, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
200, d5l68C_, 0.9991, 0.17, 1.000, 240, 240, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
201, d5l60Q_, 0.9991, 0.16, 1.000, 240, 240, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
202, d5l60C_, 0.9991, 0.16, 1.000, 240, 240, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
203, d5l5vQ_, 0.9991, 0.17, 1.000, 240, 240,  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
204, d5l5vC_, 0.9991, 0.17, 1.000, 240, 240,  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
205, d5l5jQ_, 0.9991, 0.17, 1.000, 240, 240, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
206, d5l5jC_, 0.9991, 0.17, 1.000, 240, 240, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
207, d5l55Q_, 0.9991, 0.17, 1.000, 240, 240, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
208, d5l55C_, 0.9991, 0.17, 1.000, 240, 240, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
209, d5l52Q_, 0.9991, 0.17, 1.000, 240, 240, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
210, d5l52C_, 0.9991, 0.17, 1.000, 240, 240, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
211, d5fggQ_, 0.9991, 0.17, 1.000, 240, 240, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
212, d5fggC_, 0.9991, 0.17, 1.000, 240, 240, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
213, d5dkiQ_, 0.9991, 0.17, 1.000, 240, 240, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
214, d5dkiC_, 0.9991, 0.17, 1.000, 240, 240, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
215, p5cgiQ_, 0.9991, 0.17, 1.000, 240, 240, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
216, p5cgiC_, 0.9991, 0.17, 1.000, 240, 240, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
217, d5ahjQ_, 0.9991, 0.17, 1.000, 240, 240, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
218, d5ahjC_, 0.9991, 0.17, 1.000, 240, 240, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
219, p4ya5Q_, 0.9991, 0.17, 1.000, 240, 240, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
220, p4ya5C_, 0.9991, 0.17, 1.000, 240, 240, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
221, p4y6aQ_, 0.9991, 0.16, 1.000, 240, 240, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
222, p4y6aC_, 0.9991, 0.16, 1.000, 240, 240, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
223, d4qwlQ_, 0.9991, 0.17, 1.000, 240, 240, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
224, d4qwlC_, 0.9991, 0.17, 1.000, 240, 240, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
225, d4qw7Q_, 0.9991, 0.17, 1.000, 240, 240, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
226, d4qw7C_, 0.9991, 0.17, 1.000, 240, 240, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
227, d4qw5Q_, 0.9991, 0.17, 1.000, 240, 240, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
228, d4qw5C_, 0.9991, 0.17, 1.000, 240, 240, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
229, d4qw4Q_, 0.9991, 0.17, 1.000, 240, 240, YCP IN COMPLEX WITH CARFILZOMIB
230, d4qw4C_, 0.9991, 0.17, 1.000, 240, 240, YCP IN COMPLEX WITH CARFILZOMIB
231, d4nnnQ_, 0.9991, 0.17, 1.000, 240, 240, YCP IN COMPLEX WITH MG132
232, d4nnnC_, 0.9991, 0.17, 1.000, 240, 240, YCP IN COMPLEX WITH MG132
233, d5jhsQ_, 0.9990, 0.18, 1.000, 240, 240, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
234, d5jhsC_, 0.9990, 0.18, 1.000, 240, 240, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
235, d5d0zQ_, 0.9990, 0.18, 1.000, 240, 240, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
236, d5d0zC_, 0.9990, 0.18, 1.000, 240, 240, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
237, d5cz9Q_, 0.9990, 0.18, 1.000, 240, 240, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
238, d5cz9C_, 0.9990, 0.18, 1.000, 240, 240, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
239, d5cz4Q_, 0.9990, 0.18, 1.000, 240, 240, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
240, d5cz4C_, 0.9990, 0.18, 1.000, 240, 240, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
241, p4y8lC_, 0.9990, 0.18, 1.000, 240, 240, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
242, p4y8jQ_, 0.9990, 0.18, 1.000, 240, 240, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
243, p4y8jC_, 0.9990, 0.18, 1.000, 240, 240, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
244, p4y70C_, 0.9990, 0.18, 1.000, 240, 240, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
245, d4qzwQ_, 0.9990, 0.17, 1.000, 240, 240, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
246, d4qzwC_, 0.9990, 0.17, 1.000, 240, 240, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
247, d4qz2Q_, 0.9990, 0.18, 1.000, 240, 240, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
248, d4qz2C_, 0.9990, 0.18, 1.000, 240, 240, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
249, d5l69Q_, 0.9989, 0.18, 1.000, 240, 240, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
250, d5l69C_, 0.9989, 0.18, 1.000, 240, 240, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
251, d5d0sQ_, 0.9989, 0.18, 1.000, 240, 240, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
252, d5d0sC_, 0.9989, 0.18, 1.000, 240, 240, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
253, p4ya3Q_, 0.9989, 0.19, 1.000, 240, 240, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
254, p4ya3C_, 0.9989, 0.19, 1.000, 240, 240, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
255, p4y8tQ_, 0.9989, 0.19, 1.000, 240, 240, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
256, p4y8tC_, 0.9989, 0.19, 1.000, 240, 240, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
257, p4y8sQ_, 0.9989, 0.19, 1.000, 240, 240, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
258, p4y8sC_, 0.9989, 0.19, 1.000, 240, 240, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
259, p4y8lQ_, 0.9989, 0.18, 1.000, 240, 240, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
260, p4y8kQ_, 0.9989, 0.19, 1.000, 240, 240, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
261, p4y8kC_, 0.9989, 0.19, 1.000, 240, 240, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
262, p4y8iQ_, 0.9989, 0.19, 1.000, 240, 240, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
263, p4y8iC_, 0.9989, 0.19, 1.000, 240, 240, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
264, p4y82Q_, 0.9989, 0.18, 1.000, 240, 240, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
265, p4y82C_, 0.9989, 0.18, 1.000, 240, 240, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
266, p4y7wQ_, 0.9989, 0.19, 1.000, 240, 240, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
267, p4y7wC_, 0.9989, 0.19, 1.000, 240, 240, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
268, p4y74Q_, 0.9989, 0.19, 1.000, 240, 240, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
269, p4y74C_, 0.9989, 0.19, 1.000, 240, 240, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
270, p4y70Q_, 0.9989, 0.18, 1.000, 240, 240, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
271, d4r17Q_, 0.9989, 0.18, 1.000, 240, 240, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
272, d4r17C_, 0.9989, 0.18, 1.000, 240, 240, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
273, d4qz7Q_, 0.9989, 0.18, 1.000, 240, 240, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
274, d4qz7C_, 0.9989, 0.18, 1.000, 240, 240, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
275, d5lajQ_, 0.9988, 0.19, 1.000, 240, 240, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
276, d5lajC_, 0.9988, 0.19, 1.000, 240, 240, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
277, d5fgfQ_, 0.9988, 0.19, 1.000, 240, 240, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
278, d5fgfC_, 0.9988, 0.19, 1.000, 240, 240, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
279, d5fgeQ_, 0.9988, 0.19, 1.000, 240, 240, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
280, d5fgeC_, 0.9988, 0.19, 1.000, 240, 240, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
281, p4ya0Q_, 0.9988, 0.20, 1.000, 240, 240, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
282, p4ya0C_, 0.9988, 0.20, 1.000, 240, 240, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
283, p4y8qQ_, 0.9988, 0.19, 1.000, 240, 240, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
284, p4y8qC_, 0.9988, 0.19, 1.000, 240, 240, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
285, p4y8oQ_, 0.9988, 0.20, 1.000, 240, 240, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
286, p4y8oC_, 0.9988, 0.20, 1.000, 240, 240, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
287, p4y80Q_, 0.9988, 0.19, 1.000, 240, 240, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
288, p4y80C_, 0.9988, 0.19, 1.000, 240, 240, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
289, p4y7yQ_, 0.9988, 0.19, 1.000, 240, 240, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
290, p4y7yC_, 0.9988, 0.19, 1.000, 240, 240, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
291, d4r18Q_, 0.9988, 0.20, 1.000, 240, 240, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
292, d4r18C_, 0.9988, 0.20, 1.000, 240, 240, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
293, d4qz1Q_, 0.9988, 0.19, 1.000, 240, 240, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
294, d4qz1C_, 0.9988, 0.19, 1.000, 240, 240, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
295, d4qxjC_, 0.9988, 0.20, 1.000, 240, 240, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
296, d4qwrQ_, 0.9988, 0.19, 1.000, 240, 240, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
297, d4qwrC_, 0.9988, 0.19, 1.000, 240, 240, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
298, d4qwiQ_, 0.9988, 0.20, 1.000, 240, 240, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
299, d4qwiC_, 0.9988, 0.20, 1.000, 240, 240, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
300, d5fhsQ_, 0.9987, 0.21, 1.000, 240, 240, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
301, d5fhsC_, 0.9987, 0.21, 1.000, 240, 240, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
302, d5fgiC_, 0.9987, 0.21, 1.000, 240, 240, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
303, d5fgdQ_, 0.9987, 0.21, 1.000, 240, 240, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
304, d5fgdC_, 0.9987, 0.21, 1.000, 240, 240, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
305, p4y81Q_, 0.9987, 0.20, 1.000, 240, 240, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
306, p4y81C_, 0.9987, 0.20, 1.000, 240, 240, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
307, p4y7xQ_, 0.9987, 0.20, 1.000, 240, 240, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
308, p4y7xC_, 0.9987, 0.20, 1.000, 240, 240, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
309, d4qxjQ_, 0.9987, 0.20, 1.000, 240, 240, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
310, d4qw3Q_, 0.9987, 0.21, 1.000, 240, 240, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
311, d4qw3C_, 0.9987, 0.21, 1.000, 240, 240, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
312, d5laiQ_, 0.9986, 0.21, 1.000, 240, 240, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
313, d5laiC_, 0.9986, 0.21, 1.000, 240, 240, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
314, d5fgiQ_, 0.9986, 0.21, 1.000, 240, 240, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
315, d5cz8Q_, 0.9986, 0.21, 1.000, 240, 240, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
316, d5cz8C_, 0.9986, 0.21, 1.000, 240, 240, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
317, d5cz5Q_, 0.9986, 0.21, 1.000, 240, 240, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
318, d5cz5C_, 0.9986, 0.21, 1.000, 240, 240, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
319, d4qzxQ_, 0.9986, 0.21, 1.000, 240, 240, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
320, d4qzxC_, 0.9986, 0.21, 1.000, 240, 240, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
321, d4qwkQ_, 0.9986, 0.21, 1.000, 240, 240, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
322, d4qwkC_, 0.9986, 0.21, 1.000, 240, 240, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
323, d4no8Q_, 0.9986, 0.21, 1.000, 240, 240, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
324, d4no8C_, 0.9986, 0.21, 1.000, 240, 240, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
325, d4no1Q_, 0.9986, 0.21, 1.000, 240, 240, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
326, d4no1C_, 0.9986, 0.21, 1.000, 240, 240, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
327, p4ya2Q_, 0.9985, 0.22, 1.000, 240, 240, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
328, p4ya2C_, 0.9985, 0.22, 1.000, 240, 240, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
329, p4y78Q_, 0.9985, 0.22, 1.000, 240, 240, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP
330, p4y78C_, 0.9985, 0.22, 1.000, 240, 240, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP
331, p4y6zQ_, 0.9985, 0.22, 1.000, 240, 240, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
332, p4y6zC_, 0.9985, 0.22, 1.000, 240, 240, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
333, d4qwjQ_, 0.9985, 0.22, 1.000, 240, 240, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
334, d4qwjC_, 0.9985, 0.22, 1.000, 240, 240, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
335, d4qlsC_, 0.9984, 0.23, 1.000, 240, 240, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
336, p4y8gQ_, 0.9983, 0.24, 1.000, 240, 240, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
337, p4y8gC_, 0.9983, 0.23, 1.000, 240, 240, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
338, d4qltQ_, 0.9983, 0.24, 1.000, 240, 240, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
339, d4qltC_, 0.9983, 0.24, 1.000, 240, 240, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
340, d4qlsQ_, 0.9983, 0.23, 1.000, 240, 240, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
341, d4qlqQ_, 0.9983, 0.24, 1.000, 240, 240, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
342, d4qlqC_, 0.9983, 0.24, 1.000, 240, 240, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
343, d5l54Q_, 0.9982, 0.24, 1.000, 240, 240, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
344, d5l54C_, 0.9982, 0.24, 1.000, 240, 240, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
345, d4no6Q_, 0.9982, 0.24, 1.000, 240, 240, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
346, d4no6C_, 0.9982, 0.24, 1.000, 240, 240, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
347, p4y8hQ_, 0.9981, 0.25, 1.000, 240, 240, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
348, p4y8hC_, 0.9981, 0.25, 1.000, 240, 240, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
349, p4y84Q_, 0.9981, 0.25, 1.000, 240, 240, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
350, p4y84C_, 0.9981, 0.25, 1.000, 240, 240, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
351, d4qwsQ_, 0.9981, 0.25, 1.000, 240, 240, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
352, d4qwsC_, 0.9981, 0.25, 1.000, 240, 240, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
353, d4qlvQ_, 0.9978, 0.27, 1.000, 240, 240, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
354, d4qlvC_, 0.9978, 0.27, 1.000, 240, 240, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
355, d4no9C_, 0.9978, 0.27, 1.000, 240, 240, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
356, d4qwgQ_, 0.9977, 0.27, 1.000, 240, 240, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
357, d4qwgC_, 0.9977, 0.27, 1.000, 240, 240, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
358, d4no9Q_, 0.9977, 0.27, 1.000, 240, 240, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
359, d4r02Q_, 0.9976, 0.28, 1.000, 240, 240, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
360, d4nnwQ_, 0.9976, 0.28, 1.000, 240, 240, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
361, d4nnwC_, 0.9976, 0.28, 1.000, 240, 240, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
362, d4r02C_, 0.9975, 0.29, 1.000, 240, 240, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
363, d4qluQ_, 0.9975, 0.29, 1.000, 240, 240, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
364, d4qluC_, 0.9975, 0.29, 1.000, 240, 240, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
365, p4qbyQ_, 0.9969, 0.33, 1.000, 240, 240, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
366, p4qbyC_, 0.9969, 0.33, 1.000, 240, 240, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
367, d4j70C_, 0.9961, 0.36, 0.996, 241, 240, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
368, d4j70Q_, 0.9960, 0.37, 0.996, 241, 240, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
369, d3sdkC_, 0.9960, 0.36, 1.000, 241, 240, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
370, d3oeuC_, 0.9958, 0.38, 1.000, 241, 240, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
371, d4q1sC_, 0.9957, 0.38, 0.996, 241, 240, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
372, d4ltcC_, 0.9957, 0.39, 1.000, 241, 240, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
373, d3mg4C_, 0.9957, 0.38, 1.000, 241, 240, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
374, d4fzcQ_, 0.9956, 0.39, 0.996, 241, 240, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
375, d4fzcC_, 0.9956, 0.39, 0.996, 241, 240, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
376, d3mg8C_, 0.9956, 0.39, 1.000, 241, 240, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
377, d3mg7C_, 0.9956, 0.38, 1.000, 241, 240, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
378, d4hrcC_, 0.9955, 0.39, 0.996, 241, 240, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
379, d4hnpC_, 0.9955, 0.39, 1.000, 241, 240, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
380, d3oevC_, 0.9955, 0.39, 1.000, 241, 240, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
381, d3mg0C_, 0.9955, 0.39, 0.996, 241, 240, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
382, d4ltcQ_, 0.9954, 0.40, 1.000, 241, 240, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
383, d4lqiQ_, 0.9954, 0.40, 0.996, 241, 240, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
384, d4lqiC_, 0.9954, 0.40, 0.996, 241, 240, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
385, d4jsuQ_, 0.9953, 0.41, 0.996, 241, 240, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
386, d4jsuC_, 0.9953, 0.41, 0.996, 241, 240, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
387, d4hrdC_, 0.9953, 0.41, 1.000, 241, 240, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
388, p4gk7Q_, 0.9953, 0.41, 0.996, 241, 240, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
389, p4gk7C_, 0.9953, 0.40, 0.996, 241, 240, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
390, d4eu2D_, 0.9953, 0.41, 0.996, 241, 240, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
391, d4fzgC_, 0.9952, 0.41, 0.996, 241, 240, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
392, d3mg6C_, 0.9952, 0.40, 1.000, 241, 240, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
393, d3hyeC_, 0.9952, 0.41, 0.996, 241, 240, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
394, d4jt0Q_, 0.9951, 0.42, 0.996, 241, 240, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
395, d4jt0C_, 0.9951, 0.42, 0.996, 241, 240, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
396, d4jsqQ_, 0.9951, 0.42, 0.996, 241, 240, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
397, d4jsqC_, 0.9951, 0.42, 0.996, 241, 240, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
398, d4fzgQ_, 0.9951, 0.41, 0.996, 241, 240, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
399, p3un4Q_, 0.9951, 0.42, 0.996, 241, 240, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
400, p3un4C_, 0.9951, 0.42, 0.996, 241, 240, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
401, d3tddQ_, 0.9951, 0.42, 0.996, 241, 240, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
402, d3tddC_, 0.9951, 0.42, 0.996, 241, 240, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
403, d3shjQ_, 0.9951, 0.42, 0.996, 241, 240, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
404, d3shjC_, 0.9951, 0.41, 0.996, 241, 240, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
405, d3mg0Q_, 0.9951, 0.41, 0.996, 241, 240, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
406, d3hyeQ_, 0.9951, 0.42, 0.996, 241, 240, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
407, d3gptQ_, 0.9951, 0.42, 0.996, 241, 240, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
408, d3gptC_, 0.9951, 0.42, 0.996, 241, 240, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
409, d4hrdQ_, 0.9950, 0.42, 1.000, 241, 240, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
410, d3nzwQ_, 0.9950, 0.42, 0.996, 241, 240, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
411, d3nzwC_, 0.9950, 0.42, 0.996, 241, 240, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
412, d3nzjQ_, 0.9950, 0.42, 0.996, 241, 240, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
413, d3nzjC_, 0.9950, 0.42, 0.996, 241, 240, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
414, d3gpwQ_, 0.9950, 0.42, 0.996, 241, 240, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
415, d3gpwC_, 0.9950, 0.42, 0.996, 241, 240, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
416, d3e47C_, 0.9950, 0.42, 0.996, 241, 240, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
417, d2fnyC_, 0.9950, 0.42, 0.996, 241, 240,  
418, d4intQ_, 0.9949, 0.42, 0.996, 241, 240, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
419, d4intC_, 0.9949, 0.42, 0.996, 241, 240, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
420, d4inrC_, 0.9949, 0.43, 0.996, 241, 240, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
421, d3un8C_, 0.9949, 0.42, 0.996, 241, 240, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
422, d3nzxQ_, 0.9949, 0.43, 0.996, 241, 240, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
423, d3nzxC_, 0.9949, 0.42, 0.996, 241, 240, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
424, d3e47Q_, 0.9949, 0.42, 0.996, 241, 240, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
425, d2fnyQ_, 0.9949, 0.42, 0.996, 241, 240,  
426, d2fakQ_, 0.9949, 0.43, 0.996, 241, 240, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
427, d2fakC_, 0.9949, 0.42, 0.996, 241, 240, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
428, p4x6zD_, 0.9948, 0.43, 0.996, 241, 240, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
429, d4inuC_, 0.9948, 0.43, 0.996, 241, 240, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
430, d3un8Q_, 0.9948, 0.43, 0.996, 241, 240, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
431, d2f16C_, 0.9948, 0.43, 0.996, 241, 240, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
432, d4inuQ_, 0.9947, 0.43, 0.996, 241, 240, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
433, d4inrQ_, 0.9947, 0.43, 0.996, 241, 240, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
434, d2gplC_, 0.9947, 0.43, 0.996, 241, 240, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
435, d2f16Q_, 0.9947, 0.43, 0.996, 241, 240, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
436, d3okjQ_, 0.9946, 0.44, 0.996, 241, 240, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
437, d3okjC_, 0.9946, 0.44, 0.996, 241, 240, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
438, d3dy4Q_, 0.9946, 0.44, 0.996, 241, 240, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
439, d3dy4C_, 0.9946, 0.44, 0.996, 241, 240, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
440, d3dy3Q_, 0.9946, 0.44, 0.996, 241, 240, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
441, d3dy3C_, 0.9946, 0.44, 0.996, 241, 240, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
442, d2gplQ_, 0.9946, 0.44, 0.996, 241, 240, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
443, p4x6zR_, 0.9945, 0.44, 1.000, 241, 240, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
444, d3gpjQ_, 0.9943, 0.45, 0.996, 241, 240, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
445, d3gpjC_, 0.9943, 0.45, 0.996, 241, 240, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
446, d2zcyQ_, 0.9943, 0.45, 0.996, 241, 240, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
447, d2zcyC_, 0.9943, 0.45, 0.996, 241, 240, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
448, d4q1sQ_, 0.9942, 0.47, 1.000, 241, 240, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
449, d4hrcQ_, 0.9942, 0.45, 0.996, 241, 240, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
450, p5nifR_, 0.9941, 0.46, 1.000, 241, 240, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
451, p4zzgR_, 0.9940, 0.46, 1.000, 241, 240, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
452, d4hnpQ_, 0.9940, 0.46, 1.000, 241, 240, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
453, d3bdmQ_, 0.9940, 0.46, 0.996, 241, 240, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
454, d3bdmC_, 0.9940, 0.46, 0.996, 241, 240, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
455, p5nifD_, 0.9935, 0.48, 1.000, 241, 240, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
456, d4eu2R_, 0.9934, 0.48, 0.996, 241, 240, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
457, d3oevQ_, 0.9932, 0.49, 1.000, 241, 240, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
458, p4zzgD_, 0.9931, 0.49, 1.000, 241, 240, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
459, d3mg8Q_, 0.9931, 0.49, 1.000, 241, 240, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
460, d3wxrD_, 0.9930, 0.50, 1.000, 241, 240, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
461, d3sdkQ_, 0.9929, 0.50, 1.000, 241, 240, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
462, d3mg4Q_, 0.9928, 0.51, 1.000, 241, 240, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
463, d1rypD_, 0.9924, 0.52, 0.996, 241, 240, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
464, d1rypR_, 0.9921, 0.53, 0.996, 241, 240, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
465, d3oeuQ_, 0.9919, 0.54, 1.000, 241, 240, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
466, d3mg6Q_, 0.9917, 0.55, 1.000, 241, 240, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
467, d3mg7Q_, 0.9904, 0.60, 1.000, 241, 240, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
468, d3wxrR_, 0.9903, 0.68, 1.000, 241, 240, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
469, d1jd2C_, 0.9896, 0.61, 0.996, 241, 240, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
470, d1g65C_, 0.9895, 0.64, 0.996, 241, 240, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
471, d1g65Q_, 0.9892, 0.65, 0.996, 241, 240, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
472, d1jd2X_, 0.9890, 0.63, 0.996, 241, 240, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
473, p5mp9d_, 0.9864, 0.68, 1.000, 240, 240, 26S PROTEASOME IN PRESENCE OF ATP (S1)
474, p3jcpMA_, 0.9851, 0.72, 0.996, 241, 240, 
475, p3jcpM_, 0.9851, 0.72, 0.996, 241, 240, 
476, p5mpad_, 0.9844, 0.73, 1.000, 240, 240, 26S PROTEASOME IN PRESENCE OF ATP (S2)
477, p5mp9D_, 0.9820, 0.80, 1.000, 240, 240, 26S PROTEASOME IN PRESENCE OF ATP (S1)
478, d3sdiC_, 0.9814, 0.47, 0.996, 238, 237, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
479, p3jcoMA_, 0.9801, 0.83, 0.996, 241, 240, 
480, p3jcoM_, 0.9801, 0.83, 0.996, 241, 240, 
481, d1g0uC_, 0.9797, 0.54, 0.996, 238, 237, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
482, d3sdiQ_, 0.9794, 0.55, 0.996, 238, 237, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
483, d1g0uQ_, 0.9791, 0.56, 0.996, 238, 237, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
484, p5wvkR_, 0.9704, 1.02, 1.000, 241, 240, 
485, p5mpaD_, 0.9703, 1.09, 1.000, 240, 240, 26S PROTEASOME IN PRESENCE OF ATP (S2)
486, d3d29Q2, 0.9700, 0.43, 1.000, 234, 234, PROTEASOME INHIBITION BY FELLUTAMIDE B
487, d3d29C2, 0.9700, 0.43, 1.000, 234, 234, PROTEASOME INHIBITION BY FELLUTAMIDE B
488, p5wvkY_, 0.9697, 1.05, 1.000, 241, 240, 
489, d4cr2D_, 0.9638, 1.15, 1.000, 242, 240, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
490, p5a5bD_, 0.9625, 1.17, 1.000, 242, 240, STRUCTURE OF THE 26S PROTEASOME-UBP6 COMPLEX
491, p4cr3D_, 0.9625, 1.17, 1.000, 242, 240, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
492, p4cr4D_, 0.9570, 1.34, 1.000, 242, 240, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
493, d1z7qR1, 0.9558, 1.30, 1.000, 241, 237, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
494, d1z7qD1, 0.9558, 1.30, 1.000, 241, 237, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
495, p3unes_, 0.9547, 1.21, 0.591, 239, 237, MOUSE CONSTITUTIVE 20S PROTEASOME
496, p3uneC_, 0.9541, 1.21, 0.591, 239, 237, MOUSE CONSTITUTIVE 20S PROTEASOME
497, p3unbs_, 0.9539, 1.24, 0.586, 239, 237, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
498, p3unbQ_, 0.9539, 1.23, 0.586, 239, 237, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
499, d3unfQ_, 0.9536, 1.24, 0.595, 238, 237, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
500, d3unfC_, 0.9536, 1.24, 0.595, 238, 237, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
501, p3unhQ_, 0.9534, 1.24, 0.595, 238, 237, MOUSE 20S IMMUNOPROTEASOME
502, p3unhC_, 0.9534, 1.24, 0.595, 238, 237, MOUSE 20S IMMUNOPROTEASOME
503, p3uneQ_, 0.9534, 1.22, 0.595, 239, 237, MOUSE CONSTITUTIVE 20S PROTEASOME
504, p3unee_, 0.9529, 1.23, 0.591, 239, 237, MOUSE CONSTITUTIVE 20S PROTEASOME
505, p3unbC_, 0.9523, 1.26, 0.586, 239, 237, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
506, p1fntD_, 0.9519, 1.17, 1.000, 239, 236, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
507, p1fntR_, 0.9518, 1.17, 1.000, 239, 236, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
508, p5lf6Q_, 0.9517, 1.19, 0.597, 238, 236, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
509, p3unbe_, 0.9516, 1.28, 0.586, 239, 237, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
510, d5lf1Q_, 0.9514, 1.20, 0.597, 238, 236, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
511, d5le5C_, 0.9513, 1.19, 0.597, 236, 236, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
512, d5lf3Q_, 0.9507, 1.21, 0.597, 238, 236, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
513, d5lexC_, 0.9507, 1.20, 0.597, 236, 236, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
514, p5leyQ_, 0.9506, 1.22, 0.597, 239, 236, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
515, d5lf7Q_, 0.9505, 1.22, 0.597, 238, 236, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
516, p5lezC_, 0.9505, 1.20, 0.597, 236, 236, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
517, d5lf4Q_, 0.9504, 1.22, 0.597, 238, 236, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
518, d5lf3C_, 0.9503, 1.21, 0.597, 236, 236, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
519, p5leyC_, 0.9502, 1.21, 0.597, 236, 236, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
520, d5lf7C_, 0.9501, 1.21, 0.597, 236, 236, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
521, p5lf0Q_, 0.9501, 1.22, 0.597, 238, 236, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
522, p5lf6C_, 0.9499, 1.22, 0.597, 236, 236, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
523, d5lf1C_, 0.9497, 1.22, 0.597, 236, 236, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
524, d5lf4C_, 0.9495, 1.22, 0.597, 236, 236, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
525, p5lf0C_, 0.9494, 1.23, 0.597, 236, 236, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
526, p5mpbR_, 0.9486, 1.43, 1.000, 240, 240, 
527, d1iruR_, 0.9474, 1.31, 0.586, 243, 237, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
528, d1iruD_, 0.9474, 1.31, 0.586, 243, 237, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
529, p5mpbD_, 0.9469, 1.41, 1.000, 240, 240, 
530, p5vfsD_, 0.9384, 1.42, 0.591, 239, 237, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
531, p5vfuU_, 0.9374, 1.43, 0.591, 239, 237, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
532, p5vftJ_, 0.9374, 1.43, 0.591, 239, 237, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
533, p5vfsCA_, 0.9373, 1.44, 0.591, 239, 237, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
534, p5m32Q_, 0.9366, 1.36, 0.591, 235, 235, HUMAN 26S PROTEASOME IN COMPLEX WITH OPROZOMIB
535, p6avoI_, 0.9348, 1.19, 0.595, 232, 232, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
536, p5m32C_, 0.9347, 1.38, 0.585, 234, 234, HUMAN 26S PROTEASOME IN COMPLEX WITH OPROZOMIB
537, p5mpcR_, 0.9346, 1.55, 1.000, 240, 237, 
538, p4r67t_, 0.9339, 1.21, 0.595, 232, 232, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
539, p4r67f_, 0.9339, 1.21, 0.595, 232, 232, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
540, p4r67D_, 0.9339, 1.21, 0.595, 232, 232, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
541, p5t0cV_, 0.9338, 1.49, 0.591, 239, 237, 
542, p5t0cBB_, 0.9338, 1.49, 0.591, 239, 237, 
543, p4r67R_, 0.9338, 1.21, 0.595, 232, 232, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
544, d5le5Q_, 0.9334, 1.16, 0.597, 233, 231, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
545, p6avoN_, 0.9333, 1.22, 0.595, 232, 232, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
546, d5lexQ_, 0.9325, 1.18, 0.597, 233, 231, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
547, p5lezQ_, 0.9315, 1.19, 0.597, 234, 231, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
548, p5gjrV_, 0.9315, 1.19, 0.593, 231, 231, 
549, p5gjrJA_, 0.9313, 1.19, 0.593, 231, 231, 
550, p4r3oR_, 0.9307, 1.21, 0.593, 231, 231, HUMAN CONSTITUTIVE 20S PROTEASOME
551, p4r3oD_, 0.9307, 1.21, 0.593, 231, 231, HUMAN CONSTITUTIVE 20S PROTEASOME
552, p5l4gR_, 0.9298, 1.31, 0.573, 232, 232, 
553, p5l4gD_, 0.9285, 1.24, 0.571, 231, 231, 
554, p5vfuIA_, 0.9280, 1.58, 0.591, 239, 237, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
555, p5vftj_, 0.9280, 1.58, 0.591, 239, 237, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
556, p5gjqk_, 0.9280, 1.24, 0.593, 231, 231, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
557, p5t0gJ_, 0.9278, 1.56, 0.591, 239, 237, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
558, p5gjqE_, 0.9274, 1.26, 0.571, 231, 231, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
559, p5gjrIA_, 0.9268, 2.00, 0.321, 250, 237, 
560, p5gjrU_, 0.9267, 2.01, 0.321, 250, 237, 
561, p5leyB_, 0.9260, 1.99, 0.321, 248, 237, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
562, d5lf7B_, 0.9257, 1.99, 0.321, 248, 237, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
563, d5lf4B_, 0.9257, 1.99, 0.321, 248, 237, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
564, p5lf0B_, 0.9257, 2.00, 0.321, 248, 237, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
565, d5lf1B_, 0.9255, 1.99, 0.321, 248, 237, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
566, d5le5P_, 0.9255, 1.99, 0.325, 247, 237, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
567, d5le5B_, 0.9255, 1.99, 0.325, 248, 237, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
568, p5lf6B_, 0.9254, 2.00, 0.321, 248, 237, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
569, p5lezB_, 0.9254, 2.01, 0.321, 248, 237, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
570, d5lf3B_, 0.9253, 2.00, 0.321, 248, 237, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
571, d5lexB_, 0.9253, 2.01, 0.321, 248, 237, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
572, d5lf7P_, 0.9250, 2.02, 0.325, 247, 237, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
573, d5lf1P_, 0.9248, 2.02, 0.325, 248, 237, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
574, p5lezP_, 0.9246, 2.04, 0.325, 247, 237, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
575, p5leyP_, 0.9246, 2.02, 0.325, 247, 237, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
576, d5lexP_, 0.9246, 2.03, 0.325, 247, 237, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
577, p5lf6P_, 0.9245, 2.02, 0.325, 248, 237, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
578, d5lf4P_, 0.9245, 2.03, 0.325, 248, 237, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
579, p3uneP_, 0.9245, 2.00, 0.325, 248, 237, MOUSE CONSTITUTIVE 20S PROTEASOME
580, p3unbB_, 0.9244, 1.90, 0.322, 248, 236, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
581, d4r67Q_, 0.9243, 1.91, 0.322, 250, 236, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
582, d4r67C_, 0.9243, 1.91, 0.322, 250, 236, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
583, p3unbP_, 0.9243, 1.91, 0.322, 248, 236, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
584, p3unbr_, 0.9242, 1.91, 0.322, 248, 236, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
585, p5lf0P_, 0.9240, 2.04, 0.325, 248, 237, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
586, d5lf3P_, 0.9239, 2.03, 0.325, 248, 237, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
587, p3unbd_, 0.9237, 1.91, 0.322, 248, 236, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
588, d4r3oQ_, 0.9230, 1.93, 0.322, 250, 236, HUMAN CONSTITUTIVE 20S PROTEASOME
589, d4r3oC_, 0.9230, 1.93, 0.322, 250, 236, HUMAN CONSTITUTIVE 20S PROTEASOME
590, p3unhP_, 0.9229, 2.05, 0.321, 248, 237, MOUSE 20S IMMUNOPROTEASOME
591, p3unhB_, 0.9229, 2.05, 0.321, 248, 237, MOUSE 20S IMMUNOPROTEASOME
592, d1iruQ_, 0.9224, 2.05, 0.325, 250, 237, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
593, d1iruC_, 0.9223, 2.05, 0.325, 250, 237, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
594, d3unfP_, 0.9221, 1.91, 0.322, 248, 236, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
595, p3unfB_, 0.9221, 1.91, 0.322, 248, 236, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
596, p3uner_, 0.9221, 2.03, 0.325, 248, 237, MOUSE CONSTITUTIVE 20S PROTEASOME
597, p5vfoj_, 0.9219, 1.69, 0.595, 239, 237, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
598, p3uned_, 0.9209, 1.94, 0.326, 248, 236, MOUSE CONSTITUTIVE 20S PROTEASOME
599, p3uneB_, 0.9198, 1.81, 0.328, 248, 235, MOUSE CONSTITUTIVE 20S PROTEASOME
600, p5vfqCA_, 0.9195, 1.73, 0.591, 239, 237, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
601, p5vfpBA_, 0.9192, 1.72, 0.595, 239, 237, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
602, p5vfrj_, 0.9179, 1.75, 0.595, 239, 237, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
603, p5t0hJ_, 0.9137, 1.75, 0.578, 239, 237, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
604, p4v7oZA_, 0.9136, 1.11, 0.991, 227, 226, 
605, p4v7oR_, 0.9136, 1.11, 0.991, 227, 226, 
606, p4v7oLA_, 0.9136, 1.11, 0.991, 227, 226, 
607, p4v7oD_, 0.9136, 1.11, 0.991, 227, 226, 
608, d3l5qU_, 0.9136, 1.11, 0.991, 227, 226,  
609, d3l5qI_, 0.9136, 1.11, 0.991, 227, 226,  
610, d1vsyR_, 0.9136, 1.11, 0.991, 227, 226,  
611, d1vsyD_, 0.9136, 1.11, 0.991, 227, 226,  
612, p5vfsC_, 0.9107, 1.98, 0.335, 250, 236, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
613, p5vfuT_, 0.9075, 2.00, 0.335, 250, 236, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
614, p5vftI_, 0.9075, 2.00, 0.335, 250, 236, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
615, d4g4sD_, 0.9074, 0.71, 0.995, 220, 220, STRUCTURE OF PROTEASOME-PBA1-PBA2 COMPLEX
616, p5gjqj_, 0.9072, 2.01, 0.319, 240, 232, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
617, p5gjqD_, 0.9065, 2.00, 0.319, 240, 232, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
618, p5m32P_, 0.9060, 2.21, 0.314, 244, 236, HUMAN 26S PROTEASOME IN COMPLEX WITH OPROZOMIB
619, p5l4gQ_, 0.9058, 1.98, 0.328, 240, 232, 
620, p5wviI_, 0.9054, 1.50, 0.991, 231, 231, 
621, p6avoZ_, 0.9047, 1.86, 0.325, 240, 231, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
622, p6avoO_, 0.9047, 1.86, 0.325, 240, 231, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
623, p4r67s_, 0.9047, 1.92, 0.320, 240, 231, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
624, p5vfoI_, 0.9045, 1.87, 0.329, 248, 234, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
625, p5vfqC_, 0.9044, 1.87, 0.325, 248, 234, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
626, p5vfrI_, 0.9043, 1.87, 0.325, 248, 234, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
627, p5t0cU_, 0.9041, 2.09, 0.326, 250, 236, 
628, p5t0cAB_, 0.9041, 2.09, 0.326, 250, 236, 
629, p5vfoJ_, 0.9037, 1.85, 0.573, 239, 234, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
630, p5l4gC_, 0.9036, 2.00, 0.323, 240, 232, 
631, p5vfpC_, 0.9030, 1.88, 0.329, 248, 234, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
632, p5vfqD_, 0.9029, 1.86, 0.590, 239, 234, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
633, p5vfrJ_, 0.9022, 1.86, 0.590, 239, 234, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
634, d1g65O_, 0.9013, 1.52, 0.367, 250, 229, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
635, d5lf1O_, 0.9012, 1.34, 0.388, 230, 227, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
636, d5lexO_, 0.9012, 1.34, 0.392, 230, 227, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
637, d1g65A_, 0.9010, 1.53, 0.367, 250, 229, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
638, d5lf3O_, 0.9009, 1.35, 0.388, 230, 227, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
639, p5lezO_, 0.9009, 1.35, 0.392, 230, 227, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
640, p5vfuS_, 0.9006, 1.43, 0.386, 232, 228, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
641, p5vftH_, 0.9006, 1.43, 0.386, 232, 228, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
642, d5lf7O_, 0.9006, 1.35, 0.388, 230, 227, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
643, p5lf0O_, 0.9006, 1.36, 0.388, 230, 227, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
644, p4r67e_, 0.9006, 1.92, 0.317, 239, 230, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
645, d3okjO_, 0.9006, 1.54, 0.367, 250, 229, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
646, d3okjA_, 0.9006, 1.54, 0.367, 250, 229, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
647, d1rypB_, 0.9006, 1.53, 0.367, 250, 229, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
648, p5lf6O_, 0.9005, 1.36, 0.388, 230, 227, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
649, p5lezA_, 0.9005, 1.35, 0.392, 230, 227, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
650, p5leyO_, 0.9005, 1.36, 0.388, 230, 227, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
651, d5lexA_, 0.9005, 1.35, 0.392, 230, 227, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
652, d3un8O_, 0.9005, 1.54, 0.367, 250, 229, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
653, d1rypP_, 0.9005, 1.53, 0.367, 250, 229, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
654, p4zzgP_, 0.9004, 1.54, 0.362, 250, 229, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
655, d2gplA_, 0.9004, 1.53, 0.367, 250, 229, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
656, p5nifP_, 0.9003, 1.54, 0.362, 250, 229, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
657, d4intA_, 0.9003, 1.54, 0.367, 250, 229, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
658, d2gplO_, 0.9003, 1.53, 0.367, 250, 229, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
659, d5lf4O_, 0.9002, 1.36, 0.388, 230, 227, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
660, p3uneq_, 0.9002, 1.53, 0.390, 233, 228, MOUSE CONSTITUTIVE 20S PROTEASOME
661, d3e47O_, 0.9002, 1.54, 0.367, 250, 229, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
662, d3e47A_, 0.9002, 1.54, 0.367, 250, 229, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
663, d5lf1A_, 0.9001, 1.36, 0.392, 230, 227, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
664, d3un8A_, 0.9001, 1.54, 0.367, 250, 229, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
665, d2f16O_, 0.9001, 1.54, 0.367, 250, 229, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
666, d2f16A_, 0.9001, 1.54, 0.367, 250, 229, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
667, d5le5O_, 0.9000, 1.37, 0.392, 230, 227, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
668, d4intO_, 0.9000, 1.54, 0.367, 250, 229, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
669, d4inrA_, 0.9000, 1.54, 0.367, 250, 229, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
670, d2fnyO_, 0.9000, 1.54, 0.367, 250, 229,  
671, d2fnyA_, 0.9000, 1.54, 0.367, 250, 229,  
672, d4inrO_, 0.8999, 1.54, 0.367, 250, 229, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
673, d2fakA_, 0.8999, 1.54, 0.367, 250, 229, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
674, p4y8kO_, 0.8998, 1.55, 0.367, 250, 229, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
675, d2fakO_, 0.8998, 1.54, 0.367, 250, 229, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
676, p5vfsAA_, 0.8997, 1.46, 0.386, 232, 228, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
677, p5lf6A_, 0.8997, 1.37, 0.392, 230, 227, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
678, p4zzgB_, 0.8997, 1.55, 0.362, 250, 229, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
679, d4qv3O_, 0.8997, 1.55, 0.367, 250, 229, YCP BETA5-M45V MUTANT
680, d4no1O_, 0.8997, 1.55, 0.367, 250, 229, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
681, d4no1A_, 0.8997, 1.55, 0.367, 250, 229, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
682, d4inuA_, 0.8997, 1.54, 0.367, 250, 229, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
683, d4r67r_, 0.8996, 1.39, 0.396, 233, 227, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
684, d4r3oP_, 0.8996, 1.39, 0.396, 233, 227, HUMAN CONSTITUTIVE 20S PROTEASOME
685, d4r3oB_, 0.8996, 1.39, 0.396, 233, 227, HUMAN CONSTITUTIVE 20S PROTEASOME
686, d4qv5O_, 0.8996, 1.55, 0.367, 250, 229, YCP BETA5-M45I MUTANT
687, d4qv5A_, 0.8996, 1.55, 0.367, 250, 229, YCP BETA5-M45I MUTANT
688, d4qv3A_, 0.8996, 1.55, 0.367, 250, 229, YCP BETA5-M45V MUTANT
689, d4jsqO_, 0.8996, 1.55, 0.367, 250, 229, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
690, d4jsqA_, 0.8996, 1.55, 0.367, 250, 229, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
691, d4inuO_, 0.8996, 1.54, 0.367, 250, 229, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
692, d3tddO_, 0.8996, 1.54, 0.367, 250, 229, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
693, d3tddA_, 0.8996, 1.54, 0.367, 250, 229, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
694, d3gptO_, 0.8996, 1.55, 0.367, 250, 229, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
695, d3gptA_, 0.8996, 1.55, 0.367, 250, 229, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
696, p5nifB_, 0.8995, 1.55, 0.362, 250, 229, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
697, d5fgfO_, 0.8995, 1.55, 0.367, 250, 229, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
698, d5fgfA_, 0.8995, 1.55, 0.367, 250, 229, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
699, d4qwlO_, 0.8995, 1.56, 0.367, 250, 229, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
700, d4qwlA_, 0.8995, 1.56, 0.367, 250, 229, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
701, d4jt0O_, 0.8995, 1.55, 0.367, 250, 229, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
702, d4jt0A_, 0.8995, 1.55, 0.367, 250, 229, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
703, d3oevA_, 0.8995, 1.55, 0.362, 250, 229, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
704, d3nzjA_, 0.8995, 1.55, 0.367, 250, 229, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
705, d1jd2V_, 0.8995, 1.55, 0.367, 250, 229, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
706, p5vfsB_, 0.8994, 1.46, 0.382, 232, 228, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
707, d5lf4A_, 0.8994, 1.37, 0.392, 230, 227, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
708, d5lf3A_, 0.8994, 1.37, 0.392, 230, 227, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
709, p5lf0A_, 0.8994, 1.38, 0.388, 230, 227, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
710, p5leyA_, 0.8994, 1.37, 0.392, 230, 227, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
711, d5l55A_, 0.8994, 1.56, 0.367, 250, 229, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
712, p5cggO_, 0.8994, 1.56, 0.367, 250, 229, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
713, d5ahjO_, 0.8994, 1.56, 0.367, 250, 229, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
714, d5ahjA_, 0.8994, 1.56, 0.367, 250, 229, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
715, d4r67P_, 0.8994, 1.39, 0.396, 233, 227, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
716, d4r00O_, 0.8994, 1.56, 0.367, 250, 229, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
717, d4r00A_, 0.8994, 1.56, 0.367, 250, 229, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
718, d4qwrO_, 0.8994, 1.56, 0.367, 250, 229, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
719, d4qwrA_, 0.8994, 1.56, 0.367, 250, 229, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
720, d3nzxO_, 0.8994, 1.55, 0.367, 250, 229, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
721, d3nzxA_, 0.8994, 1.55, 0.367, 250, 229, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
722, d3nzjO_, 0.8994, 1.55, 0.367, 250, 229, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
723, d1iruP_, 0.8994, 1.39, 0.392, 233, 227, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
724, d5l55O_, 0.8993, 1.56, 0.367, 250, 229, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
725, d5l52O_, 0.8993, 1.56, 0.367, 250, 229, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
726, d5l52A_, 0.8993, 1.56, 0.367, 250, 229, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
727, d5jhrO_, 0.8993, 1.56, 0.367, 250, 229, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
728, d5jhrA_, 0.8993, 1.56, 0.367, 250, 229, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
729, d5fgiA_, 0.8993, 1.56, 0.367, 249, 229, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
730, d5fgeO_, 0.8993, 1.56, 0.367, 250, 229, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
731, d5fgeA_, 0.8993, 1.56, 0.367, 250, 229, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
732, d5d0zO_, 0.8993, 1.56, 0.367, 250, 229, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
733, d5d0zA_, 0.8993, 1.56, 0.367, 250, 229, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
734, d5d0sO_, 0.8993, 1.56, 0.367, 250, 229, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
735, d5d0sA_, 0.8993, 1.56, 0.367, 250, 229, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
736, d5cz9O_, 0.8993, 1.56, 0.367, 250, 229, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
737, d5cz9A_, 0.8993, 1.56, 0.367, 250, 229, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
738, p5cghO_, 0.8993, 1.56, 0.362, 250, 229, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
739, p4y8pO_, 0.8993, 1.56, 0.367, 250, 229, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
740, d4r67d_, 0.8993, 1.39, 0.396, 233, 227, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
741, d4qzwO_, 0.8993, 1.56, 0.367, 250, 229, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
742, d4qzwA_, 0.8993, 1.56, 0.367, 250, 229, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
743, d4qz7O_, 0.8993, 1.56, 0.367, 250, 229, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
744, d4qz7A_, 0.8993, 1.56, 0.367, 250, 229, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
745, d4qv7O_, 0.8993, 1.56, 0.367, 250, 229, YCP BETA5-A50V MUTANT
746, d4qv7A_, 0.8993, 1.56, 0.367, 250, 229, YCP BETA5-A50V MUTANT
747, d4qv4O_, 0.8993, 1.56, 0.367, 250, 229, YCP BETA5-M45T MUTANT
748, d4qv4A_, 0.8993, 1.56, 0.367, 250, 229, YCP BETA5-M45T MUTANT
749, d4ltcO_, 0.8993, 1.56, 0.367, 250, 229, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
750, p3unec_, 0.8993, 1.52, 0.395, 233, 228, MOUSE CONSTITUTIVE 20S PROTEASOME
751, d3mg7O_, 0.8993, 1.55, 0.367, 250, 229, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
752, d5lf7A_, 0.8992, 1.38, 0.392, 230, 227, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
753, d5fhsO_, 0.8992, 1.56, 0.367, 250, 229, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
754, d5fhsA_, 0.8992, 1.56, 0.367, 250, 229, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
755, d5fgiO_, 0.8992, 1.56, 0.367, 249, 229, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
756, d4ya1O_, 0.8992, 1.56, 0.367, 250, 229, YEAST 20S PROTEASOME BETA2-H116N MUTANT
757, d4ya1A_, 0.8992, 1.56, 0.367, 250, 229, YEAST 20S PROTEASOME BETA2-H116N MUTANT
758, p4y8qO_, 0.8992, 1.56, 0.367, 250, 229, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
759, p4y82O_, 0.8992, 1.56, 0.367, 250, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
760, p4x6zP_, 0.8992, 1.56, 0.367, 249, 229, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
761, d4r67B_, 0.8992, 1.39, 0.396, 233, 227, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
762, d4qv8O_, 0.8992, 1.56, 0.367, 250, 229, YCP BETA5-C52F MUTANT
763, d4qv8A_, 0.8992, 1.56, 0.367, 250, 229, YCP BETA5-C52F MUTANT
764, d4qlqO_, 0.8992, 1.56, 0.367, 250, 229, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
765, d4qlqA_, 0.8992, 1.56, 0.367, 250, 229, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
766, p4qbyO_, 0.8992, 1.56, 0.367, 250, 229, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
767, d4ltcA_, 0.8992, 1.56, 0.367, 250, 229, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
768, p3uneO_, 0.8992, 1.56, 0.395, 233, 228, MOUSE CONSTITUTIVE 20S PROTEASOME
769, d3mg6A_, 0.8992, 1.56, 0.362, 250, 229, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
770, d3mg0O_, 0.8992, 1.56, 0.367, 250, 229, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
771, p3h4pJ_, 0.8992, 1.66, 0.402, 232, 229, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
772, d3dy3A_, 0.8992, 1.55, 0.367, 250, 229, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
773, d5le5A_, 0.8991, 1.38, 0.392, 230, 227, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
774, d5jhsO_, 0.8991, 1.56, 0.367, 250, 229, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
775, d5jhsA_, 0.8991, 1.56, 0.367, 250, 229, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
776, d5fggO_, 0.8991, 1.56, 0.367, 250, 229, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
777, d5fggA_, 0.8991, 1.56, 0.367, 250, 229, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
778, d5fgdO_, 0.8991, 1.56, 0.367, 250, 229, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
779, d5fgdA_, 0.8991, 1.56, 0.367, 250, 229, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
780, d5fg7O_, 0.8991, 1.56, 0.367, 250, 229, YEAST 20S PROTEASOME BETA2-T1A MUTANT
781, d5fg7A_, 0.8991, 1.56, 0.367, 250, 229, YEAST 20S PROTEASOME BETA2-T1A MUTANT
782, p5cgiO_, 0.8991, 1.56, 0.367, 250, 229, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
783, p4ya2O_, 0.8991, 1.56, 0.367, 250, 229, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
784, d4y8mO_, 0.8991, 1.56, 0.367, 250, 229, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
785, p4y8lO_, 0.8991, 1.56, 0.367, 250, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
786, p4y7xO_, 0.8991, 1.56, 0.367, 250, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
787, p4y77O_, 0.8991, 1.56, 0.367, 250, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
788, d4qzxO_, 0.8991, 1.56, 0.367, 250, 229, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
789, d4qzxA_, 0.8991, 1.56, 0.367, 250, 229, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
790, d4qz3O_, 0.8991, 1.56, 0.367, 250, 229, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
791, d4qz3A_, 0.8991, 1.56, 0.367, 250, 229, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
792, d4qwjO_, 0.8991, 1.56, 0.367, 250, 229, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
793, d4qwjA_, 0.8991, 1.56, 0.367, 250, 229, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
794, d4qwiO_, 0.8991, 1.56, 0.367, 250, 229, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
795, d4qwiA_, 0.8991, 1.56, 0.367, 250, 229, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
796, d4qw7O_, 0.8991, 1.56, 0.367, 250, 229, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
797, d4qw7A_, 0.8991, 1.56, 0.367, 250, 229, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
798, d4qw6O_, 0.8991, 1.56, 0.367, 250, 229, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
799, d4qw6A_, 0.8991, 1.56, 0.367, 250, 229, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
800, d4qw5O_, 0.8991, 1.56, 0.367, 250, 229, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
801, d4qw5A_, 0.8991, 1.56, 0.367, 250, 229, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
802, d4qv1O_, 0.8991, 1.56, 0.367, 250, 229, YCP BETA5-M45A MUTANT
803, d4qv1A_, 0.8991, 1.56, 0.367, 250, 229, YCP BETA5-M45A MUTANT
804, d4q1sA_, 0.8991, 1.56, 0.362, 250, 229, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
805, p3un4O_, 0.8991, 1.55, 0.367, 250, 229, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
806, d3shjO_, 0.8991, 1.55, 0.367, 250, 229, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
807, d3oevO_, 0.8991, 1.55, 0.367, 250, 229, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
808, d3nzwO_, 0.8991, 1.56, 0.367, 250, 229, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
809, d3nzwA_, 0.8991, 1.56, 0.367, 250, 229, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
810, d3mg0A_, 0.8991, 1.56, 0.367, 250, 229, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
811, d3gpwO_, 0.8991, 1.55, 0.367, 250, 229, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
812, d3gpwA_, 0.8991, 1.55, 0.367, 250, 229, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
813, d3dy3O_, 0.8991, 1.55, 0.367, 250, 229, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
814, d3d29A_, 0.8991, 1.55, 0.367, 250, 229, PROTEASOME INHIBITION BY FELLUTAMIDE B
815, d2zcyA_, 0.8991, 1.55, 0.367, 250, 229, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
816, p6avoP_, 0.8990, 1.38, 0.388, 230, 227, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
817, p6avob_, 0.8990, 1.38, 0.388, 230, 227, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
818, d5l54A_, 0.8990, 1.56, 0.367, 250, 229, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
819, d5d0vO_, 0.8990, 1.56, 0.367, 250, 229, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
820, d5d0vA_, 0.8990, 1.56, 0.367, 250, 229, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
821, d5czaO_, 0.8990, 1.56, 0.367, 250, 229, YEAST 20S PROTEASOME BETA5-D166N MUTANT
822, d5czaA_, 0.8990, 1.56, 0.367, 250, 229, YEAST 20S PROTEASOME BETA5-D166N MUTANT
823, d5cz5O_, 0.8990, 1.56, 0.367, 250, 229, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
824, d5cz5A_, 0.8990, 1.56, 0.367, 250, 229, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
825, d5cgfO_, 0.8990, 1.56, 0.367, 250, 229, YEAST 20S PROTEASOME BETA5-G48C MUTANT
826, d5cgfA_, 0.8990, 1.56, 0.367, 250, 229, YEAST 20S PROTEASOME BETA5-G48C MUTANT
827, d5bxlO_, 0.8990, 1.56, 0.367, 250, 229, YEAST 20S PROTEASOME BETA2-G170A MUTANT
828, d5bxlA_, 0.8990, 1.56, 0.367, 250, 229, YEAST 20S PROTEASOME BETA2-G170A MUTANT
829, d4z1lO_, 0.8990, 1.56, 0.367, 250, 229, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
830, p4ya7O_, 0.8990, 1.56, 0.367, 250, 229, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
831, d4y9yO_, 0.8990, 1.56, 0.367, 250, 229, YEAST 20S PROTEASOME BETA2-H116E MUTANT
832, d4y9yA_, 0.8990, 1.56, 0.367, 250, 229, YEAST 20S PROTEASOME BETA2-H116E MUTANT
833, p4y8sO_, 0.8990, 1.56, 0.367, 250, 229, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
834, d4y8mA_, 0.8990, 1.56, 0.367, 250, 229, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
835, d4r02A_, 0.8990, 1.57, 0.362, 250, 229, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
836, d4qz6O_, 0.8990, 1.56, 0.367, 250, 229, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
837, d4qz6A_, 0.8990, 1.56, 0.367, 250, 229, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
838, d4qz0O_, 0.8990, 1.56, 0.367, 250, 229, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
839, d4qz0A_, 0.8990, 1.56, 0.367, 250, 229, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
840, d4qwxO_, 0.8990, 1.56, 0.367, 250, 229, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
841, d4qwxA_, 0.8990, 1.56, 0.367, 250, 229, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
842, d4jsuO_, 0.8990, 1.55, 0.367, 250, 229, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
843, d4jsuA_, 0.8990, 1.55, 0.367, 250, 229, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
844, d4fzcO_, 0.8990, 1.56, 0.367, 250, 229, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
845, d4fzcA_, 0.8990, 1.56, 0.367, 250, 229, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
846, d3shjA_, 0.8990, 1.55, 0.367, 250, 229, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
847, d3mg7A_, 0.8990, 1.57, 0.358, 250, 229, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
848, d3h4pA_, 0.8990, 1.65, 0.402, 232, 229, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
849, d3d29O_, 0.8990, 1.55, 0.367, 250, 229, PROTEASOME INHIBITION BY FELLUTAMIDE B
850, d2zcyO_, 0.8990, 1.55, 0.367, 250, 229, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
851, d1jd2A_, 0.8990, 1.56, 0.367, 250, 229, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
852, d5l67O_, 0.8989, 1.56, 0.367, 250, 229, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
853, d5l64O_, 0.8989, 1.56, 0.367, 250, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
854, d5l61O_, 0.8989, 1.56, 0.367, 250, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
855, d5l61A_, 0.8989, 1.56, 0.367, 250, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
856, d5l5wO_, 0.8989, 1.56, 0.367, 250, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
857, d5l5wA_, 0.8989, 1.56, 0.367, 250, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
858, d5l5vO_, 0.8989, 1.56, 0.367, 250, 229,  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
859, d5l5vA_, 0.8989, 1.56, 0.367, 250, 229,  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
860, d5l5oO_, 0.8989, 1.56, 0.367, 250, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
861, d5l5oA_, 0.8989, 1.56, 0.367, 250, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
862, d5l5bO_, 0.8989, 1.56, 0.367, 250, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
863, d5l5bA_, 0.8989, 1.56, 0.367, 250, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
864, d5l54O_, 0.8989, 1.56, 0.367, 250, 229, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
865, d5fg9O_, 0.8989, 1.56, 0.367, 250, 229, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
866, d5fg9A_, 0.8989, 1.56, 0.367, 250, 229, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
867, d5d0wO_, 0.8989, 1.56, 0.367, 250, 229, YEAST 20S PROTEASOME BETA5-T1S MUTANT
868, d5d0wA_, 0.8989, 1.56, 0.367, 250, 229, YEAST 20S PROTEASOME BETA5-T1S MUTANT
869, d5cz8O_, 0.8989, 1.56, 0.367, 250, 229, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
870, d5cz8A_, 0.8989, 1.57, 0.367, 250, 229, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
871, d4z1lA_, 0.8989, 1.56, 0.367, 250, 229, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
872, p4ya9O_, 0.8989, 1.56, 0.367, 250, 229, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
873, p4y9zO_, 0.8989, 1.56, 0.367, 250, 229, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
874, p4y8hO_, 0.8989, 1.56, 0.367, 250, 229, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
875, p4y80O_, 0.8989, 1.56, 0.367, 250, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
876, p4y7yO_, 0.8989, 1.56, 0.367, 250, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
877, p4y7wO_, 0.8989, 1.56, 0.367, 250, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
878, p4y75O_, 0.8989, 1.56, 0.367, 250, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
879, p4y70O_, 0.8989, 1.56, 0.367, 250, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
880, d4qz5O_, 0.8989, 1.56, 0.367, 250, 229, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
881, d4qz5A_, 0.8989, 1.56, 0.367, 250, 229, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
882, d4qz4O_, 0.8989, 1.56, 0.367, 250, 229, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
883, d4qz4A_, 0.8989, 1.56, 0.367, 250, 229, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
884, d4qwkO_, 0.8989, 1.57, 0.367, 250, 229, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
885, d4qwkA_, 0.8989, 1.57, 0.367, 250, 229, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
886, d4qwfO_, 0.8989, 1.57, 0.367, 250, 229, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
887, d4qwfA_, 0.8989, 1.57, 0.367, 250, 229, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
888, d4qv0O_, 0.8989, 1.56, 0.367, 250, 229, YCP BETA5-A49T-A50V-DOUBLE MUTANT
889, d4quyO_, 0.8989, 1.56, 0.367, 250, 229, YCP BETA5-A49S-MUTANT
890, d4quyA_, 0.8989, 1.56, 0.367, 250, 229, YCP BETA5-A49S-MUTANT
891, d4quxO_, 0.8989, 1.56, 0.367, 250, 229, YCP BETA5-A49T-MUTANT
892, d4quxA_, 0.8989, 1.56, 0.367, 250, 229, YCP BETA5-A49T-MUTANT
893, d4no8O_, 0.8989, 1.56, 0.367, 250, 229, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
894, d4no8A_, 0.8989, 1.56, 0.367, 250, 229, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
895, d3sdkO_, 0.8989, 1.56, 0.367, 250, 229, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
896, d3mg8A_, 0.8989, 1.56, 0.367, 250, 229, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
897, d3hyeA_, 0.8989, 1.56, 0.367, 250, 229, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
898, d5m2bO_, 0.8988, 1.56, 0.367, 250, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
899, d5m2bA_, 0.8988, 1.57, 0.367, 250, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
900, d5lttO_, 0.8988, 1.56, 0.367, 250, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
901, d5lttA_, 0.8988, 1.56, 0.367, 250, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
902, d5lajO_, 0.8988, 1.56, 0.367, 250, 229, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
903, d5lajA_, 0.8988, 1.56, 0.367, 250, 229, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
904, d5l6cO_, 0.8988, 1.56, 0.367, 250, 229, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
905, d5l6cA_, 0.8988, 1.56, 0.367, 250, 229, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
906, d5l6bO_, 0.8988, 1.56, 0.367, 250, 229, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
907, d5l6bA_, 0.8988, 1.57, 0.367, 250, 229, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
908, d5l6aO_, 0.8988, 1.56, 0.367, 250, 229, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
909, d5l6aA_, 0.8988, 1.56, 0.367, 250, 229, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
910, d5l67A_, 0.8988, 1.56, 0.367, 250, 229, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
911, d5l64A_, 0.8988, 1.56, 0.367, 250, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
912, d5l62O_, 0.8988, 1.57, 0.367, 250, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
913, d5l5xO_, 0.8988, 1.57, 0.367, 250, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
914, d5l5xA_, 0.8988, 1.57, 0.367, 250, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
915, d5l5tO_, 0.8988, 1.57, 0.367, 250, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
916, d5l5tA_, 0.8988, 1.57, 0.367, 250, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
917, d5l5aO_, 0.8988, 1.56, 0.367, 250, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
918, d5l5aA_, 0.8988, 1.56, 0.367, 250, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
919, d5fgaO_, 0.8988, 1.56, 0.367, 250, 229, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
920, d5fgaA_, 0.8988, 1.56, 0.367, 250, 229, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
921, d5cz7O_, 0.8988, 1.56, 0.367, 250, 229, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
922, d5cz7A_, 0.8988, 1.56, 0.367, 250, 229, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
923, p4y8uO_, 0.8988, 1.56, 0.367, 250, 229, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
924, d4y8rO_, 0.8988, 1.56, 0.367, 250, 229, YEAST 20S PROTEASOME BETA2-H116D MUTANT
925, d4y8rA_, 0.8988, 1.56, 0.367, 250, 229, YEAST 20S PROTEASOME BETA2-H116D MUTANT
926, p4y8jO_, 0.8988, 1.56, 0.367, 250, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
927, p4y6zO_, 0.8988, 1.56, 0.367, 250, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
928, p4y6aO_, 0.8988, 1.56, 0.367, 250, 229, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
929, d4r18O_, 0.8988, 1.56, 0.367, 250, 229, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
930, d4r18A_, 0.8988, 1.56, 0.367, 250, 229, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
931, d4qzzO_, 0.8988, 1.56, 0.367, 250, 229, YCP IN COMPLEX WITH OMURALIDE
932, d4qzzA_, 0.8988, 1.56, 0.367, 250, 229, YCP IN COMPLEX WITH OMURALIDE
933, d4qz2O_, 0.8988, 1.57, 0.367, 250, 229, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
934, d4qz2A_, 0.8988, 1.57, 0.367, 250, 229, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
935, d4qxjO_, 0.8988, 1.56, 0.367, 250, 229, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
936, d4qxjA_, 0.8988, 1.56, 0.367, 250, 229, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
937, d4qv9O_, 0.8988, 1.56, 0.367, 250, 229, YCP BETA5-C63F MUTANT
938, d4qv9A_, 0.8988, 1.56, 0.367, 250, 229, YCP BETA5-C63F MUTANT
939, d4qv0A_, 0.8988, 1.56, 0.367, 250, 229, YCP BETA5-A49T-A50V-DOUBLE MUTANT
940, d4fzgO_, 0.8988, 1.56, 0.367, 250, 229, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
941, d4fzgA_, 0.8988, 1.56, 0.367, 250, 229, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
942, d3wxrB_, 0.8988, 1.56, 0.367, 249, 229, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
943, d3sdkA_, 0.8988, 1.57, 0.362, 250, 229, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
944, d3oeuO_, 0.8988, 1.56, 0.367, 250, 229, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
945, d3hyeO_, 0.8988, 1.56, 0.367, 250, 229, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
946, p3h4pL_, 0.8988, 1.65, 0.402, 232, 229, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
947, d3gpjO_, 0.8988, 1.56, 0.367, 250, 229, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
948, d3gpjA_, 0.8988, 1.56, 0.367, 250, 229, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
949, d3bdmA_, 0.8988, 1.56, 0.367, 250, 229, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
950, d5l68O_, 0.8987, 1.57, 0.367, 250, 229, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
951, d5l68A_, 0.8987, 1.57, 0.367, 250, 229, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
952, d5l66O_, 0.8987, 1.57, 0.367, 250, 229, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
953, d5l66A_, 0.8987, 1.57, 0.367, 250, 229, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
954, d5l63O_, 0.8987, 1.57, 0.367, 250, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
955, d5l63A_, 0.8987, 1.57, 0.367, 250, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
956, d5l62A_, 0.8987, 1.57, 0.367, 250, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
957, d5l60O_, 0.8987, 1.57, 0.367, 250, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
958, d5l60A_, 0.8987, 1.57, 0.367, 250, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
959, d5l5rO_, 0.8987, 1.56, 0.367, 250, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
960, d5l5rA_, 0.8987, 1.57, 0.367, 250, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
961, d5l5qO_, 0.8987, 1.57, 0.367, 250, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
962, d5l5qA_, 0.8987, 1.57, 0.367, 250, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
963, d5l5pO_, 0.8987, 1.57, 0.367, 250, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
964, d5l5pA_, 0.8987, 1.57, 0.367, 250, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
965, d5l5jO_, 0.8987, 1.57, 0.367, 250, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
966, d5l5jA_, 0.8987, 1.57, 0.362, 250, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
967, d5l5hO_, 0.8987, 1.57, 0.367, 250, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
968, d5l5hA_, 0.8987, 1.57, 0.367, 250, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
969, d5l5fO_, 0.8987, 1.57, 0.367, 250, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
970, d5d0tO_, 0.8987, 1.57, 0.367, 250, 229, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
971, d5d0tA_, 0.8987, 1.57, 0.367, 250, 229, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
972, d5bxnA_, 0.8987, 1.57, 0.367, 250, 229, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
973, p4y8nO_, 0.8987, 1.56, 0.367, 250, 229, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
974, p4y8iO_, 0.8987, 1.57, 0.367, 250, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
975, p4y8gO_, 0.8987, 1.56, 0.367, 250, 229, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
976, p4y81O_, 0.8987, 1.57, 0.367, 250, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
977, p4y78O_, 0.8987, 1.56, 0.367, 250, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP
978, p4y74O_, 0.8987, 1.56, 0.367, 250, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
979, p4y6vO_, 0.8987, 1.56, 0.367, 250, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
980, d4r17A_, 0.8987, 1.57, 0.367, 249, 229, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
981, d4qw4O_, 0.8987, 1.57, 0.367, 250, 229, YCP IN COMPLEX WITH CARFILZOMIB
982, d4qw4A_, 0.8987, 1.57, 0.367, 250, 229, YCP IN COMPLEX WITH CARFILZOMIB
983, d4qvyO_, 0.8987, 1.57, 0.367, 250, 229, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
984, d4qvyA_, 0.8987, 1.57, 0.367, 250, 229, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
985, d4qlvO_, 0.8987, 1.57, 0.362, 250, 229, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
986, d4qlvA_, 0.8987, 1.57, 0.362, 250, 229, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
987, d4qltO_, 0.8987, 1.56, 0.367, 250, 229, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
988, d4qltA_, 0.8987, 1.56, 0.367, 250, 229, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
989, d4nnnO_, 0.8987, 1.56, 0.367, 250, 229, YCP IN COMPLEX WITH MG132
990, d4nnnA_, 0.8987, 1.56, 0.367, 250, 229, YCP IN COMPLEX WITH MG132
991, p4gk7O_, 0.8987, 1.56, 0.367, 250, 229, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
992, d3mg4A_, 0.8987, 1.56, 0.362, 250, 229, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
993, p3h4pH_, 0.8987, 1.66, 0.402, 232, 229, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
994, d3h4pC_, 0.8987, 1.66, 0.402, 232, 229, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
995, d3bdmO_, 0.8987, 1.56, 0.367, 250, 229, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
996, p5wviAA_, 0.8986, 1.60, 0.991, 231, 231, 
997, d5l65O_, 0.8986, 1.57, 0.367, 250, 229, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
998, d5l65A_, 0.8986, 1.57, 0.367, 250, 229, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
999, d5l5zO_, 0.8986, 1.57, 0.367, 250, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
1000, d5l5zA_, 0.8986, 1.57, 0.367, 250, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
1001, d5l5uO_, 0.8986, 1.57, 0.367, 250, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
1002, d5l5uA_, 0.8986, 1.57, 0.367, 250, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
1003, d5l5fA_, 0.8986, 1.57, 0.367, 250, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
1004, d5l5eO_, 0.8986, 1.57, 0.367, 250, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
1005, d5l5eA_, 0.8986, 1.57, 0.367, 250, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
1006, d5cz6O_, 0.8986, 1.57, 0.367, 250, 229, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
1007, d5cz6A_, 0.8986, 1.57, 0.367, 250, 229, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
1008, d5bxnO_, 0.8986, 1.57, 0.367, 250, 229, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
1009, p4ya5O_, 0.8986, 1.57, 0.367, 250, 229, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
1010, d4ya4O_, 0.8986, 1.57, 0.367, 250, 229, YEAST 20S PROTEASOME BETA2-H114D MUTANT
1011, p4y8oO_, 0.8986, 1.57, 0.367, 250, 229, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
1012, p4y84O_, 0.8986, 1.57, 0.367, 250, 229, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
1013, p4y69O_, 0.8986, 1.57, 0.367, 250, 229, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
1014, d4rurO_, 0.8986, 1.57, 0.367, 250, 229, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
1015, d4rurA_, 0.8986, 1.57, 0.367, 250, 229, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
1016, d4r17O_, 0.8986, 1.57, 0.367, 249, 229, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
1017, d4r02O_, 0.8986, 1.57, 0.367, 250, 229, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
1018, d4qwgA_, 0.8986, 1.57, 0.362, 250, 229, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
1019, d4qvlO_, 0.8986, 1.57, 0.367, 250, 229, YCP IN COMPLEX WITH BORTEZOMIB
1020, d4qvlA_, 0.8986, 1.57, 0.367, 250, 229, YCP IN COMPLEX WITH BORTEZOMIB
1021, d3oeuA_, 0.8986, 1.57, 0.362, 250, 229, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
1022, d3mg6O_, 0.8986, 1.56, 0.367, 250, 229, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
1023, d5l5yO_, 0.8985, 1.57, 0.367, 250, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
1024, d5l5yA_, 0.8985, 1.57, 0.367, 250, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
1025, d5l5sO_, 0.8985, 1.57, 0.367, 250, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
1026, d5l5sA_, 0.8985, 1.57, 0.367, 250, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
1027, d5l5iO_, 0.8985, 1.57, 0.367, 250, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
1028, d5l5dO_, 0.8985, 1.57, 0.367, 250, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
1029, d5l5dA_, 0.8985, 1.57, 0.367, 250, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
1030, d5d0xO_, 0.8985, 1.57, 0.367, 250, 229, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
1031, d5d0xA_, 0.8985, 1.57, 0.367, 250, 229, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
1032, d5bouO_, 0.8985, 1.57, 0.367, 250, 229, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
1033, d5bouA_, 0.8985, 1.57, 0.367, 250, 229, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
1034, d4ya4A_, 0.8985, 1.57, 0.367, 250, 229, YEAST 20S PROTEASOME BETA2-H114D MUTANT
1035, p4y8tO_, 0.8985, 1.57, 0.367, 250, 229, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
1036, d4qwsO_, 0.8985, 1.57, 0.367, 250, 229, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
1037, d4qwsA_, 0.8985, 1.57, 0.367, 250, 229, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
1038, d4qwgO_, 0.8985, 1.57, 0.362, 250, 229, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
1039, d4qw0O_, 0.8985, 1.57, 0.367, 250, 229, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
1040, d4qw0A_, 0.8985, 1.57, 0.367, 250, 229, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
1041, d4qvwO_, 0.8985, 1.57, 0.367, 250, 229, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
1042, d4qvwA_, 0.8985, 1.57, 0.367, 250, 229, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
1043, d4qvqO_, 0.8985, 1.57, 0.367, 250, 229, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
1044, d4qvqA_, 0.8985, 1.57, 0.367, 250, 229, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
1045, d4qvpO_, 0.8985, 1.57, 0.367, 250, 229, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
1046, d4qvpA_, 0.8985, 1.57, 0.367, 250, 229, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
1047, d4qluO_, 0.8985, 1.57, 0.367, 250, 229, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
1048, d4qluA_, 0.8985, 1.57, 0.367, 250, 229, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
1049, d3mg8O_, 0.8985, 1.56, 0.367, 250, 229, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
1050, p5vfpZ_, 0.8984, 1.51, 0.377, 232, 228, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
1051, d5l5iA_, 0.8984, 1.57, 0.367, 250, 229, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
1052, p5fghO_, 0.8984, 1.57, 0.367, 250, 229, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
1053, d5dkjO_, 0.8984, 1.57, 0.367, 250, 229, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
1054, d5dkjA_, 0.8984, 1.57, 0.367, 250, 229, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
1055, d5cz4O_, 0.8984, 1.57, 0.367, 250, 229, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
1056, d5cz4A_, 0.8984, 1.57, 0.367, 250, 229, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
1057, p4ya3O_, 0.8984, 1.57, 0.367, 250, 229, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
1058, d4qwuO_, 0.8984, 1.57, 0.367, 250, 229, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
1059, d4qwuA_, 0.8984, 1.57, 0.367, 250, 229, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
1060, d4qw1O_, 0.8984, 1.57, 0.367, 250, 229, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
1061, d4qw1A_, 0.8984, 1.57, 0.367, 250, 229, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
1062, d4qvnO_, 0.8984, 1.57, 0.367, 250, 229, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
1063, d4qvnA_, 0.8984, 1.57, 0.367, 250, 229, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
1064, d4qlsO_, 0.8984, 1.57, 0.367, 250, 229, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
1065, d4qlsA_, 0.8984, 1.57, 0.367, 250, 229, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
1066, d4q1sO_, 0.8984, 1.56, 0.367, 250, 229, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
1067, d4no6O_, 0.8984, 1.57, 0.367, 250, 229, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
1068, d4no6A_, 0.8984, 1.57, 0.367, 250, 229, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
1069, d5laiO_, 0.8983, 1.57, 0.367, 250, 229, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
1070, d5laiA_, 0.8983, 1.57, 0.367, 250, 229, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
1071, d4nnwO_, 0.8983, 1.57, 0.367, 250, 229, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
1072, d4nnwA_, 0.8983, 1.57, 0.367, 250, 229, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
1073, d4lqiA_, 0.8983, 1.57, 0.367, 250, 229, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
1074, d3h4pD_, 0.8983, 1.66, 0.402, 232, 229, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
1075, d5l69O_, 0.8982, 1.58, 0.362, 250, 229, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1076, d5l69A_, 0.8982, 1.58, 0.362, 250, 229, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1077, d4qz1O_, 0.8982, 1.58, 0.362, 250, 229, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1078, d4qz1A_, 0.8982, 1.58, 0.362, 250, 229, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1079, d4qvvO_, 0.8982, 1.57, 0.367, 250, 229, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
1080, d4qvvA_, 0.8982, 1.57, 0.367, 250, 229, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
1081, d4no9O_, 0.8982, 1.57, 0.367, 250, 229, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
1082, d4no9A_, 0.8982, 1.57, 0.367, 250, 229, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
1083, d4lqiO_, 0.8982, 1.57, 0.367, 250, 229, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
1084, d4hrdO_, 0.8982, 1.56, 0.362, 250, 229, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
1085, d4hnpO_, 0.8982, 1.56, 0.367, 250, 229, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
1086, p3h4pN_, 0.8982, 1.67, 0.402, 232, 229, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
1087, p3h4pK_, 0.8982, 1.67, 0.402, 232, 229, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
1088, d3dy4A_, 0.8982, 1.57, 0.367, 250, 229, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
1089, p4ya0O_, 0.8981, 1.57, 0.367, 250, 229, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
1090, d4qvmO_, 0.8981, 1.57, 0.367, 250, 229, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
1091, d4qvmA_, 0.8981, 1.57, 0.367, 250, 229, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
1092, p3uneA_, 0.8981, 1.56, 0.395, 233, 228, MOUSE CONSTITUTIVE 20S PROTEASOME
1093, d3h4pG_, 0.8981, 1.68, 0.402, 232, 229, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
1094, d3h4pF_, 0.8981, 1.67, 0.402, 232, 229, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
1095, d3dy4O_, 0.8981, 1.57, 0.367, 250, 229, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
1096, p6gopO_, 0.8980, 1.58, 0.367, 250, 229, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
1097, d4hrdA_, 0.8980, 1.57, 0.362, 250, 229, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
1098, d3mg4O_, 0.8980, 1.57, 0.367, 250, 229, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
1099, d3h4pE_, 0.8980, 1.69, 0.402, 232, 229, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
1100, p5vfoh_, 0.8979, 1.52, 0.377, 232, 228, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
1101, d4hnpA_, 0.8979, 1.57, 0.367, 250, 229, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
1102, p5gjqC_, 0.8978, 1.41, 0.396, 233, 227, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
1103, d5dkiO_, 0.8978, 1.58, 0.367, 250, 229, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
1104, d5dkiA_, 0.8978, 1.58, 0.367, 250, 229, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
1105, d4qw3O_, 0.8978, 1.58, 0.362, 250, 229, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
1106, d4qw3A_, 0.8978, 1.58, 0.362, 250, 229, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
1107, d4j70A_, 0.8978, 1.57, 0.367, 250, 229, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
1108, p3h4pM_, 0.8978, 1.70, 0.402, 232, 229, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
1109, p3h4pI_, 0.8977, 1.71, 0.402, 232, 229, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
1110, d4qv6O_, 0.8976, 1.58, 0.367, 250, 229, YCP BETA5-A49V MUTANT
1111, d4qv6A_, 0.8976, 1.58, 0.367, 250, 229, YCP BETA5-A49V MUTANT
1112, d3h4pB_, 0.8976, 1.69, 0.402, 232, 229, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
1113, d4j70O_, 0.8975, 1.58, 0.367, 250, 229, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
1114, d4hrcO_, 0.8974, 1.57, 0.367, 249, 229, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
1115, d1g0uA_, 0.8974, 1.52, 0.368, 246, 228, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
1116, p5vfqAA_, 0.8972, 1.53, 0.377, 232, 228, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
1117, d3wxrP_, 0.8971, 1.58, 0.367, 249, 229, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
1118, p5vfrh_, 0.8969, 1.53, 0.377, 232, 228, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
1119, p5l4gB_, 0.8968, 1.51, 0.396, 233, 227, 
1120, d4hrcA_, 0.8967, 1.59, 0.367, 249, 229, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
1121, d3unbO_, 0.8967, 1.35, 0.389, 231, 226, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
1122, d3unbc_, 0.8967, 1.36, 0.389, 231, 226, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
1123, d3unbA_, 0.8967, 1.36, 0.389, 231, 226, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
1124, p5t0gI_, 0.8965, 2.16, 0.322, 250, 236, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
1125, p5mpcD_, 0.8965, 1.22, 1.000, 224, 224, 
1126, d1iruB_, 0.8964, 1.47, 0.392, 233, 227, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
1127, d1g0uO_, 0.8964, 1.53, 0.368, 246, 228, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
1128, d3unbq_, 0.8963, 1.36, 0.389, 231, 226, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
1129, d4eu2B_, 0.8961, 1.55, 0.368, 249, 228, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
1130, p5l4gP_, 0.8960, 1.60, 0.395, 233, 228, 
1131, d4eu2P_, 0.8959, 1.55, 0.368, 249, 228, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
1132, d3sdiA_, 0.8955, 1.56, 0.368, 246, 228, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
1133, d3sdiO_, 0.8954, 1.55, 0.368, 246, 228, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
1134, p5gjrT_, 0.8951, 1.38, 0.394, 231, 226, 
1135, p5gjrHA_, 0.8949, 1.39, 0.394, 231, 226, 
1136, d1j2qB_, 0.8949, 1.79, 0.435, 237, 230, 20S PROTEASOME IN COMPLEX WITH CALPAIN-INHIBITOR I FROM ARCHAEOGLOBUS FULGIDUS
1137, d1j2qA_, 0.8948, 1.80, 0.435, 237, 230, 20S PROTEASOME IN COMPLEX WITH CALPAIN-INHIBITOR I FROM ARCHAEOGLOBUS FULGIDUS
1138, d1j2qF_, 0.8947, 1.80, 0.435, 237, 230, 20S PROTEASOME IN COMPLEX WITH CALPAIN-INHIBITOR I FROM ARCHAEOGLOBUS FULGIDUS
1139, d1j2qE_, 0.8947, 1.80, 0.435, 237, 230, 20S PROTEASOME IN COMPLEX WITH CALPAIN-INHIBITOR I FROM ARCHAEOGLOBUS FULGIDUS
1140, d1j2qD_, 0.8947, 1.80, 0.435, 237, 230, 20S PROTEASOME IN COMPLEX WITH CALPAIN-INHIBITOR I FROM ARCHAEOGLOBUS FULGIDUS
1141, d1j2qC_, 0.8946, 1.80, 0.435, 237, 230, 20S PROTEASOME IN COMPLEX WITH CALPAIN-INHIBITOR I FROM ARCHAEOGLOBUS FULGIDUS
1142, d1j2qG_, 0.8945, 1.80, 0.435, 237, 230, 20S PROTEASOME IN COMPLEX WITH CALPAIN-INHIBITOR I FROM ARCHAEOGLOBUS FULGIDUS
1143, p4x6zB_, 0.8940, 1.58, 0.368, 248, 228, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
1144, p5t0cZA_, 0.8939, 1.54, 0.386, 232, 228, 
1145, p5t0cT_, 0.8939, 1.54, 0.386, 232, 228, 
1146, p3unhO_, 0.8938, 1.33, 0.391, 230, 225, MOUSE 20S IMMUNOPROTEASOME
1147, p3unhA_, 0.8938, 1.33, 0.391, 230, 225, MOUSE 20S IMMUNOPROTEASOME
1148, d1z7qE1, 0.8938, 2.02, 0.336, 242, 232, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
1149, d4g4sB_, 0.8937, 1.57, 0.364, 246, 228, STRUCTURE OF PROTEASOME-PBA1-PBA2 COMPLEX
1150, d1z7qS1, 0.8937, 2.02, 0.336, 242, 232, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
1151, d3unfO_, 0.8935, 1.34, 0.391, 230, 225, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
1152, d3unfA_, 0.8935, 1.34, 0.391, 230, 225, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
1153, p5mp9B_, 0.8934, 1.63, 0.362, 250, 229, 26S PROTEASOME IN PRESENCE OF ATP (S1)
1154, d4r02P_, 0.8933, 2.05, 0.306, 244, 232, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
1155, d5dkjP_, 0.8932, 2.05, 0.306, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
1156, d5dkjB_, 0.8932, 2.05, 0.306, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
1157, d5d0tP_, 0.8932, 2.05, 0.306, 244, 232, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
1158, d4qvqP_, 0.8932, 2.05, 0.306, 244, 232, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
1159, d4qvqB_, 0.8932, 2.05, 0.306, 244, 232, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
1160, p3jcpKA_, 0.8932, 1.63, 0.367, 250, 229, 
1161, p3jcpK_, 0.8932, 1.63, 0.367, 250, 229, 
1162, p5gjqi_, 0.8931, 1.41, 0.394, 231, 226, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
1163, d5d0tB_, 0.8931, 2.05, 0.306, 244, 232, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
1164, d4qvpP_, 0.8931, 2.05, 0.306, 244, 232, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
1165, d4qvmP_, 0.8931, 2.06, 0.306, 244, 232, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
1166, d4qvmB_, 0.8931, 2.06, 0.306, 244, 232, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
1167, d5dkiP_, 0.8930, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
1168, d5dkiB_, 0.8930, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
1169, d5d0xP_, 0.8930, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
1170, d5d0xB_, 0.8930, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
1171, d4qw1P_, 0.8930, 2.05, 0.306, 244, 232, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
1172, d4qw1B_, 0.8930, 2.05, 0.306, 244, 232, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
1173, d4qvpB_, 0.8930, 2.05, 0.306, 244, 232, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
1174, d3d29R_, 0.8930, 1.94, 0.341, 242, 232, PROTEASOME INHIBITION BY FELLUTAMIDE B
1175, p4y8uP_, 0.8929, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
1176, p4y8uB_, 0.8929, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
1177, d4qwuP_, 0.8929, 2.05, 0.306, 244, 232, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
1178, d4qwuB_, 0.8929, 2.05, 0.306, 244, 232, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
1179, d4qw0B_, 0.8929, 2.06, 0.306, 244, 232, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
1180, d4qvwP_, 0.8929, 2.06, 0.306, 244, 232, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
1181, d4qvwB_, 0.8929, 2.06, 0.306, 244, 232, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
1182, d4qvvP_, 0.8929, 2.06, 0.306, 244, 232, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
1183, d4qvnP_, 0.8929, 2.05, 0.306, 244, 232, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
1184, d4qvnB_, 0.8929, 2.05, 0.306, 244, 232, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
1185, d4ltcP_, 0.8929, 2.06, 0.306, 244, 232, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
1186, d4intP_, 0.8929, 2.07, 0.306, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
1187, d4hrdB_, 0.8929, 2.07, 0.306, 244, 232, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
1188, d3d29D_, 0.8929, 1.94, 0.341, 242, 232, PROTEASOME INHIBITION BY FELLUTAMIDE B
1189, d2zcyR_, 0.8929, 1.94, 0.341, 242, 232, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
1190, d2zcyD_, 0.8929, 1.94, 0.341, 242, 232, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
1191, p6epfD_, 0.8928, 2.03, 0.582, 246, 237, GROUND STATE 26S PROTEASOME (GS1)
1192, d5lajP_, 0.8928, 2.06, 0.306, 244, 232, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
1193, d5lajB_, 0.8928, 2.06, 0.306, 244, 232, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
1194, p5fghP_, 0.8928, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
1195, p5fghB_, 0.8928, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
1196, d5cz7P_, 0.8928, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
1197, d5cz7B_, 0.8928, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
1198, d4z1lP_, 0.8928, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
1199, d4z1lB_, 0.8928, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
1200, p4ya0P_, 0.8928, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
1201, p4ya0B_, 0.8928, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
1202, p4y69P_, 0.8928, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
1203, p4y69B_, 0.8928, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
1204, d4r02B_, 0.8928, 2.05, 0.306, 244, 232, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
1205, d4r00P_, 0.8928, 2.06, 0.306, 244, 232, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
1206, d4qw0P_, 0.8928, 2.06, 0.306, 244, 232, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
1207, d4qvvB_, 0.8928, 2.06, 0.306, 244, 232, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
1208, d4eu2S_, 0.8928, 1.96, 0.336, 242, 232, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
1209, d3dy3R_, 0.8928, 1.94, 0.341, 242, 232, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
1210, d2gplP_, 0.8928, 2.06, 0.306, 244, 232, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
1211, d2gplB_, 0.8928, 2.06, 0.306, 244, 232, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
1212, d2fakP_, 0.8928, 2.05, 0.306, 244, 232, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
1213, d2fakB_, 0.8928, 2.05, 0.306, 244, 232, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
1214, d2f16B_, 0.8928, 2.06, 0.306, 244, 232, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
1215, d5l5iP_, 0.8927, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
1216, d5l5iB_, 0.8927, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
1217, d5cgfP_, 0.8927, 2.05, 0.306, 244, 232, YEAST 20S PROTEASOME BETA5-G48C MUTANT
1218, d5cgfB_, 0.8927, 2.05, 0.306, 244, 232, YEAST 20S PROTEASOME BETA5-G48C MUTANT
1219, p4ya5P_, 0.8927, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
1220, p4ya5B_, 0.8927, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
1221, p4y8lP_, 0.8927, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
1222, p4y8lB_, 0.8927, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
1223, p4y8iP_, 0.8927, 2.07, 0.306, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
1224, p4y8iB_, 0.8927, 2.07, 0.306, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
1225, d4rurP_, 0.8927, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
1226, d4rurB_, 0.8927, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
1227, d4r00B_, 0.8927, 2.06, 0.306, 244, 232, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
1228, d4qz2P_, 0.8927, 2.06, 0.306, 244, 232, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1229, d4qz2B_, 0.8927, 2.06, 0.306, 244, 232, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1230, d4qz1P_, 0.8927, 2.06, 0.306, 244, 232, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1231, d4qw3P_, 0.8927, 2.07, 0.306, 244, 232, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
1232, d4qw3B_, 0.8927, 2.07, 0.306, 244, 232, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
1233, d3dy3D_, 0.8927, 1.94, 0.341, 242, 232, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
1234, d3bdmR_, 0.8927, 1.95, 0.341, 242, 232, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
1235, d3bdmD_, 0.8927, 1.95, 0.341, 242, 232, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
1236, d2fnyP_, 0.8927, 2.06, 0.306, 244, 232,  
1237, d2fnyB_, 0.8927, 2.06, 0.306, 244, 232,  
1238, d2f16P_, 0.8927, 2.06, 0.306, 244, 232, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
1239, d5l68P_, 0.8926, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
1240, d5l68B_, 0.8926, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
1241, d5l5tP_, 0.8926, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1242, d5l5tB_, 0.8926, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1243, d5l5jP_, 0.8926, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
1244, d5l5jB_, 0.8926, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
1245, d5l5eP_, 0.8926, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
1246, d5l5eB_, 0.8926, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
1247, d5l54P_, 0.8926, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1248, d5l54B_, 0.8926, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1249, d5fgaP_, 0.8926, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
1250, d5fgaB_, 0.8926, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
1251, d5cz8P_, 0.8926, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
1252, d5cz8B_, 0.8926, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
1253, p5cgiP_, 0.8926, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
1254, p5cgiB_, 0.8926, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
1255, p4ya3P_, 0.8926, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
1256, p4ya3B_, 0.8926, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
1257, p4y8nP_, 0.8926, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
1258, p4y8nB_, 0.8926, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
1259, p4y6vP_, 0.8926, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
1260, p4y6vB_, 0.8926, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
1261, d4qzxP_, 0.8926, 2.06, 0.306, 244, 232, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1262, d4qz1B_, 0.8926, 2.06, 0.306, 244, 232, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1263, d4qz0P_, 0.8926, 2.06, 0.306, 244, 232, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1264, d4qz0B_, 0.8926, 2.06, 0.306, 244, 232, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1265, d4qxjP_, 0.8926, 2.07, 0.306, 244, 232, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1266, d4qxjB_, 0.8926, 2.07, 0.306, 244, 232, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1267, d4qw6P_, 0.8926, 2.06, 0.306, 244, 232, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
1268, d4qvyP_, 0.8926, 2.06, 0.306, 244, 232, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
1269, d4qvyB_, 0.8926, 2.06, 0.306, 244, 232, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
1270, d4qvlP_, 0.8926, 2.06, 0.306, 244, 232, YCP IN COMPLEX WITH BORTEZOMIB
1271, d4qvlB_, 0.8926, 2.06, 0.306, 244, 232, YCP IN COMPLEX WITH BORTEZOMIB
1272, d4intB_, 0.8926, 2.07, 0.306, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
1273, d4inrB_, 0.8926, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
1274, d3nzjP_, 0.8926, 2.05, 0.306, 244, 232, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
1275, d3nzjB_, 0.8926, 2.06, 0.306, 244, 232, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
1276, d3hyeP_, 0.8926, 2.05, 0.306, 244, 232, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
1277, d5lttP_, 0.8925, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
1278, d5lttB_, 0.8925, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
1279, d5l65P_, 0.8925, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
1280, d5l65B_, 0.8925, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
1281, d5l60P_, 0.8925, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
1282, d5l60B_, 0.8925, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
1283, d5l5xP_, 0.8925, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
1284, d5l5xB_, 0.8925, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
1285, d5l5sB_, 0.8925, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
1286, d5l5oP_, 0.8925, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1287, d5l5fP_, 0.8925, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
1288, d5l5fB_, 0.8925, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
1289, d5l52P_, 0.8925, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
1290, d5l52B_, 0.8925, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
1291, d5fg9P_, 0.8925, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
1292, d5fg9B_, 0.8925, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
1293, d5fg7P_, 0.8925, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME BETA2-T1A MUTANT
1294, d5fg7B_, 0.8925, 2.05, 0.306, 244, 232, YEAST 20S PROTEASOME BETA2-T1A MUTANT
1295, d5cz4P_, 0.8925, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
1296, d5cz4B_, 0.8925, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
1297, d5bouP_, 0.8925, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
1298, d5bouB_, 0.8925, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
1299, p5a0qQ_, 0.8925, 1.92, 0.328, 237, 229, CRYO-EM REVEALS THE CONFORMATION OF A SUBSTRATE ANALOGUE IN THE HUMAN 20S PROTEASOME CORE
1300, p5a0qC_, 0.8925, 1.92, 0.328, 237, 229, CRYO-EM REVEALS THE CONFORMATION OF A SUBSTRATE ANALOGUE IN THE HUMAN 20S PROTEASOME CORE
1301, d4ya1P_, 0.8925, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME BETA2-H116N MUTANT
1302, d4y9yP_, 0.8925, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME BETA2-H116E MUTANT
1303, d4y9yB_, 0.8925, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME BETA2-H116E MUTANT
1304, p4y8pP_, 0.8925, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
1305, p4y8kP_, 0.8925, 2.07, 0.306, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
1306, p4y8kB_, 0.8925, 2.07, 0.306, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
1307, p4y8jP_, 0.8925, 2.07, 0.306, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
1308, p4y8jB_, 0.8925, 2.07, 0.306, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
1309, p4y7yP_, 0.8925, 2.07, 0.306, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
1310, p4y7yB_, 0.8925, 2.07, 0.306, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
1311, p4y6aP_, 0.8925, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
1312, p4y6aB_, 0.8925, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
1313, d4r18P_, 0.8925, 2.06, 0.306, 244, 232, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
1314, p4r18B_, 0.8925, 2.06, 0.306, 244, 232, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
1315, d4qzxB_, 0.8925, 2.06, 0.306, 244, 232, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1316, d4qz5P_, 0.8925, 2.06, 0.306, 244, 232, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
1317, d4qz5B_, 0.8925, 2.06, 0.306, 244, 232, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
1318, d4qwrP_, 0.8925, 2.07, 0.306, 244, 232, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
1319, d4qwrB_, 0.8925, 2.07, 0.306, 244, 232, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
1320, d4qwiP_, 0.8925, 2.07, 0.306, 244, 232, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
1321, d4qwiB_, 0.8925, 2.07, 0.306, 244, 232, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
1322, d4qw7P_, 0.8925, 2.07, 0.306, 244, 232, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
1323, d4qw6B_, 0.8925, 2.06, 0.306, 244, 232, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
1324, d4qv7P_, 0.8925, 2.06, 0.306, 244, 232, YCP BETA5-A50V MUTANT
1325, d4qv7B_, 0.8925, 2.06, 0.306, 244, 232, YCP BETA5-A50V MUTANT
1326, d4qv3P_, 0.8925, 2.06, 0.306, 244, 232, YCP BETA5-M45V MUTANT
1327, d4quxP_, 0.8925, 2.06, 0.306, 244, 232, YCP BETA5-A49T-MUTANT
1328, d4quxB_, 0.8925, 2.06, 0.306, 244, 232, YCP BETA5-A49T-MUTANT
1329, d4hrcB_, 0.8925, 1.93, 0.307, 244, 231, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
1330, d4hnpB_, 0.8925, 2.07, 0.306, 244, 232, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
1331, d3nzwP_, 0.8925, 2.06, 0.306, 244, 232, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
1332, d3mg0P_, 0.8925, 2.06, 0.306, 244, 232, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
1333, d3hyeB_, 0.8925, 2.05, 0.306, 244, 232, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
1334, d3e47P_, 0.8925, 2.06, 0.306, 244, 232, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
1335, d1g65B_, 0.8925, 2.07, 0.306, 244, 232, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
1336, d5laiP_, 0.8924, 2.06, 0.306, 244, 232, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
1337, d5laiB_, 0.8924, 2.06, 0.306, 244, 232, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
1338, d5l6bP_, 0.8924, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
1339, d5l6bB_, 0.8924, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
1340, d5l67P_, 0.8924, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
1341, d5l67B_, 0.8924, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
1342, d5l66P_, 0.8924, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
1343, d5l5zP_, 0.8924, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
1344, d5l5zB_, 0.8924, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
1345, d5l5yP_, 0.8924, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
1346, d5l5yB_, 0.8924, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
1347, d5l5vP_, 0.8924, 2.06, 0.306, 244, 232,  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
1348, d5l5vB_, 0.8924, 2.06, 0.306, 244, 232,  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
1349, d5l5sP_, 0.8924, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
1350, d5l5oB_, 0.8924, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1351, d5jhsP_, 0.8924, 2.07, 0.306, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
1352, d5jhsB_, 0.8924, 2.07, 0.306, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
1353, d5d0zP_, 0.8924, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
1354, d5d0zB_, 0.8924, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
1355, d5cz6P_, 0.8924, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
1356, d5cz6B_, 0.8924, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
1357, d4ya1B_, 0.8924, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME BETA2-H116N MUTANT
1358, p4y9zP_, 0.8924, 2.07, 0.306, 244, 232, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
1359, p4y8qP_, 0.8924, 2.07, 0.306, 244, 232, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
1360, p4y8qB_, 0.8924, 2.07, 0.306, 244, 232, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
1361, p4y8pB_, 0.8924, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
1362, p4y8oP_, 0.8924, 2.07, 0.306, 244, 232, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
1363, d4y8mP_, 0.8924, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
1364, d4y8mB_, 0.8924, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
1365, p4y80P_, 0.8924, 2.07, 0.306, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
1366, p4y80B_, 0.8924, 2.07, 0.306, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
1367, p4y78P_, 0.8924, 2.07, 0.306, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP
1368, p4y78B_, 0.8924, 2.07, 0.306, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP
1369, p4y77P_, 0.8924, 2.07, 0.306, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
1370, d4r17P_, 0.8924, 2.06, 0.306, 244, 232, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
1371, d4qz7P_, 0.8924, 2.06, 0.306, 244, 232, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1372, d4qz7B_, 0.8924, 2.06, 0.306, 244, 232, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1373, d4qz6P_, 0.8924, 2.07, 0.306, 244, 232, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1374, d4qz6B_, 0.8924, 2.07, 0.306, 244, 232, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1375, d4qz4P_, 0.8924, 2.07, 0.306, 244, 232, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1376, d4qz4B_, 0.8924, 2.07, 0.306, 244, 232, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1377, d4qwxP_, 0.8924, 2.07, 0.306, 244, 232, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1378, d4qwxB_, 0.8924, 2.07, 0.306, 244, 232, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1379, d4qwjP_, 0.8924, 2.07, 0.306, 244, 232, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
1380, d4qwfP_, 0.8924, 2.07, 0.306, 244, 232, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
1381, d4qwfB_, 0.8924, 2.07, 0.306, 244, 232, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
1382, d4qw7B_, 0.8924, 2.07, 0.306, 244, 232, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
1383, d4qw4P_, 0.8924, 2.07, 0.306, 244, 232, YCP IN COMPLEX WITH CARFILZOMIB
1384, d4qw4B_, 0.8924, 2.07, 0.306, 244, 232, YCP IN COMPLEX WITH CARFILZOMIB
1385, d4qv8P_, 0.8924, 2.06, 0.306, 244, 232, YCP BETA5-C52F MUTANT
1386, d4qv8B_, 0.8924, 2.06, 0.306, 244, 232, YCP BETA5-C52F MUTANT
1387, d4qv3B_, 0.8924, 2.06, 0.306, 244, 232, YCP BETA5-M45V MUTANT
1388, d4qv0P_, 0.8924, 2.06, 0.306, 244, 232, YCP BETA5-A49T-A50V-DOUBLE MUTANT
1389, d4qv0B_, 0.8924, 2.06, 0.306, 244, 232, YCP BETA5-A49T-A50V-DOUBLE MUTANT
1390, d4qltP_, 0.8924, 2.06, 0.306, 244, 232, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
1391, p4qltB_, 0.8924, 2.06, 0.306, 244, 232, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
1392, d4qlsP_, 0.8924, 2.06, 0.306, 244, 232, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
1393, p4qlsB_, 0.8924, 2.06, 0.306, 244, 232, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
1394, d4ltcB_, 0.8924, 2.05, 0.306, 244, 232, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
1395, d4inrP_, 0.8924, 2.07, 0.306, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
1396, d3nzwB_, 0.8924, 2.06, 0.306, 244, 232, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
1397, d3gpjR_, 0.8924, 1.95, 0.341, 242, 232, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
1398, d3gpjD_, 0.8924, 1.95, 0.341, 242, 232, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
1399, d3e47B_, 0.8924, 2.06, 0.306, 244, 232, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
1400, d5l6cP_, 0.8923, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
1401, d5l6cB_, 0.8923, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
1402, d5l69B_, 0.8923, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1403, d5l66B_, 0.8923, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
1404, d5l62P_, 0.8923, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1405, d5l62B_, 0.8923, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1406, d5l61P_, 0.8923, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
1407, d5l61B_, 0.8923, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
1408, d5l5qP_, 0.8923, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
1409, d5l5qB_, 0.8923, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
1410, d5l5pP_, 0.8923, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
1411, d5l5pB_, 0.8923, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
1412, d5fhsP_, 0.8923, 2.07, 0.306, 244, 232, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
1413, d5fhsB_, 0.8923, 2.07, 0.306, 244, 232, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
1414, d5fgfP_, 0.8923, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
1415, d5fgfB_, 0.8923, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
1416, d5fgdP_, 0.8923, 2.07, 0.306, 244, 232, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1417, d5fgdB_, 0.8923, 2.07, 0.306, 244, 232, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1418, d5d0vP_, 0.8923, 2.07, 0.306, 244, 232, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
1419, d5d0vB_, 0.8923, 2.07, 0.306, 244, 232, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
1420, d5czaP_, 0.8923, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME BETA5-D166N MUTANT
1421, d5czaB_, 0.8923, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME BETA5-D166N MUTANT
1422, d5cz5P_, 0.8923, 2.07, 0.306, 244, 232, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
1423, d5cz5B_, 0.8923, 2.07, 0.306, 244, 232, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
1424, d5bxnP_, 0.8923, 2.05, 0.306, 244, 232, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
1425, d5bxnB_, 0.8923, 2.05, 0.306, 244, 232, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
1426, d5bxlP_, 0.8923, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME BETA2-G170A MUTANT
1427, d5bxlB_, 0.8923, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME BETA2-G170A MUTANT
1428, p4ya9P_, 0.8923, 2.07, 0.306, 244, 232, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
1429, p4ya9B_, 0.8923, 2.07, 0.306, 244, 232, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
1430, p4y9zB_, 0.8923, 2.07, 0.306, 244, 232, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
1431, p4y8oB_, 0.8923, 2.07, 0.306, 244, 232, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
1432, p4y8hP_, 0.8923, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
1433, p4y84P_, 0.8923, 2.07, 0.306, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
1434, p4y84B_, 0.8923, 2.07, 0.306, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
1435, p4y82P_, 0.8923, 2.07, 0.306, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
1436, p4y82B_, 0.8923, 2.07, 0.306, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
1437, p4y81P_, 0.8923, 2.07, 0.306, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
1438, p4y81B_, 0.8923, 2.07, 0.306, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
1439, p4y7xP_, 0.8923, 2.07, 0.306, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
1440, p4y7xB_, 0.8923, 2.07, 0.306, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
1441, p4y7wP_, 0.8923, 2.07, 0.306, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
1442, p4y7wB_, 0.8923, 2.07, 0.306, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
1443, p4y77B_, 0.8923, 2.07, 0.306, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
1444, p4y70P_, 0.8923, 2.07, 0.306, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
1445, p4y70B_, 0.8923, 2.07, 0.306, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
1446, d4qzwP_, 0.8923, 2.07, 0.306, 244, 232, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1447, d4qzwB_, 0.8923, 2.07, 0.306, 244, 232, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1448, d4qz3P_, 0.8923, 2.07, 0.306, 244, 232, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1449, d4qz3B_, 0.8923, 2.07, 0.306, 244, 232, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1450, d4qwlP_, 0.8923, 2.06, 0.306, 244, 232, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
1451, d4qwlB_, 0.8923, 2.06, 0.306, 244, 232, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
1452, d4qwkP_, 0.8923, 2.07, 0.306, 244, 232, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1453, d4qwkB_, 0.8923, 2.07, 0.306, 244, 232, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1454, d4qwjB_, 0.8923, 2.07, 0.306, 244, 232, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
1455, d4qw5P_, 0.8923, 2.07, 0.306, 244, 232, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
1456, d4qw5B_, 0.8923, 2.07, 0.306, 244, 232, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
1457, d4qv4P_, 0.8923, 2.06, 0.306, 244, 232, YCP BETA5-M45T MUTANT
1458, d4quyP_, 0.8923, 2.06, 0.306, 244, 232, YCP BETA5-A49S-MUTANT
1459, d4quyB_, 0.8923, 2.06, 0.306, 244, 232, YCP BETA5-A49S-MUTANT
1460, d4jsuP_, 0.8923, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
1461, d4jsuB_, 0.8923, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
1462, p4gk7P_, 0.8923, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
1463, p4gk7B_, 0.8923, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
1464, d3okjP_, 0.8923, 2.06, 0.306, 244, 232, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
1465, d3okjB_, 0.8923, 2.06, 0.306, 244, 232, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
1466, d3mg0B_, 0.8923, 2.05, 0.306, 244, 232, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
1467, d3dy4R_, 0.8923, 1.95, 0.341, 242, 232, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
1468, d1g65P_, 0.8923, 2.21, 0.309, 244, 233, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
1469, p1fntS_, 0.8923, 1.90, 0.333, 244, 231, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
1470, p1fntE_, 0.8923, 1.90, 0.333, 244, 231, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
1471, d5l69P_, 0.8922, 2.07, 0.306, 244, 232, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1472, d5l64P_, 0.8922, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
1473, d5l64B_, 0.8922, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
1474, d5l63P_, 0.8922, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
1475, d5l63B_, 0.8922, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
1476, d5l5hP_, 0.8922, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
1477, d5l5hB_, 0.8922, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
1478, d5jhrP_, 0.8922, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
1479, d5jhrB_, 0.8922, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
1480, d5fgiP_, 0.8922, 2.07, 0.306, 244, 232, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1481, d5fgiB_, 0.8922, 2.07, 0.306, 244, 232, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1482, d5d0sP_, 0.8922, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
1483, d5d0sB_, 0.8922, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
1484, d5cz9P_, 0.8922, 2.07, 0.306, 244, 232, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
1485, d5cz9B_, 0.8922, 2.07, 0.306, 244, 232, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
1486, p4ya7P_, 0.8922, 2.07, 0.306, 244, 232, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
1487, p4ya7B_, 0.8922, 2.07, 0.306, 244, 232, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
1488, d4y8rP_, 0.8922, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME BETA2-H116D MUTANT
1489, d4y8rB_, 0.8922, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME BETA2-H116D MUTANT
1490, p4y8hB_, 0.8922, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
1491, p4y8gP_, 0.8922, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
1492, d4r17B_, 0.8922, 2.06, 0.306, 244, 232, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
1493, d4qzzP_, 0.8922, 2.06, 0.306, 244, 232, YCP IN COMPLEX WITH OMURALIDE
1494, d4qzzB_, 0.8922, 2.06, 0.306, 244, 232, YCP IN COMPLEX WITH OMURALIDE
1495, d4qv4B_, 0.8922, 2.06, 0.306, 244, 232, YCP BETA5-M45T MUTANT
1496, d4nnwP_, 0.8922, 2.07, 0.306, 244, 232, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
1497, d4nnwB_, 0.8922, 2.07, 0.306, 244, 232, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
1498, d3dy4D_, 0.8922, 1.95, 0.341, 242, 232, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
1499, d5m2bP_, 0.8921, 2.07, 0.306, 244, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
1500, d5m2bB_, 0.8921, 2.07, 0.306, 244, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
1501, d5l5uP_, 0.8921, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
1502, d5l5uB_, 0.8921, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
1503, d5l5dP_, 0.8921, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
1504, d5l5dB_, 0.8921, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
1505, d5l5aP_, 0.8921, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
1506, d5l5aB_, 0.8921, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
1507, d5l55P_, 0.8921, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
1508, d5l55B_, 0.8921, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
1509, d5fgeP_, 0.8921, 2.07, 0.306, 244, 232, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1510, d5fgeB_, 0.8921, 2.07, 0.306, 244, 232, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1511, d5d0wP_, 0.8921, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME BETA5-T1S MUTANT
1512, d5d0wB_, 0.8921, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME BETA5-T1S MUTANT
1513, d4ya4P_, 0.8921, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME BETA2-H114D MUTANT
1514, d4ya4B_, 0.8921, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME BETA2-H114D MUTANT
1515, p4y8gB_, 0.8921, 2.07, 0.306, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
1516, p4y75P_, 0.8921, 2.07, 0.306, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
1517, p4y75B_, 0.8921, 2.07, 0.306, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
1518, p4y74P_, 0.8921, 2.07, 0.306, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
1519, p4y74B_, 0.8921, 2.07, 0.306, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
1520, p4y6zP_, 0.8921, 2.07, 0.306, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
1521, p4y6zB_, 0.8921, 2.07, 0.306, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
1522, d4qv9P_, 0.8921, 2.06, 0.306, 244, 232, YCP BETA5-C63F MUTANT
1523, d4qv5P_, 0.8921, 2.06, 0.306, 244, 232, YCP BETA5-M45I MUTANT
1524, d4qv5B_, 0.8921, 2.06, 0.306, 244, 232, YCP BETA5-M45I MUTANT
1525, d4qv1P_, 0.8921, 2.06, 0.306, 244, 232, YCP BETA5-M45A MUTANT
1526, d4qv1B_, 0.8921, 2.06, 0.306, 244, 232, YCP BETA5-M45A MUTANT
1527, d4jsqP_, 0.8921, 2.07, 0.306, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
1528, d4jsqB_, 0.8921, 2.07, 0.306, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
1529, d3gpwP_, 0.8921, 2.06, 0.306, 244, 232, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
1530, d3gpwB_, 0.8921, 2.06, 0.306, 244, 232, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
1531, d5l5wP_, 0.8920, 2.07, 0.306, 244, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
1532, d5l5wB_, 0.8920, 2.07, 0.306, 244, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
1533, p4y8sP_, 0.8920, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
1534, p4y8sB_, 0.8920, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
1535, d4qwsP_, 0.8920, 2.08, 0.306, 244, 232, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
1536, d4qwsB_, 0.8920, 2.08, 0.306, 244, 232, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
1537, d4qv9B_, 0.8920, 2.06, 0.306, 244, 232, YCP BETA5-C63F MUTANT
1538, d4lqiP_, 0.8920, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
1539, d4lqiB_, 0.8920, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
1540, d4inuB_, 0.8920, 2.07, 0.306, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
1541, d3tddP_, 0.8920, 2.07, 0.306, 244, 232, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
1542, d3tddB_, 0.8920, 2.07, 0.306, 244, 232, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
1543, p6gopP_, 0.8919, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
1544, p5t0hI_, 0.8919, 2.20, 0.322, 250, 236, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
1545, d5l6aP_, 0.8919, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
1546, d5l6aB_, 0.8919, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
1547, d5fggP_, 0.8919, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1548, d5fggB_, 0.8919, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1549, p5cggP_, 0.8919, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
1550, p5cggB_, 0.8919, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
1551, d4nnnP_, 0.8919, 2.07, 0.306, 244, 232, YCP IN COMPLEX WITH MG132
1552, d4nnnB_, 0.8919, 2.07, 0.306, 244, 232, YCP IN COMPLEX WITH MG132
1553, d4inuP_, 0.8919, 2.08, 0.306, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
1554, p3un4P_, 0.8919, 2.07, 0.306, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
1555, p3un4B_, 0.8919, 2.07, 0.306, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
1556, d3nzjR_, 0.8919, 1.96, 0.341, 242, 232, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
1557, p6gopB_, 0.8918, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
1558, p5cghP_, 0.8918, 2.07, 0.306, 244, 232, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
1559, p5cghB_, 0.8918, 2.07, 0.306, 244, 232, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
1560, d5ahjP_, 0.8918, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
1561, d5ahjB_, 0.8918, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
1562, d4qlqP_, 0.8918, 2.07, 0.306, 244, 232, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
1563, p4qlqB_, 0.8918, 2.07, 0.306, 244, 232, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
1564, d4jt0P_, 0.8918, 2.07, 0.306, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
1565, d4jt0B_, 0.8918, 2.07, 0.306, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
1566, d4fzcB_, 0.8918, 2.08, 0.306, 244, 232, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
1567, d3nzjD_, 0.8918, 1.96, 0.341, 242, 232, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
1568, d3gptP_, 0.8918, 2.06, 0.306, 244, 232, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
1569, d3gptB_, 0.8918, 2.06, 0.306, 244, 232, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
1570, p5m32O_, 0.8917, 1.48, 0.392, 230, 227, HUMAN 26S PROTEASOME IN COMPLEX WITH OPROZOMIB
1571, p5m32A_, 0.8917, 1.48, 0.392, 230, 227, HUMAN 26S PROTEASOME IN COMPLEX WITH OPROZOMIB
1572, d4qwgP_, 0.8917, 2.08, 0.306, 244, 232, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
1573, d4qwgB_, 0.8917, 2.08, 0.306, 244, 232, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
1574, d4qluP_, 0.8917, 2.07, 0.306, 244, 232, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
1575, p4qluB_, 0.8917, 2.07, 0.306, 244, 232, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
1576, d4fzcP_, 0.8917, 2.08, 0.306, 244, 232, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
1577, d5l5bP_, 0.8916, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
1578, d5l5bB_, 0.8916, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
1579, p4ya2P_, 0.8916, 2.07, 0.306, 244, 232, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
1580, p4ya2B_, 0.8916, 2.07, 0.306, 244, 232, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
1581, p4y8tP_, 0.8916, 2.07, 0.306, 244, 232, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
1582, p4y8tB_, 0.8916, 2.07, 0.306, 244, 232, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
1583, p4jt0R_, 0.8916, 1.96, 0.341, 242, 232, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
1584, d4hnpR_, 0.8916, 1.99, 0.341, 242, 232, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
1585, d3un8R_, 0.8916, 1.96, 0.341, 242, 232, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
1586, d3mg0R_, 0.8916, 1.97, 0.341, 242, 232, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
1587, d5l5rP_, 0.8915, 2.07, 0.306, 244, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
1588, d4qv6P_, 0.8915, 2.07, 0.306, 244, 232, YCP BETA5-A49V MUTANT
1589, d4qv6B_, 0.8915, 2.07, 0.306, 244, 232, YCP BETA5-A49V MUTANT
1590, d4q1sP_, 0.8915, 2.08, 0.306, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
1591, p4jt0D_, 0.8915, 1.96, 0.341, 242, 232, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
1592, d4hrcP_, 0.8915, 1.95, 0.307, 244, 231, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
1593, p3un4R_, 0.8915, 1.96, 0.341, 242, 232, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
1594, p3un4D_, 0.8915, 1.96, 0.341, 242, 232, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
1595, d3tddD_, 0.8915, 1.95, 0.341, 242, 232, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
1596, d3nzxP_, 0.8915, 2.07, 0.306, 244, 232, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
1597, d3nzxB_, 0.8915, 2.07, 0.306, 244, 232, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
1598, d5l5rB_, 0.8914, 2.07, 0.306, 244, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
1599, d4inrR_, 0.8914, 1.96, 0.341, 242, 232, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
1600, d4inrD_, 0.8914, 1.96, 0.341, 242, 232, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
1601, d4fzcR_, 0.8914, 1.96, 0.341, 242, 232, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
1602, d4fzcD_, 0.8914, 1.96, 0.341, 242, 232, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
1603, d3tddR_, 0.8914, 1.96, 0.341, 242, 232, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
1604, d4q1sR_, 0.8913, 1.98, 0.341, 242, 232, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
1605, d4no6P_, 0.8913, 2.09, 0.306, 244, 232, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
1606, d4no6B_, 0.8913, 2.08, 0.306, 244, 232, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
1607, d4no1P_, 0.8913, 2.08, 0.306, 244, 232, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
1608, d4no1B_, 0.8913, 2.08, 0.306, 244, 232, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
1609, p4inuD_, 0.8913, 1.96, 0.341, 242, 232, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
1610, d4intD_, 0.8913, 1.96, 0.341, 242, 232, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
1611, d4hrdP_, 0.8913, 1.95, 0.307, 244, 231, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
1612, d4hnpP_, 0.8913, 1.95, 0.307, 244, 231, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
1613, d4fzgP_, 0.8913, 2.08, 0.306, 244, 232, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
1614, d4fzgB_, 0.8913, 2.08, 0.306, 244, 232, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
1615, d3mg4P_, 0.8913, 2.10, 0.306, 244, 232, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
1616, d2gplR_, 0.8913, 1.95, 0.341, 242, 232, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
1617, d2gplD_, 0.8913, 1.95, 0.341, 242, 232, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
1618, d2fakR_, 0.8913, 1.96, 0.341, 242, 232, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
1619, d2fakD_, 0.8913, 1.96, 0.341, 242, 232, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
1620, p5nifS_, 0.8912, 2.00, 0.341, 236, 232, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
1621, d4qlvP_, 0.8912, 2.07, 0.306, 244, 232, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
1622, p4qlvB_, 0.8912, 2.07, 0.306, 244, 232, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
1623, d3un8P_, 0.8912, 2.08, 0.306, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
1624, d3shjR_, 0.8912, 1.96, 0.341, 242, 232, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
1625, d3shjD_, 0.8912, 1.96, 0.341, 242, 232, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
1626, d3nzwR_, 0.8912, 1.96, 0.341, 242, 232, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
1627, p4zzgS_, 0.8911, 2.00, 0.341, 236, 232, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
1628, d4jsuR_, 0.8911, 1.97, 0.341, 242, 232, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
1629, d4j70P_, 0.8911, 2.09, 0.306, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
1630, d4j70B_, 0.8911, 2.08, 0.306, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
1631, p4inuR_, 0.8911, 1.96, 0.341, 242, 232, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
1632, d4intR_, 0.8911, 1.97, 0.341, 242, 232, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
1633, d3un8B_, 0.8911, 2.08, 0.306, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
1634, d3shjP_, 0.8911, 2.08, 0.306, 244, 232, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
1635, d3shjB_, 0.8911, 2.08, 0.306, 244, 232, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
1636, d3nzwD_, 0.8911, 1.96, 0.341, 242, 232, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
1637, p5nifQ_, 0.8910, 2.10, 0.306, 242, 232, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
1638, d4ltcR_, 0.8910, 1.98, 0.341, 242, 232, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
1639, d4jsuD_, 0.8910, 1.97, 0.341, 242, 232, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
1640, d3hyeR_, 0.8910, 1.97, 0.341, 242, 232, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
1641, d3hyeD_, 0.8910, 1.97, 0.341, 242, 232, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
1642, d3gpwR_, 0.8910, 1.96, 0.341, 242, 232, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
1643, d3gpwD_, 0.8910, 1.96, 0.341, 242, 232, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
1644, d3gptR_, 0.8910, 1.96, 0.341, 242, 232, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
1645, d2f16R_, 0.8910, 1.96, 0.341, 242, 232, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
1646, d2f16D_, 0.8910, 1.96, 0.341, 242, 232, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
1647, p4q1sB_, 0.8909, 2.07, 0.306, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
1648, d4no9P_, 0.8909, 2.10, 0.306, 244, 232, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
1649, d4no9B_, 0.8909, 2.10, 0.306, 244, 232, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
1650, d4jsqR_, 0.8909, 1.97, 0.341, 242, 232, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
1651, d4jsqD_, 0.8909, 1.97, 0.341, 242, 232, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
1652, d3gptD_, 0.8909, 1.97, 0.341, 242, 232, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
1653, p5vfuGA_, 0.8908, 1.59, 0.382, 232, 228, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
1654, p5vfth_, 0.8908, 1.59, 0.382, 232, 228, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
1655, p4x6zC_, 0.8908, 2.06, 0.306, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
1656, d4j70R_, 0.8908, 1.98, 0.341, 242, 232, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
1657, d3nzxR_, 0.8908, 1.97, 0.341, 242, 232, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
1658, d3nzxD_, 0.8908, 1.97, 0.341, 242, 232, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
1659, d3mg4B_, 0.8908, 2.08, 0.306, 244, 232, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
1660, d3d29P_, 0.8908, 2.09, 0.306, 244, 232, PROTEASOME INHIBITION BY FELLUTAMIDE B
1661, d3d29B_, 0.8908, 2.09, 0.306, 244, 232, PROTEASOME INHIBITION BY FELLUTAMIDE B
1662, d1rypQ_, 0.8908, 2.09, 0.306, 244, 232, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
1663, d4no8P_, 0.8907, 2.08, 0.306, 244, 232, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
1664, d4no8B_, 0.8907, 2.08, 0.306, 244, 232, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
1665, d3un8D_, 0.8907, 1.98, 0.341, 242, 232, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
1666, p3e47R_, 0.8907, 1.97, 0.341, 242, 232, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
1667, p3e47D_, 0.8907, 1.97, 0.341, 242, 232, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
1668, d4hnpD_, 0.8906, 2.00, 0.341, 242, 232, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
1669, p4fzgR_, 0.8906, 1.97, 0.341, 242, 232, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
1670, p4fzgD_, 0.8906, 1.97, 0.341, 242, 232, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
1671, d4eu2Q_, 0.8906, 1.97, 0.307, 244, 231, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
1672, d1rypS_, 0.8906, 1.98, 0.341, 242, 232, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
1673, p4qbyP_, 0.8905, 2.08, 0.306, 244, 232, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
1674, p4qbyB_, 0.8905, 2.08, 0.306, 244, 232, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
1675, d3okjR_, 0.8905, 1.97, 0.341, 242, 232, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
1676, d3okjD_, 0.8905, 1.97, 0.341, 242, 232, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
1677, d3mg8R_, 0.8905, 2.02, 0.341, 242, 232, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
1678, d3mg7R_, 0.8905, 2.02, 0.341, 242, 232, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
1679, d3mg6R_, 0.8905, 2.01, 0.341, 242, 232, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
1680, d3mg0D_, 0.8905, 1.98, 0.341, 242, 232, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
1681, d4lqiR_, 0.8904, 1.98, 0.341, 242, 232, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
1682, p5t0gH_, 0.8903, 1.60, 0.377, 233, 228, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
1683, d4lqiD_, 0.8903, 1.98, 0.341, 242, 232, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
1684, d4j70D_, 0.8903, 1.98, 0.341, 242, 232, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
1685, d4eu2C_, 0.8903, 2.11, 0.306, 244, 232, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
1686, d3wxrS_, 0.8903, 2.01, 0.341, 238, 232, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
1687, d1rypE_, 0.8903, 1.99, 0.341, 242, 232, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
1688, d3mg4R_, 0.8902, 2.01, 0.341, 242, 232, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
1689, d3dy3B_, 0.8902, 2.09, 0.306, 244, 232, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
1690, d1rypC_, 0.8902, 2.10, 0.306, 244, 232, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
1691, d3dy3P_, 0.8901, 2.09, 0.306, 244, 232, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
1692, p5nifE_, 0.8900, 1.85, 0.343, 236, 230, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
1693, d3bdmP_, 0.8900, 2.10, 0.306, 244, 232, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
1694, d3bdmB_, 0.8900, 2.10, 0.306, 244, 232, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
1695, p4zzgQ_, 0.8899, 1.98, 0.307, 242, 231, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
1696, d4hrdR_, 0.8899, 2.02, 0.341, 242, 232, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
1697, d4hrcR_, 0.8899, 2.02, 0.336, 242, 232, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
1698, d5l64R_, 0.8898, 1.83, 0.343, 235, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
1699, d5l61R_, 0.8898, 1.83, 0.343, 235, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
1700, d5l5wR_, 0.8898, 1.83, 0.343, 235, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
1701, d4eu2E_, 0.8898, 2.02, 0.341, 242, 232, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
1702, d3oeuR_, 0.8898, 2.07, 0.341, 236, 232, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
1703, d2zcyB_, 0.8898, 2.10, 0.306, 244, 232, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
1704, p5vfsBA_, 0.8897, 2.02, 0.333, 240, 231, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
1705, d5l64D_, 0.8897, 1.83, 0.343, 235, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
1706, d5l63R_, 0.8897, 1.83, 0.343, 235, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
1707, d5l62R_, 0.8897, 1.83, 0.343, 235, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1708, d5l61D_, 0.8897, 1.83, 0.343, 235, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
1709, d5l5wD_, 0.8897, 1.83, 0.343, 235, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
1710, d5cz6R_, 0.8897, 1.83, 0.343, 235, 230, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
1711, d4r17R_, 0.8897, 1.83, 0.343, 235, 230, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
1712, d3wxrC_, 0.8897, 2.11, 0.306, 242, 232, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
1713, d3mg4D_, 0.8897, 2.05, 0.341, 242, 232, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
1714, d3gpjP_, 0.8897, 2.10, 0.306, 244, 232, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
1715, d3gpjB_, 0.8897, 2.10, 0.306, 244, 232, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
1716, d3dy4P_, 0.8897, 2.10, 0.306, 244, 232, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
1717, d3dy4B_, 0.8897, 2.10, 0.306, 244, 232, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
1718, d2zcyP_, 0.8897, 2.10, 0.306, 244, 232, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
1719, d5lttR_, 0.8896, 1.84, 0.343, 235, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
1720, d5lttD_, 0.8896, 1.84, 0.343, 235, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
1721, d5laiR_, 0.8896, 1.83, 0.343, 235, 230, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
1722, d5l63D_, 0.8896, 1.83, 0.343, 235, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
1723, d5l62D_, 0.8896, 1.83, 0.343, 235, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1724, d5l5yR_, 0.8896, 1.84, 0.343, 235, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
1725, d5l5yD_, 0.8896, 1.84, 0.343, 235, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
1726, d5l5rR_, 0.8896, 1.83, 0.343, 235, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
1727, d5l5pR_, 0.8896, 1.83, 0.343, 235, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
1728, d5l5pD_, 0.8896, 1.84, 0.343, 235, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
1729, d5cz6D_, 0.8896, 1.83, 0.343, 235, 230, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
1730, p4zzgC_, 0.8896, 2.11, 0.306, 241, 232, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
1731, d4ya1R_, 0.8896, 1.83, 0.343, 235, 230, YEAST 20S PROTEASOME BETA2-H116N MUTANT
1732, d4y8mR_, 0.8896, 1.83, 0.343, 235, 230, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
1733, d4r17D_, 0.8896, 1.83, 0.343, 235, 230, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
1734, p4gk7R_, 0.8896, 1.98, 0.341, 242, 232, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
1735, p5nifC_, 0.8895, 2.12, 0.306, 241, 232, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
1736, p5mp9b_, 0.8895, 1.69, 0.362, 250, 229, 26S PROTEASOME IN PRESENCE OF ATP (S1)
1737, d5m2bR_, 0.8895, 1.84, 0.343, 235, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
1738, d5laiD_, 0.8895, 1.83, 0.343, 235, 230, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
1739, d5l60R_, 0.8895, 1.84, 0.343, 235, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
1740, d5l5zR_, 0.8895, 1.84, 0.343, 235, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
1741, d5l5zD_, 0.8895, 1.84, 0.343, 235, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
1742, d5l5xR_, 0.8895, 1.84, 0.343, 235, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
1743, d5l5xD_, 0.8895, 1.84, 0.343, 235, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
1744, d5l5vR_, 0.8895, 1.84, 0.343, 235, 230,  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
1745, d5l5vD_, 0.8895, 1.84, 0.343, 235, 230,  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
1746, d5l5tR_, 0.8895, 1.84, 0.343, 235, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1747, d5l5tD_, 0.8895, 1.84, 0.343, 235, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1748, d5l5rD_, 0.8895, 1.84, 0.343, 235, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
1749, d5l5qR_, 0.8895, 1.84, 0.343, 235, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
1750, d5l5oR_, 0.8895, 1.84, 0.343, 235, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1751, d5l5hR_, 0.8895, 1.84, 0.343, 235, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
1752, d5l5hD_, 0.8895, 1.84, 0.343, 235, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
1753, d5l5bR_, 0.8895, 1.83, 0.343, 235, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
1754, d5l5aR_, 0.8895, 1.84, 0.343, 235, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
1755, d5fg9R_, 0.8895, 1.83, 0.343, 235, 230, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
1756, d5fg9D_, 0.8895, 1.83, 0.343, 235, 230, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
1757, d5fg7R_, 0.8895, 1.83, 0.343, 235, 230, YEAST 20S PROTEASOME BETA2-T1A MUTANT
1758, d5bouR_, 0.8895, 1.83, 0.343, 235, 230, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
1759, p4zzgE_, 0.8895, 1.86, 0.343, 236, 230, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
1760, d4ya1D_, 0.8895, 1.83, 0.343, 235, 230, YEAST 20S PROTEASOME BETA2-H116N MUTANT
1761, d4y8mD_, 0.8895, 1.83, 0.343, 235, 230, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
1762, p4y6vR_, 0.8895, 1.83, 0.343, 235, 230, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
1763, p4y6vD_, 0.8895, 1.83, 0.343, 235, 230, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
1764, d4r02R_, 0.8895, 1.83, 0.343, 235, 230, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
1765, p4quxR_, 0.8895, 1.83, 0.343, 235, 230, YCP BETA5-A49T-MUTANT
1766, p4gk7D_, 0.8895, 1.98, 0.341, 242, 232, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
1767, d5m2bD_, 0.8894, 1.84, 0.343, 235, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
1768, d5l6cR_, 0.8894, 1.84, 0.343, 235, 230, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
1769, d5l6cD_, 0.8894, 1.84, 0.343, 235, 230, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
1770, d5l6aR_, 0.8894, 1.84, 0.343, 235, 230, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
1771, d5l6aD_, 0.8894, 1.84, 0.343, 235, 230, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
1772, d5l66R_, 0.8894, 1.84, 0.343, 235, 230, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
1773, d5l66D_, 0.8894, 1.84, 0.343, 235, 230, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
1774, d5l60D_, 0.8894, 1.84, 0.343, 235, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
1775, d5l5uR_, 0.8894, 1.84, 0.343, 235, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
1776, d5l5uD_, 0.8894, 1.84, 0.343, 235, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
1777, d5l5sR_, 0.8894, 1.84, 0.343, 235, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
1778, d5l5sD_, 0.8894, 1.84, 0.343, 235, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
1779, d5l5qD_, 0.8894, 1.84, 0.343, 235, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
1780, d5l5oD_, 0.8894, 1.84, 0.343, 235, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1781, d5l5fR_, 0.8894, 1.84, 0.343, 235, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
1782, d5l5fD_, 0.8894, 1.84, 0.343, 235, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
1783, d5l5bD_, 0.8894, 1.84, 0.343, 235, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
1784, d5l5aD_, 0.8894, 1.84, 0.343, 235, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
1785, d5fg7D_, 0.8894, 1.83, 0.343, 235, 230, YEAST 20S PROTEASOME BETA2-T1A MUTANT
1786, d5d0wR_, 0.8894, 1.83, 0.343, 235, 230, YEAST 20S PROTEASOME BETA5-T1S MUTANT
1787, d5d0wD_, 0.8894, 1.84, 0.343, 235, 230, YEAST 20S PROTEASOME BETA5-T1S MUTANT
1788, d5bouD_, 0.8894, 1.83, 0.343, 235, 230, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
1789, d4y9yR_, 0.8894, 1.83, 0.343, 235, 230, YEAST 20S PROTEASOME BETA2-H116E MUTANT
1790, d4y9yD_, 0.8894, 1.83, 0.343, 235, 230, YEAST 20S PROTEASOME BETA2-H116E MUTANT
1791, d4rurR_, 0.8894, 1.84, 0.343, 235, 230, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
1792, d4qvyR_, 0.8894, 1.83, 0.343, 235, 230, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
1793, d4qvyD_, 0.8894, 1.83, 0.343, 235, 230, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
1794, p4quxD_, 0.8894, 1.84, 0.343, 235, 230, YCP BETA5-A49T-MUTANT
1795, d4no9R_, 0.8894, 1.84, 0.343, 235, 230, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
1796, d4no9D_, 0.8894, 1.84, 0.343, 235, 230, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
1797, d3oevR_, 0.8894, 2.02, 0.341, 242, 232, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
1798, d3mg7D_, 0.8894, 2.03, 0.341, 242, 232, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
1799, d5l67R_, 0.8893, 1.84, 0.343, 235, 230, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
1800, d5l67D_, 0.8893, 1.84, 0.343, 235, 230, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
1801, d5l5jR_, 0.8893, 1.84, 0.343, 235, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
1802, d5l5jD_, 0.8893, 1.84, 0.343, 235, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
1803, d5l5dR_, 0.8893, 1.84, 0.343, 235, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
1804, d5l5dD_, 0.8893, 1.84, 0.343, 235, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
1805, d5czaR_, 0.8893, 1.84, 0.343, 235, 230, YEAST 20S PROTEASOME BETA5-D166N MUTANT
1806, d5czaD_, 0.8893, 1.84, 0.343, 235, 230, YEAST 20S PROTEASOME BETA5-D166N MUTANT
1807, d5cz7R_, 0.8893, 1.84, 0.343, 235, 230, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
1808, d5cz7D_, 0.8893, 1.84, 0.343, 235, 230, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
1809, d5bxlR_, 0.8893, 1.84, 0.343, 235, 230, YEAST 20S PROTEASOME BETA2-G170A MUTANT
1810, d5bxlD_, 0.8893, 1.84, 0.343, 235, 230, YEAST 20S PROTEASOME BETA2-G170A MUTANT
1811, p4ya5R_, 0.8893, 1.84, 0.343, 235, 230, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
1812, p4y8sR_, 0.8893, 1.84, 0.343, 235, 230, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
1813, p4y8sD_, 0.8893, 1.84, 0.343, 235, 230, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
1814, p4y8nR_, 0.8893, 1.84, 0.343, 235, 230, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
1815, p4y8nD_, 0.8893, 1.84, 0.343, 235, 230, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
1816, p4y75R_, 0.8893, 1.84, 0.343, 235, 230, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
1817, p4y75D_, 0.8893, 1.84, 0.343, 235, 230, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
1818, p4y74R_, 0.8893, 1.84, 0.343, 235, 230, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
1819, p4y6aR_, 0.8893, 1.84, 0.343, 235, 230, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
1820, d4rurD_, 0.8893, 1.84, 0.343, 235, 230, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
1821, p4qv0R_, 0.8893, 1.84, 0.343, 235, 230, YCP BETA5-A49T-A50V-DOUBLE MUTANT
1822, d4no1R_, 0.8893, 1.84, 0.343, 235, 230, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
1823, d4no1D_, 0.8893, 1.84, 0.343, 235, 230, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
1824, d4ltcD_, 0.8893, 2.00, 0.341, 242, 232, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
1825, d5l6bR_, 0.8892, 1.84, 0.343, 235, 230, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
1826, d5l6bD_, 0.8892, 1.84, 0.343, 235, 230, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
1827, d5l69R_, 0.8892, 1.84, 0.343, 235, 230, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1828, d5l68R_, 0.8892, 1.84, 0.343, 235, 230, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
1829, d5l5iR_, 0.8892, 1.84, 0.343, 235, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
1830, d5l5iD_, 0.8892, 1.84, 0.343, 235, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
1831, d5fgaR_, 0.8892, 1.84, 0.343, 235, 230, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
1832, d5fgaD_, 0.8892, 1.84, 0.343, 235, 230, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
1833, p4ya5D_, 0.8892, 1.84, 0.343, 235, 230, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
1834, d4ya4R_, 0.8892, 1.84, 0.343, 235, 230, YEAST 20S PROTEASOME BETA2-H114D MUTANT
1835, d4ya4D_, 0.8892, 1.84, 0.343, 235, 230, YEAST 20S PROTEASOME BETA2-H114D MUTANT
1836, p4y8uR_, 0.8892, 1.84, 0.343, 235, 230, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
1837, p4y8tR_, 0.8892, 1.84, 0.343, 235, 230, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
1838, p4y8tD_, 0.8892, 1.84, 0.343, 235, 230, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
1839, d4y8rR_, 0.8892, 1.84, 0.343, 235, 230, YEAST 20S PROTEASOME BETA2-H116D MUTANT
1840, p4y8pR_, 0.8892, 1.84, 0.343, 235, 230, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
1841, p4y8pD_, 0.8892, 1.84, 0.343, 235, 230, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
1842, p4y7wR_, 0.8892, 1.84, 0.343, 235, 230, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
1843, p4y77R_, 0.8892, 1.84, 0.343, 235, 230, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
1844, p4y77D_, 0.8892, 1.84, 0.343, 235, 230, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
1845, p4y74D_, 0.8892, 1.84, 0.343, 235, 230, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
1846, p4y70R_, 0.8892, 1.84, 0.343, 235, 230, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
1847, p4y6zR_, 0.8892, 1.84, 0.343, 235, 230, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
1848, p4y6aD_, 0.8892, 1.84, 0.343, 235, 230, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
1849, p4y69R_, 0.8892, 1.84, 0.343, 235, 230, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
1850, p4y69D_, 0.8892, 1.84, 0.343, 235, 230, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
1851, d4qvvR_, 0.8892, 1.84, 0.343, 235, 230, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
1852, d4qvlR_, 0.8892, 1.84, 0.343, 235, 230, YCP IN COMPLEX WITH BORTEZOMIB
1853, d4qvlD_, 0.8892, 1.84, 0.343, 235, 230, YCP IN COMPLEX WITH BORTEZOMIB
1854, d4qv5R_, 0.8892, 1.84, 0.343, 235, 230, YCP BETA5-M45I MUTANT
1855, d4qv4R_, 0.8892, 1.84, 0.343, 235, 230, YCP BETA5-M45T MUTANT
1856, d4qv4D_, 0.8892, 1.84, 0.343, 235, 230, YCP BETA5-M45T MUTANT
1857, d4qv1R_, 0.8892, 1.84, 0.343, 235, 230, YCP BETA5-M45A MUTANT
1858, p4qv0D_, 0.8892, 1.84, 0.343, 235, 230, YCP BETA5-A49T-A50V-DOUBLE MUTANT
1859, d1g65D_, 0.8892, 2.00, 0.336, 242, 232, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
1860, d5l69D_, 0.8891, 1.84, 0.343, 235, 230, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
1861, d5l68D_, 0.8891, 1.84, 0.343, 235, 230, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
1862, d5l5eR_, 0.8891, 1.84, 0.343, 235, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
1863, d5cz4R_, 0.8891, 1.84, 0.343, 235, 230, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
1864, d5cz4D_, 0.8891, 1.84, 0.343, 235, 230, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
1865, d5cgfR_, 0.8891, 1.84, 0.343, 235, 230, YEAST 20S PROTEASOME BETA5-G48C MUTANT
1866, d5cgfD_, 0.8891, 1.84, 0.343, 235, 230, YEAST 20S PROTEASOME BETA5-G48C MUTANT
1867, d5bxnR_, 0.8891, 1.84, 0.343, 235, 230, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
1868, d5bxnD_, 0.8891, 1.84, 0.343, 235, 230, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
1869, p4ya7R_, 0.8891, 1.84, 0.343, 235, 230, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
1870, p4ya7D_, 0.8891, 1.84, 0.343, 235, 230, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
1871, p4y9zR_, 0.8891, 1.84, 0.343, 235, 230, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
1872, p4y9zD_, 0.8891, 1.84, 0.343, 235, 230, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
1873, p4y8uD_, 0.8891, 1.84, 0.343, 235, 230, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
1874, d4y8rD_, 0.8891, 1.84, 0.343, 235, 230, YEAST 20S PROTEASOME BETA2-H116D MUTANT
1875, p4y82R_, 0.8891, 1.84, 0.343, 235, 230, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
1876, p4y82D_, 0.8891, 1.84, 0.343, 235, 230, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
1877, p4y80R_, 0.8891, 1.84, 0.343, 235, 230, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
1878, p4y7wD_, 0.8891, 1.84, 0.343, 235, 230, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
1879, p4y70D_, 0.8891, 1.84, 0.343, 235, 230, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
1880, p4y6zD_, 0.8891, 1.84, 0.343, 235, 230, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
1881, d4r00R_, 0.8891, 1.84, 0.343, 235, 230, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
1882, d4r00D_, 0.8891, 1.84, 0.343, 235, 230, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
1883, d4qwjR_, 0.8891, 1.84, 0.343, 235, 230, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
1884, d4qw0R_, 0.8891, 1.84, 0.343, 235, 230, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
1885, d4qw0D_, 0.8891, 1.84, 0.343, 235, 230, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
1886, p4qvwR_, 0.8891, 1.84, 0.343, 235, 230, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
1887, p4qvwD_, 0.8891, 1.84, 0.343, 235, 230, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
1888, d4qvvD_, 0.8891, 1.84, 0.343, 235, 230, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
1889, d4qv8R_, 0.8891, 1.84, 0.343, 235, 230, YCP BETA5-C52F MUTANT
1890, d4qv8D_, 0.8891, 1.84, 0.343, 235, 230, YCP BETA5-C52F MUTANT
1891, d4qv7R_, 0.8891, 1.84, 0.343, 235, 230, YCP BETA5-A50V MUTANT
1892, d4qv7D_, 0.8891, 1.84, 0.343, 235, 230, YCP BETA5-A50V MUTANT
1893, d4qv5D_, 0.8891, 1.84, 0.343, 235, 230, YCP BETA5-M45I MUTANT
1894, p4qv3R_, 0.8891, 1.84, 0.343, 235, 230, YCP BETA5-M45V MUTANT
1895, p4qv3D_, 0.8891, 1.84, 0.343, 235, 230, YCP BETA5-M45V MUTANT
1896, d4qv1D_, 0.8891, 1.84, 0.343, 235, 230, YCP BETA5-M45A MUTANT
1897, d4quyR_, 0.8891, 1.84, 0.343, 235, 230, YCP BETA5-A49S-MUTANT
1898, d4q1sD_, 0.8891, 2.02, 0.341, 242, 232, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
1899, d4nnnR_, 0.8891, 1.84, 0.343, 235, 230, YCP IN COMPLEX WITH MG132
1900, d4nnnD_, 0.8891, 1.84, 0.343, 235, 230, YCP IN COMPLEX WITH MG132
1901, d4hrdD_, 0.8891, 2.03, 0.341, 242, 232, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
1902, d1jd2W_, 0.8891, 2.11, 0.306, 244, 232, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
1903, d1jd2B_, 0.8891, 2.11, 0.306, 244, 232, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
1904, d1j2pF_, 0.8891, 1.92, 0.430, 243, 230, ALPHA-RING FROM THE PROTEASOME FROM ARCHAEOGLOBUS FULGIDUS
1905, d5l65R_, 0.8890, 1.84, 0.343, 235, 230, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
1906, d5l65D_, 0.8890, 1.84, 0.343, 235, 230, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
1907, d5l5eD_, 0.8890, 1.84, 0.343, 235, 230, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
1908, d4z1lR_, 0.8890, 1.84, 0.343, 235, 230, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
1909, d4z1lD_, 0.8890, 1.84, 0.343, 235, 230, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
1910, p4ya9R_, 0.8890, 1.84, 0.343, 235, 230, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
1911, p4ya3R_, 0.8890, 1.84, 0.343, 235, 230, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
1912, p4ya3D_, 0.8890, 1.84, 0.343, 235, 230, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
1913, p4y8oR_, 0.8890, 1.84, 0.343, 235, 230, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
1914, p4y8oD_, 0.8890, 1.84, 0.343, 235, 230, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
1915, p4y8kR_, 0.8890, 1.84, 0.343, 235, 230, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
1916, p4y8kD_, 0.8890, 1.85, 0.343, 235, 230, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
1917, p4y8jR_, 0.8890, 1.84, 0.343, 235, 230, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
1918, p4y80D_, 0.8890, 1.84, 0.343, 235, 230, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
1919, d4qz5R_, 0.8890, 1.84, 0.343, 235, 230, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
1920, d4qz5D_, 0.8890, 1.84, 0.343, 235, 230, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
1921, d4qz3R_, 0.8890, 1.84, 0.343, 235, 230, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1922, d4qz3D_, 0.8890, 1.84, 0.343, 235, 230, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1923, d4qwrR_, 0.8890, 1.85, 0.343, 235, 230, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
1924, d4qwrD_, 0.8890, 1.85, 0.343, 235, 230, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
1925, d4qwkR_, 0.8890, 1.85, 0.343, 235, 230, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1926, d4qwjD_, 0.8890, 1.84, 0.343, 235, 230, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
1927, d4qwiR_, 0.8890, 1.84, 0.343, 235, 230, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
1928, d4qwiD_, 0.8890, 1.84, 0.343, 235, 230, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
1929, d4quyD_, 0.8890, 1.84, 0.343, 235, 230, YCP BETA5-A49S-MUTANT
1930, d4qlqR_, 0.8890, 1.84, 0.343, 235, 230, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
1931, d3wxrQ_, 0.8890, 2.15, 0.306, 244, 232, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
1932, d5jhrR_, 0.8889, 1.84, 0.343, 235, 230, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
1933, d5jhrD_, 0.8889, 1.84, 0.343, 235, 230, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
1934, p5fghR_, 0.8889, 1.84, 0.343, 235, 230, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
1935, p5fghD_, 0.8889, 1.84, 0.343, 235, 230, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
1936, d5dkjR_, 0.8889, 1.84, 0.343, 235, 230, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
1937, d5dkjD_, 0.8889, 1.84, 0.343, 235, 230, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
1938, d5d0xR_, 0.8889, 1.84, 0.343, 235, 230, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
1939, d5d0xD_, 0.8889, 1.84, 0.343, 235, 230, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
1940, p5cghR_, 0.8889, 1.85, 0.343, 235, 230, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
1941, p5cghD_, 0.8889, 1.85, 0.343, 235, 230, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
1942, p4ya9D_, 0.8889, 1.85, 0.343, 235, 230, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
1943, p4y8qR_, 0.8889, 1.84, 0.343, 235, 230, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
1944, p4y8qD_, 0.8889, 1.85, 0.343, 235, 230, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
1945, p4y8lR_, 0.8889, 1.84, 0.343, 235, 230, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
1946, p4y8jD_, 0.8889, 1.84, 0.343, 235, 230, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
1947, p4y81R_, 0.8889, 1.85, 0.343, 235, 230, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
1948, p4y81D_, 0.8889, 1.85, 0.343, 235, 230, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
1949, p4y7xR_, 0.8889, 1.84, 0.343, 235, 230, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
1950, p4y7xD_, 0.8889, 1.84, 0.343, 235, 230, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
1951, p4x6zS_, 0.8889, 2.07, 0.336, 242, 232, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
1952, p4x6zQ_, 0.8889, 2.11, 0.306, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
1953, d4qzzR_, 0.8889, 1.84, 0.343, 235, 230, YCP IN COMPLEX WITH OMURALIDE
1954, d4qzzD_, 0.8889, 1.84, 0.343, 235, 230, YCP IN COMPLEX WITH OMURALIDE
1955, d4qwkD_, 0.8889, 1.85, 0.343, 235, 230, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1956, d4qw1R_, 0.8889, 1.84, 0.343, 235, 230, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
1957, d4qvnR_, 0.8889, 1.85, 0.343, 235, 230, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
1958, d4qvnD_, 0.8889, 1.85, 0.343, 235, 230, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
1959, d4qlsR_, 0.8889, 1.84, 0.343, 235, 230, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
1960, d4qlsD_, 0.8889, 1.84, 0.343, 235, 230, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
1961, d4qlqD_, 0.8889, 1.84, 0.343, 235, 230, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
1962, d4nnwR_, 0.8889, 1.84, 0.343, 235, 230, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
1963, d4nnwD_, 0.8889, 1.84, 0.343, 235, 230, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
1964, d4hrcD_, 0.8889, 2.02, 0.341, 242, 232, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
1965, d3mg6D_, 0.8889, 2.03, 0.341, 242, 232, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
1966, d1j2pG_, 0.8889, 1.92, 0.430, 243, 230, ALPHA-RING FROM THE PROTEASOME FROM ARCHAEOGLOBUS FULGIDUS
1967, d1j2pE_, 0.8889, 1.92, 0.430, 243, 230, ALPHA-RING FROM THE PROTEASOME FROM ARCHAEOGLOBUS FULGIDUS
1968, d1j2pC_, 0.8889, 1.92, 0.430, 243, 230, ALPHA-RING FROM THE PROTEASOME FROM ARCHAEOGLOBUS FULGIDUS
1969, d1j2pA_, 0.8889, 1.92, 0.430, 243, 230, ALPHA-RING FROM THE PROTEASOME FROM ARCHAEOGLOBUS FULGIDUS
1970, d1g65R_, 0.8889, 2.00, 0.336, 242, 232, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
1971, p5mpab_, 0.8888, 1.69, 0.362, 250, 229, 26S PROTEASOME IN PRESENCE OF ATP (S2)
1972, d5fgeR_, 0.8888, 1.85, 0.343, 235, 230, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1973, d5d0tR_, 0.8888, 1.84, 0.343, 235, 230, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
1974, d5d0tD_, 0.8888, 1.84, 0.343, 235, 230, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
1975, p5cggR_, 0.8888, 1.85, 0.343, 235, 230, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
1976, p5cggD_, 0.8888, 1.85, 0.343, 235, 230, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
1977, p4ya0R_, 0.8888, 1.84, 0.343, 235, 230, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
1978, p4ya0D_, 0.8888, 1.84, 0.343, 235, 230, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
1979, p4y8lD_, 0.8888, 1.85, 0.343, 235, 230, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
1980, p4y8iR_, 0.8888, 1.85, 0.343, 235, 230, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
1981, p4y7yR_, 0.8888, 1.85, 0.343, 235, 230, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
1982, p4y7yD_, 0.8888, 1.85, 0.343, 235, 230, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
1983, d4qz6D_, 0.8888, 1.85, 0.343, 235, 230, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1984, p4qz4R_, 0.8888, 1.85, 0.343, 235, 230, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1985, p4qz4D_, 0.8888, 1.85, 0.343, 235, 230, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1986, d4qwxR_, 0.8888, 1.85, 0.343, 235, 230, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1987, d4qwxD_, 0.8888, 1.85, 0.343, 235, 230, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
1988, d4qwgR_, 0.8888, 1.85, 0.343, 235, 230, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
1989, d4qw1D_, 0.8888, 1.84, 0.343, 235, 230, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
1990, d4qvmR_, 0.8888, 1.85, 0.343, 235, 230, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
1991, d4qvmD_, 0.8888, 1.85, 0.343, 235, 230, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
1992, p4no6R_, 0.8888, 1.84, 0.343, 235, 230, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
1993, d1j2pD_, 0.8888, 1.92, 0.430, 243, 230, ALPHA-RING FROM THE PROTEASOME FROM ARCHAEOGLOBUS FULGIDUS
1994, d1j2pB_, 0.8888, 1.92, 0.430, 243, 230, ALPHA-RING FROM THE PROTEASOME FROM ARCHAEOGLOBUS FULGIDUS
1995, d5l55R_, 0.8887, 1.85, 0.343, 235, 230, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
1996, d5fgeD_, 0.8887, 1.85, 0.343, 235, 230, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
1997, d5d0zR_, 0.8887, 1.85, 0.343, 235, 230, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
1998, d5d0zD_, 0.8887, 1.85, 0.343, 235, 230, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
1999, d5cz9R_, 0.8887, 1.85, 0.343, 235, 230, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
2000, d5cz9D_, 0.8887, 1.85, 0.343, 235, 230, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
2001, p4y8iD_, 0.8887, 1.85, 0.343, 235, 230, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
2002, p4y8gR_, 0.8887, 1.85, 0.343, 235, 230, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
2003, p4y8gD_, 0.8887, 1.85, 0.343, 235, 230, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
2004, p4y78R_, 0.8887, 1.85, 0.343, 235, 230, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP
2005, p4y78D_, 0.8887, 1.85, 0.343, 235, 230, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP
2006, p4qzwR_, 0.8887, 1.85, 0.343, 235, 230, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2007, p4qzwD_, 0.8887, 1.85, 0.343, 235, 230, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2008, d4qz7R_, 0.8887, 1.85, 0.343, 235, 230, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2009, d4qz7D_, 0.8887, 1.85, 0.343, 235, 230, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2010, d4qz6R_, 0.8887, 1.85, 0.343, 235, 230, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2011, d4qwlR_, 0.8887, 1.85, 0.343, 235, 230, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
2012, d4qwlD_, 0.8887, 1.85, 0.343, 235, 230, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
2013, d4qwgD_, 0.8887, 1.85, 0.343, 235, 230, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
2014, d4qvqR_, 0.8887, 1.85, 0.343, 235, 230, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
2015, d4qvqD_, 0.8887, 1.85, 0.343, 235, 230, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
2016, d4qvpR_, 0.8887, 1.85, 0.343, 235, 230, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
2017, d4qvpD_, 0.8887, 1.85, 0.343, 235, 230, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
2018, d4qv9R_, 0.8887, 1.85, 0.343, 235, 230, YCP BETA5-C63F MUTANT
2019, d4qv9D_, 0.8887, 1.85, 0.343, 235, 230, YCP BETA5-C63F MUTANT
2020, p4no6D_, 0.8887, 1.85, 0.343, 235, 230, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
2021, d5l55D_, 0.8886, 1.85, 0.343, 235, 230, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2022, d5jhsR_, 0.8886, 1.85, 0.343, 235, 230, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
2023, d5jhsD_, 0.8886, 1.85, 0.343, 235, 230, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
2024, d5fgiR_, 0.8886, 1.85, 0.343, 235, 230, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2025, d5fgiD_, 0.8886, 1.85, 0.343, 235, 230, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2026, d5fggR_, 0.8886, 1.85, 0.343, 235, 230, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2027, d5fggD_, 0.8886, 1.85, 0.343, 235, 230, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2028, d5fgfR_, 0.8886, 1.85, 0.343, 235, 230, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
2029, d5fgfD_, 0.8886, 1.85, 0.343, 235, 230, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
2030, d5fgdR_, 0.8886, 1.85, 0.343, 235, 230, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2031, d5fgdD_, 0.8886, 1.85, 0.343, 235, 230, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2032, p4y8hR_, 0.8886, 1.85, 0.343, 235, 230, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
2033, p4y84R_, 0.8886, 1.85, 0.343, 235, 230, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
2034, p4y84D_, 0.8886, 1.85, 0.343, 235, 230, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
2035, p4x6zE_, 0.8886, 2.04, 0.341, 242, 232, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
2036, d4qw6R_, 0.8886, 1.85, 0.343, 235, 230, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
2037, d4qw4R_, 0.8886, 1.85, 0.343, 235, 230, YCP IN COMPLEX WITH CARFILZOMIB
2038, d4no8R_, 0.8886, 1.85, 0.343, 235, 230, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
2039, d5l52R_, 0.8885, 1.85, 0.343, 235, 230, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
2040, d5l52D_, 0.8885, 1.85, 0.343, 235, 230, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
2041, d5fhsR_, 0.8885, 1.85, 0.343, 235, 230, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
2042, d5fhsD_, 0.8885, 1.85, 0.343, 235, 230, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
2043, d5dkiR_, 0.8885, 1.85, 0.343, 235, 230, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
2044, d5d0sR_, 0.8885, 1.85, 0.343, 235, 230, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
2045, d5d0sD_, 0.8885, 1.85, 0.343, 235, 230, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
2046, d5cz5R_, 0.8885, 1.85, 0.343, 235, 230, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
2047, p5cgiR_, 0.8885, 1.85, 0.343, 235, 230, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
2048, p5cgiD_, 0.8885, 1.85, 0.343, 235, 230, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
2049, d5ahjR_, 0.8885, 1.85, 0.343, 235, 230, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
2050, d5ahjD_, 0.8885, 1.85, 0.343, 235, 230, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
2051, p4y8hD_, 0.8885, 1.85, 0.343, 235, 230, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
2052, p4qwfR_, 0.8885, 1.85, 0.343, 235, 230, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
2053, p4qwfD_, 0.8885, 1.85, 0.343, 235, 230, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
2054, d4qw6D_, 0.8885, 1.85, 0.343, 235, 230, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
2055, p4qw5R_, 0.8885, 1.85, 0.343, 235, 230, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
2056, p4qw5D_, 0.8885, 1.85, 0.343, 235, 230, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
2057, d4qw4D_, 0.8885, 1.85, 0.343, 235, 230, YCP IN COMPLEX WITH CARFILZOMIB
2058, d4no8D_, 0.8885, 1.85, 0.343, 235, 230, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
2059, d5dkiD_, 0.8884, 1.85, 0.343, 235, 230, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
2060, d5d0vR_, 0.8884, 1.85, 0.343, 235, 230, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
2061, d5d0vD_, 0.8884, 1.85, 0.343, 235, 230, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
2062, d5cz5D_, 0.8884, 1.85, 0.343, 235, 230, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
2063, d4r18R_, 0.8884, 1.85, 0.343, 235, 230, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
2064, d4r18D_, 0.8884, 1.85, 0.343, 235, 230, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
2065, d4qxjR_, 0.8884, 1.85, 0.343, 235, 230, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2066, d4qxjD_, 0.8884, 1.85, 0.343, 235, 230, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2067, p4qwsR_, 0.8884, 1.85, 0.343, 235, 230, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
2068, p4qwsD_, 0.8884, 1.86, 0.343, 235, 230, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
2069, d4qw7R_, 0.8884, 1.85, 0.343, 235, 230, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
2070, d4qw7D_, 0.8884, 1.85, 0.343, 235, 230, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
2071, d4qv6R_, 0.8884, 1.85, 0.343, 235, 230, YCP BETA5-A49V MUTANT
2072, d4qv6D_, 0.8884, 1.85, 0.343, 235, 230, YCP BETA5-A49V MUTANT
2073, d3oeuD_, 0.8884, 2.03, 0.341, 242, 232, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
2074, p6gopR_, 0.8883, 1.85, 0.343, 235, 230, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
2075, d5lajR_, 0.8883, 1.85, 0.343, 235, 230, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
2076, d5lajD_, 0.8883, 1.85, 0.343, 235, 230, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
2077, p4ya2R_, 0.8883, 1.85, 0.343, 235, 230, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
2078, p4ya2D_, 0.8883, 1.85, 0.343, 235, 230, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
2079, d4qzxR_, 0.8883, 1.85, 0.343, 235, 230, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2080, d4qzxD_, 0.8883, 1.85, 0.343, 235, 230, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2081, p4qwuR_, 0.8883, 1.85, 0.343, 235, 230, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
2082, p4qwuD_, 0.8883, 1.85, 0.343, 235, 230, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
2083, d4qw3R_, 0.8883, 1.85, 0.343, 235, 230, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
2084, d4qw3D_, 0.8883, 1.85, 0.343, 235, 230, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
2085, d4qluR_, 0.8883, 1.85, 0.343, 235, 230, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
2086, d4qluD_, 0.8883, 1.85, 0.343, 235, 230, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
2087, d3oevD_, 0.8883, 2.03, 0.341, 242, 232, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
2088, p6gopD_, 0.8882, 1.85, 0.343, 235, 230, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
2089, p4qz1R_, 0.8882, 1.86, 0.343, 235, 230, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2090, p4qz1D_, 0.8882, 1.86, 0.343, 235, 230, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2091, p4qz0R_, 0.8882, 1.86, 0.343, 235, 230, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2092, p4qz0D_, 0.8882, 1.86, 0.343, 235, 230, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2093, d4qz2R_, 0.8881, 1.86, 0.343, 235, 230, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2094, d4qz2D_, 0.8881, 1.86, 0.343, 235, 230, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2095, d3mg8D_, 0.8881, 2.04, 0.341, 242, 232, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
2096, d5cz8R_, 0.8880, 1.86, 0.343, 235, 230, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
2097, d5cz8D_, 0.8880, 1.86, 0.343, 235, 230, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
2098, d4qlvR_, 0.8880, 1.86, 0.343, 235, 230, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
2099, d4qlvD_, 0.8880, 1.86, 0.343, 235, 230, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
2100, p5mpaC_, 0.8878, 2.19, 0.306, 244, 232, 26S PROTEASOME IN PRESENCE OF ATP (S2)
2101, d5l54R_, 0.8877, 1.86, 0.343, 235, 230, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2102, d5l54D_, 0.8876, 1.86, 0.343, 235, 230, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2103, d4qltR_, 0.8875, 1.86, 0.343, 235, 230, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
2104, d4qltD_, 0.8875, 1.86, 0.343, 235, 230, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
2105, p4qbyR_, 0.8873, 1.87, 0.343, 235, 230, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
2106, p4qbyD_, 0.8873, 1.87, 0.343, 235, 230, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
2107, d4r3oO_, 0.8870, 1.87, 0.296, 244, 230, HUMAN CONSTITUTIVE 20S PROTEASOME
2108, p3jcoKA_, 0.8870, 1.72, 0.358, 250, 229, 
2109, p3jcoK_, 0.8870, 1.72, 0.358, 250, 229, 
2110, p5mpaB_, 0.8868, 1.72, 0.362, 250, 229, 26S PROTEASOME IN PRESENCE OF ATP (S2)
2111, d4r3oA_, 0.8868, 1.88, 0.287, 244, 230, HUMAN CONSTITUTIVE 20S PROTEASOME
2112, d4r02D_, 0.8868, 1.87, 0.343, 235, 230, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
2113, d1iruO_, 0.8866, 1.89, 0.291, 244, 230, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
2114, d1iruA_, 0.8866, 1.89, 0.291, 244, 230, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
2115, d1jd2D_, 0.8865, 2.05, 0.336, 242, 232, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
2116, p5mp9e_, 0.8864, 2.08, 0.341, 242, 232, 26S PROTEASOME IN PRESENCE OF ATP (S1)
2117, d1jd2Y_, 0.8864, 2.05, 0.336, 242, 232, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
2118, p5ln3D_, 0.8862, 1.81, 0.589, 232, 231, THE HUMAN 26S PROTEASOME AT 6.8 ANG.
2119, p5wvkW_, 0.8861, 1.71, 0.367, 250, 229, 
2120, p3uneG_, 0.8861, 1.88, 0.291, 244, 230, MOUSE CONSTITUTIVE 20S PROTEASOME
2121, p3uneU_, 0.8860, 1.88, 0.291, 244, 230, MOUSE CONSTITUTIVE 20S PROTEASOME
2122, p4r67q_, 0.8859, 1.89, 0.296, 244, 230, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
2123, d4r67O_, 0.8859, 1.89, 0.296, 244, 230, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
2124, p4r67c_, 0.8859, 1.89, 0.296, 244, 230, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
2125, d4r67A_, 0.8859, 1.89, 0.296, 244, 230, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
2126, d4cr2B_, 0.8858, 1.76, 0.362, 250, 229, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
2127, p3jcpNA_, 0.8857, 2.04, 0.341, 242, 232, 
2128, p3jcpN_, 0.8857, 2.04, 0.341, 242, 232, 
2129, d3wxrE_, 0.8856, 2.08, 0.341, 239, 232, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
2130, p5mp9c_, 0.8855, 2.17, 0.306, 244, 232, 26S PROTEASOME IN PRESENCE OF ATP (S1)
2131, p3jcpLA_, 0.8854, 2.14, 0.306, 244, 232, 
2132, p3jcpL_, 0.8854, 2.14, 0.306, 244, 232, 
2133, d4g4sC_, 0.8851, 2.04, 0.309, 237, 230, STRUCTURE OF PROTEASOME-PBA1-PBA2 COMPLEX
2134, p5mpaE_, 0.8846, 1.98, 0.346, 242, 231, 26S PROTEASOME IN PRESENCE OF ATP (S2)
2135, p5vfuHA_, 0.8844, 2.09, 0.329, 240, 231, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
2136, p5vfti_, 0.8844, 2.09, 0.329, 240, 231, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
2137, p5mp9C_, 0.8843, 2.16, 0.306, 244, 232, 26S PROTEASOME IN PRESENCE OF ATP (S1)
2138, p5l4gG_, 0.8843, 2.16, 0.284, 242, 232, 
2139, p5mp9E_, 0.8842, 2.12, 0.341, 242, 232, 26S PROTEASOME IN PRESENCE OF ATP (S1)
2140, d3mg7U_, 0.8842, 2.04, 0.259, 243, 232, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
2141, p5t0jI_, 0.8841, 2.10, 0.329, 250, 234, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
2142, p5l4gU_, 0.8840, 2.16, 0.284, 241, 232, 
2143, p6epfB_, 0.8838, 1.66, 0.390, 234, 228, GROUND STATE 26S PROTEASOME (GS1)
2144, p5mpac_, 0.8837, 2.19, 0.310, 244, 232, 26S PROTEASOME IN PRESENCE OF ATP (S2)
2145, d1rypO_, 0.8836, 2.05, 0.259, 243, 232, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
2146, p3unei_, 0.8835, 1.93, 0.291, 244, 230, MOUSE CONSTITUTIVE 20S PROTEASOME
2147, d3sdkU_, 0.8835, 2.05, 0.259, 243, 232, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
2148, d3unbU_, 0.8832, 1.87, 0.306, 243, 229, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
2149, d3unbG_, 0.8830, 1.87, 0.306, 243, 229, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
2150, p5t0iH_, 0.8829, 1.71, 0.377, 233, 228, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
2151, p3unbi_, 0.8829, 1.87, 0.306, 243, 229, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
2152, d3mg6U_, 0.8829, 2.06, 0.259, 243, 232, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
2153, d3mg7P_, 0.8828, 1.84, 0.313, 235, 227, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
2154, p5mpae_, 0.8827, 1.98, 0.339, 242, 230, 26S PROTEASOME IN PRESENCE OF ATP (S2)
2155, p3unew_, 0.8827, 1.91, 0.296, 244, 230, MOUSE CONSTITUTIVE 20S PROTEASOME
2156, d3sdiU_, 0.8826, 2.08, 0.263, 240, 232, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
2157, d3oevU_, 0.8826, 2.06, 0.259, 243, 232, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
2158, d3oeuP_, 0.8826, 1.85, 0.313, 235, 227, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
2159, d3oeuB_, 0.8825, 1.83, 0.313, 235, 227, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
2160, d1g0uU_, 0.8825, 2.07, 0.263, 240, 232, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
2161, p5gjqn_, 0.8824, 2.20, 0.280, 243, 232, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
2162, p3unbw_, 0.8824, 1.88, 0.301, 243, 229, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
2163, d3un8U_, 0.8824, 2.07, 0.259, 243, 232, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
2164, d3mg8U_, 0.8824, 2.07, 0.259, 243, 232, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
2165, d3mg8B_, 0.8824, 1.83, 0.313, 235, 227, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
2166, d3mg6P_, 0.8824, 1.85, 0.313, 235, 227, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
2167, d1z7qQ1, 0.8824, 1.95, 0.310, 243, 229, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
2168, d1z7qC1, 0.8824, 1.96, 0.310, 243, 229, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
2169, p5t0iI_, 0.8823, 2.19, 0.323, 250, 235, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
2170, d3sdkP_, 0.8823, 1.85, 0.313, 235, 227, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
2171, d3mg0U_, 0.8823, 2.06, 0.259, 243, 232, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
2172, d1g65U_, 0.8823, 2.05, 0.259, 243, 232, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
2173, d3sdiP_, 0.8822, 1.85, 0.313, 235, 227, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
2174, d3mg8P_, 0.8822, 1.84, 0.313, 235, 227, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
2175, d1jd22_, 0.8822, 2.08, 0.263, 243, 232, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
2176, d3oeuU_, 0.8820, 2.07, 0.259, 243, 232, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
2177, d3mg6B_, 0.8820, 1.84, 0.313, 235, 227, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
2178, d3sdkB_, 0.8819, 1.84, 0.313, 235, 227, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
2179, d4hnpF_, 0.8818, 2.23, 0.297, 244, 232, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
2180, d3sdkR_, 0.8818, 1.86, 0.346, 232, 228, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
2181, d3sdiF_, 0.8818, 2.21, 0.297, 242, 232, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
2182, d3sdiB_, 0.8818, 1.84, 0.313, 235, 227, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
2183, d3mg7B_, 0.8818, 1.83, 0.313, 235, 227, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
2184, d3mg4U_, 0.8818, 2.09, 0.263, 243, 232, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
2185, d3bdmU_, 0.8818, 2.07, 0.259, 243, 232, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
2186, d1g0uP_, 0.8818, 1.84, 0.313, 235, 227, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
2187, d3bdmG_, 0.8817, 2.08, 0.259, 243, 232, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
2188, d1rypA_, 0.8817, 2.07, 0.259, 243, 232, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
2189, d1g0uB_, 0.8817, 1.84, 0.313, 235, 227, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
2190, p6gopA_, 0.8816, 1.52, 0.375, 230, 224, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
2191, p5wvkZ_, 0.8816, 2.13, 0.341, 242, 232, 
2192, d4q1sU_, 0.8815, 2.10, 0.263, 243, 232, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
2193, d3wxrO_, 0.8815, 2.09, 0.263, 243, 232, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
2194, d3gpjU_, 0.8815, 2.08, 0.259, 243, 232, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
2195, d1g0uG_, 0.8815, 2.08, 0.263, 240, 232, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
2196, p5wvkS_, 0.8814, 2.00, 0.342, 242, 231, 
2197, p4zzgU_, 0.8814, 2.25, 0.297, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
2198, d4g4sE_, 0.8814, 2.02, 0.333, 249, 231, STRUCTURE OF PROTEASOME-PBA1-PBA2 COMPLEX
2199, d3tddU_, 0.8814, 2.08, 0.259, 243, 232, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
2200, d3gpjG_, 0.8814, 2.08, 0.259, 243, 232, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
2201, d3tddG_, 0.8813, 2.08, 0.259, 243, 232, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
2202, d3gptU_, 0.8813, 2.08, 0.259, 243, 232, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
2203, d4hrdF_, 0.8812, 2.23, 0.297, 244, 232, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
2204, d3oevP_, 0.8812, 1.70, 0.314, 235, 226, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
2205, d3nzjU_, 0.8812, 2.08, 0.259, 243, 232, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
2206, d4j70U_, 0.8811, 2.10, 0.263, 243, 232, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
2207, d3oevB_, 0.8811, 1.85, 0.313, 235, 227, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
2208, d3gpwU_, 0.8811, 2.08, 0.259, 243, 232, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
2209, d3gptG_, 0.8811, 2.08, 0.259, 243, 232, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
2210, p5m32B_, 0.8810, 2.00, 0.325, 234, 228, HUMAN 26S PROTEASOME IN COMPLEX WITH OPROZOMIB
2211, d5laiT_, 0.8810, 2.25, 0.297, 243, 232, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
2212, d5laiF_, 0.8810, 2.25, 0.297, 243, 232, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
2213, d4r17T_, 0.8810, 2.25, 0.297, 243, 232, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
2214, d4r17F_, 0.8810, 2.25, 0.297, 243, 232, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
2215, d4jsuU_, 0.8810, 2.08, 0.259, 243, 232, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
2216, d4hnpU_, 0.8810, 2.11, 0.263, 243, 232, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
2217, p3un4U_, 0.8810, 2.08, 0.259, 243, 232, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
2218, d3mg7G_, 0.8810, 2.09, 0.259, 243, 232, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
2219, d3hyeU_, 0.8810, 2.08, 0.259, 243, 232, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
2220, p5mpbB_, 0.8809, 1.83, 0.367, 250, 229, 
2221, p5gjrY_, 0.8809, 2.23, 0.280, 243, 232, 
2222, p5gjrMA_, 0.8809, 2.23, 0.280, 243, 232, 
2223, d4jsuG_, 0.8809, 2.08, 0.259, 243, 232, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
2224, p3un4G_, 0.8809, 2.08, 0.259, 243, 232, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
2225, d3nzjG_, 0.8809, 2.08, 0.259, 243, 232, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
2226, d3gpwG_, 0.8809, 2.08, 0.259, 243, 232, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
2227, d1g0uD_, 0.8809, 1.75, 0.339, 230, 227, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
2228, d4rurT_, 0.8808, 2.26, 0.297, 243, 232, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
2229, d4rurF_, 0.8808, 2.26, 0.297, 243, 232, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
2230, d4jsqU_, 0.8808, 2.09, 0.259, 243, 232, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
2231, d3nzwU_, 0.8808, 2.08, 0.259, 243, 232, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
2232, d3mg6G_, 0.8808, 2.08, 0.259, 243, 232, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
2233, p3jcoNA_, 0.8808, 2.09, 0.341, 242, 232, 
2234, p3jcoN_, 0.8808, 2.09, 0.341, 242, 232, 
2235, d3hyeG_, 0.8808, 2.08, 0.259, 243, 232, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
2236, p5wvkP_, 0.8807, 1.78, 0.367, 250, 229, 
2237, p4zzgA_, 0.8807, 2.07, 0.264, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
2238, p4ya5T_, 0.8807, 2.26, 0.297, 243, 232, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
2239, p4ya5F_, 0.8807, 2.26, 0.297, 243, 232, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
2240, p4y8nT_, 0.8807, 2.26, 0.297, 243, 232, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
2241, p4y8nF_, 0.8807, 2.26, 0.297, 243, 232, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
2242, p4x6zG_, 0.8807, 2.24, 0.297, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
2243, d4jt0U_, 0.8807, 2.09, 0.259, 243, 232, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
2244, d4jt0G_, 0.8807, 2.09, 0.259, 243, 232, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
2245, d4jsqG_, 0.8807, 2.09, 0.259, 243, 232, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
2246, d3un8G_, 0.8807, 2.08, 0.259, 243, 232, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
2247, d3oevG_, 0.8807, 2.08, 0.259, 243, 232, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
2248, d3nzxU_, 0.8807, 2.09, 0.259, 243, 232, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
2249, p5nifA_, 0.8806, 2.07, 0.264, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
2250, p5gjqX_, 0.8806, 2.23, 0.276, 243, 232, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
2251, d4r02F_, 0.8806, 2.12, 0.299, 243, 231, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
2252, d4q1sF_, 0.8806, 2.25, 0.297, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
2253, d3nzwG_, 0.8806, 2.09, 0.259, 243, 232, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
2254, p3jcoLA_, 0.8806, 2.20, 0.306, 244, 232, 
2255, p3jcoL_, 0.8806, 2.20, 0.306, 244, 232, 
2256, d1g0uR_, 0.8806, 1.75, 0.339, 230, 227, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
2257, p5mp9g_, 0.8805, 2.23, 0.297, 243, 232, 26S PROTEASOME IN PRESENCE OF ATP (S1)
2258, d5l5eT_, 0.8805, 2.26, 0.297, 243, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
2259, d5l5eF_, 0.8805, 2.26, 0.297, 243, 232, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
2260, p4y69F_, 0.8805, 2.26, 0.297, 243, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
2261, d4qvwT_, 0.8805, 2.26, 0.297, 243, 232, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
2262, d4ltcU_, 0.8805, 2.11, 0.263, 243, 232, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
2263, d4intU_, 0.8805, 2.09, 0.259, 243, 232, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
2264, d3sdkG_, 0.8805, 2.09, 0.259, 243, 232, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
2265, d3sdkD_, 0.8805, 1.97, 0.341, 233, 229, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
2266, d3nzxG_, 0.8805, 2.09, 0.259, 243, 232, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
2267, d3d29U2, 0.8805, 2.11, 0.263, 241, 232, PROTEASOME INHIBITION BY FELLUTAMIDE B
2268, d2fakU_, 0.8805, 2.08, 0.259, 243, 232, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
2269, d5m2bT_, 0.8804, 2.13, 0.299, 243, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
2270, d5m2bF_, 0.8804, 2.13, 0.299, 243, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
2271, d5lajT_, 0.8804, 2.26, 0.297, 243, 232, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
2272, p4zzgG_, 0.8804, 2.26, 0.297, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
2273, p4y8uF_, 0.8804, 2.26, 0.297, 243, 232, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
2274, p4y69T_, 0.8804, 2.26, 0.297, 243, 232, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
2275, d4qvwF_, 0.8804, 2.26, 0.297, 243, 232, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
2276, d4eu2G_, 0.8804, 2.11, 0.299, 244, 231, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
2277, d3shjU_, 0.8804, 2.09, 0.259, 243, 232, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
2278, d3e47U_, 0.8804, 2.09, 0.259, 243, 232, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
2279, d3d29G2, 0.8804, 2.11, 0.263, 241, 232, PROTEASOME INHIBITION BY FELLUTAMIDE B
2280, p5nifU_, 0.8803, 2.13, 0.299, 244, 231, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
2281, d5l64F_, 0.8803, 2.13, 0.299, 243, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2282, d5l63T_, 0.8803, 2.13, 0.299, 243, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2283, d5l63F_, 0.8803, 2.13, 0.299, 243, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2284, d5fg9T_, 0.8803, 2.26, 0.297, 243, 232, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
2285, d5fg9F_, 0.8803, 2.26, 0.297, 243, 232, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
2286, d4ya1T_, 0.8803, 2.27, 0.297, 243, 232, YEAST 20S PROTEASOME BETA2-H116N MUTANT
2287, d4ya1F_, 0.8803, 2.27, 0.297, 243, 232, YEAST 20S PROTEASOME BETA2-H116N MUTANT
2288, d4y9yT_, 0.8803, 2.26, 0.297, 243, 232, YEAST 20S PROTEASOME BETA2-H116E MUTANT
2289, d4y9yF_, 0.8803, 2.26, 0.297, 243, 232, YEAST 20S PROTEASOME BETA2-H116E MUTANT
2290, p4y8uT_, 0.8803, 2.26, 0.297, 243, 232, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
2291, d4qvmT_, 0.8803, 2.26, 0.297, 243, 232, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
2292, d4qvmF_, 0.8803, 2.26, 0.297, 243, 232, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
2293, d4inrU_, 0.8803, 2.09, 0.259, 243, 232, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
2294, d3un8F_, 0.8803, 2.26, 0.297, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
2295, d2fakG_, 0.8803, 2.09, 0.259, 243, 232, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
2296, d1g65G_, 0.8803, 2.07, 0.259, 243, 232, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
2297, d5l64T_, 0.8802, 2.13, 0.299, 243, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2298, d5l5tF_, 0.8802, 2.13, 0.299, 243, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2299, d5l5dT_, 0.8802, 2.13, 0.299, 243, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
2300, d5l5dF_, 0.8802, 2.13, 0.299, 243, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
2301, d5cz4T_, 0.8802, 2.26, 0.297, 243, 232, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
2302, d5cz4F_, 0.8802, 2.26, 0.297, 243, 232, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
2303, d5bouT_, 0.8802, 2.13, 0.299, 243, 231, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
2304, d5bouF_, 0.8802, 2.13, 0.299, 243, 231, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
2305, d4qw0T_, 0.8802, 2.26, 0.297, 243, 232, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
2306, d4qw0F_, 0.8802, 2.26, 0.297, 243, 232, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
2307, d4hrcF_, 0.8802, 2.25, 0.297, 244, 232, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
2308, d3shjG_, 0.8802, 2.09, 0.259, 243, 232, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
2309, d3okjU_, 0.8802, 2.09, 0.259, 243, 232, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
2310, d3dy3U_, 0.8802, 2.10, 0.259, 243, 232, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
2311, d3d29T_, 0.8802, 2.26, 0.297, 244, 232, PROTEASOME INHIBITION BY FELLUTAMIDE B
2312, d3d29F_, 0.8802, 2.26, 0.297, 244, 232, PROTEASOME INHIBITION BY FELLUTAMIDE B
2313, d2zcyU_, 0.8802, 2.10, 0.259, 243, 232, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
2314, d2fnyU_, 0.8802, 2.09, 0.259, 243, 232,  
2315, p5lezT_, 0.8801, 2.17, 0.277, 240, 231, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
2316, d5l6cF_, 0.8801, 2.13, 0.299, 243, 231, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2317, d5l69T_, 0.8801, 2.13, 0.299, 243, 231, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2318, d5l69F_, 0.8801, 2.13, 0.299, 243, 231, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2319, d5l62T_, 0.8801, 2.13, 0.299, 243, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2320, d5l62F_, 0.8801, 2.13, 0.299, 243, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2321, d5l61T_, 0.8801, 2.13, 0.299, 243, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
2322, d5l61F_, 0.8801, 2.13, 0.299, 243, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
2323, d5l60T_, 0.8801, 2.13, 0.299, 243, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
2324, d5l60F_, 0.8801, 2.13, 0.299, 243, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
2325, d5l5yT_, 0.8801, 2.13, 0.299, 243, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
2326, d5l5yF_, 0.8801, 2.13, 0.299, 243, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
2327, d5l5wT_, 0.8801, 2.13, 0.299, 243, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
2328, d5l5wF_, 0.8801, 2.13, 0.299, 243, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
2329, d5l5tT_, 0.8801, 2.13, 0.299, 243, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2330, d5l5pT_, 0.8801, 2.13, 0.299, 243, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2331, d5l5pF_, 0.8801, 2.13, 0.299, 243, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2332, d5l5oT_, 0.8801, 2.13, 0.299, 243, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2333, d5l5oF_, 0.8801, 2.13, 0.299, 243, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2334, d5l5jT_, 0.8801, 2.13, 0.299, 243, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
2335, d5l5jF_, 0.8801, 2.13, 0.299, 243, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
2336, d4r18T_, 0.8801, 2.13, 0.299, 243, 231, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
2337, d4r18F_, 0.8801, 2.13, 0.299, 243, 231, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
2338, d4j70G_, 0.8801, 2.11, 0.263, 243, 232, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
2339, d4hrdU_, 0.8801, 2.11, 0.263, 243, 232, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
2340, d3oeuG_, 0.8801, 2.10, 0.259, 243, 232, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
2341, d3e47G_, 0.8801, 2.09, 0.259, 243, 232, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
2342, d3dy4U_, 0.8801, 2.10, 0.259, 243, 232, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
2343, d3dy3G_, 0.8801, 2.10, 0.259, 243, 232, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
2344, d2zcyG_, 0.8801, 2.10, 0.259, 243, 232, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
2345, d2gplU_, 0.8801, 2.09, 0.259, 243, 232, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
2346, d5l6cT_, 0.8800, 2.13, 0.299, 243, 231, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2347, d5l68F_, 0.8800, 2.13, 0.299, 243, 231, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
2348, d5l66T_, 0.8800, 2.13, 0.299, 243, 231, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
2349, d5l66F_, 0.8800, 2.13, 0.299, 243, 231, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
2350, d5l65F_, 0.8800, 2.13, 0.299, 243, 231, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
2351, d5l5vT_, 0.8800, 2.13, 0.299, 243, 231,  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2352, d5l5vF_, 0.8800, 2.13, 0.299, 243, 231,  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2353, d5l5sF_, 0.8800, 2.13, 0.299, 243, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
2354, d5l5qT_, 0.8800, 2.13, 0.299, 243, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
2355, d5l5qF_, 0.8800, 2.13, 0.299, 243, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
2356, d5l5iT_, 0.8800, 2.13, 0.299, 243, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
2357, d5l5iF_, 0.8800, 2.13, 0.299, 243, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
2358, d5l5hT_, 0.8800, 2.13, 0.299, 243, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
2359, d5l5hF_, 0.8800, 2.13, 0.299, 243, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
2360, d5fgaT_, 0.8800, 2.27, 0.297, 243, 232, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
2361, d5fgaF_, 0.8800, 2.27, 0.297, 243, 232, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
2362, d5fg7T_, 0.8800, 2.27, 0.297, 243, 232, YEAST 20S PROTEASOME BETA2-T1A MUTANT
2363, d5fg7F_, 0.8800, 2.27, 0.297, 243, 232, YEAST 20S PROTEASOME BETA2-T1A MUTANT
2364, d5d0xT_, 0.8800, 2.26, 0.297, 243, 232, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
2365, d5d0xF_, 0.8800, 2.26, 0.297, 243, 232, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
2366, p4ya3T_, 0.8800, 2.26, 0.297, 243, 232, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
2367, p4ya3F_, 0.8800, 2.26, 0.297, 243, 232, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
2368, p4ya0F_, 0.8800, 2.26, 0.297, 243, 232, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
2369, d4y8rF_, 0.8800, 2.27, 0.297, 243, 232, YEAST 20S PROTEASOME BETA2-H116D MUTANT
2370, p4y6vT_, 0.8800, 2.13, 0.299, 243, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
2371, p4y6vF_, 0.8800, 2.13, 0.299, 243, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
2372, d4qlvT_, 0.8800, 2.26, 0.297, 243, 232, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
2373, d4qlvF_, 0.8800, 2.26, 0.297, 243, 232, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
2374, d4lqiU_, 0.8800, 2.09, 0.259, 243, 232, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
2375, d3wxrA_, 0.8800, 2.10, 0.259, 243, 232, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
2376, d3dy4G_, 0.8800, 2.10, 0.259, 243, 232, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
2377, p5mp9G_, 0.8799, 2.22, 0.297, 243, 232, 26S PROTEASOME IN PRESENCE OF ATP (S1)
2378, d5l6aT_, 0.8799, 2.14, 0.299, 243, 231, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2379, d5l6aF_, 0.8799, 2.14, 0.299, 243, 231, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2380, d5l68T_, 0.8799, 2.13, 0.299, 243, 231, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
2381, d5l65T_, 0.8799, 2.13, 0.299, 243, 231, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
2382, d5l5zT_, 0.8799, 2.13, 0.299, 243, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
2383, d5l5zF_, 0.8799, 2.13, 0.299, 243, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
2384, d5l5sT_, 0.8799, 2.13, 0.299, 243, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
2385, d5l5rT_, 0.8799, 2.14, 0.299, 243, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
2386, d5l5rF_, 0.8799, 2.14, 0.299, 243, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
2387, d5d0tT_, 0.8799, 2.26, 0.297, 243, 232, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
2388, d5d0tF_, 0.8799, 2.26, 0.297, 243, 232, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
2389, p4ya0T_, 0.8799, 2.26, 0.297, 243, 232, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
2390, d4y8rT_, 0.8799, 2.27, 0.297, 243, 232, YEAST 20S PROTEASOME BETA2-H116D MUTANT
2391, p4y6aT_, 0.8799, 2.14, 0.299, 243, 231, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
2392, p4y6aF_, 0.8799, 2.14, 0.299, 243, 231, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
2393, d4qvyT_, 0.8799, 2.13, 0.299, 243, 231, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
2394, d4qvyF_, 0.8799, 2.13, 0.299, 243, 231, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
2395, d4inuU_, 0.8799, 2.10, 0.259, 243, 232, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
2396, d4hrcU_, 0.8799, 2.12, 0.263, 243, 232, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
2397, d4cr2C_, 0.8799, 2.19, 0.310, 245, 232, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
2398, d3sdiT_, 0.8799, 2.11, 0.299, 242, 231, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
2399, d3okjG_, 0.8799, 2.10, 0.259, 243, 232, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
2400, d3nzwT_, 0.8799, 2.26, 0.297, 244, 232, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
2401, d3nzwF_, 0.8799, 2.26, 0.297, 244, 232, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
2402, d3gptF_, 0.8799, 2.28, 0.297, 244, 232, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
2403, d2gplG_, 0.8799, 2.10, 0.259, 243, 232, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
2404, d2fnyG_, 0.8799, 2.09, 0.259, 243, 232,  
2405, p5nifG_, 0.8798, 2.27, 0.297, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
2406, d5l6bF_, 0.8798, 2.14, 0.299, 243, 231, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
2407, d5l67T_, 0.8798, 2.14, 0.299, 243, 231, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
2408, d5l67F_, 0.8798, 2.14, 0.299, 243, 231, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
2409, d5l5xT_, 0.8798, 2.14, 0.299, 243, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
2410, d5l5xF_, 0.8798, 2.14, 0.299, 243, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
2411, d5l5fT_, 0.8798, 2.13, 0.299, 243, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
2412, d5l5fF_, 0.8798, 2.13, 0.299, 243, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
2413, d5l5aT_, 0.8798, 2.14, 0.299, 243, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
2414, d5l5aF_, 0.8798, 2.14, 0.299, 243, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
2415, d5l54T_, 0.8798, 2.27, 0.297, 243, 232, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2416, d5l54F_, 0.8798, 2.27, 0.297, 243, 232, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2417, d5dkiT_, 0.8798, 2.26, 0.297, 243, 232, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
2418, d5dkiF_, 0.8798, 2.26, 0.297, 243, 232, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
2419, d5cz6T_, 0.8798, 2.14, 0.299, 243, 231, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
2420, d5cz6F_, 0.8798, 2.14, 0.299, 243, 231, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
2421, d4y8mF_, 0.8798, 2.14, 0.299, 243, 231, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
2422, p4x6zU_, 0.8798, 2.13, 0.299, 244, 231, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
2423, d4quxF_, 0.8798, 2.14, 0.299, 243, 231, YCP BETA5-A49T-MUTANT
2424, d4qltT_, 0.8798, 2.27, 0.297, 243, 232, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
2425, d4qltF_, 0.8798, 2.27, 0.297, 243, 232, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
2426, d4lqiG_, 0.8798, 2.10, 0.259, 243, 232, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
2427, d4fzgU_, 0.8798, 2.11, 0.263, 243, 232, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
2428, d4fzgF_, 0.8798, 2.25, 0.297, 244, 232, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
2429, d3gptT_, 0.8798, 2.28, 0.297, 244, 232, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
2430, d5lf1T_, 0.8797, 2.19, 0.277, 240, 231, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
2431, p5lezF_, 0.8797, 2.18, 0.277, 239, 231, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
2432, d5l6bT_, 0.8797, 2.14, 0.299, 243, 231, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
2433, d5l5bF_, 0.8797, 2.14, 0.299, 243, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
2434, d5cgfT_, 0.8797, 2.27, 0.297, 243, 232, YEAST 20S PROTEASOME BETA5-G48C MUTANT
2435, d5cgfF_, 0.8797, 2.27, 0.297, 243, 232, YEAST 20S PROTEASOME BETA5-G48C MUTANT
2436, d5bxnT_, 0.8797, 2.14, 0.299, 243, 231, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
2437, d5bxnF_, 0.8797, 2.14, 0.299, 243, 231, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
2438, d5bxlT_, 0.8797, 2.14, 0.299, 243, 231, YEAST 20S PROTEASOME BETA2-G170A MUTANT
2439, d5bxlF_, 0.8797, 2.14, 0.299, 243, 231, YEAST 20S PROTEASOME BETA2-G170A MUTANT
2440, d4y8mT_, 0.8797, 2.14, 0.299, 243, 231, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
2441, d4quxT_, 0.8797, 2.14, 0.299, 243, 231, YCP BETA5-A49T-MUTANT
2442, d4intT_, 0.8797, 2.29, 0.297, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
2443, d4inrG_, 0.8797, 2.10, 0.259, 243, 232, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
2444, d4fzcU_, 0.8797, 2.10, 0.259, 243, 232, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
2445, d3hyeF_, 0.8797, 2.28, 0.297, 244, 232, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
2446, d2f16U_, 0.8797, 2.10, 0.259, 243, 232, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
2447, d5lajF_, 0.8796, 2.14, 0.299, 243, 231, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
2448, d5l5uT_, 0.8796, 2.14, 0.299, 243, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2449, d5l5uF_, 0.8796, 2.14, 0.299, 243, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2450, d5l5bT_, 0.8796, 2.15, 0.299, 243, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
2451, p5dsvG_, 0.8796, 2.28, 0.280, 242, 232, CRYSTAL STRUCTURE OF HUMAN PROTEASOME ALPHA7 TETRADECAMER
2452, p5dsvE_, 0.8796, 2.27, 0.280, 245, 232, CRYSTAL STRUCTURE OF HUMAN PROTEASOME ALPHA7 TETRADECAMER
2453, p5dsvD_, 0.8796, 2.27, 0.280, 244, 232, CRYSTAL STRUCTURE OF HUMAN PROTEASOME ALPHA7 TETRADECAMER
2454, d4z1lF_, 0.8796, 2.27, 0.297, 243, 232, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
2455, d4qvlT_, 0.8796, 2.14, 0.299, 243, 231, YCP IN COMPLEX WITH BORTEZOMIB
2456, d4qvlF_, 0.8796, 2.14, 0.299, 243, 231, YCP IN COMPLEX WITH BORTEZOMIB
2457, d4intF_, 0.8796, 2.26, 0.297, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
2458, d4inrT_, 0.8796, 2.27, 0.297, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
2459, d4inrF_, 0.8796, 2.27, 0.297, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
2460, d4fzgT_, 0.8796, 2.28, 0.297, 244, 232, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
2461, d4fzgG_, 0.8796, 2.12, 0.263, 243, 232, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
2462, d4cr2G_, 0.8796, 2.17, 0.293, 245, 232, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
2463, d3tddT_, 0.8796, 2.26, 0.297, 244, 232, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
2464, d3tddF_, 0.8796, 2.26, 0.297, 244, 232, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
2465, d3mg4F_, 0.8796, 2.12, 0.299, 244, 231, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
2466, d3hyeT_, 0.8796, 2.28, 0.297, 244, 232, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
2467, d5lttT_, 0.8795, 2.14, 0.299, 243, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
2468, d5lttF_, 0.8795, 2.14, 0.299, 243, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
2469, p5fghT_, 0.8795, 2.13, 0.299, 243, 231, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
2470, p5fghF_, 0.8795, 2.13, 0.299, 243, 231, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
2471, d5cz7T_, 0.8795, 2.14, 0.299, 243, 231, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
2472, d5cz7F_, 0.8795, 2.14, 0.299, 243, 231, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
2473, d4z1lT_, 0.8795, 2.27, 0.297, 243, 232, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
2474, d4ya4T_, 0.8795, 2.15, 0.299, 243, 231, YEAST 20S PROTEASOME BETA2-H114D MUTANT
2475, d4ya4F_, 0.8795, 2.15, 0.299, 243, 231, YEAST 20S PROTEASOME BETA2-H114D MUTANT
2476, p4v7oIA_, 0.8795, 2.10, 0.259, 243, 232, 
2477, d4qvvT_, 0.8795, 2.27, 0.297, 243, 232, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
2478, d4qvvF_, 0.8795, 2.27, 0.297, 243, 232, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
2479, d4qvnT_, 0.8795, 2.14, 0.299, 243, 231, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
2480, d4qvnF_, 0.8795, 2.14, 0.299, 243, 231, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
2481, d4inuG_, 0.8795, 2.10, 0.259, 243, 232, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
2482, d4fzcG_, 0.8795, 2.10, 0.259, 243, 232, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
2483, d3nzjT_, 0.8795, 2.14, 0.299, 244, 231, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
2484, d3nzjF_, 0.8795, 2.14, 0.299, 244, 231, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
2485, d2f16G_, 0.8795, 2.10, 0.259, 243, 232, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
2486, d1vsyA_, 0.8795, 2.10, 0.259, 243, 232,  
2487, p5mpbS_, 0.8794, 2.16, 0.332, 242, 232, 
2488, d5lexT_, 0.8794, 2.18, 0.277, 240, 231, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
2489, d5lexF_, 0.8794, 2.19, 0.277, 239, 231, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
2490, d5le5T_, 0.8794, 2.19, 0.277, 240, 231, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
2491, p5dsvA_, 0.8794, 2.27, 0.280, 244, 232, CRYSTAL STRUCTURE OF HUMAN PROTEASOME ALPHA7 TETRADECAMER
2492, d5czaT_, 0.8794, 2.15, 0.299, 243, 231, YEAST 20S PROTEASOME BETA5-D166N MUTANT
2493, d5czaF_, 0.8794, 2.15, 0.299, 243, 231, YEAST 20S PROTEASOME BETA5-D166N MUTANT
2494, p5cghT_, 0.8794, 2.15, 0.299, 243, 231, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
2495, p5cghF_, 0.8794, 2.15, 0.299, 243, 231, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
2496, p4y8tF_, 0.8794, 2.14, 0.299, 243, 231, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
2497, p4y8gT_, 0.8794, 2.14, 0.299, 243, 231, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
2498, p4y8gF_, 0.8794, 2.14, 0.299, 243, 231, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
2499, p4v7oWA_, 0.8794, 2.10, 0.259, 243, 232, 
2500, p4v7oO_, 0.8794, 2.10, 0.259, 243, 232, 
2501, p4v7oA_, 0.8794, 2.10, 0.259, 243, 232, 
2502, d4qlsF_, 0.8794, 2.14, 0.299, 243, 231, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
2503, d4inuF_, 0.8794, 2.27, 0.297, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
2504, d3sdiG_, 0.8794, 2.11, 0.263, 240, 232, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
2505, d3l5qC_, 0.8794, 2.10, 0.259, 243, 232,  
2506, d3l5qA_, 0.8794, 2.10, 0.259, 243, 232,  
2507, d3gpwF_, 0.8794, 2.27, 0.297, 244, 232, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
2508, d1vsyO_, 0.8794, 2.10, 0.259, 243, 232,  
2509, d1jd2G_, 0.8794, 2.11, 0.263, 243, 232, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
2510, d5lf7T_, 0.8793, 2.19, 0.277, 240, 231, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
2511, p5dsvL_, 0.8793, 2.27, 0.280, 245, 232, CRYSTAL STRUCTURE OF HUMAN PROTEASOME ALPHA7 TETRADECAMER
2512, d5dkjT_, 0.8793, 2.14, 0.299, 243, 231, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
2513, d5dkjF_, 0.8793, 2.14, 0.299, 243, 231, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
2514, d5d0wT_, 0.8793, 2.15, 0.299, 243, 231, YEAST 20S PROTEASOME BETA5-T1S MUTANT
2515, d5d0wF_, 0.8793, 2.15, 0.299, 243, 231, YEAST 20S PROTEASOME BETA5-T1S MUTANT
2516, p4ya9T_, 0.8793, 2.14, 0.299, 243, 231, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
2517, p4ya9F_, 0.8793, 2.14, 0.299, 243, 231, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
2518, p4y8tT_, 0.8793, 2.14, 0.299, 243, 231, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
2519, p4y8kT_, 0.8793, 2.14, 0.299, 243, 231, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
2520, p4y84T_, 0.8793, 2.14, 0.299, 243, 231, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
2521, p4y84F_, 0.8793, 2.14, 0.299, 243, 231, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
2522, d4qw3T_, 0.8793, 2.13, 0.299, 243, 231, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
2523, d4qw3F_, 0.8793, 2.13, 0.299, 243, 231, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
2524, d4qlsT_, 0.8793, 2.14, 0.299, 243, 231, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
2525, d4ltcF_, 0.8793, 2.13, 0.299, 244, 231, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
2526, d4j70F_, 0.8793, 2.14, 0.299, 244, 231, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
2527, d4inuT_, 0.8793, 2.27, 0.297, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
2528, d4intG_, 0.8793, 2.10, 0.259, 243, 232, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
2529, d3nzxT_, 0.8793, 2.26, 0.297, 244, 232, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
2530, d3nzxF_, 0.8793, 2.26, 0.297, 244, 232, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
2531, d3gpwT_, 0.8793, 2.27, 0.297, 244, 232, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
2532, d3dy3T_, 0.8793, 2.14, 0.299, 244, 231, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
2533, d3dy3F_, 0.8793, 2.14, 0.299, 244, 231, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
2534, d3bdmT_, 0.8793, 2.14, 0.299, 244, 231, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
2535, d3bdmF_, 0.8793, 2.14, 0.299, 244, 231, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
2536, d2zcyT_, 0.8793, 2.14, 0.299, 244, 231, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
2537, d2zcyF_, 0.8793, 2.14, 0.299, 244, 231, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
2538, p5lf6T_, 0.8792, 2.19, 0.277, 240, 231, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
2539, p5cghA_, 0.8792, 1.50, 0.377, 229, 223, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
2540, p5cggA_, 0.8792, 1.50, 0.377, 229, 223, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
2541, p4y8kF_, 0.8792, 2.14, 0.299, 243, 231, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
2542, p4y81T_, 0.8792, 2.14, 0.299, 243, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
2543, p4y81F_, 0.8792, 2.14, 0.299, 243, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
2544, p4y75T_, 0.8792, 2.14, 0.299, 243, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
2545, p4y75F_, 0.8792, 2.14, 0.299, 243, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
2546, p4y6zT_, 0.8792, 2.14, 0.299, 243, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
2547, p4y6zF_, 0.8792, 2.14, 0.299, 243, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
2548, d4qwgT_, 0.8792, 2.14, 0.299, 243, 231, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
2549, d4qwgF_, 0.8792, 2.14, 0.299, 243, 231, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
2550, d4qw1T_, 0.8792, 2.14, 0.299, 243, 231, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
2551, d4qw1F_, 0.8792, 2.14, 0.299, 243, 231, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
2552, d4qvqT_, 0.8792, 2.14, 0.299, 243, 231, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
2553, d4qvqF_, 0.8792, 2.14, 0.299, 243, 231, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
2554, d4qvpT_, 0.8792, 2.14, 0.299, 243, 231, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
2555, d4qvpF_, 0.8792, 2.14, 0.299, 243, 231, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
2556, d4qv4T_, 0.8792, 2.15, 0.299, 243, 231, YCP BETA5-M45T MUTANT
2557, d4qv4F_, 0.8792, 2.15, 0.299, 243, 231, YCP BETA5-M45T MUTANT
2558, d4qv1T_, 0.8792, 2.15, 0.299, 243, 231, YCP BETA5-M45A MUTANT
2559, d4qv1F_, 0.8792, 2.15, 0.299, 243, 231, YCP BETA5-M45A MUTANT
2560, d4q1sT_, 0.8792, 2.16, 0.299, 244, 231, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
2561, d3mg8G_, 0.8792, 2.10, 0.259, 243, 232, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
2562, d3mg4T_, 0.8792, 2.29, 0.297, 244, 232, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
2563, d2gplF_, 0.8792, 2.28, 0.297, 244, 232, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
2564, d2fakT_, 0.8792, 2.29, 0.297, 244, 232, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
2565, d2fakF_, 0.8792, 2.27, 0.297, 244, 232, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
2566, d5lf4T_, 0.8791, 2.19, 0.277, 240, 231, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
2567, p4y8oF_, 0.8791, 2.14, 0.299, 243, 231, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
2568, p4y7xT_, 0.8791, 2.14, 0.299, 243, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
2569, p4y7xF_, 0.8791, 2.14, 0.299, 243, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
2570, p4y77T_, 0.8791, 2.14, 0.299, 243, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
2571, p4y77F_, 0.8791, 2.14, 0.299, 243, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
2572, d4r3oU_, 0.8791, 2.27, 0.280, 245, 232, HUMAN CONSTITUTIVE 20S PROTEASOME
2573, d4r3oG_, 0.8791, 2.27, 0.280, 245, 232, HUMAN CONSTITUTIVE 20S PROTEASOME
2574, d4qzzT_, 0.8791, 2.15, 0.299, 243, 231, YCP IN COMPLEX WITH OMURALIDE
2575, d4qzzF_, 0.8791, 2.15, 0.299, 243, 231, YCP IN COMPLEX WITH OMURALIDE
2576, d4qv5F_, 0.8791, 2.15, 0.299, 243, 231, YCP BETA5-M45I MUTANT
2577, p4qbyA_, 0.8791, 1.50, 0.377, 229, 223, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
2578, d2gplT_, 0.8791, 2.28, 0.297, 244, 232, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
2579, p6avoJ_, 0.8790, 2.21, 0.277, 239, 231, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
2580, d5lf3T_, 0.8790, 2.19, 0.277, 240, 231, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
2581, d5fgiT_, 0.8790, 2.15, 0.299, 243, 231, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2582, d5fgiF_, 0.8790, 2.15, 0.299, 243, 231, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2583, d5fgeT_, 0.8790, 2.15, 0.299, 243, 231, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2584, d5fgeF_, 0.8790, 2.15, 0.299, 243, 231, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2585, p5dsvB_, 0.8790, 2.27, 0.280, 245, 232, CRYSTAL STRUCTURE OF HUMAN PROTEASOME ALPHA7 TETRADECAMER
2586, p5cgiA_, 0.8790, 1.50, 0.377, 229, 223, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
2587, p4y8pT_, 0.8790, 2.14, 0.299, 243, 231, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
2588, p4y8pF_, 0.8790, 2.14, 0.299, 243, 231, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
2589, p4y8oT_, 0.8790, 2.14, 0.299, 243, 231, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
2590, p4y8lA_, 0.8790, 1.50, 0.377, 229, 223, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
2591, p4y74T_, 0.8790, 2.14, 0.299, 243, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
2592, p4y74F_, 0.8790, 2.14, 0.299, 243, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
2593, d4qv8T_, 0.8790, 2.15, 0.299, 243, 231, YCP BETA5-C52F MUTANT
2594, d4qv8F_, 0.8790, 2.15, 0.299, 243, 231, YCP BETA5-C52F MUTANT
2595, d4qv7T_, 0.8790, 2.15, 0.299, 243, 231, YCP BETA5-A50V MUTANT
2596, d4qv7F_, 0.8790, 2.15, 0.299, 243, 231, YCP BETA5-A50V MUTANT
2597, d4qv6T_, 0.8790, 2.15, 0.299, 243, 231, YCP BETA5-A49V MUTANT
2598, d4qv6F_, 0.8790, 2.15, 0.299, 243, 231, YCP BETA5-A49V MUTANT
2599, d4qv5T_, 0.8790, 2.16, 0.299, 243, 231, YCP BETA5-M45I MUTANT
2600, d4qv0F_, 0.8790, 2.15, 0.299, 243, 231, YCP BETA5-A49T-A50V-DOUBLE MUTANT
2601, d4quyT_, 0.8790, 2.15, 0.299, 243, 231, YCP BETA5-A49S-MUTANT
2602, d4quyF_, 0.8790, 2.15, 0.299, 243, 231, YCP BETA5-A49S-MUTANT
2603, d4nnwT_, 0.8790, 2.15, 0.299, 243, 231, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
2604, d4nnwF_, 0.8790, 2.15, 0.299, 243, 231, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
2605, d4hrdT_, 0.8790, 2.29, 0.297, 244, 232, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
2606, d4hnpT_, 0.8790, 2.14, 0.299, 244, 231, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
2607, d3un8T_, 0.8790, 2.14, 0.299, 244, 231, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
2608, d1rypG_, 0.8790, 2.26, 0.297, 244, 232, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
2609, p6avoQ_, 0.8789, 2.21, 0.277, 239, 231, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
2610, d5l5bU_, 0.8789, 2.09, 0.264, 241, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
2611, d5fggT_, 0.8789, 2.15, 0.299, 243, 231, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2612, d5fggF_, 0.8789, 2.15, 0.299, 243, 231, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2613, d5cz9T_, 0.8789, 2.15, 0.299, 243, 231, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
2614, d5cz9F_, 0.8789, 2.15, 0.299, 243, 231, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
2615, p4ya2A_, 0.8789, 1.50, 0.377, 229, 223, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
2616, p4y8sT_, 0.8789, 2.14, 0.299, 243, 231, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
2617, p4y8sF_, 0.8789, 2.14, 0.299, 243, 231, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
2618, p4y8sA_, 0.8789, 1.51, 0.377, 229, 223, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
2619, p4y82T_, 0.8789, 2.14, 0.299, 243, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
2620, p4y82F_, 0.8789, 2.14, 0.299, 243, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
2621, p4y77A_, 0.8789, 1.50, 0.377, 229, 223, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
2622, d4qz7T_, 0.8789, 2.15, 0.299, 243, 231, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2623, d4qz7F_, 0.8789, 2.15, 0.299, 243, 231, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2624, d4qz1T_, 0.8789, 2.14, 0.299, 243, 231, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2625, d4qz1F_, 0.8789, 2.14, 0.299, 243, 231, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2626, d4qwxT_, 0.8789, 2.14, 0.299, 243, 231, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2627, d4qwxF_, 0.8789, 2.14, 0.299, 243, 231, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2628, d4qwfT_, 0.8789, 2.15, 0.299, 243, 231, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
2629, d4qwfF_, 0.8789, 2.15, 0.299, 243, 231, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
2630, d4qv0T_, 0.8789, 2.15, 0.299, 243, 231, YCP BETA5-A49T-A50V-DOUBLE MUTANT
2631, d4no1T_, 0.8789, 2.15, 0.299, 243, 231, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
2632, d4no1F_, 0.8789, 2.15, 0.299, 243, 231, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
2633, d4ltcT_, 0.8789, 2.14, 0.299, 244, 231, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
2634, d4j70T_, 0.8789, 2.14, 0.299, 244, 231, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
2635, d3mg4G_, 0.8789, 2.12, 0.263, 243, 232, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
2636, d3gpjT_, 0.8789, 2.14, 0.299, 244, 231, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
2637, d3gpjF_, 0.8789, 2.14, 0.299, 244, 231, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
2638, d3dy4T_, 0.8789, 2.15, 0.299, 244, 231, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
2639, d3dy4F_, 0.8789, 2.15, 0.299, 244, 231, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
2640, p5lf0T_, 0.8788, 2.19, 0.277, 240, 231, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
2641, d5l5bG_, 0.8788, 2.09, 0.264, 241, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
2642, d5jhrF_, 0.8788, 2.15, 0.299, 243, 231, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
2643, d5fgdT_, 0.8788, 2.15, 0.299, 243, 231, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2644, d5fgdF_, 0.8788, 2.15, 0.299, 243, 231, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2645, p4ya7A_, 0.8788, 1.50, 0.377, 229, 223, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
2646, p4ya2T_, 0.8788, 2.15, 0.299, 243, 231, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
2647, p4ya2F_, 0.8788, 2.15, 0.299, 243, 231, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
2648, p4y8hT_, 0.8788, 2.15, 0.299, 243, 231, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
2649, p4y8hF_, 0.8788, 2.15, 0.299, 243, 231, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
2650, p4r67i_, 0.8788, 2.27, 0.280, 245, 232, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
2651, d4r00T_, 0.8788, 2.15, 0.299, 243, 231, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
2652, d4r00F_, 0.8788, 2.15, 0.299, 243, 231, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
2653, d4qw6T_, 0.8788, 2.15, 0.299, 243, 231, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
2654, d4qw6F_, 0.8788, 2.15, 0.299, 243, 231, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
2655, d4qw4T_, 0.8788, 2.14, 0.299, 243, 231, YCP IN COMPLEX WITH CARFILZOMIB
2656, d4qw4F_, 0.8788, 2.14, 0.299, 243, 231, YCP IN COMPLEX WITH CARFILZOMIB
2657, d4qluF_, 0.8788, 2.15, 0.299, 243, 231, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
2658, d4qlqF_, 0.8788, 2.15, 0.299, 243, 231, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
2659, p4qbyF_, 0.8788, 2.16, 0.299, 243, 231, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
2660, d4no9T_, 0.8788, 2.15, 0.299, 243, 231, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
2661, d4no6F_, 0.8788, 2.14, 0.299, 243, 231, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
2662, d4jt0T_, 0.8788, 2.27, 0.297, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
2663, d4jt0F_, 0.8788, 2.27, 0.297, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
2664, d4jsqT_, 0.8788, 2.27, 0.297, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
2665, d4jsqF_, 0.8788, 2.27, 0.297, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
2666, d4cr2E_, 0.8788, 2.14, 0.341, 243, 232, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
2667, d3okjF_, 0.8788, 2.27, 0.297, 244, 232, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
2668, d1g65F_, 0.8788, 2.26, 0.297, 244, 232, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
2669, d1g0uF_, 0.8788, 2.26, 0.297, 242, 232, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
2670, d5jhrT_, 0.8787, 2.15, 0.299, 243, 231, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
2671, p5cggF_, 0.8787, 2.16, 0.299, 243, 231, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
2672, d5ahjT_, 0.8787, 2.16, 0.299, 243, 231, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
2673, d5ahjF_, 0.8787, 2.16, 0.299, 243, 231, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
2674, p4ya7T_, 0.8787, 2.15, 0.299, 243, 231, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
2675, p4ya7F_, 0.8787, 2.15, 0.299, 243, 231, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
2676, p4y9zA_, 0.8787, 1.51, 0.377, 229, 223, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
2677, p4y8qT_, 0.8787, 2.15, 0.299, 243, 231, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
2678, p4y8qF_, 0.8787, 2.15, 0.299, 243, 231, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
2679, p4y8iT_, 0.8787, 2.14, 0.299, 243, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
2680, p4y8iF_, 0.8787, 2.14, 0.299, 243, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
2681, p4y8hA_, 0.8787, 1.50, 0.377, 229, 223, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
2682, p4y7yA_, 0.8787, 1.50, 0.377, 229, 223, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
2683, p4y7wA_, 0.8787, 1.51, 0.377, 229, 223, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
2684, p4y75A_, 0.8787, 1.51, 0.377, 229, 223, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
2685, p4y70A_, 0.8787, 1.50, 0.377, 229, 223, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
2686, d4qz4T_, 0.8787, 2.15, 0.299, 243, 231, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2687, d4qz4F_, 0.8787, 2.15, 0.299, 243, 231, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2688, d4qwrF_, 0.8787, 2.15, 0.299, 243, 231, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
2689, d4qwkT_, 0.8787, 2.15, 0.299, 243, 231, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2690, d4qwkF_, 0.8787, 2.15, 0.299, 243, 231, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2691, d4qw7T_, 0.8787, 2.15, 0.299, 243, 231, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
2692, d4qw7F_, 0.8787, 2.15, 0.299, 243, 231, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
2693, d4qluT_, 0.8787, 2.15, 0.299, 243, 231, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
2694, d4qlqT_, 0.8787, 2.15, 0.299, 243, 231, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
2695, p4qbyT_, 0.8787, 2.16, 0.299, 243, 231, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
2696, d4no9F_, 0.8787, 2.15, 0.299, 243, 231, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
2697, d4no8T_, 0.8787, 2.15, 0.299, 243, 231, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
2698, d4no8F_, 0.8787, 2.15, 0.299, 243, 231, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
2699, d4no6T_, 0.8787, 2.14, 0.299, 243, 231, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
2700, p3unbh_, 0.8787, 2.08, 0.278, 244, 230, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
2701, d3shjT_, 0.8787, 2.27, 0.297, 244, 232, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
2702, d3shjF_, 0.8787, 2.27, 0.297, 244, 232, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
2703, d3okjT_, 0.8787, 2.27, 0.297, 244, 232, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
2704, d1rypU_, 0.8787, 2.27, 0.297, 244, 232, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
2705, d1iruU_, 0.8787, 2.27, 0.280, 245, 232, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
2706, d1iruG_, 0.8787, 2.27, 0.280, 245, 232, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
2707, p6gopT_, 0.8786, 2.15, 0.299, 243, 231, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
2708, p6gopF_, 0.8786, 2.15, 0.299, 243, 231, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
2709, p5ln3B_, 0.8786, 1.73, 0.382, 234, 228, THE HUMAN 26S PROTEASOME AT 6.8 ANG.
2710, p5leyT_, 0.8786, 2.20, 0.277, 240, 231, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
2711, d5jhsT_, 0.8786, 2.15, 0.299, 243, 231, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
2712, d5jhsF_, 0.8786, 2.15, 0.299, 243, 231, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
2713, p5cggT_, 0.8786, 2.16, 0.299, 243, 231, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
2714, p4ya9A_, 0.8786, 1.51, 0.377, 229, 223, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
2715, p4y8uA_, 0.8786, 1.51, 0.377, 229, 223, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
2716, p4y8nA_, 0.8786, 1.51, 0.377, 229, 223, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
2717, p4y8lT_, 0.8786, 2.15, 0.299, 243, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
2718, p4y8jA_, 0.8786, 1.51, 0.377, 229, 223, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
2719, p4y8iA_, 0.8786, 1.51, 0.377, 229, 223, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
2720, p4y80F_, 0.8786, 2.14, 0.299, 243, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
2721, p4y6vA_, 0.8786, 1.51, 0.377, 229, 223, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
2722, p4r67w_, 0.8786, 2.28, 0.280, 245, 232, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
2723, d4r67U_, 0.8786, 2.28, 0.280, 245, 232, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
2724, d4qz0T_, 0.8786, 2.15, 0.299, 243, 231, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2725, d4qz0F_, 0.8786, 2.15, 0.299, 243, 231, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2726, d4qwuT_, 0.8786, 2.15, 0.299, 243, 231, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
2727, d4qwuF_, 0.8786, 2.15, 0.299, 243, 231, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
2728, d4qwrT_, 0.8786, 2.15, 0.299, 243, 231, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
2729, p4gk7U_, 0.8786, 2.13, 0.263, 243, 232, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
2730, d3e47T_, 0.8786, 2.28, 0.297, 244, 232, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
2731, d3e47F_, 0.8786, 2.28, 0.297, 244, 232, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
2732, d1g65T_, 0.8786, 2.26, 0.297, 244, 232, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
2733, d5fgfT_, 0.8785, 2.15, 0.299, 243, 231, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
2734, d5fgfF_, 0.8785, 2.15, 0.299, 243, 231, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
2735, p5dsvN_, 0.8785, 2.28, 0.280, 244, 232, CRYSTAL STRUCTURE OF HUMAN PROTEASOME ALPHA7 TETRADECAMER
2736, p5dsvF_, 0.8785, 2.28, 0.280, 244, 232, CRYSTAL STRUCTURE OF HUMAN PROTEASOME ALPHA7 TETRADECAMER
2737, d5d0wU_, 0.8785, 2.09, 0.264, 241, 231, YEAST 20S PROTEASOME BETA5-T1S MUTANT
2738, d5d0vT_, 0.8785, 2.15, 0.299, 243, 231, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
2739, d5d0vF_, 0.8785, 2.15, 0.299, 243, 231, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
2740, d5d0sT_, 0.8785, 2.16, 0.299, 243, 231, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
2741, d5d0sF_, 0.8785, 2.15, 0.299, 243, 231, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
2742, p4ya5A_, 0.8785, 1.51, 0.377, 229, 223, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
2743, p4y9zT_, 0.8785, 2.15, 0.299, 243, 231, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
2744, p4y9zF_, 0.8785, 2.15, 0.299, 243, 231, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
2745, p4y8lF_, 0.8785, 2.15, 0.299, 243, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
2746, p4y8gA_, 0.8785, 1.51, 0.377, 229, 223, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
2747, p4y80T_, 0.8785, 2.14, 0.299, 243, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
2748, p4y70F_, 0.8785, 2.15, 0.299, 243, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
2749, p4y69A_, 0.8785, 1.51, 0.377, 229, 223, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
2750, d4r02T_, 0.8785, 2.18, 0.299, 243, 231, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
2751, d4qzwT_, 0.8785, 2.15, 0.299, 243, 231, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2752, d4qzwF_, 0.8785, 2.15, 0.299, 243, 231, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2753, d4qz6T_, 0.8785, 2.15, 0.299, 243, 231, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2754, d4qz6F_, 0.8785, 2.15, 0.299, 243, 231, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2755, d4qwiT_, 0.8785, 2.15, 0.299, 243, 231, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
2756, d4qwiF_, 0.8785, 2.15, 0.299, 243, 231, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
2757, d4qw5T_, 0.8785, 2.15, 0.299, 243, 231, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
2758, d4qw5F_, 0.8785, 2.15, 0.299, 243, 231, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
2759, d4qv3T_, 0.8785, 2.16, 0.299, 243, 231, YCP BETA5-M45V MUTANT
2760, d4qv3F_, 0.8785, 2.16, 0.299, 243, 231, YCP BETA5-M45V MUTANT
2761, d3unbF_, 0.8785, 2.22, 0.277, 244, 231, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
2762, d3sdiR_, 0.8785, 1.72, 0.345, 229, 226, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
2763, d5lf1F_, 0.8784, 2.21, 0.277, 239, 231, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
2764, d5l5rU_, 0.8784, 2.09, 0.264, 241, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
2765, d5d0zT_, 0.8784, 2.16, 0.299, 243, 231, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
2766, d5d0zF_, 0.8784, 2.15, 0.299, 243, 231, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
2767, d5d0wG_, 0.8784, 2.10, 0.264, 241, 231, YEAST 20S PROTEASOME BETA5-T1S MUTANT
2768, d4ya4U_, 0.8784, 2.09, 0.264, 241, 231, YEAST 20S PROTEASOME BETA2-H114D MUTANT
2769, p4y8oA_, 0.8784, 1.51, 0.377, 229, 223, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
2770, p4y84A_, 0.8784, 1.51, 0.377, 229, 223, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
2771, p4y7wT_, 0.8784, 2.15, 0.299, 243, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
2772, p4y7wF_, 0.8784, 2.15, 0.299, 243, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
2773, p4y70T_, 0.8784, 2.15, 0.299, 243, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
2774, d4qz3T_, 0.8784, 2.15, 0.299, 243, 231, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2775, d4qz3F_, 0.8784, 2.15, 0.299, 243, 231, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2776, d4qz2T_, 0.8784, 2.15, 0.299, 243, 231, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2777, d4qz2F_, 0.8784, 2.15, 0.299, 243, 231, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2778, d4qwsT_, 0.8784, 2.15, 0.299, 243, 231, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
2779, d4qwsF_, 0.8784, 2.15, 0.299, 243, 231, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
2780, d4qwlT_, 0.8784, 2.15, 0.299, 243, 231, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
2781, d4qwlF_, 0.8784, 2.15, 0.299, 243, 231, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
2782, d4nnnT_, 0.8784, 2.15, 0.299, 243, 231, YCP IN COMPLEX WITH MG132
2783, d4nnnF_, 0.8784, 2.15, 0.299, 243, 231, YCP IN COMPLEX WITH MG132
2784, d4lqiF_, 0.8784, 2.15, 0.299, 244, 231, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
2785, p4gk7G_, 0.8784, 2.13, 0.263, 243, 232, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
2786, d4fzcF_, 0.8784, 2.29, 0.297, 244, 232, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
2787, d4eu2O_, 0.8784, 2.03, 0.265, 241, 230, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
2788, d5l5rG_, 0.8783, 2.10, 0.264, 241, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
2789, d5l55T_, 0.8783, 2.16, 0.299, 243, 231, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2790, d5l55F_, 0.8783, 2.16, 0.299, 243, 231, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2791, p5fghA_, 0.8783, 1.51, 0.377, 229, 223, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
2792, d5czaU_, 0.8783, 2.10, 0.264, 241, 231, YEAST 20S PROTEASOME BETA5-D166N MUTANT
2793, d4ya4G_, 0.8783, 2.09, 0.264, 241, 231, YEAST 20S PROTEASOME BETA2-H114D MUTANT
2794, p4ya3A_, 0.8783, 1.51, 0.377, 229, 223, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
2795, p4y8tA_, 0.8783, 1.51, 0.377, 229, 223, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
2796, p4y8jT_, 0.8783, 2.15, 0.299, 243, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
2797, p4y8jF_, 0.8783, 2.15, 0.299, 243, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
2798, p4y78F_, 0.8783, 2.15, 0.299, 243, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP
2799, d4r67G_, 0.8783, 2.28, 0.280, 245, 232, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
2800, d4qv9U_, 0.8783, 2.10, 0.264, 241, 231, YCP BETA5-C63F MUTANT
2801, d4qv9T_, 0.8783, 2.16, 0.299, 243, 231, YCP BETA5-C63F MUTANT
2802, d4qv9F_, 0.8783, 2.16, 0.299, 243, 231, YCP BETA5-C63F MUTANT
2803, d4lqiT_, 0.8783, 2.15, 0.299, 244, 231, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
2804, d4fzcT_, 0.8783, 2.29, 0.297, 244, 232, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
2805, d3mg0F_, 0.8783, 2.14, 0.299, 244, 231, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
2806, d2f16F_, 0.8783, 2.28, 0.297, 244, 232, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
2807, d5fhsT_, 0.8782, 2.16, 0.299, 243, 231, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
2808, d5fhsF_, 0.8782, 2.16, 0.299, 243, 231, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
2809, d5czaG_, 0.8782, 2.10, 0.264, 241, 231, YEAST 20S PROTEASOME BETA5-D166N MUTANT
2810, d5cz5T_, 0.8782, 2.15, 0.299, 243, 231, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
2811, d5cz5F_, 0.8782, 2.15, 0.299, 243, 231, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
2812, p5cgiT_, 0.8782, 2.15, 0.299, 243, 231, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
2813, p5cgiF_, 0.8782, 2.15, 0.299, 243, 231, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
2814, p4y78T_, 0.8782, 2.15, 0.299, 243, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP
2815, d4qz5T_, 0.8782, 2.15, 0.299, 243, 231, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
2816, d4qz5F_, 0.8782, 2.15, 0.299, 243, 231, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
2817, d4qxjT_, 0.8782, 2.15, 0.299, 243, 231, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2818, d4qxjF_, 0.8782, 2.15, 0.299, 243, 231, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2819, d4ltcG_, 0.8782, 2.14, 0.263, 243, 232, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
2820, d4eu2U_, 0.8782, 2.16, 0.299, 244, 231, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
2821, p3unbv_, 0.8782, 2.21, 0.273, 244, 231, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
2822, d5le5F_, 0.8781, 2.21, 0.277, 239, 231, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
2823, d5l52T_, 0.8781, 2.16, 0.299, 243, 231, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
2824, d5l52F_, 0.8781, 2.16, 0.299, 243, 231, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
2825, d4ya1U_, 0.8781, 2.10, 0.264, 241, 231, YEAST 20S PROTEASOME BETA2-H116N MUTANT
2826, d4y8rU_, 0.8781, 2.10, 0.264, 241, 231, YEAST 20S PROTEASOME BETA2-H116D MUTANT
2827, p4y7yF_, 0.8781, 2.15, 0.299, 243, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
2828, d4qv9G_, 0.8781, 2.10, 0.264, 241, 231, YCP BETA5-C63F MUTANT
2829, d2f16T_, 0.8781, 2.28, 0.297, 244, 232, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
2830, d5lf7F_, 0.8780, 2.21, 0.277, 239, 231, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
2831, d5fg7U_, 0.8780, 2.10, 0.264, 241, 231, YEAST 20S PROTEASOME BETA2-T1A MUTANT
2832, p4zzgO_, 0.8780, 2.10, 0.264, 242, 231, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
2833, d4ya1G_, 0.8780, 2.10, 0.264, 241, 231, YEAST 20S PROTEASOME BETA2-H116N MUTANT
2834, p4ya0A_, 0.8780, 1.52, 0.377, 229, 223, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
2835, d4y8rG_, 0.8780, 2.10, 0.264, 241, 231, YEAST 20S PROTEASOME BETA2-H116D MUTANT
2836, p4y7yT_, 0.8780, 2.15, 0.299, 243, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
2837, d4qzxT_, 0.8780, 2.15, 0.299, 243, 231, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2838, d4qzxF_, 0.8780, 2.15, 0.299, 243, 231, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
2839, d4no9U_, 0.8780, 2.10, 0.264, 241, 231, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
2840, d4hrcT_, 0.8780, 2.15, 0.299, 244, 231, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
2841, d3unbT_, 0.8780, 2.22, 0.277, 244, 231, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
2842, p3un4F_, 0.8780, 2.28, 0.297, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
2843, d3mg0T_, 0.8780, 2.15, 0.299, 244, 231, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
2844, d1g0uT_, 0.8780, 2.28, 0.297, 242, 232, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
2845, p5lf0F_, 0.8779, 2.21, 0.277, 239, 231, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
2846, d5fg7G_, 0.8779, 2.10, 0.264, 241, 231, YEAST 20S PROTEASOME BETA2-T1A MUTANT
2847, d5bxlU_, 0.8779, 2.10, 0.264, 241, 231, YEAST 20S PROTEASOME BETA2-G170A MUTANT
2848, d4qwjF_, 0.8779, 2.15, 0.299, 243, 231, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
2849, d4no9G_, 0.8779, 2.10, 0.264, 241, 231, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
2850, p3unhT_, 0.8779, 2.10, 0.274, 244, 230, MOUSE 20S IMMUNOPROTEASOME
2851, p3unhF_, 0.8779, 2.10, 0.274, 244, 230, MOUSE 20S IMMUNOPROTEASOME
2852, p3un4T_, 0.8779, 2.28, 0.297, 244, 232, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
2853, d2fnyF_, 0.8779, 2.15, 0.299, 244, 231,  
2854, p5nifO_, 0.8778, 2.10, 0.264, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
2855, d5l6aU_, 0.8778, 2.10, 0.264, 241, 231, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2856, p5dsvI_, 0.8778, 2.24, 0.277, 244, 231, CRYSTAL STRUCTURE OF HUMAN PROTEASOME ALPHA7 TETRADECAMER
2857, d5bxlG_, 0.8778, 2.10, 0.264, 241, 231, YEAST 20S PROTEASOME BETA2-G170A MUTANT
2858, d4qwjT_, 0.8778, 2.15, 0.299, 243, 231, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
2859, d4quyU_, 0.8778, 2.10, 0.264, 241, 231, YCP BETA5-A49S-MUTANT
2860, d4no1U_, 0.8778, 2.11, 0.264, 241, 231, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
2861, d4hnpG_, 0.8778, 2.14, 0.263, 243, 232, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
2862, p4gk7F_, 0.8778, 2.15, 0.299, 244, 231, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
2863, d3unfT_, 0.8778, 2.10, 0.274, 244, 230, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
2864, d3unfF_, 0.8778, 2.10, 0.274, 244, 230, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
2865, d2fnyT_, 0.8778, 2.15, 0.299, 244, 231,  
2866, p5lf6F_, 0.8777, 2.21, 0.277, 239, 231, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
2867, d5lf4F_, 0.8777, 2.21, 0.277, 239, 231, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
2868, d5l6aG_, 0.8777, 2.10, 0.264, 241, 231, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2869, d5l5uU_, 0.8777, 2.10, 0.264, 241, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2870, d5fgaU_, 0.8777, 2.10, 0.264, 241, 231, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
2871, d5cz8T_, 0.8777, 2.16, 0.299, 243, 231, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
2872, d5cz8F_, 0.8777, 2.16, 0.299, 243, 231, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
2873, d5cgfU_, 0.8777, 2.10, 0.264, 241, 231, YEAST 20S PROTEASOME BETA5-G48C MUTANT
2874, d5bxnU_, 0.8777, 2.10, 0.264, 241, 231, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
2875, p4y8tU_, 0.8777, 2.10, 0.264, 241, 231, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
2876, d4qv7U_, 0.8777, 2.11, 0.264, 241, 231, YCP BETA5-A50V MUTANT
2877, d4quyG_, 0.8777, 2.10, 0.264, 241, 231, YCP BETA5-A49S-MUTANT
2878, d4no1G_, 0.8777, 2.11, 0.264, 241, 231, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
2879, d4jsuF_, 0.8777, 2.15, 0.299, 244, 231, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
2880, p4gk7T_, 0.8777, 2.16, 0.299, 244, 231, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
2881, d5lf3F_, 0.8776, 2.21, 0.277, 239, 231, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
2882, d5l5uG_, 0.8776, 2.10, 0.264, 241, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2883, d5fgaG_, 0.8776, 2.10, 0.264, 241, 231, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
2884, d5cgfG_, 0.8776, 2.11, 0.264, 241, 231, YEAST 20S PROTEASOME BETA5-G48C MUTANT
2885, d5bxnG_, 0.8776, 2.10, 0.264, 241, 231, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
2886, p4y8tG_, 0.8776, 2.10, 0.264, 241, 231, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
2887, d4qv7G_, 0.8776, 2.11, 0.264, 241, 231, YCP BETA5-A50V MUTANT
2888, d4q1sG_, 0.8776, 2.12, 0.259, 243, 232, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
2889, d4jsuT_, 0.8776, 2.16, 0.299, 244, 231, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
2890, p5wviOA_, 0.8775, 1.82, 0.362, 250, 229, 
2891, d4y8mU_, 0.8775, 2.11, 0.264, 241, 231, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
2892, d4y8mG_, 0.8775, 2.11, 0.264, 241, 231, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
2893, d4r17U_, 0.8775, 2.11, 0.264, 241, 231, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
2894, d4qv3U_, 0.8775, 2.10, 0.264, 241, 231, YCP BETA5-M45V MUTANT
2895, d4qv3G_, 0.8775, 2.10, 0.264, 241, 231, YCP BETA5-M45V MUTANT
2896, d4qv1U_, 0.8775, 2.11, 0.264, 241, 231, YCP BETA5-M45A MUTANT
2897, d3mg0G_, 0.8775, 2.13, 0.259, 243, 232, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
2898, d5l5aU_, 0.8774, 2.11, 0.264, 241, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
2899, d5fggU_, 0.8774, 2.11, 0.264, 241, 231, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2900, d5fg9U_, 0.8774, 2.11, 0.264, 241, 231, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
2901, d4r17G_, 0.8774, 2.11, 0.264, 241, 231, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
2902, d4qv1G_, 0.8774, 2.11, 0.264, 241, 231, YCP BETA5-M45A MUTANT
2903, p1fntQ_, 0.8774, 2.01, 0.310, 241, 229, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
2904, p1fntC_, 0.8774, 2.01, 0.310, 241, 229, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
2905, d5l5aG_, 0.8773, 2.11, 0.264, 241, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
2906, d5fggG_, 0.8773, 2.11, 0.264, 241, 231, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
2907, d5ahjU_, 0.8773, 2.11, 0.264, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
2908, d4y9yU_, 0.8773, 2.11, 0.264, 241, 231, YEAST 20S PROTEASOME BETA2-H116E MUTANT
2909, d4y9yG_, 0.8773, 2.11, 0.264, 241, 231, YEAST 20S PROTEASOME BETA2-H116E MUTANT
2910, p4x6zA_, 0.8773, 2.15, 0.263, 242, 232, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
2911, d4qv8U_, 0.8773, 2.11, 0.264, 241, 231, YCP BETA5-C52F MUTANT
2912, d4qv5U_, 0.8773, 2.11, 0.264, 241, 231, YCP BETA5-M45I MUTANT
2913, d4qv4U_, 0.8773, 2.11, 0.264, 241, 231, YCP BETA5-M45T MUTANT
2914, p3jcpJA_, 0.8773, 2.11, 0.259, 243, 232, 
2915, p3jcpJ_, 0.8773, 2.11, 0.259, 243, 232, 
2916, d2ku2A1, 0.8773, 1.57, 0.357, 233, 224, DYNAMIC REGULATION OF ARCHAEAL PROTEASOME GATE OPENING AS STUDIED BY TROSY-NMR
2917, p5t0hH_, 0.8772, 1.78, 0.377, 232, 228, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
2918, d5l6bU_, 0.8772, 2.11, 0.264, 241, 231, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
2919, d5l5dU_, 0.8772, 2.11, 0.264, 241, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
2920, d5jhrU_, 0.8772, 2.11, 0.264, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
2921, d5fg9G_, 0.8772, 2.11, 0.264, 241, 231, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
2922, p5dsvK_, 0.8772, 2.24, 0.277, 244, 231, CRYSTAL STRUCTURE OF HUMAN PROTEASOME ALPHA7 TETRADECAMER
2923, d5cz6U_, 0.8772, 2.11, 0.264, 241, 231, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
2924, d5ahjG_, 0.8772, 2.11, 0.264, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
2925, d4z1lU_, 0.8772, 2.11, 0.264, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
2926, d4qwuU_, 0.8772, 2.11, 0.264, 241, 231, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
2927, d4qvnU_, 0.8772, 2.11, 0.264, 241, 231, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
2928, d4qv8G_, 0.8772, 2.11, 0.264, 241, 231, YCP BETA5-C52F MUTANT
2929, d4qv5G_, 0.8772, 2.11, 0.264, 241, 231, YCP BETA5-M45I MUTANT
2930, d4qv4G_, 0.8772, 2.11, 0.264, 241, 231, YCP BETA5-M45T MUTANT
2931, d4nnnU_, 0.8772, 2.11, 0.264, 241, 231, YCP IN COMPLEX WITH MG132
2932, d4g4sA_, 0.8772, 2.23, 0.263, 241, 232, STRUCTURE OF PROTEASOME-PBA1-PBA2 COMPLEX
2933, d2ku1A1, 0.8772, 1.57, 0.366, 233, 224, DYNAMIC REGULATION OF ARCHAEAL PROTEASOME GATE OPENING AS STUDIED BY TROSY-NMR
2934, p6epfC_, 0.8771, 2.29, 0.306, 249, 235, GROUND STATE 26S PROTEASOME (GS1)
2935, p5wviDA_, 0.8771, 1.82, 0.362, 250, 229, 
2936, p5leyF_, 0.8771, 2.22, 0.277, 239, 231, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
2937, d5l6bG_, 0.8771, 2.11, 0.264, 241, 231, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
2938, d5l5oU_, 0.8771, 2.11, 0.264, 241, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2939, d5l5hU_, 0.8771, 2.11, 0.264, 241, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
2940, d5l5dG_, 0.8771, 2.11, 0.264, 241, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
2941, d5l55U_, 0.8771, 2.11, 0.264, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2942, d5jhrG_, 0.8771, 2.11, 0.264, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
2943, d5cz6G_, 0.8771, 2.11, 0.264, 241, 231, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
2944, p4x6zO_, 0.8771, 2.11, 0.264, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
2945, d4qzzU_, 0.8771, 2.11, 0.264, 241, 231, YCP IN COMPLEX WITH OMURALIDE
2946, d4qwuG_, 0.8771, 2.11, 0.264, 241, 231, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
2947, d4qvnG_, 0.8771, 2.11, 0.264, 241, 231, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
2948, d4nnnG_, 0.8771, 2.11, 0.264, 241, 231, YCP IN COMPLEX WITH MG132
2949, d5lttU_, 0.8770, 2.11, 0.264, 241, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
2950, d5l63U_, 0.8770, 2.11, 0.264, 241, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2951, d5l5oG_, 0.8770, 2.11, 0.264, 241, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
2952, d5l5hG_, 0.8770, 2.11, 0.264, 241, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
2953, d5l55G_, 0.8770, 2.12, 0.264, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2954, d5cz7U_, 0.8770, 2.11, 0.264, 241, 231, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
2955, p5cggU_, 0.8770, 2.11, 0.264, 241, 231, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
2956, d4z1lG_, 0.8770, 2.11, 0.264, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
2957, p4y8sU_, 0.8770, 2.11, 0.264, 241, 231, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
2958, d4qzzG_, 0.8770, 2.11, 0.264, 241, 231, YCP IN COMPLEX WITH OMURALIDE
2959, d4qvlU_, 0.8770, 2.11, 0.264, 241, 231, YCP IN COMPLEX WITH BORTEZOMIB
2960, d4qv0U_, 0.8770, 2.11, 0.264, 241, 231, YCP BETA5-A49T-A50V-DOUBLE MUTANT
2961, d4qv0G_, 0.8770, 2.11, 0.264, 241, 231, YCP BETA5-A49T-A50V-DOUBLE MUTANT
2962, p4qbyU_, 0.8770, 2.10, 0.264, 241, 231, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
2963, d3unfU_, 0.8770, 1.95, 0.301, 243, 229, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
2964, d3unfG_, 0.8770, 1.95, 0.301, 243, 229, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
2965, p6gopU_, 0.8769, 2.11, 0.264, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
2966, d5lttG_, 0.8769, 2.11, 0.264, 241, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
2967, d5l67U_, 0.8769, 2.11, 0.264, 241, 231, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
2968, d5l64U_, 0.8769, 2.11, 0.264, 241, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2969, d5l5pU_, 0.8769, 2.11, 0.264, 241, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2970, d5cz7G_, 0.8769, 2.11, 0.264, 241, 231, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
2971, p5cggG_, 0.8769, 2.11, 0.264, 241, 231, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
2972, p4ya2U_, 0.8769, 2.11, 0.264, 241, 231, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
2973, p4y8sG_, 0.8769, 2.12, 0.264, 241, 231, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
2974, d4r00U_, 0.8769, 2.12, 0.264, 241, 231, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
2975, d4qvlG_, 0.8769, 2.11, 0.264, 241, 231, YCP IN COMPLEX WITH BORTEZOMIB
2976, d4quxU_, 0.8769, 2.11, 0.264, 241, 231, YCP BETA5-A49T-MUTANT
2977, p4qbyG_, 0.8769, 2.10, 0.264, 241, 231, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
2978, p3unev_, 0.8769, 2.11, 0.278, 244, 230, MOUSE CONSTITUTIVE 20S PROTEASOME
2979, d2ku2B1, 0.8769, 1.61, 0.366, 233, 224, DYNAMIC REGULATION OF ARCHAEAL PROTEASOME GATE OPENING AS STUDIED BY TROSY-NMR
2980, p5mpag_, 0.8768, 2.29, 0.297, 243, 232, 26S PROTEASOME IN PRESENCE OF ATP (S2)
2981, d5l67G_, 0.8768, 2.11, 0.264, 241, 231, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
2982, d5l66U_, 0.8768, 2.11, 0.264, 241, 231, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
2983, d5l64G_, 0.8768, 2.11, 0.264, 241, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2984, d5l63G_, 0.8768, 2.11, 0.264, 241, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2985, d5l61U_, 0.8768, 2.11, 0.264, 241, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
2986, d5l5pG_, 0.8768, 2.11, 0.264, 241, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
2987, p4ya7U_, 0.8768, 2.12, 0.264, 241, 231, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
2988, p4ya7G_, 0.8768, 2.12, 0.264, 241, 231, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
2989, p4ya2G_, 0.8768, 2.11, 0.264, 241, 231, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
2990, d4r00G_, 0.8768, 2.12, 0.264, 241, 231, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
2991, d4qwlU_, 0.8768, 2.12, 0.264, 241, 231, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
2992, d4qvyU_, 0.8768, 2.11, 0.264, 241, 231, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
2993, d4quxG_, 0.8768, 2.11, 0.264, 241, 231, YCP BETA5-A49T-MUTANT
2994, d1z7qU1, 0.8768, 2.28, 0.297, 243, 232, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
2995, d1jd21_, 0.8768, 2.29, 0.297, 244, 232, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
2996, p6gopG_, 0.8767, 2.11, 0.264, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
2997, d5m2bU_, 0.8767, 2.11, 0.264, 241, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
2998, d5l6cU_, 0.8767, 2.11, 0.264, 241, 231, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
2999, d5l66G_, 0.8767, 2.11, 0.264, 241, 231, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
3000, d5l65U_, 0.8767, 2.11, 0.264, 241, 231, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
3001, d5l61G_, 0.8767, 2.11, 0.264, 241, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
3002, d5l5wU_, 0.8767, 2.11, 0.264, 241, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
3003, p4y8pU_, 0.8767, 2.12, 0.264, 241, 231, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
3004, p4y8pG_, 0.8767, 2.12, 0.264, 241, 231, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
3005, d4r02U_, 0.8767, 2.11, 0.264, 241, 231, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
3006, d4qwlG_, 0.8767, 2.12, 0.264, 241, 231, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
3007, d4qvyG_, 0.8767, 2.11, 0.264, 241, 231, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
3008, d4qv6U_, 0.8767, 2.11, 0.264, 241, 231, YCP BETA5-A49V MUTANT
3009, d4no8U_, 0.8767, 2.12, 0.264, 241, 231, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
3010, d1z7qG1, 0.8767, 2.28, 0.297, 243, 232, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
3011, d5m2bG_, 0.8766, 2.11, 0.264, 241, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
3012, d5l6cG_, 0.8766, 2.11, 0.264, 241, 231, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
3013, d5l65G_, 0.8766, 2.11, 0.264, 241, 231, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
3014, d5l62U_, 0.8766, 2.11, 0.264, 241, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3015, d5l5wG_, 0.8766, 2.11, 0.264, 241, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
3016, d5l5fU_, 0.8766, 2.11, 0.264, 241, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
3017, d5d0sU_, 0.8766, 2.12, 0.264, 241, 231, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
3018, p4y8kU_, 0.8766, 2.12, 0.264, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
3019, p4y8kG_, 0.8766, 2.12, 0.264, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
3020, d4qw1U_, 0.8766, 2.11, 0.264, 241, 231, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
3021, d4qw1G_, 0.8766, 2.11, 0.264, 241, 231, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
3022, d4qv6G_, 0.8766, 2.11, 0.264, 241, 231, YCP BETA5-A49V MUTANT
3023, d4no8G_, 0.8766, 2.12, 0.264, 241, 231, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
3024, p3uneh_, 0.8766, 2.10, 0.278, 244, 230, MOUSE CONSTITUTIVE 20S PROTEASOME
3025, p5mpcS_, 0.8765, 2.05, 0.338, 242, 231, 
3026, d5l62G_, 0.8765, 2.11, 0.264, 241, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3027, d5l5tU_, 0.8765, 2.11, 0.264, 241, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3028, d5l5qU_, 0.8765, 2.12, 0.264, 241, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
3029, d5l5fG_, 0.8765, 2.12, 0.264, 241, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
3030, d5d0sG_, 0.8765, 2.12, 0.264, 241, 231, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
3031, p4y8uU_, 0.8765, 2.12, 0.264, 241, 231, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
3032, p4y8hU_, 0.8765, 2.12, 0.264, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
3033, p4y75U_, 0.8765, 2.12, 0.264, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
3034, p4y75G_, 0.8765, 2.12, 0.264, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
3035, p4y6vU_, 0.8765, 2.11, 0.264, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
3036, p4y6vG_, 0.8765, 2.11, 0.264, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
3037, d4qvpU_, 0.8765, 2.12, 0.264, 241, 231, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
3038, d5l5tG_, 0.8764, 2.11, 0.264, 241, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3039, d5l5qG_, 0.8764, 2.12, 0.264, 241, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
3040, d5l5eU_, 0.8764, 2.12, 0.264, 241, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
3041, d5l52U_, 0.8764, 2.12, 0.264, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
3042, d5l52G_, 0.8764, 2.12, 0.264, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
3043, d5fgfU_, 0.8764, 2.12, 0.264, 241, 231, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
3044, d5bouU_, 0.8764, 2.11, 0.264, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
3045, p4y9zU_, 0.8764, 2.12, 0.264, 241, 231, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
3046, p4y8uG_, 0.8764, 2.12, 0.264, 241, 231, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
3047, p4y8hG_, 0.8764, 2.12, 0.264, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
3048, p4y6aU_, 0.8764, 2.12, 0.264, 241, 231, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
3049, p4y6aG_, 0.8764, 2.12, 0.264, 241, 231, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
3050, d4qz6U_, 0.8764, 2.12, 0.264, 241, 231, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3051, d4qvpG_, 0.8764, 2.12, 0.264, 241, 231, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
3052, d4nnwU_, 0.8764, 2.12, 0.264, 241, 231, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
3053, d4hrdG_, 0.8764, 2.16, 0.263, 243, 232, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
3054, p3uneF_, 0.8764, 2.11, 0.278, 244, 230, MOUSE CONSTITUTIVE 20S PROTEASOME
3055, d5l5xU_, 0.8763, 2.12, 0.264, 241, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
3056, d5l5vU_, 0.8763, 2.12, 0.264, 241, 231,  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
3057, d5l5vG_, 0.8763, 2.12, 0.264, 241, 231,  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
3058, d5l5eG_, 0.8763, 2.12, 0.264, 241, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
3059, d5fgfG_, 0.8763, 2.12, 0.264, 241, 231, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
3060, d5cz9U_, 0.8763, 2.12, 0.264, 241, 231, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
3061, d5bouG_, 0.8763, 2.11, 0.264, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
3062, p4y9zG_, 0.8763, 2.12, 0.264, 241, 231, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
3063, d4qz6G_, 0.8763, 2.12, 0.264, 241, 231, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3064, d4qvwU_, 0.8763, 2.12, 0.264, 241, 231, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
3065, d4qvwG_, 0.8763, 2.12, 0.264, 241, 231, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
3066, d4nnwG_, 0.8763, 2.12, 0.264, 241, 231, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
3067, d4hrcG_, 0.8763, 2.16, 0.263, 243, 232, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
3068, d5l68U_, 0.8762, 2.12, 0.264, 241, 231, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
3069, d5l68G_, 0.8762, 2.12, 0.264, 241, 231, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
3070, d5l5sU_, 0.8762, 2.12, 0.264, 241, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
3071, d5l5sG_, 0.8762, 2.12, 0.264, 241, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
3072, d5l5jU_, 0.8762, 2.12, 0.264, 241, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
3073, d5l5jG_, 0.8762, 2.12, 0.264, 241, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
3074, d5d0zU_, 0.8762, 2.12, 0.264, 241, 231, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
3075, d5cz9G_, 0.8762, 2.12, 0.264, 241, 231, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
3076, p4ya9U_, 0.8762, 2.12, 0.264, 241, 231, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
3077, p4ya9G_, 0.8762, 2.12, 0.264, 241, 231, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
3078, p4y8nU_, 0.8762, 2.12, 0.264, 241, 231, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
3079, p4y77U_, 0.8762, 2.12, 0.264, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
3080, d4rurU_, 0.8762, 2.12, 0.264, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
3081, d4rurG_, 0.8762, 2.12, 0.264, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
3082, d4qz0U_, 0.8762, 2.12, 0.264, 241, 231, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3083, d1jd2F_, 0.8762, 2.17, 0.299, 244, 231, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
3084, d5l5zU_, 0.8761, 2.12, 0.264, 241, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
3085, d5l5xG_, 0.8761, 2.12, 0.264, 241, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
3086, d5l5iU_, 0.8761, 2.12, 0.264, 241, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
3087, d5d0zG_, 0.8761, 2.13, 0.264, 241, 231, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
3088, d5d0vU_, 0.8761, 2.12, 0.264, 241, 231, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
3089, p4y8nG_, 0.8761, 2.12, 0.264, 241, 231, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
3090, p4y8gU_, 0.8761, 2.12, 0.264, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
3091, p4y77G_, 0.8761, 2.12, 0.264, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
3092, p4y69U_, 0.8761, 2.12, 0.264, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
3093, d4qz0G_, 0.8761, 2.12, 0.264, 241, 231, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3094, d3mg8T_, 0.8761, 2.02, 0.301, 237, 229, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
3095, d5l5zG_, 0.8760, 2.12, 0.264, 241, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
3096, d5l5iG_, 0.8760, 2.12, 0.264, 241, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
3097, d5d0vG_, 0.8760, 2.12, 0.264, 241, 231, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
3098, p5cghU_, 0.8760, 2.12, 0.264, 241, 231, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
3099, p4y8gG_, 0.8760, 2.12, 0.264, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
3100, p4y69G_, 0.8760, 2.12, 0.264, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
3101, d4qz7U_, 0.8760, 2.12, 0.264, 241, 231, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3102, d5fhsU_, 0.8759, 2.13, 0.264, 241, 231, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
3103, d5fgeU_, 0.8759, 2.13, 0.264, 241, 231, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3104, d5d0tU_, 0.8759, 2.12, 0.264, 241, 231, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
3105, p5cghG_, 0.8759, 2.12, 0.264, 241, 231, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
3106, p4ya5U_, 0.8759, 2.12, 0.264, 241, 231, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
3107, p4y74U_, 0.8759, 2.13, 0.264, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
3108, p4y70U_, 0.8759, 2.13, 0.264, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
3109, p4y70G_, 0.8759, 2.13, 0.264, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
3110, d4qz7G_, 0.8759, 2.12, 0.264, 241, 231, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3111, d4qz4U_, 0.8759, 2.12, 0.264, 241, 231, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3112, d4qz3U_, 0.8759, 2.13, 0.264, 241, 231, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3113, d4qw5U_, 0.8759, 2.13, 0.264, 241, 231, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
3114, d4qlqU_, 0.8759, 2.12, 0.264, 241, 231, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
3115, p3uneT_, 0.8759, 2.13, 0.278, 244, 230, MOUSE CONSTITUTIVE 20S PROTEASOME
3116, p5vfoH_, 0.8758, 1.77, 0.373, 230, 225, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
3117, d5fhsG_, 0.8758, 2.13, 0.264, 241, 231, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
3118, d5fgeG_, 0.8758, 2.13, 0.264, 241, 231, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3119, d5d0tG_, 0.8758, 2.13, 0.264, 241, 231, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
3120, p4ya5G_, 0.8758, 2.12, 0.264, 241, 231, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
3121, p4y7wU_, 0.8758, 2.13, 0.264, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
3122, p4y74G_, 0.8758, 2.13, 0.264, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
3123, d4qz4G_, 0.8758, 2.12, 0.264, 241, 231, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3124, d4qz3G_, 0.8758, 2.13, 0.264, 241, 231, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3125, d4qw7U_, 0.8758, 2.13, 0.264, 241, 231, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
3126, d4qw5G_, 0.8758, 2.13, 0.264, 241, 231, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
3127, d4qlsU_, 0.8758, 2.13, 0.264, 241, 231, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
3128, d4qlqG_, 0.8758, 2.12, 0.264, 241, 231, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
3129, p5mpbP_, 0.8757, 1.87, 0.358, 250, 229, 
3130, d5jhsU_, 0.8757, 2.13, 0.264, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
3131, p4y8lU_, 0.8757, 2.13, 0.264, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
3132, p4y8lG_, 0.8757, 2.13, 0.264, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
3133, p4y82U_, 0.8757, 2.13, 0.264, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
3134, p4y82G_, 0.8757, 2.13, 0.264, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
3135, p4y7wG_, 0.8757, 2.13, 0.264, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
3136, d4r18U_, 0.8757, 2.13, 0.264, 241, 231, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
3137, d4qz5U_, 0.8757, 2.13, 0.264, 241, 231, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
3138, d4qz5G_, 0.8757, 2.13, 0.264, 241, 231, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
3139, d4qwrU_, 0.8757, 2.13, 0.264, 241, 231, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
3140, d4qwrG_, 0.8757, 2.14, 0.264, 241, 231, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
3141, d4qw7G_, 0.8757, 2.13, 0.264, 241, 231, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
3142, d4qw6U_, 0.8757, 2.13, 0.264, 241, 231, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
3143, d4qw0U_, 0.8757, 2.13, 0.264, 241, 231, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
3144, d4qluU_, 0.8757, 2.13, 0.264, 241, 231, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
3145, d4qlsG_, 0.8757, 2.13, 0.264, 241, 231, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
3146, d5laiU_, 0.8756, 2.13, 0.264, 241, 231, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
3147, d5laiG_, 0.8756, 2.13, 0.264, 241, 231, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
3148, d5l5yU_, 0.8756, 2.12, 0.264, 241, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
3149, d5jhsG_, 0.8756, 2.13, 0.264, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
3150, d5dkjU_, 0.8756, 2.13, 0.264, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
3151, p4y8qU_, 0.8756, 2.13, 0.264, 241, 231, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
3152, p4y8kA_, 0.8756, 1.49, 0.378, 228, 222, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
3153, p4y7xU_, 0.8756, 2.13, 0.264, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
3154, p4y7xG_, 0.8756, 2.13, 0.264, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
3155, d4r18G_, 0.8756, 2.13, 0.264, 241, 231, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
3156, d4qzwU_, 0.8756, 2.13, 0.264, 241, 231, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3157, d4qzwG_, 0.8756, 2.13, 0.264, 241, 231, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3158, d4qw6G_, 0.8756, 2.13, 0.264, 241, 231, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
3159, d4qw0G_, 0.8756, 2.13, 0.264, 241, 231, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
3160, d4qvqU_, 0.8756, 2.13, 0.264, 241, 231, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
3161, d4qluG_, 0.8756, 2.13, 0.264, 241, 231, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
3162, p4cr4E_, 0.8756, 2.16, 0.341, 243, 232, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
3163, d5l60U_, 0.8755, 2.12, 0.264, 241, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
3164, d5l60G_, 0.8755, 2.12, 0.264, 241, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
3165, d5l5yG_, 0.8755, 2.12, 0.264, 241, 231, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
3166, d5dkjG_, 0.8755, 2.13, 0.264, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
3167, d5cz8U_, 0.8755, 2.13, 0.264, 241, 231, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
3168, p5cgiU_, 0.8755, 2.13, 0.264, 241, 231, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
3169, p4y8qG_, 0.8755, 2.13, 0.264, 241, 231, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
3170, p4y7yU_, 0.8755, 2.13, 0.264, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
3171, d4qwxU_, 0.8755, 2.13, 0.264, 241, 231, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3172, d4qvqG_, 0.8755, 2.13, 0.264, 241, 231, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
3173, d3oevF_, 0.8755, 2.02, 0.301, 237, 229, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
3174, d2ku2C1, 0.8755, 1.70, 0.366, 233, 224, DYNAMIC REGULATION OF ARCHAEAL PROTEASOME GATE OPENING AS STUDIED BY TROSY-NMR
3175, d5lajU_, 0.8754, 2.13, 0.264, 241, 231, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
3176, d5l69U_, 0.8754, 2.12, 0.264, 241, 231, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3177, d5l69G_, 0.8754, 2.12, 0.264, 241, 231, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3178, d5d0xU_, 0.8754, 2.13, 0.264, 241, 231, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
3179, p5cgiG_, 0.8754, 2.13, 0.264, 241, 231, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
3180, p4y8jU_, 0.8754, 2.13, 0.264, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
3181, p4y8jG_, 0.8754, 2.13, 0.264, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
3182, p4y80U_, 0.8754, 2.13, 0.264, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
3183, p4y80G_, 0.8754, 2.13, 0.264, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
3184, p4y7yG_, 0.8754, 2.13, 0.264, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
3185, p4y6zU_, 0.8754, 2.13, 0.264, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
3186, d4qwxG_, 0.8754, 2.13, 0.264, 241, 231, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3187, d4qwjU_, 0.8754, 2.13, 0.264, 241, 231, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
3188, d4no6U_, 0.8754, 2.13, 0.264, 241, 231, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
3189, d3mg7F_, 0.8754, 2.03, 0.301, 237, 229, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
3190, d5lajG_, 0.8753, 2.13, 0.264, 241, 231, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
3191, d5cz8G_, 0.8753, 2.13, 0.264, 241, 231, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
3192, p4ya3U_, 0.8753, 2.13, 0.264, 241, 231, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
3193, p4y6zG_, 0.8753, 2.13, 0.264, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
3194, d4qwjG_, 0.8753, 2.13, 0.264, 241, 231, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
3195, d4qltU_, 0.8753, 2.13, 0.264, 241, 231, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
3196, d4no6G_, 0.8753, 2.13, 0.264, 241, 231, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
3197, p3jcpPA_, 0.8753, 2.27, 0.297, 244, 232, 
3198, p5vfrH_, 0.8752, 1.76, 0.373, 230, 225, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
3199, d5d0xG_, 0.8752, 2.13, 0.264, 241, 231, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
3200, d5cz4U_, 0.8752, 2.13, 0.264, 241, 231, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
3201, p4ya3G_, 0.8752, 2.13, 0.264, 241, 231, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
3202, d4qltG_, 0.8752, 2.13, 0.264, 241, 231, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
3203, d3mg6T_, 0.8752, 2.03, 0.301, 237, 229, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
3204, p5mpbU_, 0.8751, 2.28, 0.297, 243, 232, 
3205, d5fgiU_, 0.8751, 2.14, 0.264, 241, 231, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3206, d5fgdU_, 0.8751, 2.13, 0.264, 241, 231, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3207, d5fgdG_, 0.8751, 2.14, 0.264, 241, 231, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3208, d5cz4G_, 0.8751, 2.13, 0.264, 241, 231, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
3209, p4y8pA_, 0.8751, 1.50, 0.378, 228, 222, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
3210, p4y84U_, 0.8751, 2.13, 0.264, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
3211, d4qzxU_, 0.8751, 2.14, 0.264, 241, 231, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3212, d4qwkU_, 0.8751, 2.13, 0.264, 241, 231, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3213, d4qwiU_, 0.8751, 2.14, 0.264, 241, 231, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
3214, d4qvvU_, 0.8751, 2.13, 0.264, 241, 231, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
3215, d4qvmU_, 0.8751, 2.13, 0.264, 241, 231, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
3216, d3mg7T_, 0.8751, 2.03, 0.301, 237, 229, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
3217, p5vfqB_, 0.8750, 1.77, 0.373, 230, 225, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3218, d5l54U_, 0.8750, 2.14, 0.264, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3219, d5fgiG_, 0.8750, 2.14, 0.264, 241, 231, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3220, d5cz5U_, 0.8750, 2.14, 0.264, 241, 231, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
3221, p4y8qA_, 0.8750, 1.50, 0.378, 228, 222, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
3222, p4y84G_, 0.8750, 2.13, 0.264, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
3223, p4y82A_, 0.8750, 1.50, 0.378, 228, 222, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
3224, p4y7xA_, 0.8750, 1.50, 0.378, 228, 222, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
3225, p4v7oU_, 0.8750, 2.19, 0.299, 244, 231, 
3226, p4v7oG_, 0.8750, 2.19, 0.299, 244, 231, 
3227, d4qzxG_, 0.8750, 2.14, 0.264, 241, 231, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3228, d4qwkG_, 0.8750, 2.14, 0.264, 241, 231, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3229, d4qwiG_, 0.8750, 2.14, 0.264, 241, 231, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
3230, d4qwfU_, 0.8750, 2.13, 0.264, 241, 231, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
3231, d4qvvG_, 0.8750, 2.14, 0.264, 241, 231, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
3232, d4qvmG_, 0.8750, 2.13, 0.264, 241, 231, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
3233, p3un4A_, 0.8750, 1.50, 0.378, 228, 222, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
3234, d3mg8F_, 0.8750, 2.03, 0.301, 237, 229, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
3235, d3mg6F_, 0.8750, 2.03, 0.301, 237, 229, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
3236, d3l5qX_, 0.8750, 2.19, 0.299, 244, 231,  
3237, d3l5qL_, 0.8750, 2.19, 0.299, 244, 231,  
3238, d5l54G_, 0.8749, 2.14, 0.264, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3239, p4v7oOA_, 0.8749, 2.20, 0.299, 244, 231, 
3240, d4qz2U_, 0.8749, 2.14, 0.264, 241, 231, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3241, d4qwfG_, 0.8749, 2.13, 0.264, 241, 231, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
3242, d4qlvU_, 0.8749, 2.14, 0.264, 241, 231, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
3243, d4eu2A_, 0.8749, 2.08, 0.270, 241, 230, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
3244, d3oevT_, 0.8749, 2.05, 0.301, 237, 229, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
3245, p3jcpP_, 0.8749, 2.30, 0.297, 244, 232, 
3246, d1vsyG_, 0.8749, 2.20, 0.299, 244, 231,  
3247, p5fghU_, 0.8748, 2.13, 0.264, 241, 231, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
3248, d5cz5G_, 0.8748, 2.14, 0.264, 241, 231, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
3249, p5a5bG_, 0.8748, 2.40, 0.288, 245, 233, STRUCTURE OF THE 26S PROTEASOME-UBP6 COMPLEX
3250, p4y80A_, 0.8748, 1.50, 0.378, 228, 222, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
3251, p4v7oCB_, 0.8748, 2.20, 0.299, 244, 231, 
3252, d4qz2G_, 0.8748, 2.14, 0.264, 241, 231, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3253, d4qlvG_, 0.8748, 2.14, 0.264, 241, 231, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
3254, p4cr3G_, 0.8748, 2.40, 0.288, 245, 233, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
3255, d3oeuT_, 0.8748, 2.04, 0.301, 237, 229, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
3256, d1vsyU_, 0.8748, 2.20, 0.299, 244, 231,  
3257, p5vfpB_, 0.8747, 1.78, 0.373, 230, 225, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3258, p5fghG_, 0.8747, 2.13, 0.264, 241, 231, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
3259, p4y81U_, 0.8747, 2.14, 0.264, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
3260, p4y81G_, 0.8747, 2.14, 0.264, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
3261, p4y78U_, 0.8747, 2.14, 0.264, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP
3262, p4y6zA_, 0.8747, 1.51, 0.378, 228, 222, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
3263, p4y6aA_, 0.8747, 1.51, 0.378, 228, 222, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
3264, d3oeuF_, 0.8747, 2.03, 0.301, 237, 229, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
3265, p4ya0U_, 0.8746, 2.14, 0.264, 241, 231, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
3266, p4ya0G_, 0.8746, 2.14, 0.264, 241, 231, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
3267, p4y8iU_, 0.8746, 2.14, 0.264, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
3268, p4y8iG_, 0.8746, 2.14, 0.264, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
3269, p4y81A_, 0.8746, 1.51, 0.378, 228, 222, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
3270, p4y78G_, 0.8746, 2.14, 0.264, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP
3271, p4y78A_, 0.8746, 1.51, 0.378, 228, 222, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP
3272, d4g4sG_, 0.8746, 2.22, 0.296, 246, 230, STRUCTURE OF PROTEASOME-PBA1-PBA2 COMPLEX
3273, p4y74A_, 0.8745, 1.51, 0.378, 228, 222, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
3274, d4qz1U_, 0.8745, 2.14, 0.264, 241, 231, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3275, d4qw4U_, 0.8745, 2.14, 0.264, 241, 231, YCP IN COMPLEX WITH CARFILZOMIB
3276, d4qw4G_, 0.8745, 2.14, 0.264, 241, 231, YCP IN COMPLEX WITH CARFILZOMIB
3277, p4gk7A_, 0.8745, 1.50, 0.378, 228, 222, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
3278, d4qz1G_, 0.8744, 2.14, 0.264, 241, 231, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3279, p4y8oU_, 0.8743, 2.14, 0.264, 241, 231, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
3280, d4qxjU_, 0.8743, 2.14, 0.264, 241, 231, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3281, d4qxjG_, 0.8743, 2.14, 0.264, 241, 231, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3282, p4y8oG_, 0.8742, 2.14, 0.264, 241, 231, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
3283, d4qw3U_, 0.8742, 2.14, 0.264, 241, 231, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
3284, d4qw3G_, 0.8742, 2.14, 0.264, 241, 231, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
3285, p5wvkU_, 0.8740, 2.19, 0.299, 244, 231, 
3286, d4qwsU_, 0.8740, 2.15, 0.264, 241, 231, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
3287, d1z7qP1, 0.8740, 1.83, 0.358, 249, 226, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
3288, d1z7qB1, 0.8740, 1.83, 0.358, 249, 226, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
3289, p5vfuX_, 0.8739, 2.24, 0.277, 240, 231, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3290, p5vftM_, 0.8739, 2.24, 0.277, 240, 231, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
3291, d4qwsG_, 0.8739, 2.15, 0.264, 241, 231, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
3292, d5dkiU_, 0.8738, 2.14, 0.264, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
3293, d5dkiG_, 0.8738, 2.14, 0.264, 241, 231, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
3294, d4r02G_, 0.8738, 2.15, 0.264, 241, 231, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
3295, p5vfqG_, 0.8737, 2.24, 0.277, 240, 231, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3296, d4qwgU_, 0.8735, 2.16, 0.264, 241, 231, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
3297, p4cr4B_, 0.8735, 1.91, 0.367, 250, 229, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
3298, p1fntU_, 0.8735, 2.33, 0.297, 240, 232, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
3299, p1fntG_, 0.8735, 2.33, 0.297, 240, 232, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
3300, p5vfqFA_, 0.8734, 2.26, 0.277, 240, 231, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3301, d4qwgG_, 0.8734, 2.16, 0.264, 241, 231, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
3302, p5vfoM_, 0.8732, 2.26, 0.277, 240, 231, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
3303, p5vfom_, 0.8732, 2.25, 0.277, 240, 231, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
3304, d4cr2A_, 0.8731, 2.25, 0.258, 243, 233, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
3305, d3sdiD_, 0.8728, 1.75, 0.347, 228, 225, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
3306, p5dsvH_, 0.8727, 2.04, 0.276, 239, 228, CRYSTAL STRUCTURE OF HUMAN PROTEASOME ALPHA7 TETRADECAMER
3307, d2ku1B1, 0.8727, 1.79, 0.375, 233, 224, DYNAMIC REGULATION OF ARCHAEAL PROTEASOME GATE OPENING AS STUDIED BY TROSY-NMR
3308, p5m32T_, 0.8726, 2.28, 0.283, 240, 230, HUMAN 26S PROTEASOME IN COMPLEX WITH OPROZOMIB
3309, d3sdkT_, 0.8726, 2.02, 0.303, 236, 228, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
3310, p3jcoJA_, 0.8726, 2.18, 0.259, 243, 232, 
3311, p3jcoJ_, 0.8726, 2.18, 0.259, 243, 232, 
3312, d3sdkF_, 0.8724, 2.02, 0.303, 236, 228, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
3313, p5wvkBA_, 0.8723, 2.31, 0.297, 244, 232, 
3314, p5vfsG_, 0.8721, 2.25, 0.277, 240, 231, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3315, p5vfpG_, 0.8721, 2.27, 0.277, 240, 231, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3316, p5wvkV_, 0.8719, 2.18, 0.254, 243, 232, 
3317, p5mpcE_, 0.8719, 2.10, 0.346, 242, 231, 
3318, p5gjqm_, 0.8719, 2.25, 0.335, 238, 230, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
3319, p5vfsFA_, 0.8717, 2.25, 0.277, 240, 231, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3320, p5mpaG_, 0.8716, 2.35, 0.297, 243, 232, 26S PROTEASOME IN PRESENCE OF ATP (S2)
3321, d3wxrG1, 0.8716, 2.17, 0.301, 236, 229, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
3322, p5vfrM_, 0.8715, 2.27, 0.277, 240, 231, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
3323, p5vfuLA_, 0.8712, 2.23, 0.273, 240, 231, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3324, p5vftm_, 0.8712, 2.23, 0.273, 240, 231, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
3325, p5vfpEA_, 0.8712, 2.26, 0.277, 240, 231, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3326, p5mpbQ_, 0.8709, 2.21, 0.312, 244, 231, 
3327, p5mp9a_, 0.8709, 2.17, 0.264, 241, 231, 26S PROTEASOME IN PRESENCE OF ATP (S1)
3328, p5a5bB_, 0.8708, 1.95, 0.367, 250, 229, STRUCTURE OF THE 26S PROTEASOME-UBP6 COMPLEX
3329, p4cr3B_, 0.8708, 1.95, 0.367, 250, 229, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
3330, p1fntP_, 0.8707, 1.79, 0.364, 247, 225, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
3331, p1fntB_, 0.8707, 1.79, 0.364, 247, 225, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
3332, p5vfrm_, 0.8706, 2.28, 0.277, 240, 231, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
3333, p5mp9A_, 0.8704, 2.16, 0.260, 241, 231, 26S PROTEASOME IN PRESENCE OF ATP (S1)
3334, p5dsvJ_, 0.8704, 2.09, 0.281, 239, 228, CRYSTAL STRUCTURE OF HUMAN PROTEASOME ALPHA7 TETRADECAMER
3335, p5mpcU_, 0.8699, 2.28, 0.297, 243, 232, 
3336, p6epcD_, 0.8698, 2.32, 0.559, 246, 236, GROUND STATE 26S PROTEASOME (GS2)
3337, p5gjrX_, 0.8698, 2.26, 0.335, 238, 230, 
3338, p5gjqG_, 0.8697, 2.26, 0.335, 238, 230, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
3339, p5t0cY_, 0.8696, 2.27, 0.277, 240, 231, 
3340, p5t0cEB_, 0.8696, 2.27, 0.277, 240, 231, 
3341, d5lexR_, 0.8694, 1.95, 0.347, 233, 225, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
3342, p5mpbG_, 0.8693, 2.35, 0.297, 243, 232, 
3343, p5lf6R_, 0.8693, 1.97, 0.347, 233, 225, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
3344, p5lezR_, 0.8693, 1.96, 0.347, 233, 225, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
3345, d5le5R_, 0.8692, 1.96, 0.347, 233, 225, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
3346, p5vfrl_, 0.8690, 2.23, 0.335, 238, 230, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
3347, p5mpcC_, 0.8689, 2.16, 0.313, 244, 230, 
3348, d1iruS_, 0.8689, 1.98, 0.342, 234, 225, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
3349, d1iruE_, 0.8689, 1.98, 0.342, 234, 225, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
3350, p5l4gT_, 0.8688, 2.22, 0.335, 238, 230, 
3351, p5lf0R_, 0.8687, 1.97, 0.347, 233, 225, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
3352, d3unbD_, 0.8687, 2.00, 0.347, 233, 225, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
3353, d5lf7R_, 0.8686, 1.98, 0.347, 233, 225, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
3354, d5lf1R_, 0.8686, 1.97, 0.347, 233, 225, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
3355, d3wxrU1, 0.8686, 2.09, 0.303, 236, 228, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
3356, d5lf3R_, 0.8684, 1.98, 0.347, 233, 225, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
3357, p5lezD_, 0.8684, 1.97, 0.347, 233, 225, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
3358, p5leyR_, 0.8684, 1.97, 0.347, 233, 225, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
3359, p5gjrLA_, 0.8684, 2.28, 0.335, 238, 230, 
3360, p4r67u_, 0.8684, 1.99, 0.347, 234, 225, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
3361, d5lexD_, 0.8683, 1.98, 0.347, 233, 225, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
3362, d4r67S_, 0.8683, 1.99, 0.347, 234, 225, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
3363, p4r67h_, 0.8683, 2.25, 0.335, 238, 230, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
3364, d4r67E_, 0.8683, 1.99, 0.347, 234, 225, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
3365, p5mpcQ_, 0.8682, 2.20, 0.304, 244, 230, 
3366, p5m32F_, 0.8682, 2.06, 0.286, 232, 227, HUMAN 26S PROTEASOME IN COMPLEX WITH OPROZOMIB
3367, p5ln3G_, 0.8682, 2.24, 0.281, 242, 231, THE HUMAN 26S PROTEASOME AT 6.8 ANG.
3368, d5lf4R_, 0.8682, 1.98, 0.347, 233, 225, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
3369, p5gjrW_, 0.8682, 2.00, 0.347, 234, 225, 
3370, p4r67g_, 0.8682, 1.99, 0.347, 234, 225, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
3371, p4cr4G_, 0.8682, 2.51, 0.291, 245, 234, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
3372, d3unbR_, 0.8682, 1.99, 0.342, 233, 225, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
3373, p3unbf_, 0.8682, 2.00, 0.347, 233, 225, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
3374, p5mpaa_, 0.8681, 2.22, 0.264, 241, 231, 26S PROTEASOME IN PRESENCE OF ATP (S2)
3375, p5lf6D_, 0.8681, 1.99, 0.347, 233, 225, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
3376, d4r3oF_, 0.8679, 2.26, 0.335, 238, 230, HUMAN CONSTITUTIVE 20S PROTEASOME
3377, p5vfoL_, 0.8678, 2.24, 0.335, 238, 230, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
3378, p5gjrKA_, 0.8678, 2.01, 0.347, 234, 225, 
3379, p3jcoP_, 0.8678, 2.38, 0.297, 244, 232, 
3380, d1iruT_, 0.8678, 2.30, 0.335, 238, 230, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
3381, d4r67T_, 0.8677, 2.25, 0.335, 238, 230, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
3382, p3jcoPA_, 0.8677, 2.38, 0.297, 244, 232, 
3383, p6epdC_, 0.8676, 2.52, 0.319, 249, 235, SUBSTRATE PROCESSING STATE 26S PROTEASOME (SPS1)
3384, p6avoM_, 0.8676, 1.97, 0.347, 233, 225, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
3385, d5lf1D_, 0.8676, 2.00, 0.347, 233, 225, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
3386, p5gjql_, 0.8676, 2.00, 0.347, 234, 225, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
3387, p6avoH_, 0.8675, 1.97, 0.347, 233, 225, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
3388, d5lf7D_, 0.8675, 2.00, 0.347, 233, 225, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
3389, p5lf0D_, 0.8675, 2.00, 0.347, 233, 225, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
3390, p5leyD_, 0.8675, 1.99, 0.347, 233, 225, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
3391, d5le5D_, 0.8675, 2.00, 0.347, 233, 225, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
3392, p5vfqEA_, 0.8674, 2.26, 0.335, 238, 230, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3393, d5lf4D_, 0.8674, 2.00, 0.347, 233, 225, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
3394, d1z7qO1, 0.8674, 2.18, 0.263, 243, 232, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
3395, d1z7qA1, 0.8674, 2.18, 0.263, 243, 232, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
3396, p5vfrL_, 0.8673, 2.24, 0.335, 238, 230, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
3397, p5vfol_, 0.8673, 2.26, 0.335, 238, 230, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
3398, d5lf3D_, 0.8673, 2.00, 0.347, 233, 225, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
3399, p5gjqF_, 0.8673, 2.02, 0.347, 234, 225, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
3400, d4r67F_, 0.8673, 2.15, 0.336, 238, 229, HUMAN CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH CARFILZOMIB
3401, p5l4gS_, 0.8672, 1.85, 0.348, 234, 224, 
3402, p5l4gF_, 0.8672, 2.25, 0.335, 238, 230, 
3403, p5vfpDA_, 0.8671, 2.25, 0.335, 238, 230, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3404, p5vfsF_, 0.8670, 2.25, 0.335, 238, 230, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3405, p5vfsEA_, 0.8670, 2.25, 0.335, 238, 230, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3406, p5mpcG_, 0.8670, 2.33, 0.297, 243, 232, 
3407, d4r3oT_, 0.8668, 2.28, 0.335, 238, 230, HUMAN CONSTITUTIVE 20S PROTEASOME
3408, p4cr4C_, 0.8667, 2.41, 0.315, 245, 232, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
3409, p3unbt_, 0.8667, 2.01, 0.342, 233, 225, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
3410, d1iruF_, 0.8667, 2.27, 0.339, 238, 230, CRYSTAL STRUCTURE OF THE MAMMALIAN 20S PROTEASOME AT 2.75 A RESOLUTION
3411, d4r3oS_, 0.8666, 2.02, 0.347, 234, 225, HUMAN CONSTITUTIVE 20S PROTEASOME
3412, d4r3oE_, 0.8666, 2.02, 0.347, 234, 225, HUMAN CONSTITUTIVE 20S PROTEASOME
3413, d1ya7F_, 0.8666, 1.67, 0.371, 227, 221, IMPLICATIONS FOR INTERACTIONS OF PROTEASOME WITH PAN AND PA700 FROM THE 1.9 A STRUCTURE OF A PROTEASOME-11S ACTIVATOR COMPLEX
3414, p3uneR_, 0.8663, 2.03, 0.347, 233, 225, MOUSE CONSTITUTIVE 20S PROTEASOME
3415, p3j9iU_, 0.8663, 1.55, 0.364, 224, 220, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
3416, p3j9iT_, 0.8663, 1.55, 0.364, 224, 220, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
3417, p3j9iS_, 0.8663, 1.55, 0.364, 224, 220, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
3418, p3j9iR_, 0.8663, 1.55, 0.364, 224, 220, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
3419, p3j9iQ_, 0.8663, 1.55, 0.364, 224, 220, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
3420, p3j9iP_, 0.8663, 1.55, 0.364, 224, 220, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
3421, p3j9iO_, 0.8663, 1.55, 0.364, 224, 220, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
3422, p3j9iG_, 0.8663, 1.55, 0.364, 224, 220, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
3423, p3j9iF_, 0.8663, 1.55, 0.364, 224, 220, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
3424, p3j9iE_, 0.8663, 1.55, 0.364, 224, 220, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
3425, p3j9iD_, 0.8663, 1.55, 0.364, 224, 220, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
3426, p3j9iC_, 0.8663, 1.55, 0.364, 224, 220, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
3427, p3j9iB_, 0.8663, 1.55, 0.364, 224, 220, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
3428, p3j9iA_, 0.8663, 1.55, 0.364, 224, 220, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
3429, p5vftL_, 0.8662, 2.27, 0.335, 238, 230, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
3430, p3uneD_, 0.8662, 2.03, 0.347, 233, 225, MOUSE CONSTITUTIVE 20S PROTEASOME
3431, d1yauF_, 0.8662, 1.42, 0.365, 222, 219, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME- PA26 COMPLEX
3432, p5vfuW_, 0.8660, 2.27, 0.335, 238, 230, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3433, p5vftl_, 0.8659, 2.29, 0.335, 238, 230, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
3434, d5lexG_, 0.8659, 1.86, 0.284, 241, 225, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
3435, p5vfuKA_, 0.8658, 2.29, 0.335, 238, 230, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3436, p5l4gE_, 0.8658, 2.04, 0.347, 234, 225, 
3437, p3unhS_, 0.8658, 2.30, 0.335, 238, 230, MOUSE 20S IMMUNOPROTEASOME
3438, p3unhE_, 0.8658, 2.30, 0.335, 238, 230, MOUSE 20S IMMUNOPROTEASOME
3439, d3unfS_, 0.8658, 2.29, 0.335, 238, 230, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
3440, d3unfE_, 0.8658, 2.29, 0.335, 238, 230, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
3441, d3unbS_, 0.8658, 2.31, 0.335, 238, 230, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
3442, d2ku2G1, 0.8658, 1.60, 0.371, 233, 221, DYNAMIC REGULATION OF ARCHAEAL PROTEASOME GATE OPENING AS STUDIED BY TROSY-NMR
3443, d2ku1D1, 0.8658, 1.75, 0.374, 233, 222, DYNAMIC REGULATION OF ARCHAEAL PROTEASOME GATE OPENING AS STUDIED BY TROSY-NMR
3444, p5vfqF_, 0.8657, 2.27, 0.335, 238, 230, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3445, p3unbu_, 0.8656, 2.32, 0.335, 238, 230, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
3446, d2ku2D1, 0.8656, 1.61, 0.371, 233, 221, DYNAMIC REGULATION OF ARCHAEAL PROTEASOME GATE OPENING AS STUDIED BY TROSY-NMR
3447, p3unhR_, 0.8655, 2.03, 0.347, 233, 225, MOUSE 20S IMMUNOPROTEASOME
3448, p3unhD_, 0.8655, 2.03, 0.347, 233, 225, MOUSE 20S IMMUNOPROTEASOME
3449, d3unfR_, 0.8655, 2.03, 0.347, 233, 225, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
3450, d3unfD_, 0.8655, 2.03, 0.347, 233, 225, MOUSE 20S IMMUNOPROTEASOME IN COMPLEX WITH PR-957
3451, p1fntO_, 0.8655, 2.18, 0.260, 238, 231, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
3452, p6epcB_, 0.8654, 1.96, 0.377, 234, 228, GROUND STATE 26S PROTEASOME (GS2)
3453, p3unet_, 0.8654, 2.03, 0.342, 233, 225, MOUSE CONSTITUTIVE 20S PROTEASOME
3454, d2ku2F1, 0.8654, 1.63, 0.371, 233, 221, DYNAMIC REGULATION OF ARCHAEAL PROTEASOME GATE OPENING AS STUDIED BY TROSY-NMR
3455, d1ya7G_, 0.8654, 1.69, 0.371, 227, 221, IMPLICATIONS FOR INTERACTIONS OF PROTEASOME WITH PAN AND PA700 FROM THE 1.9 A STRUCTURE OF A PROTEASOME-11S ACTIVATOR COMPLEX
3456, p1fntA_, 0.8654, 2.19, 0.260, 238, 231, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
3457, p6epeA_, 0.8653, 2.18, 0.289, 246, 232, SUBSTRATE PROCESSING STATE 26S PROTEASOME (SPS2)
3458, p5mpbA_, 0.8653, 2.17, 0.260, 241, 231, 
3459, d2ku1F1, 0.8653, 1.63, 0.371, 233, 221, DYNAMIC REGULATION OF ARCHAEAL PROTEASOME GATE OPENING AS STUDIED BY TROSY-NMR
3460, p5vfpF_, 0.8651, 2.28, 0.335, 238, 230, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3461, p3unef_, 0.8650, 2.05, 0.347, 233, 225, MOUSE CONSTITUTIVE 20S PROTEASOME
3462, p5t0gM_, 0.8649, 2.33, 0.273, 240, 231, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
3463, p5wviBA_, 0.8648, 2.24, 0.332, 243, 232, 
3464, p3unbg_, 0.8648, 2.34, 0.335, 238, 230, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
3465, d1ya7C_, 0.8648, 1.70, 0.371, 227, 221, IMPLICATIONS FOR INTERACTIONS OF PROTEASOME WITH PAN AND PA700 FROM THE 1.9 A STRUCTURE OF A PROTEASOME-11S ACTIVATOR COMPLEX
3466, d2ku2E1, 0.8647, 1.66, 0.371, 233, 221, DYNAMIC REGULATION OF ARCHAEAL PROTEASOME GATE OPENING AS STUDIED BY TROSY-NMR
3467, d5lf3G_, 0.8646, 1.88, 0.284, 241, 225, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
3468, d5le5G_, 0.8645, 1.88, 0.284, 241, 225, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
3469, d1yauG_, 0.8644, 1.46, 0.365, 222, 219, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME- PA26 COMPLEX
3470, d3unbE_, 0.8643, 2.34, 0.335, 238, 230, MOUSE CONSTITUTIVE 20S PROTEASOME IN COMPLEX WITH PR-957
3471, d5lf7G_, 0.8641, 1.89, 0.280, 241, 225, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
3472, p3uneE_, 0.8641, 2.33, 0.335, 238, 230, MOUSE CONSTITUTIVE 20S PROTEASOME
3473, d3jrmG_, 0.8640, 1.71, 0.371, 227, 221, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
3474, d2ku1C1, 0.8640, 1.69, 0.371, 233, 221, DYNAMIC REGULATION OF ARCHAEAL PROTEASOME GATE OPENING AS STUDIED BY TROSY-NMR
3475, d5lf1G_, 0.8639, 1.89, 0.284, 241, 225, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
3476, p5lf0S_, 0.8639, 2.08, 0.339, 237, 227, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
3477, d3jrmA_, 0.8639, 1.71, 0.371, 227, 221, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
3478, d1yauC_, 0.8639, 1.47, 0.365, 222, 219, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME- PA26 COMPLEX
3479, d5lf7S_, 0.8638, 2.09, 0.339, 237, 227, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
3480, d5lf4G_, 0.8638, 1.90, 0.280, 241, 225, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
3481, d3jseG_, 0.8638, 1.72, 0.371, 227, 221, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
3482, d3jrmF_, 0.8638, 1.71, 0.371, 227, 221, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
3483, d3jrmB_, 0.8638, 1.71, 0.371, 227, 221, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
3484, d2ku1E1, 0.8638, 1.74, 0.371, 233, 221, DYNAMIC REGULATION OF ARCHAEAL PROTEASOME GATE OPENING AS STUDIED BY TROSY-NMR
3485, d3jrmE_, 0.8637, 1.72, 0.371, 227, 221, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
3486, d3jrmD_, 0.8637, 1.71, 0.371, 227, 221, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
3487, d3jrmC_, 0.8637, 1.72, 0.371, 227, 221, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
3488, d1ya7B_, 0.8637, 1.71, 0.371, 227, 221, IMPLICATIONS FOR INTERACTIONS OF PROTEASOME WITH PAN AND PA700 FROM THE 1.9 A STRUCTURE OF A PROTEASOME-11S ACTIVATOR COMPLEX
3489, d3jseF_, 0.8636, 1.72, 0.371, 227, 221, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
3490, d1yauB_, 0.8636, 1.47, 0.365, 222, 219, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME- PA26 COMPLEX
3491, p5m32G_, 0.8635, 1.90, 0.289, 233, 225, HUMAN 26S PROTEASOME IN COMPLEX WITH OPROZOMIB
3492, d1yauD_, 0.8635, 1.48, 0.365, 222, 219, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME- PA26 COMPLEX
3493, p6epcC_, 0.8634, 2.70, 0.316, 249, 237, GROUND STATE 26S PROTEASOME (GS2)
3494, p5lf6S_, 0.8634, 2.09, 0.339, 237, 227, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
3495, d5lf1S_, 0.8634, 2.09, 0.339, 237, 227, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
3496, p3uneu_, 0.8634, 2.35, 0.339, 238, 230, MOUSE CONSTITUTIVE 20S PROTEASOME
3497, d3jseE_, 0.8634, 1.72, 0.371, 227, 221, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
3498, d3jseB_, 0.8634, 1.72, 0.371, 227, 221, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
3499, d5lf4S_, 0.8633, 2.09, 0.339, 237, 227, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
3500, d5lf3S_, 0.8633, 2.09, 0.339, 237, 227, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
3501, p3uneg_, 0.8633, 2.32, 0.335, 238, 230, MOUSE CONSTITUTIVE 20S PROTEASOME
3502, d3jseD_, 0.8633, 1.72, 0.371, 227, 221, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
3503, d3jseA_, 0.8633, 1.72, 0.371, 227, 221, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
3504, d3jseC_, 0.8632, 1.73, 0.371, 227, 221, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
3505, d1yarF_, 0.8632, 1.41, 0.367, 221, 218, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME MUTANT D9S- PA26 COMPLEX
3506, d1yauA_, 0.8631, 1.48, 0.361, 222, 219, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME- PA26 COMPLEX
3507, d1yarG_, 0.8630, 1.42, 0.362, 221, 218, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME MUTANT D9S- PA26 COMPLEX
3508, p5leyS_, 0.8629, 2.10, 0.339, 235, 227, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
3509, d5le5S_, 0.8629, 2.11, 0.339, 237, 227, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
3510, d1ya7D_, 0.8628, 1.73, 0.371, 227, 221, IMPLICATIONS FOR INTERACTIONS OF PROTEASOME WITH PAN AND PA700 FROM THE 1.9 A STRUCTURE OF A PROTEASOME-11S ACTIVATOR COMPLEX
3511, p6avoL_, 0.8627, 2.06, 0.341, 234, 226, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
3512, p3uneS_, 0.8627, 2.33, 0.339, 238, 230, MOUSE CONSTITUTIVE 20S PROTEASOME
3513, d1yauE_, 0.8627, 1.49, 0.361, 222, 219, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME- PA26 COMPLEX
3514, d2ku1G1, 0.8626, 1.58, 0.368, 233, 220, DYNAMIC REGULATION OF ARCHAEAL PROTEASOME GATE OPENING AS STUDIED BY TROSY-NMR
3515, p6avoG_, 0.8625, 2.07, 0.341, 234, 226, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
3516, p3jtlG_, 0.8625, 1.74, 0.371, 227, 221, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
3517, p3jtlF_, 0.8624, 1.74, 0.371, 227, 221, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
3518, p3jtlB_, 0.8624, 1.74, 0.371, 227, 221, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
3519, p3jtlD_, 0.8623, 1.74, 0.371, 227, 221, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
3520, p3jtlC_, 0.8623, 1.74, 0.371, 227, 221, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
3521, p3jtlA_, 0.8623, 1.74, 0.371, 227, 221, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
3522, d1ya7E_, 0.8623, 1.75, 0.367, 227, 221, IMPLICATIONS FOR INTERACTIONS OF PROTEASOME WITH PAN AND PA700 FROM THE 1.9 A STRUCTURE OF A PROTEASOME-11S ACTIVATOR COMPLEX
3523, d5lexS_, 0.8622, 2.11, 0.339, 235, 227, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
3524, p3jtlE_, 0.8622, 1.74, 0.371, 227, 221, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
3525, d1yarC_, 0.8621, 1.43, 0.362, 221, 218, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME MUTANT D9S- PA26 COMPLEX
3526, d1ya7A_, 0.8621, 1.74, 0.371, 227, 221, IMPLICATIONS FOR INTERACTIONS OF PROTEASOME WITH PAN AND PA700 FROM THE 1.9 A STRUCTURE OF A PROTEASOME-11S ACTIVATOR COMPLEX
3527, p5mpbC_, 0.8617, 2.44, 0.310, 244, 232, 
3528, p5vy4Y_, 0.8614, 1.44, 0.367, 221, 218, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
3529, p5vy4W_, 0.8614, 1.44, 0.367, 221, 218, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
3530, p5vy4U_, 0.8614, 1.44, 0.367, 221, 218, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
3531, p5vy4S_, 0.8614, 1.44, 0.367, 221, 218, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
3532, p5vy4Q_, 0.8614, 1.44, 0.367, 221, 218, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
3533, p5vy4O_, 0.8614, 1.44, 0.367, 221, 218, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
3534, p5vy4M_, 0.8614, 1.44, 0.367, 221, 218, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
3535, p5vy4K_, 0.8614, 1.44, 0.367, 221, 218, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
3536, p5vy4I_, 0.8614, 1.44, 0.367, 221, 218, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
3537, p5vy4G_, 0.8614, 1.44, 0.367, 221, 218, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
3538, p5vy4E_, 0.8614, 1.44, 0.367, 221, 218, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
3539, p5vy4C_, 0.8614, 1.44, 0.367, 221, 218, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
3540, p5vy4AA_, 0.8614, 1.44, 0.367, 221, 218, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
3541, p5vy4A_, 0.8614, 1.44, 0.367, 221, 218, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
3542, p5vy40_, 0.8614, 1.44, 0.367, 221, 218, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
3543, p5vy3Y_, 0.8614, 1.45, 0.367, 221, 218, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
3544, p5vy3W_, 0.8614, 1.45, 0.367, 221, 218, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
3545, p5vy3U_, 0.8614, 1.45, 0.367, 221, 218, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
3546, p5vy3S_, 0.8614, 1.45, 0.367, 221, 218, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
3547, p5vy3Q_, 0.8614, 1.45, 0.367, 221, 218, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
3548, p5vy3O_, 0.8614, 1.45, 0.367, 221, 218, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
3549, p5vy3M_, 0.8614, 1.45, 0.367, 221, 218, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
3550, p5vy3K_, 0.8614, 1.45, 0.367, 221, 218, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
3551, p5vy3I_, 0.8614, 1.45, 0.367, 221, 218, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
3552, p5vy3G_, 0.8614, 1.45, 0.367, 221, 218, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
3553, p5vy3C_, 0.8614, 1.45, 0.367, 221, 218, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
3554, p5vy3A_, 0.8614, 1.45, 0.367, 221, 218, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
3555, p5vy30_, 0.8614, 1.45, 0.367, 221, 218, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
3556, d1yarD_, 0.8614, 1.45, 0.367, 221, 218, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME MUTANT D9S- PA26 COMPLEX
3557, d1vsyQ_, 0.8614, 1.84, 0.305, 232, 223,  
3558, p5vy3E_, 0.8613, 1.45, 0.367, 221, 218, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
3559, p5t0cX_, 0.8613, 2.32, 0.335, 238, 230, 
3560, p5t0cDB_, 0.8613, 2.32, 0.335, 238, 230, 
3561, p5lezS_, 0.8613, 2.12, 0.339, 237, 227, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
3562, p4v7oQ_, 0.8613, 1.85, 0.305, 232, 223, 
3563, p4v7oC_, 0.8613, 1.85, 0.305, 232, 223, 
3564, d3l5qT_, 0.8613, 1.85, 0.305, 232, 223,  
3565, d3l5qH_, 0.8613, 1.85, 0.305, 232, 223,  
3566, p4v7oKA_, 0.8612, 1.85, 0.305, 232, 223, 
3567, d1vsyC_, 0.8612, 1.85, 0.305, 232, 223,  
3568, p6bdfY_, 0.8607, 1.45, 0.367, 221, 218, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
3569, p6bdfW_, 0.8607, 1.45, 0.367, 221, 218, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
3570, p6bdfU_, 0.8607, 1.45, 0.367, 221, 218, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
3571, p6bdfS_, 0.8607, 1.45, 0.367, 221, 218, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
3572, p6bdfQ_, 0.8607, 1.45, 0.367, 221, 218, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
3573, p6bdfO_, 0.8607, 1.45, 0.367, 221, 218, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
3574, p6bdfM_, 0.8607, 1.45, 0.367, 221, 218, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
3575, p6bdfK_, 0.8607, 1.45, 0.367, 221, 218, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
3576, p6bdfI_, 0.8607, 1.45, 0.367, 221, 218, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
3577, p6bdfG_, 0.8607, 1.45, 0.367, 221, 218, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
3578, p6bdfE_, 0.8607, 1.45, 0.367, 221, 218, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
3579, p6bdfC_, 0.8607, 1.45, 0.367, 221, 218, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
3580, p6bdfA_, 0.8607, 1.45, 0.367, 221, 218, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
3581, p6bdf0_, 0.8607, 1.45, 0.367, 221, 218, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
3582, d1yarB_, 0.8607, 1.46, 0.362, 221, 218, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME MUTANT D9S- PA26 COMPLEX
3583, p5t0hM_, 0.8606, 2.38, 0.268, 240, 231, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
3584, p5m32E_, 0.8605, 2.02, 0.332, 234, 226, HUMAN 26S PROTEASOME IN COMPLEX WITH OPROZOMIB
3585, d1yarA_, 0.8605, 1.46, 0.362, 221, 218, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME MUTANT D9S- PA26 COMPLEX
3586, d1yarE_, 0.8604, 1.47, 0.367, 221, 218, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME MUTANT D9S- PA26 COMPLEX
3587, p5mpcO_, 0.8598, 2.24, 0.257, 241, 230, 
3588, p5wviX_, 0.8597, 2.46, 0.292, 245, 233, 
3589, p5mpcB_, 0.8595, 1.97, 0.367, 250, 226, 
3590, p5vfqBA_, 0.8592, 1.72, 0.326, 232, 221, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3591, p5vfoi_, 0.8592, 1.73, 0.326, 232, 221, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
3592, p5mpcP_, 0.8590, 2.05, 0.363, 250, 226, 
3593, p5vfrK_, 0.8589, 1.85, 0.351, 228, 222, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
3594, d1pmaO_, 0.8587, 1.49, 0.367, 221, 218, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
3595, d1pmaK_, 0.8586, 1.49, 0.367, 221, 218, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
3596, d1pmaC_, 0.8586, 1.49, 0.367, 221, 218, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
3597, d1pmaM_, 0.8585, 1.49, 0.367, 221, 218, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
3598, d1pmaE_, 0.8585, 1.49, 0.367, 221, 218, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
3599, d1pmaD_, 0.8585, 1.49, 0.367, 221, 218, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
3600, d1pmaG_, 0.8584, 1.49, 0.367, 221, 218, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
3601, p5t0gL_, 0.8583, 2.33, 0.330, 238, 230, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
3602, d1pmaN_, 0.8583, 1.49, 0.367, 221, 218, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
3603, d1pmaL_, 0.8583, 1.49, 0.367, 221, 218, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
3604, d1pmaH_, 0.8583, 1.49, 0.367, 221, 218, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
3605, p5vfri_, 0.8582, 1.74, 0.326, 232, 221, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
3606, p5vfoK_, 0.8582, 1.85, 0.351, 228, 222, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
3607, p4cr4A_, 0.8582, 2.29, 0.263, 243, 232, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
3608, d1pmaJ_, 0.8582, 1.49, 0.367, 221, 218, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
3609, d1pmaF_, 0.8582, 1.50, 0.367, 221, 218, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
3610, p5t0jM_, 0.8581, 2.28, 0.284, 240, 229, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
3611, p5lf0E_, 0.8581, 2.05, 0.342, 233, 225, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
3612, d5le5E_, 0.8581, 2.06, 0.342, 233, 225, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
3613, d1pmaI_, 0.8581, 1.50, 0.367, 221, 218, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
3614, p5vfpAA_, 0.8580, 1.74, 0.326, 232, 221, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3615, d3c92U1, 0.8580, 1.50, 0.367, 221, 218, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
3616, d3c92T1, 0.8580, 1.50, 0.367, 221, 218, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
3617, d3c92S1, 0.8580, 1.50, 0.367, 221, 218, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
3618, d3c92R1, 0.8580, 1.50, 0.367, 221, 218, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
3619, d3c92Q1, 0.8580, 1.50, 0.367, 221, 218, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
3620, d3c92P1, 0.8580, 1.50, 0.367, 221, 218, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
3621, d3c92O1, 0.8580, 1.50, 0.367, 221, 218, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
3622, d3c92G1, 0.8580, 1.50, 0.367, 221, 218, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
3623, d3c92F1, 0.8580, 1.50, 0.367, 221, 218, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
3624, d3c92E1, 0.8580, 1.50, 0.367, 221, 218, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
3625, d3c92D1, 0.8580, 1.50, 0.367, 221, 218, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
3626, d3c92C1, 0.8580, 1.50, 0.367, 221, 218, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
3627, d3c92B1, 0.8580, 1.50, 0.367, 221, 218, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
3628, d3c92A1, 0.8580, 1.50, 0.367, 221, 218, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
3629, d1pmaA_, 0.8580, 1.50, 0.367, 221, 218, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
3630, d5lf7E_, 0.8578, 2.06, 0.342, 233, 225, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
3631, d5lf4E_, 0.8578, 2.06, 0.342, 233, 225, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
3632, d5lf1E_, 0.8578, 2.06, 0.342, 233, 225, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
3633, p5m32R_, 0.8575, 2.05, 0.344, 233, 224, HUMAN 26S PROTEASOME IN COMPLEX WITH OPROZOMIB
3634, p5m32D_, 0.8575, 2.05, 0.344, 233, 224, HUMAN 26S PROTEASOME IN COMPLEX WITH OPROZOMIB
3635, p5lf6E_, 0.8575, 2.06, 0.342, 233, 225, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
3636, p5vfqE_, 0.8574, 1.87, 0.351, 228, 222, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3637, p5leyE_, 0.8574, 2.07, 0.342, 233, 225, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
3638, p5vfsDA_, 0.8573, 1.87, 0.351, 228, 222, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3639, p6epeC_, 0.8572, 2.35, 0.313, 249, 233, SUBSTRATE PROCESSING STATE 26S PROTEASOME (SPS2)
3640, d5lf3E_, 0.8572, 2.07, 0.342, 233, 225, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
3641, d3c91U1, 0.8572, 1.51, 0.367, 221, 218, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
3642, d3c91T1, 0.8572, 1.51, 0.367, 221, 218, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
3643, d3c91S1, 0.8572, 1.51, 0.367, 221, 218, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
3644, d3c91R1, 0.8572, 1.51, 0.367, 221, 218, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
3645, d3c91Q1, 0.8572, 1.51, 0.367, 221, 218, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
3646, d3c91P1, 0.8572, 1.51, 0.367, 221, 218, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
3647, d3c91O1, 0.8572, 1.51, 0.367, 221, 218, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
3648, d3c91G1, 0.8572, 1.51, 0.367, 221, 218, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
3649, d3c91F1, 0.8572, 1.51, 0.367, 221, 218, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
3650, d3c91E1, 0.8572, 1.51, 0.367, 221, 218, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
3651, d3c91D1, 0.8572, 1.51, 0.367, 221, 218, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
3652, d3c91C1, 0.8572, 1.51, 0.367, 221, 218, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
3653, d3c91B1, 0.8572, 1.51, 0.367, 221, 218, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
3654, d3c91A1, 0.8572, 1.51, 0.367, 221, 218, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
3655, p5vfpE_, 0.8571, 1.87, 0.351, 228, 222, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3656, p5a5bE_, 0.8571, 2.49, 0.345, 243, 232, STRUCTURE OF THE 26S PROTEASOME-UBP6 COMPLEX
3657, p4cr3E_, 0.8571, 2.49, 0.345, 243, 232, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
3658, p5vfok_, 0.8569, 1.72, 0.348, 228, 221, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
3659, p5vfsE_, 0.8567, 1.88, 0.351, 228, 222, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3660, p5vfpCA_, 0.8566, 1.72, 0.348, 228, 221, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3661, p5vfqDA_, 0.8565, 1.72, 0.348, 228, 221, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3662, d5lexE_, 0.8564, 2.09, 0.342, 233, 225, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
3663, p5a0qR_, 0.8564, 1.24, 0.593, 214, 214, CRYO-EM REVEALS THE CONFORMATION OF A SUBSTRATE ANALOGUE IN THE HUMAN 20S PROTEASOME CORE
3664, p5a0qD_, 0.8564, 1.24, 0.593, 214, 214, CRYO-EM REVEALS THE CONFORMATION OF A SUBSTRATE ANALOGUE IN THE HUMAN 20S PROTEASOME CORE
3665, p6epdB_, 0.8560, 2.13, 0.382, 234, 228, SUBSTRATE PROCESSING STATE 26S PROTEASOME (SPS1)
3666, p5lezE_, 0.8560, 2.09, 0.342, 233, 225, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
3667, p5vfrk_, 0.8559, 1.73, 0.348, 228, 221, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
3668, p5vftk_, 0.8550, 1.98, 0.350, 228, 223, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
3669, p6epfG_, 0.8549, 2.40, 0.270, 245, 230, GROUND STATE 26S PROTEASOME (GS1)
3670, d4g4sF_, 0.8545, 2.02, 0.305, 234, 223, STRUCTURE OF PROTEASOME-PBA1-PBA2 COMPLEX
3671, p5wviCA_, 0.8540, 2.51, 0.310, 245, 232, 
3672, p3ipmG_, 0.8540, 1.84, 0.362, 227, 221, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH THE C- TERMINUS OF PAN
3673, p5vfuJA_, 0.8539, 2.00, 0.350, 228, 223, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3674, d3sdkE_, 0.8539, 2.02, 0.305, 233, 223, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
3675, p3ipmF_, 0.8539, 1.84, 0.362, 227, 221, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH THE C- TERMINUS OF PAN
3676, p3ipmE_, 0.8539, 1.84, 0.362, 227, 221, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH THE C- TERMINUS OF PAN
3677, p3ipmD_, 0.8539, 1.84, 0.362, 227, 221, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH THE C- TERMINUS OF PAN
3678, p3ipmC_, 0.8539, 1.84, 0.362, 227, 221, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH THE C- TERMINUS OF PAN
3679, p3ipmB_, 0.8539, 1.84, 0.362, 227, 221, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH THE C- TERMINUS OF PAN
3680, p3ipmA_, 0.8539, 1.84, 0.362, 227, 221, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH THE C- TERMINUS OF PAN
3681, d4hrdE_, 0.8537, 2.03, 0.305, 233, 223, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
3682, p5mpaf_, 0.8536, 2.01, 0.305, 231, 223, 26S PROTEASOME IN PRESENCE OF ATP (S2)
3683, d5lajS_, 0.8536, 2.03, 0.305, 231, 223, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
3684, d5lajE_, 0.8536, 2.03, 0.305, 231, 223, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
3685, p5dsvC_, 0.8535, 2.12, 0.290, 234, 224, CRYSTAL STRUCTURE OF HUMAN PROTEASOME ALPHA7 TETRADECAMER
3686, d3sdkS_, 0.8535, 2.04, 0.305, 233, 223, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 34
3687, d3sdiE_, 0.8535, 2.02, 0.305, 230, 223, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
3688, d3mg6S_, 0.8535, 2.04, 0.305, 233, 223, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
3689, d3mg6E_, 0.8535, 2.03, 0.305, 233, 223, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 6
3690, d4hrdS_, 0.8534, 2.03, 0.305, 233, 223, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE NATURAL PRODUCT CARMAPHYCIN A
3691, p5vftK_, 0.8533, 1.92, 0.351, 228, 222, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
3692, d5fgfS_, 0.8533, 2.04, 0.305, 231, 223, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
3693, d5fgfE_, 0.8533, 2.04, 0.305, 231, 223, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
3694, d4intS_, 0.8533, 2.04, 0.305, 233, 223, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
3695, d4intE_, 0.8533, 2.04, 0.305, 233, 223, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU122
3696, d5dkjS_, 0.8532, 2.04, 0.305, 231, 223, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
3697, d5dkjE_, 0.8532, 2.04, 0.305, 231, 223, YEAST 20S PROTEASOME IN COMPLEX WITH OCTREOTIDE-PI
3698, d4r18S_, 0.8532, 2.04, 0.305, 231, 223, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
3699, d4r18E_, 0.8532, 2.04, 0.305, 231, 223, LIGAND-INDUCED LYS33-THR1 CROSSLINKING AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
3700, d4qvvS_, 0.8532, 2.03, 0.305, 231, 223, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
3701, d4qvvE_, 0.8532, 2.03, 0.305, 231, 223, YCP BETA5-A49V MUTANT IN COMPLEX WITH BORTEZOMIB
3702, d4hnpS_, 0.8532, 2.04, 0.305, 233, 223, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
3703, d5d0tS_, 0.8531, 2.04, 0.305, 231, 223, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
3704, d5d0tE_, 0.8531, 2.04, 0.305, 231, 223, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH MG132
3705, d5cz7S_, 0.8531, 2.04, 0.305, 231, 223, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
3706, d5cz7E_, 0.8531, 2.04, 0.305, 231, 223, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
3707, d4r00S_, 0.8531, 2.04, 0.305, 231, 223, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
3708, d4r00E_, 0.8531, 2.04, 0.305, 231, 223, YCP BETA5-C52F MUTANT IN COMPLEX WITH OMURALIDE
3709, d4qwjS_, 0.8531, 2.04, 0.305, 231, 223, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
3710, d4fzgS_, 0.8531, 2.04, 0.305, 233, 223, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
3711, d4fzgE_, 0.8531, 2.04, 0.305, 233, 223, 20S YEAST PROTEASOME IN COMPLEX WITH GLIDOBACTIN
3712, d3oevE_, 0.8531, 2.03, 0.305, 233, 223, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
3713, d3oeuE_, 0.8531, 2.02, 0.305, 233, 223, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
3714, p5vfuV_, 0.8530, 1.93, 0.351, 228, 222, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
3715, p5mp9F_, 0.8530, 2.00, 0.305, 233, 223, 26S PROTEASOME IN PRESENCE OF ATP (S1)
3716, d5lttS_, 0.8530, 2.04, 0.305, 231, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
3717, d5lttE_, 0.8530, 2.04, 0.305, 231, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)IN COMPLEX WITH PR-924
3718, d5l61S_, 0.8530, 2.04, 0.305, 231, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
3719, d5l61E_, 0.8530, 2.04, 0.305, 231, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (99- 132) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
3720, d5fhsS_, 0.8530, 2.05, 0.305, 231, 223, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
3721, d5fhsE_, 0.8530, 2.05, 0.305, 231, 223, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH CARFILZOMIB
3722, d5fgeS_, 0.8530, 2.05, 0.305, 231, 223, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3723, d5fgeE_, 0.8530, 2.05, 0.305, 231, 223, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3724, d5d0xS_, 0.8530, 2.04, 0.305, 231, 223, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
3725, d5d0xE_, 0.8530, 2.04, 0.305, 231, 223, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH BORTEZOMIB
3726, d5cgfS_, 0.8530, 2.04, 0.305, 231, 223, YEAST 20S PROTEASOME BETA5-G48C MUTANT
3727, d5cgfE_, 0.8530, 2.04, 0.305, 231, 223, YEAST 20S PROTEASOME BETA5-G48C MUTANT
3728, d4z1lE_, 0.8530, 2.04, 0.305, 231, 223, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
3729, d4qwjE_, 0.8530, 2.04, 0.305, 231, 223, YCP BETA5-A49T-MUTANT IN COMPLEX WITH CARFILZOMIB
3730, d4qw0S_, 0.8530, 2.03, 0.305, 231, 223, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
3731, d4qw0E_, 0.8530, 2.03, 0.305, 231, 223, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB
3732, d3mg8E_, 0.8530, 2.02, 0.305, 233, 223, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
3733, d5l62S_, 0.8529, 2.04, 0.305, 231, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3734, d5l62E_, 0.8529, 2.04, 0.305, 231, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3735, d5l5vS_, 0.8529, 2.04, 0.305, 231, 223,  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
3736, d5l5vE_, 0.8529, 2.04, 0.305, 231, 223,  YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
3737, d5l5tS_, 0.8529, 2.04, 0.305, 231, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3738, d5l5tE_, 0.8529, 2.04, 0.305, 231, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3739, d5jhsS_, 0.8529, 2.05, 0.305, 231, 223, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
3740, d5jhsE_, 0.8529, 2.05, 0.305, 231, 223, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 15
3741, d5fgdS_, 0.8529, 2.04, 0.305, 231, 223, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3742, d5fgdE_, 0.8529, 2.04, 0.305, 231, 223, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3743, d5cz9S_, 0.8529, 2.05, 0.305, 231, 223, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
3744, d5cz9E_, 0.8529, 2.05, 0.305, 231, 223, YEAST 20S PROTEASOME BETA5-D17N MUTANT IN COMPLEX WITH CARFILZOMIB; PROPEPTIDE EXPRESSED IN TRANS
3745, d5cz8S_, 0.8529, 2.05, 0.305, 231, 223, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
3746, d5cz8E_, 0.8529, 2.05, 0.305, 231, 223, YEAST 20S PROTEASOME BETA5-L(-49)S-K33A MUTANT IN COMPLEX WITH CARFILZOMIB
3747, d4z1lS_, 0.8529, 2.04, 0.305, 231, 223, YEAST 20S PROTEASOME IN COMPLEX WITH BELACTOSIN C DERIVATIVE 3
3748, p4y8uS_, 0.8529, 2.04, 0.305, 231, 223, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
3749, p4y8uE_, 0.8529, 2.04, 0.305, 231, 223, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAD-EP
3750, p4y69E_, 0.8529, 2.04, 0.305, 231, 223, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
3751, d2fakE_, 0.8529, 2.05, 0.305, 233, 223, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
3752, p5t0gK_, 0.8528, 1.90, 0.351, 228, 222, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
3753, d5l6cS_, 0.8528, 2.04, 0.305, 231, 223, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
3754, d5l6cE_, 0.8528, 2.04, 0.305, 231, 223, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
3755, d5l67S_, 0.8528, 2.04, 0.305, 231, 223, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
3756, d5l67E_, 0.8528, 2.04, 0.305, 231, 223, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
3757, d5l60S_, 0.8528, 2.04, 0.305, 231, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
3758, d5l60E_, 0.8528, 2.04, 0.305, 231, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
3759, d5l5xS_, 0.8528, 2.04, 0.305, 231, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
3760, d5l5xE_, 0.8528, 2.04, 0.305, 231, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
3761, d5l5qS_, 0.8528, 2.04, 0.305, 231, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
3762, d5l5qE_, 0.8528, 2.04, 0.305, 231, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE 18
3763, d5l5pS_, 0.8528, 2.04, 0.305, 231, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
3764, d5l5pE_, 0.8528, 2.04, 0.305, 231, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
3765, d5l5oS_, 0.8528, 2.04, 0.305, 231, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3766, d5l5oE_, 0.8528, 2.04, 0.305, 231, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
3767, d5l5jS_, 0.8528, 2.04, 0.305, 231, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
3768, d5l5jE_, 0.8528, 2.04, 0.305, 231, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
3769, d5l5eS_, 0.8528, 2.04, 0.305, 231, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
3770, d5l5eE_, 0.8528, 2.04, 0.305, 231, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
3771, d5fgiS_, 0.8528, 2.05, 0.305, 231, 223, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3772, d5fgiE_, 0.8528, 2.05, 0.305, 231, 223, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3773, d5fgaS_, 0.8528, 2.04, 0.305, 231, 223, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
3774, d5fgaE_, 0.8528, 2.04, 0.305, 231, 223, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS)
3775, d5fg9S_, 0.8528, 2.04, 0.305, 231, 223, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
3776, d5fg9E_, 0.8528, 2.04, 0.305, 231, 223, YEAST 20S PROTEASOME BETA2-T(-2)V MUTANT
3777, d5fg7S_, 0.8528, 2.04, 0.305, 231, 223, YEAST 20S PROTEASOME BETA2-T1A MUTANT
3778, d5fg7E_, 0.8528, 2.04, 0.305, 231, 223, YEAST 20S PROTEASOME BETA2-T1A MUTANT
3779, d5d0zS_, 0.8528, 2.05, 0.305, 231, 223, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
3780, d5d0sS_, 0.8528, 2.05, 0.305, 231, 223, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
3781, d5d0sE_, 0.8528, 2.05, 0.305, 231, 223, YEAST 20S PROTEASOME BETA5-D166N MUTANT IN COMPLEX WITH CARFILZOMIB
3782, d5cz5S_, 0.8528, 2.05, 0.305, 231, 223, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
3783, p4y8kE_, 0.8528, 2.05, 0.305, 231, 223, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
3784, p4y6aS_, 0.8528, 2.04, 0.305, 231, 223, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
3785, p4y6aE_, 0.8528, 2.04, 0.305, 231, 223, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAD-EP
3786, p4y69S_, 0.8528, 2.04, 0.305, 231, 223, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAD-EP
3787, d4qzzS_, 0.8528, 2.04, 0.305, 231, 223, YCP IN COMPLEX WITH OMURALIDE
3788, d4qzzE_, 0.8528, 2.04, 0.305, 231, 223, YCP IN COMPLEX WITH OMURALIDE
3789, d4qzxS_, 0.8528, 2.05, 0.305, 231, 223, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3790, d4qzxE_, 0.8528, 2.05, 0.305, 231, 223, YCP BETA5-C63F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3791, d4qwrS_, 0.8528, 2.05, 0.305, 231, 223, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
3792, d4qwrE_, 0.8528, 2.05, 0.305, 231, 223, YCP BETA5-C52F MUTANT IN COMPLEX WITH CARFILZOMIB
3793, d4qwiS_, 0.8528, 2.04, 0.305, 231, 223, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
3794, d4qwiE_, 0.8528, 2.04, 0.305, 231, 223, YCP BETA5-A49S-MUTANT IN COMPLEX WITH CARFILZOMIB
3795, d4qvyS_, 0.8528, 2.04, 0.305, 231, 223, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
3796, d4qvyE_, 0.8528, 2.04, 0.305, 231, 223, YCP BETA5-A49T-MUTANT IN COMPLEX WITH BORTEZOMIB
3797, d4qvpS_, 0.8528, 2.04, 0.305, 231, 223, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
3798, d4qvpE_, 0.8528, 2.04, 0.305, 231, 223, YCP BETA5-M45T MUTANT IN COMPLEX WITH BORTEZOMIB
3799, d4jt0S_, 0.8528, 2.04, 0.305, 233, 223, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
3800, d4jt0E_, 0.8528, 2.04, 0.305, 233, 223, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4A
3801, d3sdiS_, 0.8528, 2.04, 0.305, 230, 223, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 20
3802, d3mg0S_, 0.8528, 2.04, 0.305, 233, 223, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
3803, d2fakS_, 0.8528, 2.05, 0.305, 233, 223, CRYSTAL STRUCTURE OF SALINOSPORAMIDE A IN COMPLEX WITH THE YEAST 20S PROTEASOME
3804, d5l6bS_, 0.8527, 2.04, 0.305, 231, 223, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
3805, d5l6bE_, 0.8527, 2.04, 0.305, 231, 223, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
3806, d5l64S_, 0.8527, 2.04, 0.305, 231, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
3807, d5l64E_, 0.8527, 2.04, 0.305, 231, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
3808, d5l5zS_, 0.8527, 2.04, 0.305, 231, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
3809, d5l5zE_, 0.8527, 2.04, 0.305, 231, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
3810, d5l5uS_, 0.8527, 2.05, 0.305, 231, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
3811, d5l5uE_, 0.8527, 2.05, 0.305, 231, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
3812, d5l5fS_, 0.8527, 2.04, 0.305, 231, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
3813, d5l5fE_, 0.8527, 2.04, 0.305, 231, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
3814, d5l52S_, 0.8527, 2.05, 0.305, 231, 223, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
3815, d5l52E_, 0.8527, 2.05, 0.305, 231, 223, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
3816, p5fghS_, 0.8527, 2.04, 0.305, 231, 223, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
3817, p5fghE_, 0.8527, 2.04, 0.305, 231, 223, YEAST 20S PROTEASOME BETA5-K33A MUTANT (PROPEPTIDE EXPRESSED IN TRANS) IN COMPLEX WITH MG132
3818, d5dkiS_, 0.8527, 2.04, 0.305, 231, 223, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
3819, d5dkiE_, 0.8527, 2.04, 0.305, 231, 223, YEAST 20S PROTEASOME IN COMPLEX WITH ALKYNE-PI
3820, d5d0zE_, 0.8527, 2.05, 0.305, 231, 223, YEAST 20S PROTEASOME BETA5-T1S MUTANT IN COMPLEX WITH CARFILZOMIB
3821, d5czaS_, 0.8527, 2.04, 0.305, 231, 223, YEAST 20S PROTEASOME BETA5-D166N MUTANT
3822, d5czaE_, 0.8527, 2.04, 0.305, 231, 223, YEAST 20S PROTEASOME BETA5-D166N MUTANT
3823, d5cz5E_, 0.8527, 2.05, 0.305, 231, 223, YEAST 20S PROTEASOME BETA1-T1A MUTANT IN COMPLEX WITH CARFILZOMIB
3824, p5cgiS_, 0.8527, 2.05, 0.305, 231, 223, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
3825, p5cggS_, 0.8527, 2.05, 0.305, 231, 223, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
3826, p4zzgF_, 0.8527, 2.03, 0.305, 232, 223, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
3827, p4ya5S_, 0.8527, 2.04, 0.305, 231, 223, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
3828, p4ya5E_, 0.8527, 2.04, 0.305, 231, 223, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-PAE-EP
3829, d4y8mS_, 0.8527, 2.04, 0.305, 231, 223, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
3830, d4y8mE_, 0.8527, 2.04, 0.305, 231, 223, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT
3831, p4y8lS_, 0.8527, 2.05, 0.305, 231, 223, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
3832, p4y8lE_, 0.8527, 2.05, 0.305, 231, 223, YEAST 20S PROTEASOME IN COMPLEX WITH AC-APLL-EP
3833, p4y8kS_, 0.8527, 2.05, 0.305, 231, 223, YEAST 20S PROTEASOME IN COMPLEX WITH H-APLL-EP
3834, p4y7yS_, 0.8527, 2.05, 0.305, 231, 223, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
3835, p4y7yE_, 0.8527, 2.05, 0.305, 231, 223, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAA-EP
3836, d4r02S_, 0.8527, 2.04, 0.305, 231, 223, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
3837, d4qz3S_, 0.8527, 2.05, 0.305, 231, 223, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3838, d4qz3E_, 0.8527, 2.05, 0.305, 231, 223, YCP BETA5-A49V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3839, d4qwlS_, 0.8527, 2.05, 0.305, 231, 223, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
3840, d4qwlE_, 0.8527, 2.05, 0.305, 231, 223, YCP BETA5-A50V MUTANT IN COMPLEX WITH CARFILZOMIB
3841, d4qvwS_, 0.8527, 2.04, 0.305, 231, 223, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
3842, d4qvwE_, 0.8527, 2.04, 0.305, 231, 223, YCP BETA5-A49S-MUTANT IN COMPLEX WITH BORTEZOMIB
3843, d4qvqS_, 0.8527, 2.04, 0.305, 231, 223, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
3844, d4qvqE_, 0.8527, 2.04, 0.305, 231, 223, YCP BETA5-M45I MUTANT IN COMPLEX WITH BORTEZOMIB
3845, d4qv8S_, 0.8527, 2.05, 0.305, 231, 223, YCP BETA5-C52F MUTANT
3846, d4qv8E_, 0.8527, 2.05, 0.305, 231, 223, YCP BETA5-C52F MUTANT
3847, d4qv7S_, 0.8527, 2.05, 0.305, 231, 223, YCP BETA5-A50V MUTANT
3848, d4qv7E_, 0.8527, 2.05, 0.305, 231, 223, YCP BETA5-A50V MUTANT
3849, d4quxS_, 0.8527, 2.04, 0.305, 231, 223, YCP BETA5-A49T-MUTANT
3850, d4quxE_, 0.8527, 2.04, 0.305, 231, 223, YCP BETA5-A49T-MUTANT
3851, d4jsqS_, 0.8527, 2.04, 0.305, 233, 223, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
3852, d4jsqE_, 0.8527, 2.04, 0.305, 233, 223, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:4E
3853, d3mg8S_, 0.8527, 2.04, 0.305, 233, 223, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 16
3854, d3dy3S_, 0.8527, 2.04, 0.305, 233, 223, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
3855, d3dy3E_, 0.8527, 2.04, 0.305, 233, 223, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH THE EPIMER FORM OF SPIROLACTACYSTIN
3856, d5l68S_, 0.8526, 2.04, 0.305, 231, 223, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
3857, d5l68E_, 0.8526, 2.04, 0.305, 231, 223, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 14
3858, d5l66S_, 0.8526, 2.04, 0.305, 231, 223, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
3859, d5l66E_, 0.8526, 2.04, 0.305, 231, 223, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH BORTEZOMIB
3860, d5l65S_, 0.8526, 2.04, 0.305, 231, 223, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
3861, d5l65E_, 0.8526, 2.04, 0.305, 231, 223, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
3862, d5l5sS_, 0.8526, 2.04, 0.305, 231, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
3863, d5l5sE_, 0.8526, 2.04, 0.305, 231, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; V31M) AND HUMAN BETA6 (97-111; 118-133) IN COMPLEX WITH PR-924
3864, d5l5iE_, 0.8526, 2.04, 0.305, 231, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
3865, d5cz6S_, 0.8526, 2.04, 0.305, 231, 223, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
3866, d5cz6E_, 0.8526, 2.04, 0.305, 231, 223, YEAST 20S PROTEASOME BETA5-T1A MUTANT IN COMPLEX WITH SYRINGOLIN A PROPEPTIDE EXPRESSED IN TRANS
3867, p5cgiE_, 0.8526, 2.05, 0.305, 231, 223, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ONX 0914
3868, p5cggE_, 0.8526, 2.05, 0.305, 231, 223, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 1
3869, p4ya3S_, 0.8526, 2.04, 0.305, 231, 223, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
3870, p4ya3E_, 0.8526, 2.04, 0.305, 231, 223, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-PAE-EP
3871, d4ya1S_, 0.8526, 2.05, 0.305, 231, 223, YEAST 20S PROTEASOME BETA2-H116N MUTANT
3872, d4ya1E_, 0.8526, 2.04, 0.305, 231, 223, YEAST 20S PROTEASOME BETA2-H116N MUTANT
3873, d4y9yS_, 0.8526, 2.04, 0.305, 231, 223, YEAST 20S PROTEASOME BETA2-H116E MUTANT
3874, d4y9yE_, 0.8526, 2.04, 0.305, 231, 223, YEAST 20S PROTEASOME BETA2-H116E MUTANT
3875, p4y8nS_, 0.8526, 2.04, 0.305, 231, 223, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
3876, p4y8nE_, 0.8526, 2.04, 0.305, 231, 223, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAE- EP
3877, p4y80S_, 0.8526, 2.05, 0.305, 231, 223, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
3878, p4y80E_, 0.8526, 2.05, 0.305, 231, 223, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAI-EP
3879, p4y6vS_, 0.8526, 2.04, 0.305, 231, 223, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
3880, p4y6vE_, 0.8526, 2.04, 0.305, 231, 223, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAE-EP
3881, d4r02E_, 0.8526, 2.04, 0.305, 231, 223, YCP IN COMPLEX WITH BSC4999 (ALPHA-KETO PHENYLAMIDE)
3882, d4qzwS_, 0.8526, 2.05, 0.305, 231, 223, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3883, d4qzwE_, 0.8526, 2.05, 0.305, 231, 223, YCP BETA5-C52F MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3884, d4qz7S_, 0.8526, 2.05, 0.305, 231, 223, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3885, d4qz7E_, 0.8526, 2.05, 0.305, 231, 223, YCP BETA5-A50V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3886, d4qwkS_, 0.8526, 2.05, 0.305, 231, 223, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3887, d4qwkE_, 0.8526, 2.05, 0.305, 231, 223, YCP BETA5-A49T-A50V-DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3888, d4qw5S_, 0.8526, 2.05, 0.305, 231, 223, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
3889, d4qvmS_, 0.8526, 2.04, 0.305, 231, 223, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
3890, d4qvmE_, 0.8526, 2.04, 0.305, 231, 223, YCP BETA5-M45A MUTANT IN COMPLEX WITH BORTEZOMIB
3891, d4qvlS_, 0.8526, 2.04, 0.305, 231, 223, YCP IN COMPLEX WITH BORTEZOMIB
3892, d4qvlE_, 0.8526, 2.04, 0.305, 231, 223, YCP IN COMPLEX WITH BORTEZOMIB
3893, d4no8S_, 0.8526, 2.04, 0.305, 231, 223, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
3894, d4no8E_, 0.8526, 2.04, 0.305, 231, 223, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOAMIDE
3895, d4ltcS_, 0.8526, 2.05, 0.305, 233, 223, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
3896, d4inrE_, 0.8526, 2.05, 0.305, 233, 223, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
3897, d4eu2F_, 0.8526, 2.05, 0.305, 232, 223, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
3898, d3bdmS_, 0.8526, 2.04, 0.305, 233, 223, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
3899, d1rypF_, 0.8526, 2.04, 0.305, 233, 223, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
3900, d1g0uE_, 0.8526, 2.05, 0.305, 230, 223, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
3901, d5l63S_, 0.8525, 2.05, 0.305, 231, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
3902, d5l63E_, 0.8525, 2.05, 0.305, 231, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
3903, d5l5yS_, 0.8525, 2.04, 0.305, 231, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
3904, d5l5yE_, 0.8525, 2.04, 0.305, 231, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH CARFILZOMIB
3905, d5l5iS_, 0.8525, 2.04, 0.305, 231, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 9
3906, d5l5hS_, 0.8525, 2.05, 0.305, 231, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
3907, d5l5hE_, 0.8525, 2.05, 0.305, 231, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH PR-924
3908, d5l5aS_, 0.8525, 2.04, 0.305, 231, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
3909, d5l5aE_, 0.8525, 2.04, 0.305, 231, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138; R57T)
3910, d5cz4S_, 0.8525, 2.04, 0.305, 231, 223, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
3911, d5cz4E_, 0.8525, 2.04, 0.305, 231, 223, YEAST 20S PROTEASOME AT 2.3 A RESOLUTION
3912, p4zzgT_, 0.8525, 2.03, 0.305, 232, 223, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
3913, p4ya0S_, 0.8525, 2.04, 0.305, 231, 223, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
3914, p4ya0E_, 0.8525, 2.04, 0.305, 231, 223, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-PAE-EP
3915, d4y8rS_, 0.8525, 2.05, 0.305, 231, 223, YEAST 20S PROTEASOME BETA2-H116D MUTANT
3916, d4y8rE_, 0.8525, 2.05, 0.305, 231, 223, YEAST 20S PROTEASOME BETA2-H116D MUTANT
3917, p4y8qS_, 0.8525, 2.05, 0.305, 231, 223, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
3918, p4y8qE_, 0.8525, 2.05, 0.305, 231, 223, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAY- EP
3919, p4y78S_, 0.8525, 2.05, 0.305, 231, 223, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP
3920, p4y78E_, 0.8525, 2.05, 0.305, 231, 223, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAD-EP
3921, d4rurS_, 0.8525, 2.04, 0.305, 231, 223, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
3922, d4rurE_, 0.8525, 2.04, 0.305, 231, 223, YEAST 20S PROTEASOME IN COMPLEX WITH THE ALKALOID INDOLO-PHAKELLIN (4)
3923, d4qz6S_, 0.8525, 2.05, 0.305, 231, 223, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3924, d4qz6E_, 0.8525, 2.05, 0.305, 231, 223, YCP BETA5-A49T-A50V DOUBLE MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3925, d4qz5S_, 0.8525, 2.05, 0.305, 231, 223, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
3926, d4qz0S_, 0.8525, 2.06, 0.305, 231, 223, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3927, d4qz0E_, 0.8525, 2.06, 0.305, 231, 223, YCP BETA5-M45V MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3928, d4qxjS_, 0.8525, 2.05, 0.305, 231, 223, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3929, d4qxjE_, 0.8525, 2.05, 0.305, 231, 223, YCP BETA5-M45A MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3930, d4qw7S_, 0.8525, 2.05, 0.305, 231, 223, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
3931, d4qw7E_, 0.8525, 2.05, 0.305, 231, 223, YCP BETA5-M45T MUTANT IN COMPLEX WITH CARFILZOMIB
3932, d4qw6S_, 0.8525, 2.05, 0.305, 231, 223, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
3933, d4qw6E_, 0.8525, 2.05, 0.305, 231, 223, YCP BETA5-M45V MUTANT IN COMPLEX WITH CARFILZOMIB
3934, d4qw5E_, 0.8525, 2.05, 0.305, 231, 223, YCP BETA5-M45A MUTANT IN COMPLEX WITH CARFILZOMIB
3935, d4qw1S_, 0.8525, 2.05, 0.305, 231, 223, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
3936, d4qw1E_, 0.8525, 2.05, 0.305, 231, 223, YCP BETA5-A50V MUTANT IN COMPLEX WITH BORTEZOMIB
3937, d4qvnS_, 0.8525, 2.05, 0.305, 231, 223, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
3938, d4qvnE_, 0.8525, 2.05, 0.305, 231, 223, YCP BETA5-M45V MUTANT IN COMPLEX WITH BORTEZOMIB
3939, d4qv9S_, 0.8525, 2.05, 0.305, 231, 223, YCP BETA5-C63F MUTANT
3940, d4qv9E_, 0.8525, 2.05, 0.305, 231, 223, YCP BETA5-C63F MUTANT
3941, d4qv3E_, 0.8525, 2.05, 0.305, 231, 223, YCP BETA5-M45V MUTANT
3942, d4qv0S_, 0.8525, 2.05, 0.305, 231, 223, YCP BETA5-A49T-A50V-DOUBLE MUTANT
3943, d4qv0E_, 0.8525, 2.05, 0.305, 231, 223, YCP BETA5-A49T-A50V-DOUBLE MUTANT
3944, d4quyS_, 0.8525, 2.05, 0.305, 231, 223, YCP BETA5-A49S-MUTANT
3945, d4quyE_, 0.8525, 2.05, 0.305, 231, 223, YCP BETA5-A49S-MUTANT
3946, d4ltcE_, 0.8525, 2.05, 0.305, 233, 223, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH ENONE CARMAPHYCIN ANALOGUE 6
3947, d4inrS_, 0.8525, 2.05, 0.305, 233, 223, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU102
3948, d4hnpE_, 0.8525, 2.04, 0.305, 233, 223, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH VINYLKETONE CARMAPHYCIN ANALOGUE VNK1
3949, d3oevS_, 0.8525, 2.05, 0.305, 233, 223, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 25
3950, d3oeuS_, 0.8525, 2.05, 0.305, 233, 223, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 24
3951, d3nzjS_, 0.8525, 2.04, 0.305, 233, 223, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
3952, d3bdmE_, 0.8525, 2.04, 0.305, 233, 223, YEAST 20S PROTEASOME:GLIDOBACTIN A-COMPLEX
3953, d1g65E_, 0.8525, 2.05, 0.305, 233, 223, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
3954, p5t0cW_, 0.8524, 1.90, 0.351, 228, 222, 
3955, p5t0cCB_, 0.8524, 1.90, 0.351, 228, 222, 
3956, d5l5bS_, 0.8524, 2.05, 0.305, 231, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
3957, d5l5bE_, 0.8524, 2.05, 0.305, 231, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133)
3958, d5l55E_, 0.8524, 2.06, 0.305, 231, 223, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
3959, d5jhrS_, 0.8524, 2.05, 0.305, 231, 223, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
3960, d5jhrE_, 0.8524, 2.05, 0.305, 231, 223, YEAST 20S PROTEASOME IN COMPLEX WITH THE PEPTIDIC EPOXYKETONE INHIBITOR 27
3961, d5fggS_, 0.8524, 2.06, 0.305, 231, 223, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3962, d5fggE_, 0.8524, 2.06, 0.305, 231, 223, YEAST 20S PROTEASOME BETA5-L(-49S)_D17N DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
3963, d5d0vS_, 0.8524, 2.05, 0.305, 231, 223, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
3964, d5d0vE_, 0.8524, 2.05, 0.305, 231, 223, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
3965, d5bxlS_, 0.8524, 2.05, 0.305, 231, 223, YEAST 20S PROTEASOME BETA2-G170A MUTANT
3966, d5bxlE_, 0.8524, 2.05, 0.305, 231, 223, YEAST 20S PROTEASOME BETA2-G170A MUTANT
3967, d5bouS_, 0.8524, 2.04, 0.305, 231, 223, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
3968, d5bouE_, 0.8524, 2.04, 0.305, 231, 223, YEAST 20S PROTEASOME IN COMPLEX WITH A BETA1 / BETA2 SPECIFIC NON- PEPTIDIC SULFONAMIDE LIGAND
3969, p4y8jS_, 0.8524, 2.05, 0.305, 231, 223, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
3970, p4y8jE_, 0.8524, 2.05, 0.305, 231, 223, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LLL-EP
3971, p4y8iS_, 0.8524, 2.05, 0.305, 231, 223, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
3972, p4y8iE_, 0.8524, 2.05, 0.305, 231, 223, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PLL-EP
3973, p4y82S_, 0.8524, 2.05, 0.305, 231, 223, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
3974, p4y82E_, 0.8524, 2.05, 0.305, 231, 223, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAY-EP
3975, p4y7xS_, 0.8524, 2.05, 0.305, 231, 223, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
3976, p4y7xE_, 0.8524, 2.05, 0.305, 231, 223, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAA-EP
3977, p4y7wS_, 0.8524, 2.05, 0.305, 231, 223, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
3978, p4y7wE_, 0.8524, 2.05, 0.305, 231, 223, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAE-EP
3979, p4y70S_, 0.8524, 2.05, 0.305, 231, 223, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
3980, p4y70E_, 0.8524, 2.05, 0.305, 231, 223, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAV-EP
3981, d4qz5E_, 0.8524, 2.05, 0.305, 231, 223, YCP BETA5-A49T-MUTANT IN COMPLEX WITH ONX 0914
3982, d4qz2S_, 0.8524, 2.05, 0.305, 231, 223, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3983, d4qz2E_, 0.8524, 2.05, 0.305, 231, 223, YCP BETA5-M45I MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
3984, d4qwuS_, 0.8524, 2.05, 0.305, 231, 223, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
3985, d4qwuE_, 0.8524, 2.05, 0.305, 231, 223, YCP BETA5-C52F MUTANT IN COMPLEX WITH BORTEZOMIB
3986, d4qw3S_, 0.8524, 2.04, 0.305, 231, 223, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
3987, d4qw3E_, 0.8524, 2.04, 0.305, 231, 223, YCP BETA5-C63F MUTANT IN COMPLEX WITH BORTEZOMIB
3988, d4qv3S_, 0.8524, 2.05, 0.305, 231, 223, YCP BETA5-M45V MUTANT
3989, d4q1sE_, 0.8524, 2.04, 0.305, 233, 223, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
3990, p3un4S_, 0.8524, 2.05, 0.305, 233, 223, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
3991, p3un4E_, 0.8524, 2.05, 0.305, 233, 223, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (MORPHOLINE)
3992, d3nzjE_, 0.8524, 2.04, 0.305, 233, 223, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2A
3993, d3mg0E_, 0.8524, 2.04, 0.305, 233, 223, STRUCTURE OF YEAST 20S PROTEASOME WITH BORTEZOMIB
3994, d2gplS_, 0.8524, 2.05, 0.305, 233, 223, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
3995, d2gplE_, 0.8524, 2.05, 0.305, 233, 223, TMC-95 BASED BIPHENYL-ETHER MACROCYCLES: SPECIFIC PROTEASOME INHIBITORS
3996, d1rypT_, 0.8524, 2.04, 0.305, 233, 223, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION
3997, p5nifT_, 0.8523, 2.04, 0.305, 232, 223, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
3998, d5m2bS_, 0.8523, 2.05, 0.305, 231, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
3999, d5l6aS_, 0.8523, 2.05, 0.305, 231, 223, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
4000, d5l6aE_, 0.8523, 2.05, 0.305, 231, 223, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 17
4001, d5l5wS_, 0.8523, 2.05, 0.305, 231, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
4002, d5l5wE_, 0.8523, 2.05, 0.305, 231, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5C (1-138) AND HUMAN BETA6 (97- 111; 118-133)
4003, d5l5dE_, 0.8523, 2.05, 0.305, 231, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
4004, d5l55S_, 0.8523, 2.06, 0.305, 231, 223, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 18
4005, d5l54S_, 0.8523, 2.04, 0.305, 231, 223, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
4006, d5l54E_, 0.8523, 2.04, 0.305, 231, 223, YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
4007, d5d0wS_, 0.8523, 2.05, 0.305, 231, 223, YEAST 20S PROTEASOME BETA5-T1S MUTANT
4008, d5d0wE_, 0.8523, 2.05, 0.305, 231, 223, YEAST 20S PROTEASOME BETA5-T1S MUTANT
4009, p5cghS_, 0.8523, 2.05, 0.305, 231, 223, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
4010, p5cghE_, 0.8523, 2.05, 0.305, 231, 223, YEAST 20S PROTEASOME BETA5-G48C MUTANT IN COMPLEX WITH ALPHA- CHLOROACETAMIDE 5
4011, p4y9zS_, 0.8523, 2.05, 0.305, 231, 223, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
4012, p4y9zE_, 0.8523, 2.05, 0.305, 231, 223, YEAST 20S PROTEASOME BETA2-H116E MUTANT IN COMPLEX WITH AC-LAE-EP
4013, p4y8pS_, 0.8523, 2.05, 0.305, 231, 223, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
4014, p4y8pE_, 0.8523, 2.05, 0.305, 231, 223, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAL- EP
4015, d4qwsS_, 0.8523, 2.05, 0.305, 231, 223, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
4016, d4qwsE_, 0.8523, 2.05, 0.305, 231, 223, YCP BETA5-C63F MUTANT IN COMPLEX WITH CARFILZOMIB
4017, d4qw4S_, 0.8523, 2.05, 0.305, 231, 223, YCP IN COMPLEX WITH CARFILZOMIB
4018, d4qw4E_, 0.8523, 2.05, 0.305, 231, 223, YCP IN COMPLEX WITH CARFILZOMIB
4019, d4qv1S_, 0.8523, 2.05, 0.305, 231, 223, YCP BETA5-M45A MUTANT
4020, d4qv1E_, 0.8523, 2.05, 0.305, 231, 223, YCP BETA5-M45A MUTANT
4021, d4qlvE_, 0.8523, 2.04, 0.305, 231, 223, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
4022, d4inuE_, 0.8523, 2.05, 0.305, 233, 223, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
4023, d4eu2T_, 0.8523, 2.05, 0.305, 232, 223, CRYSTAL STRUCTURE OF 20S PROTEASOME WITH NOVEL INHIBITOR K-7174
4024, d3un8S_, 0.8523, 2.04, 0.305, 233, 223, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
4025, d3un8E_, 0.8523, 2.04, 0.305, 233, 223, YEAST 20S PROTEASOME IN COMPLEX WITH PR-957 (EPOXIDE)
4026, d3okjS_, 0.8523, 2.05, 0.305, 233, 223, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
4027, d3dy4S_, 0.8523, 2.04, 0.305, 233, 223, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
4028, d3dy4E_, 0.8523, 2.04, 0.305, 233, 223, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH SPIROLACTACYSTIN
4029, d3d29S_, 0.8523, 2.04, 0.305, 233, 223, PROTEASOME INHIBITION BY FELLUTAMIDE B
4030, d3d29E_, 0.8523, 2.04, 0.305, 233, 223, PROTEASOME INHIBITION BY FELLUTAMIDE B
4031, d2zcyS_, 0.8523, 2.04, 0.305, 233, 223, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
4032, d2zcyE_, 0.8523, 2.04, 0.305, 233, 223, YEAST 20S PROTEASOME:SYRINGOLIN A-COMPLEX
4033, p5nifF_, 0.8522, 2.04, 0.305, 232, 223, YEAST 20S PROTEASOME IN COMPLEX WITH BLM-PEP ACTIVATOR
4034, d5m2bE_, 0.8522, 2.05, 0.305, 231, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH THIAZOLE BASED INHIBITOR RO19
4035, d5l5dS_, 0.8522, 2.05, 0.305, 231, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138) AND HUMAN BETA6 (97- 111; 118-133) IN COMPLEX WITH ONX 0914
4036, d5bxnS_, 0.8522, 2.05, 0.305, 231, 223, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
4037, d5bxnE_, 0.8522, 2.05, 0.305, 231, 223, YEAST 20S PROTEASOME BETA2-G170A MUTANT IN COMPLEX WITH BORTEZOMIB
4038, d4ya4S_, 0.8522, 2.05, 0.305, 231, 223, YEAST 20S PROTEASOME BETA2-H114D MUTANT
4039, d4ya4E_, 0.8522, 2.05, 0.305, 231, 223, YEAST 20S PROTEASOME BETA2-H114D MUTANT
4040, p4y77S_, 0.8522, 2.05, 0.305, 231, 223, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
4041, p4y77E_, 0.8522, 2.05, 0.305, 231, 223, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAF-EP
4042, p4y6zS_, 0.8522, 2.05, 0.305, 231, 223, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
4043, p4y6zE_, 0.8522, 2.05, 0.305, 231, 223, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAL-EP
4044, d4qwfS_, 0.8522, 2.06, 0.305, 231, 223, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
4045, d4qwfE_, 0.8522, 2.06, 0.305, 231, 223, YCP BETA5-M45I MUTANT IN COMPLEX WITH CARFILZOMIB
4046, d4qlvS_, 0.8522, 2.04, 0.305, 231, 223, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 17
4047, d4qlsS_, 0.8522, 2.05, 0.305, 231, 223, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
4048, d4qlsE_, 0.8522, 2.05, 0.305, 231, 223, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 11
4049, d4no1S_, 0.8522, 2.05, 0.305, 231, 223, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
4050, d4no1E_, 0.8522, 2.05, 0.305, 231, 223, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-B(OH)2
4051, d4nnwS_, 0.8522, 2.05, 0.305, 231, 223, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
4052, d4nnwE_, 0.8522, 2.05, 0.305, 231, 223, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-KETOALDEHYDE
4053, d4j70S_, 0.8522, 2.05, 0.305, 233, 223, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
4054, d4fzcS_, 0.8522, 2.04, 0.305, 233, 223, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
4055, d3okjE_, 0.8522, 2.05, 0.305, 233, 223, ALPHA-KETO-ALDEHYDE BINDING MECHANISM REVEALS A NOVEL LEAD STRUCTURE MOTIF FOR PROTEASOME INHIBITION
4056, d3nzxS_, 0.8522, 2.05, 0.305, 233, 223, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
4057, d3nzxE_, 0.8522, 2.05, 0.305, 233, 223, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH LIGAND 2C
4058, d3nzwS_, 0.8522, 2.05, 0.305, 233, 223, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
4059, d3nzwE_, 0.8522, 2.05, 0.305, 233, 223, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH 2B
4060, d3mg7S_, 0.8522, 2.05, 0.305, 233, 223, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
4061, d3gptS_, 0.8522, 2.05, 0.305, 233, 223, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
4062, d3gptE_, 0.8522, 2.05, 0.305, 233, 223, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: SLOW SUBSTRATE LIGAND
4063, d5laiS_, 0.8521, 2.04, 0.305, 231, 223, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
4064, d5laiE_, 0.8521, 2.04, 0.305, 231, 223, LIGAND-INDUCED AZIRIDINE-FORMATION AT THE YEAST PROTEASOMAL SUBUNIT BETA5 BY SULFONATE ESTERS
4065, d5l69S_, 0.8521, 2.05, 0.305, 231, 223, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
4066, d5l69E_, 0.8521, 2.05, 0.305, 231, 223, YEAST 20S PROTEASOME WITH MOUSE BETA5I (1-138) AND MOUSE BETA6 (97- 111; 118-133) IN COMPLEX WITH EPOXYKETONE INHIBITOR 16
4067, d5l5rS_, 0.8521, 2.05, 0.305, 231, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
4068, d5l5rE_, 0.8521, 2.05, 0.305, 231, 223, YEAST 20S PROTEASOME WITH HUMAN BETA5I (1-138;V31M) AND HUMAN BETA6 (97-111; 118-133)
4069, p4ya7S_, 0.8521, 2.05, 0.305, 231, 223, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
4070, p4ya7E_, 0.8521, 2.05, 0.305, 231, 223, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAE-EP
4071, d4qz4S_, 0.8521, 2.05, 0.305, 231, 223, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4072, d4qz4E_, 0.8521, 2.05, 0.305, 231, 223, YCP BETA5-A49S MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4073, d4qwxS_, 0.8521, 2.05, 0.305, 231, 223, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4074, d4qwxE_, 0.8521, 2.05, 0.305, 231, 223, YCP IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4075, d4qv4S_, 0.8521, 2.05, 0.305, 231, 223, YCP BETA5-M45T MUTANT
4076, d4qv4E_, 0.8521, 2.05, 0.305, 231, 223, YCP BETA5-M45T MUTANT
4077, d4qluS_, 0.8521, 2.04, 0.305, 231, 223, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
4078, d4qluE_, 0.8521, 2.04, 0.305, 231, 223, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 9
4079, d4qlqS_, 0.8521, 2.05, 0.305, 231, 223, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
4080, d4qlqE_, 0.8521, 2.05, 0.305, 231, 223, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 8
4081, d4lqiS_, 0.8521, 2.05, 0.305, 233, 223, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
4082, d4lqiE_, 0.8521, 2.05, 0.305, 233, 223, YEAST 20S PROTEASOME IN COMPLEX WITH VIBRALACTONE
4083, d4jsuS_, 0.8521, 2.05, 0.305, 233, 223, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
4084, d4jsuE_, 0.8521, 2.05, 0.305, 233, 223, YEAST 20S PROTEASOME IN COMPLEX WITH THE DIMERIZED LINEAR MIMETIC OF TMC-95A - YCP:3A
4085, d4inuS_, 0.8521, 2.06, 0.305, 233, 223, YEAST 20S PROTEASOME IN COMPLEX WITH THE VINYL SULFONE LU112
4086, d4fzcE_, 0.8521, 2.04, 0.305, 233, 223, 20S YEAST PROTEASOME IN COMPLEX WITH CEPAFUNGIN I
4087, d2f16E_, 0.8521, 2.06, 0.305, 233, 223, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
4088, d5ahjS_, 0.8520, 2.06, 0.305, 231, 223, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
4089, d5ahjE_, 0.8520, 2.06, 0.305, 231, 223, YEAST 20S PROTEASOME IN COMPLEX WITH MACYRANONE A
4090, p4y8tS_, 0.8520, 2.05, 0.305, 231, 223, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
4091, p4y8tE_, 0.8520, 2.05, 0.305, 231, 223, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-PAE-EP
4092, p4y8sS_, 0.8520, 2.05, 0.305, 231, 223, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
4093, p4y8sE_, 0.8520, 2.06, 0.305, 231, 223, YEAST 20S PROTEASOME BETA2-H116D MUTANT IN COMPLEX WITH AC-LAE-EP
4094, p4y8oS_, 0.8520, 2.05, 0.305, 231, 223, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
4095, p4y81S_, 0.8520, 2.05, 0.305, 231, 223, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
4096, p4y81E_, 0.8520, 2.05, 0.305, 231, 223, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAY-EP
4097, p4y74S_, 0.8520, 2.05, 0.305, 231, 223, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
4098, p4y74E_, 0.8520, 2.05, 0.305, 231, 223, YEAST 20S PROTEASOME IN COMPLEX WITH AC-LAL-EP
4099, d4q1sS_, 0.8520, 2.04, 0.305, 233, 223, YEAST 20S PROTEASOME IN COMPLEX WITH KENDOMYCIN
4100, d4no9S_, 0.8520, 2.05, 0.305, 231, 223, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
4101, d4no9E_, 0.8520, 2.05, 0.305, 231, 223, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-EPOXYKETONE
4102, d4j70E_, 0.8520, 2.05, 0.305, 233, 223, YEAST 20S PROTEASOME IN COMPLEX WITH THE BELACTOSIN DERIVATIVE 3E
4103, d3wxrF_, 0.8520, 2.05, 0.305, 232, 223, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
4104, d3tddS_, 0.8520, 2.05, 0.305, 233, 223, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
4105, d3tddE_, 0.8520, 2.05, 0.305, 233, 223, CRYSTAL STRUCTURE OF YEAST CP IN COMPLEX WITH BELACTOSIN C
4106, d3mg7E_, 0.8520, 2.04, 0.305, 233, 223, STRUCTURE OF YEAST 20S OPEN-GATE PROTEASOME WITH COMPOUND 8
4107, d3gpjS_, 0.8520, 2.04, 0.305, 233, 223, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
4108, d3gpjE_, 0.8520, 2.04, 0.305, 233, 223, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SYRINGOLIN B
4109, d2f16S_, 0.8520, 2.06, 0.305, 233, 223, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH BORTEZOMIB
4110, p6gopS_, 0.8519, 2.06, 0.305, 231, 223, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
4111, p6gopE_, 0.8519, 2.05, 0.305, 231, 223, YEAST 20S PROTEASOME IN COMPLEX WITH HOMOSALINOSPORAMIDE A 
4112, p4y8oE_, 0.8519, 2.05, 0.305, 231, 223, YEAST 20S PROTEASOME BETA7-DELTA7_CTER MUTANT IN COMPLEX WITH AC-PAF- EP
4113, d4r17S_, 0.8519, 2.05, 0.305, 231, 223, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
4114, d4r17E_, 0.8519, 2.05, 0.305, 231, 223, LIGAND-INDUCED AZIRIDINE-FORMATION AT SUBUNIT BETA5 OF THE YEAST 20S PROTEASOME
4115, d4qz1S_, 0.8519, 2.05, 0.305, 231, 223, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4116, d4qz1E_, 0.8519, 2.05, 0.305, 231, 223, YCP BETA5-M45T MUTANT IN COMPLEX WITH THE EPOXYKETONE INHIBITOR ONX 0914
4117, d4qwgS_, 0.8519, 2.05, 0.305, 231, 223, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
4118, d4qwgE_, 0.8519, 2.05, 0.305, 231, 223, YCP BETA5-A49V MUTANT IN COMPLEX WITH CARFILZOMIB
4119, d4qltS_, 0.8519, 2.04, 0.305, 231, 223, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
4120, d4qltE_, 0.8519, 2.04, 0.305, 231, 223, YCP IN COMPLEX WITH TRIPEPTIDIC EPOXYKETONE INHIBITOR 2 (PR924)
4121, d4nnnS_, 0.8519, 2.06, 0.305, 231, 223, YCP IN COMPLEX WITH MG132
4122, d4nnnE_, 0.8519, 2.06, 0.305, 231, 223, YCP IN COMPLEX WITH MG132
4123, d4hrcE_, 0.8519, 2.05, 0.305, 233, 223, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
4124, d3shjE_, 0.8519, 2.04, 0.305, 233, 223, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
4125, d3gpwS_, 0.8519, 2.06, 0.305, 233, 223, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
4126, d3gpwE_, 0.8519, 2.06, 0.305, 233, 223, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH SALINOSPORAMIDE DERIVATIVES: IRREVERSIBLE INHIBITOR LIGAND
4127, d1g0uS_, 0.8519, 2.06, 0.305, 230, 223, A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE
4128, p4ya9S_, 0.8518, 2.06, 0.305, 231, 223, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
4129, p4ya9E_, 0.8518, 2.06, 0.305, 231, 223, YEAST 20S PROTEASOME BETA2-H114D MUTANT IN COMPLEX WITH AC-LAD-EP
4130, p4y8hS_, 0.8518, 2.05, 0.305, 231, 223, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
4131, p4y8hE_, 0.8518, 2.05, 0.305, 231, 223, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APAL-EP
4132, p4y75S_, 0.8518, 2.06, 0.305, 231, 223, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
4133, p4y75E_, 0.8518, 2.06, 0.305, 231, 223, YEAST 20S PROTEASOME IN COMPLEX WITH AC-PAF-EP
4134, d4qv5S_, 0.8518, 2.06, 0.305, 231, 223, YCP BETA5-M45I MUTANT
4135, d4qv5E_, 0.8518, 2.06, 0.305, 231, 223, YCP BETA5-M45I MUTANT
4136, p4gk7S_, 0.8518, 2.05, 0.305, 233, 223, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
4137, p4gk7E_, 0.8518, 2.06, 0.305, 233, 223, YEAST 20S PROTEASOME IN COMPLEX WITH THE SYRINGOLIN-GLIDOBACTIN CHIMERA
4138, d3shjS_, 0.8518, 2.05, 0.305, 233, 223, PROTEASOME IN COMPLEX WITH HYDROXYUREA DERIVATIVE HU10
4139, p4ya2S_, 0.8517, 2.06, 0.305, 231, 223, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
4140, p4ya2E_, 0.8517, 2.06, 0.305, 231, 223, YEAST 20S PROTEASOME BETA2-H116N MUTANT IN COMPLEX WITH AC-LAE-EP
4141, d3wxrT_, 0.8517, 2.05, 0.305, 232, 223, YEAST 20S PROTEASOME WITH A MUTATION OF ALPHA7 SUBUNIT
4142, d3mg4E_, 0.8517, 2.05, 0.305, 233, 223, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
4143, d3hyeS_, 0.8517, 2.05, 0.305, 233, 223, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
4144, d3hyeE_, 0.8517, 2.05, 0.305, 233, 223, CRYSTAL STRUCTURE OF 20S PROTEASOME IN COMPLEX WITH HYDROXYLATED SALINOSPORAMIDE
4145, d1g65S_, 0.8517, 2.06, 0.305, 233, 223, CRYSTAL STRUCTURE OF EPOXOMICIN:20S PROTEASOME REVEALS A MOLECULAR BASIS FOR SELECTIVITY OF ALPHABETA-EPOXYKETONE PROTEASOME INHIBITORS
4146, d4qv6S_, 0.8516, 2.06, 0.305, 231, 223, YCP BETA5-A49V MUTANT
4147, d4qv6E_, 0.8516, 2.06, 0.305, 231, 223, YCP BETA5-A49V MUTANT
4148, d4hrcS_, 0.8516, 2.07, 0.305, 233, 223, CRYSTAL STRUCTURE OF YEAST 20S PROTEASOME IN COMPLEX WITH EPOXYKETONE CARMAPHYCIN ANALOGUE 3
4149, d3mg4S_, 0.8516, 2.08, 0.305, 233, 223, STRUCTURE OF YEAST 20S PROTEASOME WITH COMPOUND 1
4150, d5lexU_, 0.8515, 1.86, 0.294, 235, 221, NATIVE HUMAN 20S PROTEASOME IN MG-ACETATE AT 2.2 ANGSTROM
4151, p4y84S_, 0.8515, 2.05, 0.305, 231, 223, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
4152, p4y84E_, 0.8515, 2.05, 0.305, 231, 223, YEAST 20S PROTEASOME IN COMPLEX WITH N3-A(44-F2P)NLL-EP
4153, p4y8gS_, 0.8514, 2.05, 0.305, 231, 223, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
4154, p4y8gE_, 0.8514, 2.05, 0.305, 231, 223, YEAST 20S PROTEASOME IN COMPLEX WITH N3-APNLL-EP
4155, p4qbyS_, 0.8514, 2.05, 0.305, 231, 223, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
4156, p4qbyE_, 0.8514, 2.05, 0.305, 231, 223, YCP IN COMPLEX WITH BOC-ALA-ALA-ALA-CHO
4157, d4no6S_, 0.8514, 2.06, 0.305, 231, 223, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
4158, d4no6E_, 0.8514, 2.06, 0.305, 231, 223, YCP IN COMPLEX WITH Z-LEU-LEU-LEU-VINYLSULFONE
4159, p6epeG_, 0.8513, 2.43, 0.278, 245, 230, SUBSTRATE PROCESSING STATE 26S PROTEASOME (SPS2)
4160, d3e47S_, 0.8512, 2.07, 0.305, 233, 223, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
4161, d3e47E_, 0.8512, 2.06, 0.305, 233, 223, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME IN COMPLEX WITH HOMOBELACTOSIN C
4162, d2fnyS_, 0.8512, 2.07, 0.305, 233, 223,  
4163, d2fnyE_, 0.8512, 2.07, 0.305, 233, 223,  
4164, d5lf3U_, 0.8507, 1.86, 0.294, 235, 221, HUMAN 20S PROTEASOME COMPLEX WITH BORTEZOMIB AT 2.1 ANGSTROM
4165, p5a0qP_, 0.8507, 1.35, 0.393, 214, 214, CRYO-EM REVEALS THE CONFORMATION OF A SUBSTRATE ANALOGUE IN THE HUMAN 20S PROTEASOME CORE
4166, p5a0qB_, 0.8507, 1.35, 0.393, 214, 214, CRYO-EM REVEALS THE CONFORMATION OF A SUBSTRATE ANALOGUE IN THE HUMAN 20S PROTEASOME CORE
4167, p5mpcA_, 0.8504, 2.54, 0.254, 241, 232, 
4168, p5t0jL_, 0.8503, 2.42, 0.335, 238, 230, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
4169, d5lf7U_, 0.8503, 1.88, 0.290, 235, 221, HUMAN 20S PROTEASOME COMPLEX WITH IXAZOMIB AT 2.0 ANGSTROM
4170, p5lf6U_, 0.8502, 1.88, 0.290, 235, 221, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
4171, p4x6zT_, 0.8502, 2.08, 0.305, 232, 223, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
4172, d5lf4U_, 0.8499, 1.88, 0.290, 235, 221, HUMAN 20S PROTEASOME COMPLEX WITH DELANZOMIB AT 2.0 ANGSTROM
4173, d5lf1U_, 0.8499, 1.87, 0.294, 235, 221, HUMAN 20S PROTEASOME COMPLEX WITH DIHYDROEPONEMYCIN AT 2.0 ANGSTROM
4174, p6epfF_, 0.8498, 2.38, 0.338, 238, 228, GROUND STATE 26S PROTEASOME (GS1)
4175, d1z7qF1, 0.8497, 2.08, 0.305, 233, 223, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
4176, p4x6zF_, 0.8496, 2.08, 0.305, 232, 223, YEAST 20S PROTEASOME IN COMPLEX WITH PR-VI MODULATOR
4177, d1z7qT1, 0.8496, 2.08, 0.305, 233, 223, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
4178, p3jcpOA_, 0.8494, 2.11, 0.305, 233, 223, 
4179, p3jcpO_, 0.8494, 2.11, 0.305, 233, 223, 
4180, p5mp9f_, 0.8493, 2.06, 0.305, 231, 223, 26S PROTEASOME IN PRESENCE OF ATP (S1)
4181, p6epdD_, 0.8491, 2.58, 0.565, 246, 237, SUBSTRATE PROCESSING STATE 26S PROTEASOME (SPS1)
4182, d1jd2E_, 0.8491, 2.09, 0.305, 233, 223, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
4183, p5wvkT_, 0.8490, 2.02, 0.305, 233, 223, 
4184, p5ln3E_, 0.8490, 2.15, 0.351, 232, 225, THE HUMAN 26S PROTEASOME AT 6.8 ANG.
4185, p1fntF_, 0.8489, 2.08, 0.305, 233, 223, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
4186, p4v7oT_, 0.8488, 2.09, 0.305, 234, 223, 
4187, p4v7oF_, 0.8488, 2.09, 0.305, 234, 223, 
4188, d3l5qW_, 0.8488, 2.09, 0.305, 234, 223,  
4189, d3l5qK_, 0.8488, 2.09, 0.305, 234, 223,  
4190, p4v7oBB_, 0.8487, 2.09, 0.305, 234, 223, 
4191, d1vsyT_, 0.8487, 2.09, 0.305, 234, 223,  
4192, p1fntT_, 0.8487, 2.08, 0.305, 233, 223, CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FROM TRYPANOSOME BRUCEI AT 3.2 ANGSTROMS RESOLUTION
4193, p5t0hK_, 0.8486, 2.02, 0.350, 228, 223, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
4194, p4v7oNA_, 0.8486, 2.09, 0.305, 234, 223, 
4195, d1vsyF_, 0.8486, 2.09, 0.305, 234, 223,  
4196, d1jd2Z_, 0.8485, 2.09, 0.305, 233, 223, CRYSTAL STRUCTURE OF THE YEAST 20S PROTEASOME:TMC-95A COMPLEX: A NON- COVALENT PROTEASOME INHIBITOR
4197, p5t0hL_, 0.8476, 2.37, 0.336, 238, 229, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
4198, p5a5bA_, 0.8474, 2.64, 0.248, 243, 234, STRUCTURE OF THE 26S PROTEASOME-UBP6 COMPLEX
4199, p4cr3A_, 0.8474, 2.64, 0.248, 243, 234, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
4200, p5mpaF_, 0.8465, 2.08, 0.305, 233, 223, 26S PROTEASOME IN PRESENCE OF ATP (S2)
4201, p5a5bF_, 0.8462, 2.10, 0.305, 233, 223, STRUCTURE OF THE 26S PROTEASOME-UBP6 COMPLEX
4202, p4cr3F_, 0.8462, 2.10, 0.305, 233, 223, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
4203, p5fmgQ_, 0.8457, 1.61, 0.343, 220, 216, STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS
4204, p5fmgC_, 0.8457, 1.61, 0.343, 220, 216, STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS
4205, p5mpbT_, 0.8456, 2.06, 0.305, 233, 223, 
4206, p5fmgR_, 0.8454, 1.58, 0.479, 215, 215, STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS
4207, p5fmgD_, 0.8454, 1.58, 0.479, 215, 215, STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS
4208, p5a0qS_, 0.8447, 1.39, 0.362, 215, 213, CRYO-EM REVEALS THE CONFORMATION OF A SUBSTRATE ANALOGUE IN THE HUMAN 20S PROTEASOME CORE
4209, p5a0qE_, 0.8447, 1.39, 0.362, 215, 213, CRYO-EM REVEALS THE CONFORMATION OF A SUBSTRATE ANALOGUE IN THE HUMAN 20S PROTEASOME CORE
4210, p6epeF_, 0.8443, 2.53, 0.342, 238, 228, SUBSTRATE PROCESSING STATE 26S PROTEASOME (SPS2)
4211, p5vfpD_, 0.8442, 1.66, 0.576, 219, 217, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
4212, p6epeB_, 0.8437, 2.15, 0.371, 234, 224, SUBSTRATE PROCESSING STATE 26S PROTEASOME (SPS2)
4213, p5t0iM_, 0.8432, 2.46, 0.289, 240, 228, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
4214, d5le5U_, 0.8426, 1.79, 0.294, 232, 218, NATIVE HUMAN 20S PROTEASOME AT 1.8 ANGSTROM
4215, p3jcoOA_, 0.8423, 2.19, 0.305, 233, 223, 
4216, p3jcoO_, 0.8423, 2.19, 0.305, 233, 223, 
4217, p5mpbF_, 0.8418, 2.15, 0.305, 231, 223, 
4218, p6epfE_, 0.8398, 2.22, 0.339, 233, 224, GROUND STATE 26S PROTEASOME (GS1)
4219, p5gjqh_, 0.8394, 1.78, 0.290, 221, 217, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
4220, p5mpbE_, 0.8393, 1.97, 0.329, 228, 219, 
4221, p5gjrGA_, 0.8388, 1.81, 0.290, 221, 217, 
4222, p5gjrS_, 0.8386, 1.82, 0.286, 221, 217, 
4223, p5gjqB_, 0.8386, 1.81, 0.290, 221, 217, STRUCTURE OF THE HUMAN 26S PROTEASOME BOUND TO USP14-UBAL
4224, p6epcF_, 0.8380, 2.57, 0.342, 238, 228, GROUND STATE 26S PROTEASOME (GS2)
4225, p5fmgT_, 0.8373, 1.94, 0.321, 219, 218, STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS
4226, p5fmgF_, 0.8373, 1.94, 0.321, 219, 218, STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS
4227, p5l4gO_, 0.8371, 1.83, 0.286, 221, 217, 
4228, d4cr2F_, 0.8364, 2.18, 0.305, 233, 223, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
4229, p5l4gA_, 0.8353, 1.85, 0.290, 221, 217, 
4230, p6epcE_, 0.8352, 2.32, 0.342, 233, 225, GROUND STATE 26S PROTEASOME (GS2)
4231, p6epcG_, 0.8345, 2.62, 0.281, 245, 231, GROUND STATE 26S PROTEASOME (GS2)
4232, p5ln3C_, 0.8345, 1.94, 0.320, 225, 219, THE HUMAN 26S PROTEASOME AT 6.8 ANG.
4233, p5fmgP_, 0.8344, 1.54, 0.340, 212, 212, STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS
4234, p5fmgB_, 0.8344, 1.54, 0.340, 212, 212, STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS
4235, p5mpcF_, 0.8338, 2.20, 0.305, 231, 223, 
4236, p4cr4F_, 0.8338, 2.29, 0.305, 233, 223, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
4237, p5fmgS_, 0.8330, 1.70, 0.341, 217, 214, STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS
4238, p5fmgE_, 0.8330, 1.70, 0.341, 217, 214, STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS
4239, p6epdG_, 0.8329, 2.68, 0.274, 245, 230, SUBSTRATE PROCESSING STATE 26S PROTEASOME (SPS1)
4240, p5t0iK_, 0.8324, 2.25, 0.354, 228, 223, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
4241, p4v7oE_, 0.8315, 2.01, 0.326, 227, 218, 
4242, p4v7oAB_, 0.8315, 2.01, 0.326, 227, 218, 
4243, p4v7oMA_, 0.8314, 2.01, 0.326, 227, 218, 
4244, p4v7oS_, 0.8313, 2.01, 0.326, 227, 218, 
4245, p3unhU_, 0.8310, 1.88, 0.292, 220, 216, MOUSE 20S IMMUNOPROTEASOME
4246, p3unhG_, 0.8310, 1.88, 0.292, 220, 216, MOUSE 20S IMMUNOPROTEASOME
4247, p4v7oP_, 0.8309, 1.64, 0.366, 231, 213, 
4248, p4v7oB_, 0.8309, 1.64, 0.366, 231, 213, 
4249, d3l5qS_, 0.8309, 1.64, 0.366, 231, 213,  
4250, d3l5qG_, 0.8309, 1.64, 0.366, 231, 213,  
4251, p4v7oJA_, 0.8307, 1.65, 0.366, 231, 213, 
4252, d1vsyB_, 0.8307, 1.65, 0.366, 231, 213,  
4253, p4v7oXA_, 0.8306, 1.65, 0.366, 231, 213, 
4254, d1vsyP_, 0.8306, 1.65, 0.366, 231, 213,  
4255, p5fmgO_, 0.8305, 1.78, 0.313, 219, 214, STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS
4256, p5fmgA_, 0.8305, 1.78, 0.313, 219, 214, STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS
4257, p6epeD_, 0.8297, 2.16, 0.557, 229, 221, SUBSTRATE PROCESSING STATE 26S PROTEASOME (SPS2)
4258, p5vfoG_, 0.8288, 1.86, 0.292, 220, 216, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
4259, p5vfrG_, 0.8283, 1.87, 0.287, 220, 216, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
4260, p6epdF_, 0.8278, 2.61, 0.333, 238, 228, SUBSTRATE PROCESSING STATE 26S PROTEASOME (SPS1)
4261, p5vfsZ_, 0.8278, 1.89, 0.296, 220, 216, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
4262, p5vfqA_, 0.8276, 1.88, 0.292, 220, 216, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
4263, p5vfog_, 0.8276, 1.87, 0.292, 220, 216, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
4264, p5vfpA_, 0.8273, 1.87, 0.296, 220, 216, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
4265, p5vfsA_, 0.8272, 1.89, 0.296, 220, 216, Nucleotide-Driven Triple-State Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
4266, p5vfrg_, 0.8270, 1.89, 0.287, 220, 216, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
4267, p5vfqZ_, 0.8268, 1.88, 0.292, 220, 216, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
4268, p5t0cYA_, 0.8266, 1.91, 0.292, 220, 216, 
4269, p5t0cS_, 0.8266, 1.91, 0.292, 220, 216, 
4270, p5vfpY_, 0.8259, 1.90, 0.292, 220, 216, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
4271, p5vfuR_, 0.8254, 1.91, 0.292, 220, 216, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
4272, p5vfuFA_, 0.8254, 1.95, 0.292, 220, 216, Nucleotide-driven Triple-state Remodeling of the AAA-ATPase Channel in the Activated Human 26S Proteasome  
4273, p5vftG_, 0.8254, 1.91, 0.292, 220, 216, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
4274, p5vftg_, 0.8254, 1.95, 0.292, 220, 216, NUCLEOTIDE-DRIVEN TRIPLE-STATE REMODELING OF THE AAA-ATPASE CHANNEL IN THE ACTIVATED HUMAN 26S PROTEASOME 
4275, p6avoR_, 0.8253, 1.78, 0.277, 217, 213, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
4276, p6avoK_, 0.8253, 1.78, 0.277, 217, 213, CRYO-EM STRUCTURE OF HUMAN IMMUNOPROTEASOME WITH A NOVEL NONCOMPETITIVE INHIBITOR THAT SELECTIVELY INHIBITS ACTIVATED LYMPHOCYTES
4277, p6epfA_, 0.8244, 2.04, 0.272, 222, 217, GROUND STATE 26S PROTEASOME (GS1)
4278, p5a5bC_, 0.8244, 2.24, 0.307, 226, 218, STRUCTURE OF THE 26S PROTEASOME-UBP6 COMPLEX
4279, p4cr3C_, 0.8244, 2.24, 0.307, 226, 218, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
4280, p5t0gG_, 0.8243, 1.91, 0.287, 220, 216, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
4281, p5t0jJ_, 0.8238, 2.05, 0.564, 222, 220, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
4282, p5m32U_, 0.8229, 1.77, 0.277, 218, 213, HUMAN 26S PROTEASOME IN COMPLEX WITH OPROZOMIB
4283, p6epeE_, 0.8223, 2.46, 0.350, 233, 223, SUBSTRATE PROCESSING STATE 26S PROTEASOME (SPS2)
4284, p5t0jH_, 0.8222, 2.48, 0.369, 232, 225, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
4285, p5wvkQ_, 0.8211, 2.11, 0.304, 225, 217, 
4286, p5wvkX_, 0.8200, 2.12, 0.304, 225, 217, 
4287, p5wviG_, 0.8185, 2.37, 0.305, 233, 223, 
4288, p5lezG_, 0.8181, 1.81, 0.269, 218, 212, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
4289, p5wviZ_, 0.8179, 2.38, 0.305, 233, 223, 
4290, p5t0jG_, 0.8176, 1.97, 0.292, 220, 216, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
4291, p5lf0G_, 0.8176, 1.82, 0.274, 218, 212, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
4292, p6epdE_, 0.8172, 2.65, 0.345, 233, 226, SUBSTRATE PROCESSING STATE 26S PROTEASOME (SPS1)
4293, p5leyG_, 0.8171, 1.82, 0.274, 218, 212, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
4294, p5lf6G_, 0.8166, 1.83, 0.274, 218, 212, HUMAN 20S PROTEASOME COMPLEX WITH Z-LLY-KETOALDEHYDE AT 2.1 ANGSTROM
4295, p5mpaA_, 0.8160, 2.11, 0.244, 224, 217, 26S PROTEASOME IN PRESENCE OF ATP (S2)
4296, p5mpbO_, 0.8157, 2.15, 0.252, 225, 218, 
4297, p5t0hG_, 0.8143, 2.02, 0.296, 220, 216, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
4298, p5m32S_, 0.8137, 1.98, 0.333, 218, 213, HUMAN 26S PROTEASOME IN COMPLEX WITH OPROZOMIB
4299, p5t0iL_, 0.8097, 2.26, 0.332, 221, 217, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
4300, p5fmgU_, 0.8096, 2.27, 0.200, 219, 215, STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS
4301, p5fmgG_, 0.8096, 2.27, 0.200, 219, 215, STRUCTURE AND FUNCTION BASED DESIGN OF PLASMODIUM-SELECTIVE PROTEASOME INHIBITORS
4302, p5t0iJ_, 0.8083, 2.28, 0.582, 222, 220, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
4303, p6epcA_, 0.8080, 2.24, 0.260, 219, 215, GROUND STATE 26S PROTEASOME (GS2)
4304, p6epdA_, 0.8078, 2.30, 0.269, 223, 219, SUBSTRATE PROCESSING STATE 26S PROTEASOME (SPS1)
4305, p5t0iG_, 0.8074, 2.09, 0.287, 220, 216, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
4306, p5ln3A_, 0.8061, 2.05, 0.262, 219, 214, THE HUMAN 26S PROTEASOME AT 6.8 ANG.
4307, p5lezU_, 0.8045, 1.79, 0.284, 212, 208, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB IN MG-ACETATE AT 2.2 ANGSTROM
4308, p5lf0U_, 0.8042, 1.79, 0.284, 212, 208, HUMAN 20S PROTEASOME COMPLEX WITH EPOXOMICIN AT 2.4 ANGSTROM
4309, p5wviY_, 0.8037, 2.24, 0.248, 225, 218, 
4310, p5leyU_, 0.8027, 1.82, 0.284, 212, 208, HUMAN 20S PROTEASOME COMPLEX WITH OPROZOMIB AT 1.9 ANGSTROM
4311, p5wviF_, 0.8011, 2.40, 0.264, 223, 216, 
4312, p5wviH_, 0.8001, 1.89, 0.333, 214, 210, 
4313, p5a0qU_, 0.7973, 1.88, 0.291, 209, 206, CRYO-EM REVEALS THE CONFORMATION OF A SUBSTRATE ANALOGUE IN THE HUMAN 20S PROTEASOME CORE
4314, p5a0qG_, 0.7973, 1.88, 0.291, 209, 206, CRYO-EM REVEALS THE CONFORMATION OF A SUBSTRATE ANALOGUE IN THE HUMAN 20S PROTEASOME CORE
4315, p5t0jK_, 0.7953, 1.93, 0.341, 212, 208, STRUCTURAL BASIS FOR DYNAMIC REGULATION OF THE HUMAN 26S PROTEASOME
4316, d5ts0G_, 0.7943, 2.16, 0.151, 220, 212, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4317, p5wviD_, 0.7942, 2.24, 0.237, 222, 215, 
4318, d5trgP_, 0.7936, 2.17, 0.151, 219, 212, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4319, p5mpcT_, 0.7925, 2.04, 0.297, 213, 209, 
4320, p5wviNA_, 0.7923, 2.16, 0.294, 222, 211, 
4321, d2h6jB1, 0.7919, 2.21, 0.175, 219, 212, CRYSTAL STRUCTURE OF THE BETA F145A RHODOCOCCUS PROTEASOME (CASP TARGET)
4322, d5trsA_, 0.7916, 2.15, 0.152, 219, 211, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4323, d5trrA_, 0.7914, 2.13, 0.152, 218, 211, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4324, d2h6jA1, 0.7912, 2.20, 0.179, 219, 212, CRYSTAL STRUCTURE OF THE BETA F145A RHODOCOCCUS PROTEASOME (CASP TARGET)
4325, d2h6jG1, 0.7910, 2.20, 0.179, 219, 212, CRYSTAL STRUCTURE OF THE BETA F145A RHODOCOCCUS PROTEASOME (CASP TARGET)
4326, d5thoG_, 0.7909, 2.16, 0.152, 218, 211, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4327, d2h6jF1, 0.7909, 2.20, 0.179, 219, 212, CRYSTAL STRUCTURE OF THE BETA F145A RHODOCOCCUS PROTEASOME (CASP TARGET)
4328, d2h6jE1, 0.7909, 2.22, 0.175, 219, 212, CRYSTAL STRUCTURE OF THE BETA F145A RHODOCOCCUS PROTEASOME (CASP TARGET)
4329, p2fhgW_, 0.7909, 2.30, 0.155, 220, 213, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
4330, p2fhgQ_, 0.7909, 2.30, 0.155, 220, 213, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
4331, p2fhgD_, 0.7909, 2.30, 0.155, 220, 213, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
4332, d5trgA_, 0.7908, 2.15, 0.152, 218, 211, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4333, d2h6jD1, 0.7908, 2.22, 0.175, 219, 212, CRYSTAL STRUCTURE OF THE BETA F145A RHODOCOCCUS PROTEASOME (CASP TARGET)
4334, d2h6jC1, 0.7908, 2.21, 0.179, 219, 212, CRYSTAL STRUCTURE OF THE BETA F145A RHODOCOCCUS PROTEASOME (CASP TARGET)
4335, p2fhgU_, 0.7908, 2.30, 0.155, 220, 213, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
4336, p2fhgM_, 0.7908, 2.30, 0.155, 220, 213, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
4337, p2fhgI_, 0.7908, 2.30, 0.155, 220, 213, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
4338, p2fhgB_, 0.7908, 2.30, 0.155, 220, 213, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
4339, p2fhgA_, 0.7908, 2.30, 0.155, 220, 213, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
4340, p2fhg1_, 0.7908, 2.31, 0.155, 220, 213, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
4341, d1q5qD_, 0.7908, 2.22, 0.179, 219, 212, THE RHODOCOCCUS 20S PROTEASOME
4342, d1q5qC_, 0.7908, 2.22, 0.179, 219, 212, THE RHODOCOCCUS 20S PROTEASOME
4343, d1q5qB_, 0.7908, 2.22, 0.179, 219, 212, THE RHODOCOCCUS 20S PROTEASOME
4344, d1q5qA_, 0.7908, 2.22, 0.179, 219, 212, THE RHODOCOCCUS 20S PROTEASOME
4345, p2fhgS_, 0.7907, 2.31, 0.155, 220, 213, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
4346, p2fhgK_, 0.7907, 2.31, 0.155, 220, 213, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
4347, d1q5qG_, 0.7907, 2.22, 0.179, 219, 212, THE RHODOCOCCUS 20S PROTEASOME
4348, d1q5qF_, 0.7907, 2.22, 0.179, 219, 212, THE RHODOCOCCUS 20S PROTEASOME
4349, d1q5qE_, 0.7907, 2.22, 0.179, 219, 212, THE RHODOCOCCUS 20S PROTEASOME
4350, p2fhgO_, 0.7906, 2.31, 0.155, 220, 213, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
4351, d1q5rF_, 0.7906, 2.24, 0.179, 219, 212, THE RHODOCOCCUS 20S PROTEASOME WITH UNPROCESSED PRO-PEPTIDES
4352, d1q5rG_, 0.7905, 2.24, 0.179, 219, 212, THE RHODOCOCCUS 20S PROTEASOME WITH UNPROCESSED PRO-PEPTIDES
4353, d1q5rE_, 0.7905, 2.24, 0.179, 219, 212, THE RHODOCOCCUS 20S PROTEASOME WITH UNPROCESSED PRO-PEPTIDES
4354, d1q5rD_, 0.7905, 2.24, 0.179, 219, 212, THE RHODOCOCCUS 20S PROTEASOME WITH UNPROCESSED PRO-PEPTIDES
4355, d1q5rC_, 0.7905, 2.24, 0.179, 219, 212, THE RHODOCOCCUS 20S PROTEASOME WITH UNPROCESSED PRO-PEPTIDES
4356, d1q5rB_, 0.7905, 2.24, 0.179, 219, 212, THE RHODOCOCCUS 20S PROTEASOME WITH UNPROCESSED PRO-PEPTIDES
4357, d1q5rA_, 0.7904, 2.24, 0.179, 219, 212, THE RHODOCOCCUS 20S PROTEASOME WITH UNPROCESSED PRO-PEPTIDES
4358, d5tryA_, 0.7903, 2.15, 0.152, 218, 211, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4359, d2fhhW_, 0.7900, 2.32, 0.155, 220, 213, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
4360, d2fhhD_, 0.7898, 2.32, 0.155, 220, 213, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
4361, d2fhhU_, 0.7897, 2.33, 0.155, 220, 213, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
4362, d2fhhS_, 0.7897, 2.33, 0.155, 220, 213, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
4363, d2fhhO_, 0.7897, 2.32, 0.155, 220, 213, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
4364, d2fhhM_, 0.7897, 2.33, 0.155, 220, 213, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
4365, d5thoA_, 0.7896, 2.17, 0.152, 218, 211, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4366, d2fhhY_, 0.7896, 2.33, 0.155, 220, 213, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
4367, d2fhhQ_, 0.7896, 2.33, 0.155, 220, 213, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
4368, d2fhhK_, 0.7896, 2.33, 0.155, 220, 213, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
4369, d2fhhI_, 0.7896, 2.33, 0.155, 220, 213, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
4370, d2fhhB_, 0.7896, 2.33, 0.155, 220, 213, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
4371, d2fhhA_, 0.7896, 2.33, 0.155, 220, 213, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
4372, d2fhhF_, 0.7895, 2.33, 0.155, 220, 213, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
4373, d2fhh1_, 0.7895, 2.33, 0.155, 220, 213, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
4374, d5ts0A_, 0.7894, 2.17, 0.152, 218, 211, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4375, d3mkaU_, 0.7893, 2.44, 0.155, 221, 213, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4376, d3mkaF_, 0.7890, 2.45, 0.150, 221, 213, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4377, d5ts0T_, 0.7889, 2.18, 0.152, 218, 211, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4378, d5trsP_, 0.7888, 2.25, 0.151, 219, 212, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4379, d3mkaA_, 0.7888, 2.46, 0.155, 222, 213, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4380, d5tryF_, 0.7887, 2.18, 0.152, 218, 211, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4381, d5trsC_, 0.7887, 2.21, 0.152, 218, 211, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4382, d3mfeI_, 0.7887, 2.12, 0.152, 217, 210, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT WITH H0 MOVEMENT
4383, d5thoS_, 0.7883, 2.26, 0.156, 221, 212, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4384, d3mkaM_, 0.7883, 2.51, 0.150, 224, 214, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4385, d5ts0U_, 0.7881, 2.15, 0.152, 217, 210, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4386, d5tryQ_, 0.7881, 2.19, 0.152, 218, 211, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4387, d3mkaB_, 0.7880, 2.37, 0.151, 220, 212, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4388, d5trgU_, 0.7879, 2.09, 0.153, 216, 209, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4389, d3mkaW_, 0.7877, 2.32, 0.152, 221, 211, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4390, d5ts0E_, 0.7875, 2.20, 0.152, 218, 211, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4391, d3h6iQ_, 0.7875, 2.27, 0.152, 218, 211, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR GL1
4392, d3mkaS_, 0.7873, 2.37, 0.151, 219, 212, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4393, d3mkaQ_, 0.7873, 2.42, 0.151, 222, 212, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4394, d3mkaO_, 0.7873, 2.32, 0.156, 218, 211, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4395, d3mi0F_, 0.7873, 2.43, 0.156, 220, 212, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4396, d5ts0C_, 0.7872, 2.16, 0.152, 217, 210, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4397, d5trgE_, 0.7872, 2.21, 0.152, 218, 211, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4398, d5tryU_, 0.7870, 2.10, 0.153, 216, 209, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4399, d5trsD_, 0.7870, 2.22, 0.152, 218, 211, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4400, d5trrT_, 0.7870, 2.15, 0.152, 217, 210, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4401, d5thoO_, 0.7870, 2.22, 0.152, 218, 211, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4402, d5trrP_, 0.7869, 2.30, 0.151, 219, 212, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4403, d5thoE_, 0.7869, 2.21, 0.152, 218, 211, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4404, d5ts0P_, 0.7868, 2.23, 0.152, 218, 211, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4405, d5tryS_, 0.7868, 2.29, 0.151, 219, 212, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4406, d5trsT_, 0.7868, 2.16, 0.152, 217, 210, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4407, d5thoT_, 0.7867, 2.16, 0.152, 217, 210, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4408, d5ts0B_, 0.7866, 2.11, 0.153, 216, 209, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4409, d5tryR_, 0.7863, 2.17, 0.152, 217, 210, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4410, d5trsU_, 0.7863, 2.12, 0.153, 216, 209, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4411, d5trgS_, 0.7863, 2.24, 0.152, 218, 211, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4412, d3mkaK_, 0.7863, 2.44, 0.156, 221, 212, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4413, d3mfeB_, 0.7863, 2.11, 0.153, 216, 209, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT WITH H0 MOVEMENT
4414, d5ts0Q_, 0.7862, 2.23, 0.152, 218, 211, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4415, d5trsO_, 0.7862, 2.17, 0.152, 217, 210, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4416, d5trrU_, 0.7860, 2.11, 0.153, 216, 209, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4417, d3mkaD_, 0.7860, 2.44, 0.156, 222, 212, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4418, d5tryD_, 0.7858, 2.18, 0.152, 217, 210, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4419, d5trrS_, 0.7858, 2.23, 0.152, 218, 211, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4420, d5trrO_, 0.7857, 2.18, 0.152, 217, 210, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4421, d5trsG_, 0.7854, 2.13, 0.153, 216, 209, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4422, d3h6iF_, 0.7854, 2.23, 0.157, 217, 210, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR GL1
4423, d5thoC_, 0.7853, 2.19, 0.152, 217, 210, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4424, d5trsE_, 0.7852, 2.18, 0.152, 217, 210, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4425, d5trsB_, 0.7852, 2.13, 0.153, 216, 209, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4426, d5trgT_, 0.7852, 2.19, 0.152, 217, 210, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4427, d3mkaY_, 0.7852, 2.26, 0.152, 224, 211, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4428, d3mfeK_, 0.7852, 2.12, 0.153, 216, 209, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT WITH H0 MOVEMENT
4429, d5trgO_, 0.7851, 2.24, 0.152, 218, 211, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4430, d5ts0D_, 0.7850, 2.19, 0.152, 217, 210, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4431, d5trrG_, 0.7850, 2.14, 0.153, 216, 209, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4432, d5trrC_, 0.7849, 2.19, 0.152, 217, 210, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4433, d5tryE_, 0.7848, 2.19, 0.152, 217, 210, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4434, d5trrE_, 0.7848, 2.18, 0.152, 217, 210, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4435, d5tryC_, 0.7847, 2.12, 0.153, 216, 209, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4436, p5wvkAA_, 0.7846, 2.01, 0.286, 210, 206, 
4437, d5ts0S_, 0.7845, 2.26, 0.152, 218, 211, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4438, d5thoR_, 0.7845, 2.21, 0.152, 217, 210, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4439, d5tryP_, 0.7844, 2.22, 0.152, 217, 210, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4440, p5lzpD_, 0.7844, 2.24, 0.157, 217, 210, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4441, d3h6fQ_, 0.7844, 2.32, 0.157, 217, 210, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR HT1171
4442, d5trsS_, 0.7843, 2.26, 0.152, 218, 211, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4443, d3h6iW_, 0.7843, 2.24, 0.152, 217, 210, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR GL1
4444, d5thoF_, 0.7842, 2.20, 0.152, 217, 210, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4445, d3mka1_, 0.7841, 2.41, 0.152, 219, 211, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4446, d3h6fW_, 0.7841, 2.22, 0.152, 217, 210, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR HT1171
4447, d5tryG_, 0.7840, 2.15, 0.153, 216, 209, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4448, d5trgG_, 0.7840, 2.16, 0.153, 216, 209, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4449, d5thoU_, 0.7840, 2.14, 0.153, 216, 209, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4450, d5ts0R_, 0.7839, 2.21, 0.152, 217, 210, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4451, d5tryT_, 0.7833, 2.15, 0.153, 216, 209, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4452, d3h6fF_, 0.7833, 2.21, 0.158, 216, 209, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR HT1171
4453, d5trrD_, 0.7832, 2.15, 0.153, 216, 209, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4454, d5thoP_, 0.7832, 2.21, 0.152, 217, 210, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4455, d3h6iA_, 0.7832, 2.16, 0.153, 216, 209, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR GL1
4456, d5thoD_, 0.7830, 2.17, 0.153, 216, 209, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4457, d5trsR_, 0.7828, 2.19, 0.153, 216, 209, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4458, d5ts0O_, 0.7825, 2.17, 0.153, 216, 209, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4459, d5tryB_, 0.7824, 2.12, 0.154, 215, 208, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4460, d3krdF_, 0.7823, 2.22, 0.158, 216, 209, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
4461, d3hfaB_, 0.7821, 2.05, 0.155, 214, 207, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4462, d3h6fA_, 0.7821, 2.11, 0.154, 215, 208, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR HT1171
4463, d3h6iK_, 0.7819, 2.33, 0.157, 217, 210, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR GL1
4464, d3h6iI_, 0.7819, 2.11, 0.154, 215, 208, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR GL1
4465, d5trgD_, 0.7818, 2.31, 0.148, 223, 210, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4466, d3mi0U_, 0.7818, 2.27, 0.158, 216, 209, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4467, d3mfeS_, 0.7818, 2.13, 0.149, 215, 208, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT WITH H0 MOVEMENT
4468, d3h6iU_, 0.7815, 2.13, 0.154, 215, 208, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR GL1
4469, d5ts0F_, 0.7814, 2.14, 0.154, 215, 208, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4470, d5trsQ_, 0.7814, 2.19, 0.153, 216, 209, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4471, d5thoQ_, 0.7814, 2.19, 0.153, 216, 209, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4472, d3h6iM_, 0.7814, 2.22, 0.153, 216, 209, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR GL1
4473, d5trsF_, 0.7813, 2.20, 0.153, 216, 209, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4474, d5trgC_, 0.7812, 2.19, 0.153, 216, 209, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4475, d3krdY_, 0.7812, 2.25, 0.158, 216, 209, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
4476, d3h6i1_, 0.7812, 2.12, 0.154, 215, 208, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR GL1
4477, d3h6fO_, 0.7809, 2.19, 0.159, 215, 208, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR HT1171
4478, d3mi0S_, 0.7808, 2.30, 0.158, 216, 209, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4479, d3h6fK_, 0.7808, 2.12, 0.154, 215, 208, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR HT1171
4480, d5trgB_, 0.7807, 2.14, 0.154, 215, 208, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4481, d3h6f1_, 0.7807, 2.13, 0.154, 215, 208, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR HT1171
4482, d3mi0O_, 0.7806, 2.29, 0.158, 216, 209, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4483, d5thoB_, 0.7803, 2.14, 0.154, 215, 208, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4484, d5tryO_, 0.7802, 2.23, 0.153, 216, 209, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4485, d5trrQ_, 0.7802, 2.15, 0.154, 215, 208, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4486, d3krdI_, 0.7802, 2.20, 0.159, 215, 208, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
4487, d3h6iO_, 0.7802, 2.15, 0.154, 215, 208, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR GL1
4488, d5trgQ_, 0.7800, 2.30, 0.152, 217, 210, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4489, d5trrR_, 0.7797, 2.16, 0.154, 215, 208, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4490, d3mi0M_, 0.7796, 2.29, 0.158, 216, 209, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4491, d3mi0K_, 0.7796, 2.31, 0.158, 216, 209, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4492, d5trrB_, 0.7793, 2.16, 0.154, 215, 208, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4493, d3krdW_, 0.7791, 2.16, 0.154, 215, 208, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
4494, d3h6fS_, 0.7790, 2.22, 0.159, 215, 208, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR HT1171
4495, d3h6iS_, 0.7789, 2.16, 0.154, 215, 208, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR GL1
4496, d3mi0Y_, 0.7788, 2.36, 0.158, 216, 209, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4497, d3mfeA_, 0.7788, 2.10, 0.150, 214, 207, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT WITH H0 MOVEMENT
4498, d3hfaA_, 0.7787, 2.11, 0.155, 214, 207, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4499, d5trgR_, 0.7786, 2.17, 0.154, 215, 208, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4500, d3h6fD_, 0.7785, 2.10, 0.155, 214, 207, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR HT1171
4501, d3h6fI_, 0.7784, 2.11, 0.155, 214, 207, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR HT1171
4502, d3mi0W_, 0.7783, 2.40, 0.158, 216, 209, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4503, d3mfeY_, 0.7783, 2.06, 0.150, 213, 206, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT WITH H0 MOVEMENT
4504, d3krdS_, 0.7783, 2.23, 0.154, 215, 208, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
4505, d3hfaW_, 0.7782, 2.12, 0.155, 214, 207, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4506, d3mi0I_, 0.7781, 2.42, 0.158, 216, 209, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4507, d3mi01_, 0.7781, 2.25, 0.159, 215, 208, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4508, d3krdO_, 0.7781, 2.19, 0.155, 214, 207, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
4509, d5trrF_, 0.7780, 2.18, 0.154, 215, 208, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4510, d3krdK_, 0.7780, 2.23, 0.159, 215, 208, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
4511, d5trgF_, 0.7779, 2.18, 0.154, 215, 208, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4512, d3h6iB_, 0.7778, 2.13, 0.155, 214, 207, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR GL1
4513, d3krd1_, 0.7777, 2.24, 0.159, 215, 208, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
4514, d3hfaS_, 0.7777, 2.13, 0.155, 214, 207, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4515, d3hfaQ_, 0.7777, 2.13, 0.155, 214, 207, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4516, p5lzpH_, 0.7776, 2.23, 0.159, 215, 208, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4517, d3hfaO_, 0.7776, 2.13, 0.155, 214, 207, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4518, d3hfa1_, 0.7776, 2.13, 0.155, 214, 207, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4519, d3mkaI_, 0.7774, 2.41, 0.148, 217, 209, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4520, p5ln3F_, 0.7773, 2.17, 0.341, 212, 208, THE HUMAN 26S PROTEASOME AT 6.8 ANG.
4521, d3mi0Q_, 0.7773, 2.31, 0.159, 215, 208, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4522, d3hfaK_, 0.7773, 2.13, 0.155, 214, 207, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4523, d3hfaF_, 0.7773, 2.14, 0.155, 214, 207, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4524, p5lzpJ_, 0.7772, 2.24, 0.154, 215, 208, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4525, d3hfaM_, 0.7772, 2.14, 0.155, 214, 207, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4526, d3h6fM_, 0.7772, 2.22, 0.154, 215, 208, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR HT1171
4527, d3mi0A_, 0.7770, 2.25, 0.159, 215, 208, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4528, d3hfaI_, 0.7770, 2.14, 0.155, 214, 207, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4529, d3hf9I_, 0.7770, 2.00, 0.151, 212, 205, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4530, d3h6iD_, 0.7770, 2.07, 0.155, 213, 206, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR GL1
4531, d3h6fB_, 0.7767, 2.21, 0.159, 214, 207, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR HT1171
4532, p5lzpS_, 0.7766, 2.26, 0.154, 215, 208, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4533, p5lzp2_, 0.7766, 2.25, 0.159, 215, 208, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4534, p5lzp0_, 0.7766, 2.25, 0.159, 215, 208, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4535, d3krdQ_, 0.7766, 2.16, 0.150, 214, 207, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
4536, p5lzpY_, 0.7764, 2.25, 0.159, 215, 208, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4537, d3mi0D_, 0.7764, 2.21, 0.159, 214, 207, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4538, d3hfaY_, 0.7764, 2.16, 0.155, 214, 207, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4539, p5lzp4_, 0.7763, 2.25, 0.159, 215, 208, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4540, p5lzpW_, 0.7762, 2.25, 0.159, 215, 208, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4541, p5lzp8_, 0.7762, 2.25, 0.159, 215, 208, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4542, p5lzp6_, 0.7762, 2.25, 0.159, 215, 208, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4543, d3hfaU_, 0.7761, 2.16, 0.155, 214, 207, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4544, d3hfaD_, 0.7761, 2.10, 0.155, 213, 206, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4545, d3krdA_, 0.7760, 2.22, 0.155, 214, 207, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
4546, p5lzpQ_, 0.7754, 2.21, 0.159, 214, 207, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4547, d3h6fU_, 0.7754, 2.22, 0.159, 214, 207, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR HT1171
4548, p5lzpB_, 0.7753, 2.22, 0.159, 214, 207, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4549, p5lzpM_, 0.7749, 2.23, 0.159, 214, 207, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4550, d3h6fY_, 0.7747, 2.11, 0.155, 213, 206, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR HT1171
4551, d3krdB_, 0.7746, 2.16, 0.155, 213, 206, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
4552, d3krdM_, 0.7742, 2.23, 0.155, 214, 207, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
4553, d3mfeO_, 0.7741, 2.18, 0.150, 214, 207, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT WITH H0 MOVEMENT
4554, d3krdU_, 0.7740, 2.25, 0.155, 214, 207, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
4555, p3hf9b_, 0.7737, 2.01, 0.152, 211, 204, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4556, p3hf9y_, 0.7736, 2.00, 0.152, 211, 204, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4557, p3hf9s_, 0.7736, 2.02, 0.152, 211, 204, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4558, p3hf9f_, 0.7735, 2.02, 0.152, 211, 204, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4559, d3krdD_, 0.7734, 2.20, 0.155, 213, 206, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
4560, d3hf9A_, 0.7733, 2.00, 0.152, 211, 204, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4561, d3mfe1_, 0.7730, 2.13, 0.150, 213, 206, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT WITH H0 MOVEMENT
4562, d3h6iY_, 0.7729, 2.15, 0.155, 213, 206, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME MODIFIED BY INHIBITOR GL1
4563, d3mi0B_, 0.7725, 2.27, 0.155, 213, 206, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4564, d3hf9K_, 0.7725, 2.04, 0.152, 211, 204, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4565, d3mfeQ_, 0.7724, 2.15, 0.150, 213, 206, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT WITH H0 MOVEMENT
4566, d3mfeD_, 0.7724, 2.15, 0.150, 213, 206, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT WITH H0 MOVEMENT
4567, p3hf9i_, 0.7723, 2.02, 0.152, 211, 204, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4568, d3hf9U_, 0.7722, 2.03, 0.152, 211, 204, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4569, d3hf9B_, 0.7721, 2.02, 0.152, 211, 204, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4570, d3hf9Q_, 0.7718, 2.04, 0.152, 211, 204, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4571, p6bgoI_, 0.7714, 2.18, 0.155, 215, 207, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4572, p6bgoH_, 0.7714, 2.18, 0.155, 215, 207, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4573, p6bgoG_, 0.7714, 2.18, 0.155, 215, 207, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4574, p6bgoF_, 0.7714, 2.18, 0.155, 215, 207, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4575, p6bgoE_, 0.7714, 2.18, 0.155, 215, 207, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4576, p6bglO_, 0.7714, 2.18, 0.155, 215, 207, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4577, p6bglN_, 0.7714, 2.18, 0.155, 215, 207, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4578, p6bglM_, 0.7714, 2.18, 0.155, 215, 207, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4579, p6bglL_, 0.7714, 2.18, 0.155, 215, 207, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4580, p6bglK_, 0.7714, 2.18, 0.155, 215, 207, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4581, p6bglJ_, 0.7714, 2.18, 0.155, 215, 207, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4582, p6bglI_, 0.7714, 2.18, 0.155, 215, 207, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4583, p6bglH_, 0.7714, 2.18, 0.155, 215, 207, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4584, p6bglG_, 0.7714, 2.18, 0.155, 215, 207, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4585, p6bglF_, 0.7714, 2.18, 0.155, 215, 207, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4586, p6bglE_, 0.7714, 2.18, 0.155, 215, 207, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4587, p6bglA_, 0.7714, 2.18, 0.155, 215, 207, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4588, p6bgoD_, 0.7713, 2.18, 0.155, 215, 207, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4589, p6bgoC_, 0.7713, 2.18, 0.155, 215, 207, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4590, p6bglD_, 0.7713, 2.18, 0.155, 215, 207, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4591, p6bglC_, 0.7713, 2.18, 0.155, 215, 207, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4592, p3hf9u_, 0.7713, 2.04, 0.152, 211, 204, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4593, p3hf9k_, 0.7713, 2.04, 0.152, 211, 204, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4594, p3hf9d_, 0.7713, 2.03, 0.152, 211, 204, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4595, d3hf9O_, 0.7711, 2.03, 0.152, 211, 204, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4596, p3hf9a_, 0.7711, 2.04, 0.152, 211, 204, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4597, d3hf91_, 0.7706, 2.04, 0.152, 211, 204, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4598, d3hf9Y_, 0.7702, 1.99, 0.153, 210, 203, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4599, p3hf9o_, 0.7698, 2.05, 0.152, 211, 204, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4600, d3hf9S_, 0.7696, 2.07, 0.152, 211, 204, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4601, p3hf9q_, 0.7694, 2.06, 0.152, 211, 204, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4602, d3mfeU_, 0.7693, 2.14, 0.151, 212, 205, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT WITH H0 MOVEMENT
4603, d3hf93_, 0.7693, 2.00, 0.153, 210, 203, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4604, p3hf9w_, 0.7686, 2.07, 0.152, 211, 204, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4605, d3hf9D_, 0.7653, 2.11, 0.153, 210, 203, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4606, p3hf9m_, 0.7639, 1.98, 0.154, 208, 201, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4607, d3mfeW_, 0.7637, 2.01, 0.153, 209, 202, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT WITH H0 MOVEMENT
4608, p2fhgF_, 0.7572, 2.10, 0.153, 209, 202, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
4609, p2fhgY_, 0.7571, 2.10, 0.153, 209, 202, CRYSTAL STRUCTURE OF MYCOBACTERIAL TUBERCULOSIS PROTEASOME
4610, p5a0qO_, 0.7563, 1.31, 0.323, 195, 189, CRYO-EM REVEALS THE CONFORMATION OF A SUBSTRATE ANALOGUE IN THE HUMAN 20S PROTEASOME CORE
4611, p5a0qA_, 0.7563, 1.31, 0.323, 195, 189, CRYO-EM REVEALS THE CONFORMATION OF A SUBSTRATE ANALOGUE IN THE HUMAN 20S PROTEASOME CORE
4612, d3hf9M_, 0.7558, 1.87, 0.157, 205, 198, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT MODIFIED BY INHIBITOR GL1
4613, p5a0qT_, 0.7540, 1.79, 0.373, 195, 193, CRYO-EM REVEALS THE CONFORMATION OF A SUBSTRATE ANALOGUE IN THE HUMAN 20S PROTEASOME CORE
4614, p5a0qF_, 0.7539, 1.79, 0.373, 195, 193, CRYO-EM REVEALS THE CONFORMATION OF A SUBSTRATE ANALOGUE IN THE HUMAN 20S PROTEASOME CORE
4615, p6bgoJ_, 0.7522, 2.04, 0.160, 207, 200, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4616, p6bgoA_, 0.7522, 2.04, 0.160, 207, 200, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4617, p6bgoN_, 0.7521, 2.04, 0.160, 207, 200, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4618, p6bgoM_, 0.7521, 2.04, 0.160, 207, 200, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4619, p6bgoL_, 0.7521, 2.04, 0.160, 207, 200, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4620, p6bgoK_, 0.7521, 2.04, 0.160, 207, 200, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4621, p6bgoO_, 0.7486, 2.03, 0.161, 206, 199, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4622, p6bdfZ_, 0.7314, 2.29, 0.233, 201, 193, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
4623, p6bdfX_, 0.7314, 2.29, 0.233, 201, 193, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
4624, p6bdfV_, 0.7314, 2.29, 0.233, 201, 193, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
4625, p6bdfT_, 0.7314, 2.29, 0.233, 201, 193, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
4626, p6bdfR_, 0.7314, 2.29, 0.233, 201, 193, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
4627, p6bdfP_, 0.7314, 2.29, 0.233, 201, 193, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
4628, p6bdfN_, 0.7314, 2.29, 0.233, 201, 193, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
4629, p6bdfL_, 0.7314, 2.29, 0.233, 201, 193, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
4630, p6bdfJ_, 0.7314, 2.29, 0.233, 201, 193, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
4631, p6bdfH_, 0.7314, 2.29, 0.233, 201, 193, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
4632, p6bdfF_, 0.7314, 2.29, 0.233, 201, 193, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
4633, p6bdfD_, 0.7314, 2.29, 0.233, 201, 193, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
4634, p6bdfB_, 0.7314, 2.29, 0.233, 201, 193, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
4635, p6bdf1_, 0.7314, 2.29, 0.233, 201, 193, 2.8 A RESOLUTION RECONSTRUCTION OF THE THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING CRYO-ELECTRON MICROSCOPY
4636, d3mkaV_, 0.7308, 2.70, 0.163, 249, 203, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4637, d3mkaL_, 0.7304, 2.70, 0.163, 251, 203, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4638, d5ts0K_, 0.7303, 2.37, 0.166, 223, 199, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4639, d5trsV_, 0.7302, 2.38, 0.166, 223, 199, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4640, d3hfaV_, 0.7300, 2.38, 0.166, 226, 199, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4641, d5ts0V_, 0.7299, 2.38, 0.166, 223, 199, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4642, d5trgV_, 0.7299, 2.38, 0.166, 223, 199, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4643, d3mkaJ_, 0.7299, 3.17, 0.159, 252, 208, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4644, d5trsK_, 0.7298, 2.38, 0.166, 223, 199, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4645, d5trrV_, 0.7297, 2.38, 0.166, 223, 199, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4646, d5trgK_, 0.7297, 2.38, 0.166, 223, 199, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4647, d3mkaT_, 0.7296, 3.18, 0.163, 250, 208, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4648, d3mkaN_, 0.7296, 3.17, 0.168, 252, 208, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4649, p3h4pf_, 0.7296, 2.16, 0.203, 202, 192, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
4650, d5tryV_, 0.7295, 2.39, 0.166, 223, 199, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4651, d3mkaP_, 0.7295, 2.66, 0.163, 250, 202, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4652, d5trgL_, 0.7293, 2.38, 0.166, 223, 199, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4653, d3hfaZ_, 0.7293, 2.40, 0.166, 224, 199, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4654, p3h4pc_, 0.7293, 2.15, 0.203, 202, 192, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
4655, d5trsL_, 0.7292, 2.38, 0.166, 223, 199, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4656, d5thoL_, 0.7292, 2.38, 0.166, 223, 199, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4657, d3h4pn_, 0.7292, 2.14, 0.203, 202, 192, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
4658, p5vy3Z_, 0.7290, 2.33, 0.223, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
4659, p5vy3X_, 0.7290, 2.33, 0.223, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
4660, p5vy3V_, 0.7290, 2.33, 0.223, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
4661, p5vy3T_, 0.7290, 2.33, 0.223, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
4662, p5vy3R_, 0.7290, 2.33, 0.223, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
4663, p5vy3P_, 0.7290, 2.33, 0.223, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
4664, p5vy3N_, 0.7290, 2.33, 0.223, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
4665, p5vy3L_, 0.7290, 2.33, 0.223, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
4666, p5vy3J_, 0.7290, 2.33, 0.223, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
4667, p5vy3H_, 0.7290, 2.33, 0.223, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
4668, p5vy3F_, 0.7290, 2.33, 0.223, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
4669, p5vy3D_, 0.7290, 2.33, 0.223, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
4670, p5vy3B_, 0.7290, 2.33, 0.223, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
4671, p5vy31_, 0.7290, 2.33, 0.223, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH STAGE POSITION
4672, p3j9iZ_, 0.7290, 2.36, 0.223, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
4673, p3j9iY_, 0.7290, 2.36, 0.223, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
4674, p3j9iX_, 0.7290, 2.36, 0.223, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
4675, p3j9iW_, 0.7290, 2.36, 0.223, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
4676, p3j9iV_, 0.7290, 2.36, 0.223, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
4677, p3j9iN_, 0.7290, 2.36, 0.223, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
4678, p3j9iM_, 0.7290, 2.36, 0.223, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
4679, p3j9iL_, 0.7290, 2.36, 0.223, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
4680, p3j9iK_, 0.7290, 2.36, 0.223, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
4681, p3j9iJ_, 0.7290, 2.36, 0.223, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
4682, p3j9iI_, 0.7290, 2.36, 0.223, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
4683, p3j9iH_, 0.7290, 2.36, 0.223, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
4684, p3j9i2_, 0.7290, 2.36, 0.223, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
4685, p3j9i1_, 0.7290, 2.36, 0.223, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME
4686, d3hfaX_, 0.7290, 2.42, 0.166, 224, 199, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4687, d3h4pm_, 0.7290, 2.15, 0.203, 202, 192, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
4688, d3h4pi_, 0.7290, 2.14, 0.203, 202, 192, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
4689, p3h4pe_, 0.7290, 2.16, 0.203, 202, 192, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
4690, p3h4pd_, 0.7290, 2.16, 0.203, 202, 192, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
4691, d5thoV_, 0.7289, 2.39, 0.166, 223, 199, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4692, p5tryb_, 0.7288, 2.40, 0.166, 223, 199, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4693, d5trrL_, 0.7288, 2.38, 0.166, 223, 199, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4694, d3mkaE_, 0.7287, 2.71, 0.163, 248, 203, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4695, d3hfaT_, 0.7287, 2.40, 0.166, 223, 199, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4696, d3h4pl_, 0.7287, 2.16, 0.203, 202, 192, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
4697, d5trsY_, 0.7286, 2.41, 0.166, 223, 199, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4698, d3hfaE_, 0.7286, 2.42, 0.166, 223, 199, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4699, d3h4ph_, 0.7286, 2.16, 0.203, 202, 192, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
4700, p3h4pa_, 0.7286, 2.16, 0.203, 202, 192, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
4701, d5tryK_, 0.7285, 2.40, 0.166, 223, 199, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4702, d3mi0V1, 0.7285, 2.38, 0.166, 234, 199, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4703, p5ts0b_, 0.7284, 2.40, 0.166, 223, 199, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4704, p5trsb_, 0.7284, 2.41, 0.166, 223, 199, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4705, p5trrb_, 0.7284, 2.41, 0.166, 223, 199, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4706, d3h4pk_, 0.7284, 2.15, 0.203, 202, 192, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
4707, p3h4pb_, 0.7284, 2.16, 0.203, 202, 192, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
4708, d3hfaH_, 0.7283, 2.41, 0.166, 223, 199, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4709, p3h4pg_, 0.7283, 2.16, 0.203, 202, 192, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
4710, p5vy4Z_, 0.7282, 2.33, 0.223, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
4711, p5vy4X_, 0.7282, 2.33, 0.223, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
4712, p5vy4V_, 0.7282, 2.33, 0.223, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
4713, p5vy4T_, 0.7282, 2.33, 0.223, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
4714, p5vy4R_, 0.7282, 2.33, 0.223, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
4715, p5vy4P_, 0.7282, 2.33, 0.223, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
4716, p5vy4N_, 0.7282, 2.33, 0.223, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
4717, p5vy4L_, 0.7282, 2.33, 0.223, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
4718, p5vy4J_, 0.7282, 2.33, 0.223, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
4719, p5vy4H_, 0.7282, 2.33, 0.223, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
4720, p5vy4F_, 0.7282, 2.33, 0.223, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
4721, p5vy4D_, 0.7282, 2.33, 0.223, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
4722, p5vy4BA_, 0.7282, 2.33, 0.223, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
4723, p5vy4B_, 0.7282, 2.33, 0.223, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
4724, p5vy41_, 0.7282, 2.33, 0.223, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME USING 200KEV WITH IMAGE SHIFT
4725, d3mi0R1, 0.7282, 2.39, 0.166, 234, 199, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4726, d5trgY_, 0.7281, 2.40, 0.166, 223, 199, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4727, d5ts0W_, 0.7280, 2.40, 0.166, 223, 199, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4728, d2h6jN1, 0.7280, 2.68, 0.175, 225, 200, CRYSTAL STRUCTURE OF THE BETA F145A RHODOCOCCUS PROTEASOME (CASP TARGET)
4729, p5lzpI_, 0.7279, 2.40, 0.161, 223, 199, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4730, d3mkaG_, 0.7279, 3.23, 0.163, 251, 208, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4731, d2h6jM1, 0.7279, 2.68, 0.175, 225, 200, CRYSTAL STRUCTURE OF THE BETA F145A RHODOCOCCUS PROTEASOME (CASP TARGET)
4732, d2h6jK1, 0.7279, 2.68, 0.175, 225, 200, CRYSTAL STRUCTURE OF THE BETA F145A RHODOCOCCUS PROTEASOME (CASP TARGET)
4733, d5trrY_, 0.7278, 2.40, 0.166, 223, 199, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4734, d5trrK_, 0.7278, 2.41, 0.166, 223, 199, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4735, d3mkaH_, 0.7278, 2.68, 0.163, 249, 202, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4736, d5tryY_, 0.7277, 2.41, 0.166, 223, 199, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4737, d5tryL_, 0.7277, 2.40, 0.166, 223, 199, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4738, d3hfaN_, 0.7277, 2.45, 0.166, 223, 199, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4739, d3h4pj_, 0.7277, 2.17, 0.203, 202, 192, PROTEASOME 20S CORE PARTICLE FROM METHANOCALDOCOCCUS JANNASCHII
4740, d5ts0L_, 0.7276, 2.41, 0.166, 223, 199, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4741, p5trsa_, 0.7275, 2.42, 0.166, 223, 199, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4742, d3c92X1, 0.7275, 2.35, 0.223, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
4743, d3c92J1, 0.7275, 2.35, 0.223, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
4744, d3c91X1, 0.7275, 2.35, 0.223, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4745, d3c91J1, 0.7275, 2.35, 0.223, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4746, d1pmaQ_, 0.7275, 2.35, 0.223, 203, 193, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
4747, d5thoK_, 0.7274, 2.41, 0.166, 223, 199, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4748, p5thob_, 0.7274, 2.42, 0.166, 223, 199, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4749, p5lzpR_, 0.7274, 2.41, 0.161, 223, 199, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4750, d3mkaC_, 0.7274, 2.67, 0.163, 250, 202, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4751, d2h6jJ1, 0.7274, 2.70, 0.185, 225, 200, CRYSTAL STRUCTURE OF THE BETA F145A RHODOCOCCUS PROTEASOME (CASP TARGET)
4752, d3c92N1, 0.7273, 2.35, 0.223, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
4753, d3c9221, 0.7273, 2.35, 0.223, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
4754, d3c91N1, 0.7273, 2.35, 0.223, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4755, d3c9121, 0.7273, 2.35, 0.223, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4756, d2h6jH1, 0.7273, 2.69, 0.175, 225, 200, CRYSTAL STRUCTURE OF THE BETA F145A RHODOCOCCUS PROTEASOME (CASP TARGET)
4757, d1pmaU_, 0.7273, 2.35, 0.223, 203, 193, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
4758, p5trra_, 0.7272, 2.42, 0.166, 223, 199, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4759, d5trgI_, 0.7272, 2.35, 0.167, 222, 198, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4760, p5lzpT_, 0.7272, 2.41, 0.161, 223, 199, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4761, d3mi0X_, 0.7272, 2.41, 0.166, 223, 199, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4762, d3mi0L_, 0.7272, 2.41, 0.166, 223, 199, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4763, d2h6jL1, 0.7272, 2.70, 0.185, 225, 200, CRYSTAL STRUCTURE OF THE BETA F145A RHODOCOCCUS PROTEASOME (CASP TARGET)
4764, d1pmaX_, 0.7272, 2.36, 0.223, 203, 193, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
4765, d1pmaV_, 0.7272, 2.35, 0.223, 203, 193, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
4766, d5trrW_, 0.7271, 2.41, 0.166, 223, 199, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4767, d5thoW_, 0.7271, 2.41, 0.166, 223, 199, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4768, d3c92M1, 0.7271, 2.35, 0.223, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
4769, d3c9211, 0.7271, 2.35, 0.223, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
4770, d3c91M1, 0.7271, 2.35, 0.223, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4771, d3c9111, 0.7271, 2.35, 0.223, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4772, d1pmaY_, 0.7271, 2.35, 0.223, 203, 193, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
4773, d1pmaT_, 0.7271, 2.35, 0.223, 203, 193, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
4774, p5ts0a_, 0.7270, 2.44, 0.166, 223, 199, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4775, d5trsW_, 0.7270, 2.42, 0.166, 223, 199, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4776, p5trga_, 0.7270, 2.42, 0.166, 223, 199, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4777, d3hfaG_, 0.7270, 2.37, 0.167, 222, 198, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4778, d2h6jI1, 0.7270, 2.70, 0.175, 225, 200, CRYSTAL STRUCTURE OF THE BETA F145A RHODOCOCCUS PROTEASOME (CASP TARGET)
4779, d1pmaZ_, 0.7270, 2.36, 0.223, 203, 193, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
4780, p5trya_, 0.7269, 2.43, 0.166, 223, 199, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4781, d3mi0Z_, 0.7269, 2.42, 0.166, 223, 199, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4782, d3c92W1, 0.7269, 2.36, 0.223, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
4783, d3c92I1, 0.7269, 2.36, 0.223, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
4784, d3c91W1, 0.7269, 2.36, 0.223, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4785, d3c91I1, 0.7269, 2.36, 0.223, 203, 193, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4786, d1pmaP_, 0.7269, 2.36, 0.223, 203, 193, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
4787, d5thoY_, 0.7268, 2.42, 0.166, 223, 199, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4788, p5lzpU_, 0.7268, 2.43, 0.161, 223, 199, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4789, p5lzpO_, 0.7268, 2.43, 0.161, 223, 199, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4790, d3hfaR_, 0.7268, 2.37, 0.167, 222, 198, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4791, d5ts0Z_, 0.7267, 2.37, 0.167, 222, 198, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4792, d1yauI_, 0.7267, 2.36, 0.233, 203, 193, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME- PA26 COMPLEX
4793, d1pmaW_, 0.7267, 2.36, 0.223, 203, 193, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
4794, d5ts0Y_, 0.7266, 2.42, 0.166, 223, 199, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4795, p5lzpC_, 0.7266, 2.43, 0.161, 223, 199, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4796, d3mi0N_, 0.7266, 2.37, 0.167, 222, 198, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4797, d3mi02_, 0.7266, 2.42, 0.166, 223, 199, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4798, d3hfaL_, 0.7266, 2.37, 0.167, 222, 198, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4799, d3hfa2_, 0.7266, 2.37, 0.167, 222, 198, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4800, d1yauH_, 0.7266, 2.23, 0.234, 203, 192, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME- PA26 COMPLEX
4801, d5trsN_, 0.7265, 2.42, 0.166, 223, 199, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4802, p5thoa_, 0.7265, 2.43, 0.166, 223, 199, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4803, d3mka2_, 0.7265, 2.70, 0.163, 246, 202, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4804, d3hfaC_, 0.7265, 2.38, 0.167, 222, 198, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4805, d5trsI_, 0.7264, 2.37, 0.167, 222, 198, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4806, p5lzpK_, 0.7264, 2.37, 0.162, 222, 198, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4807, d3hfaP_, 0.7264, 2.38, 0.167, 222, 198, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4808, d1yarK_, 0.7264, 2.36, 0.233, 203, 193, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME MUTANT D9S- PA26 COMPLEX
4809, d5fgeY_, 0.7263, 2.94, 0.178, 218, 202, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
4810, d3hfaJ_, 0.7263, 2.38, 0.167, 222, 198, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT
4811, d1yarL_, 0.7263, 2.37, 0.233, 203, 193, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME MUTANT D9S- PA26 COMPLEX
4812, d1ya7I_, 0.7263, 2.37, 0.233, 203, 193, IMPLICATIONS FOR INTERACTIONS OF PROTEASOME WITH PAN AND PA700 FROM THE 1.9 A STRUCTURE OF A PROTEASOME-11S ACTIVATOR COMPLEX
4813, p5trgb_, 0.7262, 2.44, 0.166, 223, 199, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4814, d5fgdY_, 0.7262, 2.97, 0.183, 216, 202, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
4815, d3krdV_, 0.7262, 2.42, 0.166, 229, 199, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
4816, d5trrI_, 0.7261, 2.37, 0.167, 222, 198, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4817, d5trgX_, 0.7261, 2.37, 0.167, 222, 198, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4818, d5fgeK_, 0.7261, 2.95, 0.178, 218, 202, YEAST 20S PROTEASOME BETA5-H(-2)T-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
4819, d3mi0T_, 0.7261, 2.43, 0.166, 223, 199, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4820, d3krdR_, 0.7261, 2.43, 0.166, 229, 199, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
4821, d1yauK_, 0.7261, 2.37, 0.233, 203, 193, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME- PA26 COMPLEX
4822, d5ts0I_, 0.7260, 2.38, 0.167, 222, 198, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4823, d5trrZ_, 0.7260, 2.37, 0.167, 222, 198, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4824, d5trgN_, 0.7260, 2.43, 0.166, 223, 199, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4825, d3mi0J_, 0.7260, 2.37, 0.167, 222, 198, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4826, d1ya7N_, 0.7260, 2.38, 0.233, 203, 193, IMPLICATIONS FOR INTERACTIONS OF PROTEASOME WITH PAN AND PA700 FROM THE 1.9 A STRUCTURE OF A PROTEASOME-11S ACTIVATOR COMPLEX
4827, d1ya7K_, 0.7260, 2.37, 0.233, 203, 193, IMPLICATIONS FOR INTERACTIONS OF PROTEASOME WITH PAN AND PA700 FROM THE 1.9 A STRUCTURE OF A PROTEASOME-11S ACTIVATOR COMPLEX
4828, d1ya7H_, 0.7260, 2.24, 0.234, 203, 192, IMPLICATIONS FOR INTERACTIONS OF PROTEASOME WITH PAN AND PA700 FROM THE 1.9 A STRUCTURE OF A PROTEASOME-11S ACTIVATOR COMPLEX
4829, d5trgW_, 0.7259, 2.43, 0.166, 223, 199, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4830, d1yarH_, 0.7259, 2.24, 0.234, 203, 192, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME MUTANT D9S- PA26 COMPLEX
4831, d1pma2_, 0.7259, 2.23, 0.224, 203, 192, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
4832, d5tryZ_, 0.7258, 2.37, 0.167, 222, 198, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4833, d5trsH_, 0.7258, 2.38, 0.167, 222, 198, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4834, d5thoM_, 0.7258, 2.46, 0.166, 223, 199, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4835, d5thoI_, 0.7258, 2.38, 0.167, 222, 198, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4836, p5lzpG_, 0.7258, 2.39, 0.162, 222, 198, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4837, d3jrmH_, 0.7258, 2.24, 0.234, 203, 192, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4838, d1pma1_, 0.7258, 2.24, 0.224, 203, 192, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
4839, d5ts0H_, 0.7257, 2.38, 0.167, 222, 198, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4840, d5tryI_, 0.7257, 2.38, 0.167, 222, 198, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4841, d3mkaR_, 0.7257, 2.80, 0.163, 246, 203, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4842, d3c92Z1, 0.7257, 2.24, 0.224, 203, 192, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
4843, d3c92V1, 0.7257, 2.24, 0.224, 203, 192, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
4844, d3c92L1, 0.7257, 2.24, 0.224, 203, 192, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
4845, d3c92H1, 0.7257, 2.24, 0.224, 203, 192, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
4846, d3c91Z1, 0.7257, 2.24, 0.224, 203, 192, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4847, d3c91V1, 0.7257, 2.24, 0.224, 203, 192, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4848, d3c91L1, 0.7257, 2.24, 0.224, 203, 192, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4849, d3c91H1, 0.7257, 2.24, 0.224, 203, 192, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4850, d1yauM_, 0.7257, 2.37, 0.233, 203, 193, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME- PA26 COMPLEX
4851, d1q5rN_, 0.7257, 2.57, 0.166, 251, 199, THE RHODOCOCCUS 20S PROTEASOME WITH UNPROCESSED PRO-PEPTIDES
4852, d1q5rM_, 0.7257, 2.58, 0.166, 251, 199, THE RHODOCOCCUS 20S PROTEASOME WITH UNPROCESSED PRO-PEPTIDES
4853, d1q5rL_, 0.7257, 2.58, 0.166, 251, 199, THE RHODOCOCCUS 20S PROTEASOME WITH UNPROCESSED PRO-PEPTIDES
4854, d1q5rK_, 0.7257, 2.58, 0.166, 251, 199, THE RHODOCOCCUS 20S PROTEASOME WITH UNPROCESSED PRO-PEPTIDES
4855, d1q5rJ_, 0.7257, 2.57, 0.166, 251, 199, THE RHODOCOCCUS 20S PROTEASOME WITH UNPROCESSED PRO-PEPTIDES
4856, d1pmaS_, 0.7257, 2.24, 0.224, 203, 192, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
4857, d1pmaB_, 0.7257, 2.24, 0.224, 203, 192, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
4858, d5ts0N_, 0.7256, 2.44, 0.166, 223, 199, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4859, d5tryW_, 0.7256, 2.43, 0.166, 223, 199, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4860, p5lzpE_, 0.7256, 2.38, 0.162, 222, 198, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4861, d3jrmM_, 0.7256, 2.25, 0.234, 203, 192, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4862, d3jrmK_, 0.7256, 2.25, 0.234, 203, 192, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4863, d3jrmJ_, 0.7256, 2.25, 0.234, 203, 192, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4864, d3jrmI_, 0.7256, 2.25, 0.234, 203, 192, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4865, d3c92Y1, 0.7256, 2.24, 0.224, 203, 192, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
4866, d3c92K1, 0.7256, 2.24, 0.224, 203, 192, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH A CLOSED GATE
4867, d3c91Y1, 0.7256, 2.24, 0.224, 203, 192, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4868, d3c91K1, 0.7256, 2.24, 0.224, 203, 192, THERMOPLASMA ACIDOPHILUM 20S PROTEASOME WITH AN OPEN GATE
4869, d1ya7L_, 0.7256, 2.37, 0.233, 203, 193, IMPLICATIONS FOR INTERACTIONS OF PROTEASOME WITH PAN AND PA700 FROM THE 1.9 A STRUCTURE OF A PROTEASOME-11S ACTIVATOR COMPLEX
4870, d1q5rI_, 0.7256, 2.58, 0.166, 251, 199, THE RHODOCOCCUS 20S PROTEASOME WITH UNPROCESSED PRO-PEPTIDES
4871, d1q5rH_, 0.7256, 2.58, 0.166, 251, 199, THE RHODOCOCCUS 20S PROTEASOME WITH UNPROCESSED PRO-PEPTIDES
4872, d1pmaR_, 0.7256, 2.24, 0.224, 203, 192, PROTEASOME FROM THERMOPLASMA ACIDOPHILUM
4873, d5trsZ_, 0.7255, 2.38, 0.167, 222, 198, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4874, d3jrmN_, 0.7255, 2.25, 0.234, 203, 192, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4875, d3jrmL_, 0.7255, 2.25, 0.234, 203, 192, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4876, d5trrN_, 0.7254, 2.44, 0.166, 223, 199, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4877, d5trgH_, 0.7254, 2.38, 0.167, 222, 198, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4878, d1yauJ_, 0.7254, 2.25, 0.234, 203, 192, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME- PA26 COMPLEX
4879, d1yarJ_, 0.7254, 2.24, 0.234, 203, 192, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME MUTANT D9S- PA26 COMPLEX
4880, d1yarI_, 0.7254, 2.25, 0.234, 203, 192, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME MUTANT D9S- PA26 COMPLEX
4881, d5trrM_, 0.7253, 2.39, 0.167, 222, 198, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4882, d5cz7Y_, 0.7253, 3.02, 0.183, 217, 202, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
4883, d1yarM_, 0.7253, 2.37, 0.233, 203, 193, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME MUTANT D9S- PA26 COMPLEX
4884, p5lzpA_, 0.7252, 2.40, 0.162, 222, 198, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4885, d5cz7K_, 0.7252, 3.03, 0.183, 217, 202, YEAST 20S PROTEASOME BETA5-T1A BETA5-K81R DOUBLE MUTANT IN COMPLEX WITH BORTEZOMIB PROPEPTIDE EXPRESSED IN CIS
4886, d3mi0E_, 0.7252, 2.45, 0.166, 223, 199, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4887, d3mi0C_, 0.7252, 2.39, 0.167, 222, 198, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4888, d3jseH_, 0.7252, 2.24, 0.234, 203, 192, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4889, d1yauN_, 0.7252, 2.26, 0.234, 203, 192, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME- PA26 COMPLEX
4890, d3mi0G_, 0.7251, 2.39, 0.167, 222, 198, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4891, d3jseM_, 0.7251, 2.24, 0.234, 203, 192, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4892, d3jseK_, 0.7251, 2.24, 0.234, 203, 192, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4893, d1yauL_, 0.7251, 2.25, 0.234, 203, 192, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME- PA26 COMPLEX
4894, d1ya7M_, 0.7251, 2.37, 0.233, 203, 193, IMPLICATIONS FOR INTERACTIONS OF PROTEASOME WITH PAN AND PA700 FROM THE 1.9 A STRUCTURE OF A PROTEASOME-11S ACTIVATOR COMPLEX
4895, d5tryH_, 0.7250, 2.39, 0.167, 222, 198, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4896, d5trrH_, 0.7250, 2.39, 0.167, 222, 198, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4897, d5thoZ_, 0.7250, 2.39, 0.167, 222, 198, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4898, d3jseL_, 0.7250, 2.24, 0.234, 203, 192, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4899, d3jseJ_, 0.7250, 2.24, 0.234, 203, 192, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4900, p5lzpF_, 0.7249, 2.40, 0.162, 222, 198, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4901, d3mi0H_, 0.7249, 2.39, 0.167, 222, 198, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4902, d3jseN_, 0.7249, 2.25, 0.234, 203, 192, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4903, d3jseI_, 0.7249, 2.25, 0.234, 203, 192, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4904, d1yarN_, 0.7249, 2.26, 0.234, 203, 192, STRUCTURE OF ARCHEABACTERIAL 20S PROTEASOME MUTANT D9S- PA26 COMPLEX
4905, d1ya7J_, 0.7249, 2.25, 0.234, 203, 192, IMPLICATIONS FOR INTERACTIONS OF PROTEASOME WITH PAN AND PA700 FROM THE 1.9 A STRUCTURE OF A PROTEASOME-11S ACTIVATOR COMPLEX
4906, d5ts0M_, 0.7247, 2.40, 0.167, 222, 198, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4907, d5tryN_, 0.7247, 2.45, 0.166, 223, 199, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4908, d5thoH_, 0.7247, 2.39, 0.167, 222, 198, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4909, d5fgdK_, 0.7247, 2.90, 0.184, 215, 201, YEAST 20S PROTEASOME BETA5-H(-2)L-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
4910, p6bgoX_, 0.7246, 2.41, 0.167, 222, 198, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4911, p6bgoW_, 0.7246, 2.41, 0.167, 222, 198, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4912, p6bgoV_, 0.7246, 2.41, 0.167, 222, 198, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4913, p6bgoU_, 0.7246, 2.41, 0.167, 222, 198, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4914, p6bgoT_, 0.7246, 2.41, 0.167, 222, 198, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4915, p6bgoS_, 0.7246, 2.41, 0.167, 222, 198, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4916, p6bgoR_, 0.7246, 2.41, 0.167, 222, 198, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4917, p6bgoQ_, 0.7246, 2.41, 0.167, 222, 198, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4918, p6bgoP_, 0.7246, 2.41, 0.167, 222, 198, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4919, p6bgoc_, 0.7246, 2.41, 0.167, 222, 198, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4920, p6bglZ_, 0.7246, 2.41, 0.167, 222, 198, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4921, p6bglY_, 0.7246, 2.41, 0.167, 222, 198, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4922, p6bglX_, 0.7246, 2.41, 0.167, 222, 198, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4923, p6bglW_, 0.7246, 2.41, 0.167, 222, 198, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4924, p6bglV_, 0.7246, 2.41, 0.167, 222, 198, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4925, p6bglU_, 0.7246, 2.41, 0.167, 222, 198, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4926, p6bglT_, 0.7246, 2.41, 0.167, 222, 198, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4927, p6bglS_, 0.7246, 2.41, 0.167, 222, 198, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4928, p6bglQ_, 0.7246, 2.41, 0.167, 222, 198, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4929, p6bglP_, 0.7246, 2.41, 0.167, 222, 198, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4930, p6bglc_, 0.7246, 2.41, 0.167, 222, 198, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4931, p6bgla_, 0.7246, 2.41, 0.167, 222, 198, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4932, p6bgoZ_, 0.7245, 2.41, 0.167, 222, 198, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4933, p6bgoY_, 0.7245, 2.41, 0.167, 222, 198, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4934, p6bgob_, 0.7245, 2.41, 0.167, 222, 198, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4935, p6bgoa_, 0.7245, 2.41, 0.167, 222, 198, SINGLY PAFE-CAPPED 20S CP IN MYCOBACTERIUM TUBERCULOSIS
4936, p6bglR_, 0.7245, 2.41, 0.167, 222, 198, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4937, p6bglb_, 0.7245, 2.41, 0.167, 222, 198, DOUBLY PAFE-CAPPED 20S CORE PARTICLE IN MYCOBACTERIUM TUBERCULOSIS
4938, d5trgM_, 0.7245, 2.40, 0.167, 222, 198, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4939, p5lzpL_, 0.7245, 2.41, 0.162, 222, 198, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4940, d5ts0J_, 0.7244, 2.41, 0.167, 222, 198, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4941, d3krdN_, 0.7244, 2.41, 0.167, 222, 198, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
4942, p3jtlN_, 0.7243, 2.26, 0.224, 203, 192, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4943, p3jtlH_, 0.7243, 2.25, 0.224, 203, 192, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4944, d5ts0X_, 0.7242, 2.41, 0.167, 222, 198, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2208
4945, d5thoN_, 0.7242, 2.40, 0.167, 222, 198, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4946, d3krdJ_, 0.7242, 2.41, 0.167, 222, 198, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
4947, p3jtlJ_, 0.7242, 2.25, 0.224, 203, 192, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4948, p3jtlI_, 0.7242, 2.26, 0.224, 203, 192, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4949, d5trsX_, 0.7241, 2.41, 0.167, 222, 198, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4950, d5trsM_, 0.7241, 2.41, 0.167, 222, 198, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4951, d5trsJ_, 0.7241, 2.41, 0.167, 222, 198, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2144
4952, p3jtlM_, 0.7241, 2.26, 0.224, 203, 192, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4953, p3jtlL_, 0.7241, 2.26, 0.224, 203, 192, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4954, p3jtlK_, 0.7241, 2.26, 0.224, 203, 192, CRYSTAL STRUCTURE OF ARCHAEAL 20S PROTEASOME IN COMPLEX WITH MUTATED P26 ACTIVATOR
4955, d5trrX_, 0.7240, 2.41, 0.167, 222, 198, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4956, d5trrJ_, 0.7240, 2.40, 0.167, 222, 198, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2169
4957, d3mi0P_, 0.7240, 2.40, 0.167, 222, 198, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME AT 2.2 A
4958, d5tryM_, 0.7239, 2.41, 0.167, 222, 198, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4959, d5tryX_, 0.7237, 2.42, 0.167, 222, 198, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4960, d5trgZ_, 0.7237, 2.40, 0.167, 222, 198, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4961, d3krdC_, 0.7237, 2.42, 0.167, 222, 198, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
4962, d5thoX_, 0.7235, 2.42, 0.167, 222, 198, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4963, d5thoJ_, 0.7235, 2.41, 0.167, 222, 198, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH NC-CAPPED DIPEPTIDE INHIBITOR PKS2205
4964, d3krdX_, 0.7234, 2.42, 0.167, 222, 198, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
4965, d3krdL_, 0.7233, 2.42, 0.167, 222, 198, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
4966, d3krdG_, 0.7233, 2.42, 0.167, 222, 198, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
4967, d5d0vK_, 0.7232, 3.11, 0.178, 218, 202, YEAST 20S PROTEASOME BETA5-T1C MUTANT IN COMPLEX WITH CARFILZOMIB
4968, p5lzpN_, 0.7231, 2.36, 0.162, 221, 197, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4969, d3krdH_, 0.7230, 2.43, 0.167, 222, 198, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
4970, p5lzpP_, 0.7229, 2.38, 0.162, 221, 197, BINDING OF THE C-TERMINAL GQYL MOTIF OF THE BACTERIAL PROTEASOME ACTIVATOR BPA TO THE 20S PROTEASOME
4971, d5fgfK_, 0.7229, 2.88, 0.185, 214, 200, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
4972, d3krdZ_, 0.7228, 2.43, 0.167, 222, 198, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
4973, d3krdT_, 0.7227, 2.43, 0.167, 222, 198, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
4974, d5trgJ_, 0.7226, 2.42, 0.167, 222, 198, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE DPLG-2
4975, d5fgfY_, 0.7226, 2.88, 0.185, 214, 200, YEAST 20S PROTEASOME BETA5-H(-2)A-T1A-K81R TRIPLE MUTANT IN COMPLEX WITH CARFILZOMIB
4976, d1j2qN_, 0.7226, 2.46, 0.238, 202, 193, 20S PROTEASOME IN COMPLEX WITH CALPAIN-INHIBITOR I FROM ARCHAEOGLOBUS FULGIDUS
4977, d3krd2_, 0.7225, 2.43, 0.167, 222, 198, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
4978, d1j2qM_, 0.7225, 2.46, 0.238, 202, 193, 20S PROTEASOME IN COMPLEX WITH CALPAIN-INHIBITOR I FROM ARCHAEOGLOBUS FULGIDUS
4979, d1j2qJ_, 0.7225, 2.46, 0.238, 202, 193, 20S PROTEASOME IN COMPLEX WITH CALPAIN-INHIBITOR I FROM ARCHAEOGLOBUS FULGIDUS
4980, d1j2qI_, 0.7225, 2.46, 0.238, 202, 193, 20S PROTEASOME IN COMPLEX WITH CALPAIN-INHIBITOR I FROM ARCHAEOGLOBUS FULGIDUS
4981, d1j2qL_, 0.7224, 2.46, 0.238, 202, 193, 20S PROTEASOME IN COMPLEX WITH CALPAIN-INHIBITOR I FROM ARCHAEOGLOBUS FULGIDUS
4982, d1j2qH_, 0.7224, 2.46, 0.238, 202, 193, 20S PROTEASOME IN COMPLEX WITH CALPAIN-INHIBITOR I FROM ARCHAEOGLOBUS FULGIDUS
4983, d5tryJ_, 0.7223, 2.43, 0.167, 222, 198, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH N C-CAPPED DIPEPTIDE PKS2206
4984, d1j2qK_, 0.7223, 2.46, 0.238, 202, 193, 20S PROTEASOME IN COMPLEX WITH CALPAIN-INHIBITOR I FROM ARCHAEOGLOBUS FULGIDUS
4985, d5fgiN_, 0.7221, 3.00, 0.151, 213, 199, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
4986, d3mkaX_, 0.7221, 3.30, 0.163, 249, 208, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME WITH PROPETIDE AND AN T1A MUTATION AT BETA-SUBUNIT
4987, p5fgib_, 0.7220, 3.00, 0.151, 213, 199, YEAST 20S PROTEASOME BETA1-T1A BETA2-T1A DOUBLE MUTANT IN COMPLEX WITH CARFILZOMIB
4988, d3krdE_, 0.7220, 2.44, 0.167, 222, 198, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
4989, d3mfeP_, 0.7219, 2.38, 0.162, 221, 197, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT WITH H0 MOVEMENT
4990, d3krdP_, 0.7216, 2.45, 0.167, 222, 198, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH FELLUTAMIDE B
4991, p4cr45_, 0.7204, 2.76, 0.165, 212, 200, DEEP CLASSIFICATION OF A LARGE CRYO-EM DATASET DEFINES THE CONFORMATIONAL LANDSCAPE OF THE 26S PROTEASOME
4992, d2fhhZ_, 0.7202, 2.46, 0.167, 222, 198, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
4993, d2fhhX_, 0.7202, 2.47, 0.167, 222, 198, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
4994, d2fhhG_, 0.7202, 2.47, 0.167, 222, 198, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
4995, d2fhhC_, 0.7202, 2.46, 0.167, 222, 198, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
4996, d3mfeC_, 0.7201, 2.40, 0.162, 221, 197, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME OPEN-GATE MUTANT WITH H0 MOVEMENT
4997, d2fhhR_, 0.7201, 2.47, 0.167, 222, 198, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
4998, d2fhhP_, 0.7200, 2.47, 0.167, 222, 198, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
4999, d2fhhN_, 0.7200, 2.47, 0.167, 222, 198, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
5000, d2fhhJ_, 0.7200, 2.47, 0.167, 222, 198, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS PROTEASOME IN COMPLEX WITH A PEPTIDYL BORONATE INHIBITOR MLN-273
